• Ashmore-Harris, C., Blackford, S.J., Grimsdell, B., Kurtys, E., Glatz, M.C., Rashid, T.S., Fruhwirth, G.O., 2019. Reporter gene-engineering of human induced pluripotent stem cells during differentiation renders in vivo traceable hepatocyte-like cells accessible. Stem Cell Res 41. [PMID: 31707210] 
• Banaszek, A., Bumm, T.G.P., Nowotny, B., Geis, M., Jacob, K., Wölfl, M., Trebing, J., Kucka, K., Kouhestani, D., Gogishvili, T., Krenz, B., Lutz, J., Rasche, L., Hönemann, D., Neuweiler, H., Heiby, J.C., Bargou, R.C., Wajant, H., Einsele, H., Riethmüller, G., Stuhler, G., 2019. On-target restoration of a split T cell-engaging antibody for precision immunotherapy. Nat Commun 10. [PMID: 31772172] 
• Begum, H.M., Ta, H.P., Zhou, H., Ando, Y., Kang, D., Nemes, K., Mariano, C.F., Hao, J., Yu, M., Shen, K., 2019. Spatial Regulation of Mitochondrial Heterogeneity by Stromal Confinement in Micropatterned Tumor Models. Sci Rep 9. [PMID: 31371796]
• Benabdallah, B., Désaulniers-Langevin, C., Colas, C., Li, Y., Rousseau, G., Guimond, J.V., Haddad, E., Beauséjour, C., 2019. Natural Killer Cells Prevent the Formation of Teratomas Derived From Human Induced Pluripotent Stem Cells. Front Immunol 10. [PMID: 31787975]
• Bryant, J., Batis, N., Franke, A.C., Clancey, G., Hartley, M., Ryan, G., Brooks, J., Southam, A.D., Barnes, N., Parish, J., Roberts, S., Khanim, F., Spruce, R., Mehanna, H., 2019. Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma. Oncotarget 10, 5229–5244. [PMID: 31497252]
• Caposio, P., van den Worm, S., Crawford, L., Perez, W., Kreklywich, C., Gilbride, R.M., Hughes, C.M., Ventura, A.B., Ratts, R., Marshall, E.E., Malouli, D., Axthelm, M.K., Streblow, D., Nelson, J.A., Picker, L.J., Hansen, S.G., Früh, K., 2019. Characterization of a live-attenuated HCMV-based vaccine platform. Sci Rep 9. [PMID: 31848362]
• Carpenter, R.S., Jiang, R.R., Brennan, F.H., Hall, J.C.E., Gottipati, M.K., Niewiesk, S., Popovich P.G. Human immune cells infiltrate the spinal cord and impair recovery after spinal cord injury in humanized mice [PMID: 31836828]
• Chagraoui, J., Lehnertz, B., Girard, S., Spinella, J.F., Fares, I., Tomellini, E., Mayotte, N., Corneau, S., MacRae, T., Simon, L., Sauvageau, G., 2019. UM171 induces a homeostatic inflammatory-detoxification response supporting human HSC self-renewal. PLoS One 14. [PMID: 31703090]
• Clark, A.Y., Martin, K.E., García, J.R., Johnson, C.T., Theriault, H.S., Han, W.M., Zhou, D.W., Botchwey, E.A., García, A.J., 2020. Integrin-specific hydrogels modulate transplanted human bone marrow-derived mesenchymal stem cell survival, engraftment, and reparative activities. Nat Commun 11. [PMID: 31913286]
• Crowell, P.D., Fox, J.J., Hashimoto, T., Diaz, J.A., Navarro, H.I., Henry, G.H., Feldmar, B.A., Lowe, M.G., Garcia, A.J., Wu, Y.E., Sajed, D.P., Strand, D.W., Goldstein, A.S., 2019. Expansion of Luminal Progenitor Cells in the Aging Mouse and Human Prostate. Cell Rep 28, 1499-1510.e6. [PMID: 31390564]
• Do Sacramento, V., Mallo, L., Freund, M., Eckly, A., Hechler, B., Mangin, P., Lanza, F., Gachet, C., Strassel, C., 2020. Functional properties of human platelets derived in vitro from CD34+ cells. Sci Rep 10. [PMID: 31969609]
• Durand, S., Pierre-Eugène, C., Mirabeau, O., Louis-Brennetot, C., Combaret, V., Colmet-Daage, L., Blanchard, O., Bellini, A., Daudigeos-Dubus, E., Raynal, V., Schleiermacher, G., Baulande, S., Delattre, O., Janoueix-Lerosey, I., 2019. ALK mutation dynamics and clonal evolution in a neuroblastoma model exhibiting two ALK mutations. Oncotarget 10, 4937–4950. [PMID: 31452835]
• Escudero-Pérez, B., Ruibal, P., Rottstegge, M., Lüdtke, A., Port, J.R., Hartmann, K., Gómez-Medina, S., Müller-Guhl, J., Nelson, E.V., Krasemann, S., Rodríguez, E., Muñoz-Fontela, C., 2019. Comparative pathogenesis of Ebola virus and Reston virus infection in humanized mice. JCI Insight. [PMID: 31550241]
• Fons, N.R., Sundaram, R.K., Breuer, G.A., Peng, S., McLean, R.L., Kalathil, A.N., Schmidt, M.S., Carvalho, D.M., Mackay, A., Jones, C., Carcaboso, Á.M., Nazarian, J., Berens, M.E., Brenner, C., Bindra, R.S., 2019. PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma. Nat Commun 10. [PMID: 31439867]
• Galli, V., Nixon, C.C., Strbo, N., Artesi, M., de Castro-Amarante, M.F., McKinnon, K., Fujikawa, D., Omsland, M., Washington-Parks, R., Romero, L., Caruso, B., Durkin, K., Brown, S., Karim, B., Vaccari, M., Jacobson, S., Zack, J.A., Van den Broeke, A., Pise-Masison, C., Franchini, G., 2019. Essential Role of Human T Cell Leukemia Virus Type 1 orf-I in Lethal Proliferation of CD4+ Cells in Humanized Mice. J. Virol. 93. [PMID: 31315992]
• Ghandhi, S.A., Smilenov, L., Shuryak, I., Pujol-Canadell, M., Amundson, S.A., 2019. Discordant gene responses to radiation in humans and mice and the role of hematopoietically humanized mice in the search for radiation biomarkers. Sci Rep 9. [PMID: 31857640]
• Gomes, C.P., Nóbrega-Pereira, S., Domingues-Silva, B., Rebelo, K., Alves-Vale, C., Marinho, S.P., Carvalho, T., Dias, S., Bernardes de Jesus, B., 2019. An antisense transcript mediates MALAT1 response in human breast cancer. BMC Cancer 19. [PMID: 31382922]
• Gomez-Ospina, N., Scharenberg, S.G., Mostrel, N., Bak, R.O., Mantri, S., Quadros, R.M., Gurumurthy, C.B., Lee, C., Bao, G., Suarez, C.J., Khan, S., Sawamoto, K., Tomatsu, S., Raj, N., Attardi, L.D., Aurelian, L., Porteus, M.H., 2019. Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I. Nat Commun 10. [PMID: 31492863]
• Habiel, D.M., Hohmann, M.S., Espindola, M.S., Coelho, A.L., Jones, I., Jones, H., Carnibella, R., Pinar, I., Werdiger, F., Hogaboam, C.M., 2019. DNA-PKcs modulates progenitor cell proliferation and fibroblast senescence in idiopathic pulmonary fibrosis. BMC Pulm Med 19. [PMID: 31464599]
• Harnoss, J.M., Le Thomas, A., Shemorry, A., Marsters, S.A., Lawrence, D.A., Lu, M., Chen, Y.-C.A., Qing, J., Totpal, K., Kan, D., Segal, E., Merchant, M., Reichelt, M., Ackerly Wallweber, H., Wang, W., Clark, K., Kaufman, S., Beresini, M.H., Laing, S.T., Sandoval, W., Lorenzo, M., Wu, J., Ly, J., De Bruyn, T., Heidersbach, A., Haley, B., Gogineni, A., Weimer, R.M., Lee, D., Braun, M.-G., Rudolph, J., VanWyngarden, M.J., Sherbenou, D.W., Gomez-Bougie, P., Amiot, M., Acosta-Alvear, D., Walter, P., Ashkenazi, A., 2019. Disruption of IRE1α through its kinase domain attenuates multiple myeloma. Proc Natl Acad Sci U S A 116, 16420–16429. [PMID: 31371506]
• Iliopoulou, B.P., Hsu, K., Pérez-Cruz, M., Tang, S.-W., Pang, W.W., Erkers, T., Kambham, N., Freeman, G.J., Dekruyff, R.H., Meyer, E.H., 2019. Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation. Blood Adv 3, 3419–3431. [PMID: 31714958]
• Jodeleit, H., Caesar, J., Villarroel Aguilera, C., Sterz, S., Holdt, L., Beigel, F., Stallhofer, J., Breiteneicher, S., Bartnik, E., Siebeck, M., Gropp, R., 2019. The Combination of Patient Profiling and Preclinical Studies in a Mouse Model Based on NOD/Scid IL2Rγ null Mice Reconstituted With Peripheral Blood Mononuclear Cells From Patients With Ulcerative Colitis May Lead to Stratification of Patients for Treatment With Adalimumab. Inflamm. Bowel Dis. [PMID: 31782956]
• Kalscheuer, S., Khanna, V., Kim, H., Li, S., Sachdev, D., DeCarlo, A., Yang, D., Panyam, J., 2019. Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer. Sci Rep 9, 1–11. [PMID: 31462656]
• Kannan, A., Philley, J.V., Hertweck, K.L., Ndetan, H., Singh, K.P., Sivakumar, S., Wells, R.B., Vadlamudi, R.K., Dasgupta, S., 2019. Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles. Sci Rep 9. [PMID: 31406142]
• Khosravi-Maharlooei, M., Hoelzl, M., Li, H., Madley, R., Waffarn, E., Danzl, N., Sykes, M., 2019. Rapid thymectomy of NSG mice to analyze the role of native and grafted thymi in humanized mice. Eur. J. Immunol. [PMID: 31583677]
• Kumar, P., Lele, S.S., Ragothaman, V.K., Raghunathan, D., Epstein, A.L., Chiba, S., Prabhakar, B.S., 2019. OX40L-JAG1-Induced Expansion of Lineage-Stable Regulatory T Cells Involves Noncanonical NF-κB Signaling. J. Immunol. 203, 3225–3236. [PMID: 31704879]
• Lam, N., Trinklein, N.D., Buelow, B., Patterson, G.H., Ojha, N., Kochenderfer, J.N., 2020. Anti-BCMA chimeric antigen receptors with fully human heavy-chain-only antigen recognition domains. Nat Commun 11. [PMID: 31941907]
• Manshouri, T., Verstovsek, S., Harris, D.M., Veletic, I., Zhang, X., Post, S.M., Bueso-Ramos, C.E., Estrov, Z., 2019. Primary myelofibrosis marrow-derived CD14+/CD34- monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes. PLoS ONE 14, e0222912. [PMID: 31569199]
• Marcinkowski, B., Stevanović, S., Helman, S.R., Norberg, S.M., Serna, C., Jin, B., Gkitsas, N., Kadakia, T., Warner, A., Davis, J.L., Rooper, L., Hinrichs, C.S., 2019. Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1. J Immunother Cancer 7. [PMID: 31406142]
• Mihaylova, N., Chipinski, P., Bradyanova, S., Velikova, T., Ivanova-Todorova, E., Chausheva, S., Herbáth, M., Kalinova, D., Prechl, J., Kyurkchiev, D., Tchorbanov, A.I., 2019. Suppression of autoreactive T and B lymphocytes by anti-annexin A1 antibody in a humanized NSG murine model of systemic lupus erythematosus. Clin. Exp. Immunol. [PMID: 31724735]
• Mistry, J.J., Marlein, C.R., Moore, J.A., Hellmich, C., Wojtowicz, E.E., Smith, J.G.W., Macaulay, I., Sun, Y., Morfakis, A., Patterson, A., Horton, R.H., Divekar, D., Morris, C.J., Haestier, A., Di Palma, F., Beraza, N., Bowles, K.M., Rushworth, S.A., 2019. ROS-mediated PI3K activation drives mitochondrial transfer from stromal cells to hematopoietic stem cells in response to infection. Proc Natl Acad Sci U S A 116, 24610–24619. [PMID: 31727843]
• Mohanty, S., Aghighi, M., Yerneni, K., Theruvath, J.L., Daldrup-Link, H.E., 2019. Improving the efficacy of osteosarcoma therapy: combining drugs that turn cancer cell “don’t eat me” signals off and “eat me” signals on. Mol Oncol.[PMID: 31376208]
• Nanni, P., Landuzzi, L., Manara, M.C., Righi, A., Nicoletti, G., Cristalli, C., Pasello, M., Parra, A., Carrabotta, M., Ferracin, M., Palladini, A., Ianzano, M.L., Giusti, V., Ruzzi, F., Magnani, M., Donati, D.M., Picci, P., Lollini, P.-L., Scotlandi, K., 2019. Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations. Sci Rep 9. [PMID: 31434953 ]
• Nowlan, B., Williams, E.D., Doran, M.R., Levesque, J.-P., 2020. CD27, CD201, FLT3, CD48, and CD150 cell surface staining identifies long-term mouse hematopoietic stem cells in immunodeficient non-obese diabetic severe combined immune deficient-derived strains. Haematologica 105, 71–82. [PMID: 31073070]
• Oellerich, T., Schneider, C., Thomas, D., Knecht, K.M., Buzovetsky, O., Kaderali, L., Schliemann, C., Bohnenberger, H., Angenendt, L., Hartmann, W., Wardelmann, E., Rothenburger, T., Mohr, S., Scheich, S., Comoglio, F., Wilke, A., Ströbel, P., Serve, H., Michaelis, M., Ferreirós, N., Geisslinger, G., Xiong, Y., Keppler, O.T., Cinatl, J., 2019. Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML. Nat Commun 10. [PMID: 31375673]
• Okada, S., Vaeteewoottacharn, K., Kariya, R., 2019. Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models. Cells 8. [PMID: 31412684]
• Park, S.H., Lee, C.M., Dever, D.P., Davis, T.H., Camarena, J., Srifa, W., Zhang, Y., Paikari, A., Chang, A.K., Porteus, M.H., Sheehan, V.A., Bao, G., 2019. Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease. Nucleic Acids Res. 47, 7955–7972. [PMID: 31147717]
• Petrillo, C., Calabria, A., Piras, F., Capotondo, A., Spinozzi, G., Cuccovillo, I., Benedicenti, F., Naldini, L., Montini, E., Biffi, A., Gentner, B., Kajaste-Rudnitski, A., 2019. Assessing the Impact of Cyclosporin A on Lentiviral Transduction and Preservation of Human Hematopoietic Stem Cells in Clinically Relevant Ex Vivo Gene Therapy Settings. Hum Gene Ther 30, 1133–1146. [PMID: 31037976]
• Petrovic, K., Robinson, J., Whitworth, K., Jinks, E., Shaaban, A., Lee, S.P., 2019. TEM8/ANTXR1-specific CAR T cells mediate toxicity in vivo. PLoS ONE 14, e0224015. [PMID: 31622431]
• Ramani, V.C., Lemaire, C.A., Triboulet, M., Casey, K.M., Heirich, K., Renier, C., Vilches-Moure, J.G., Gupta, R., Razmara, A.M., Zhang, H., Sledge, G.W., Sollier, E., Jeffrey, S.S., 2019. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer. Breast Cancer Res 21. [PMID: 31462307]
• Sachdeva, M., Busser, B.W., Temburni, S., Jahangiri, B., Gautron, A.-S., Maréchal, A., Juillerat, A., Williams, A., Depil, S., Duchateau, P., Poirot, L., Valton, J., 2019. Repurposing endogenous immune pathways to tailor and control chimeric antigen receptor T cell functionality. Nat Commun 10. [PMID: 31723132]
• Saenz, F., Ory, V., Schmidt, M., Kallakury, B., Mueller, S., Furth, P., Wellstein, A., Riegel, A., 2019. Depletion of the Transcriptional Coactivator Amplified in Breast Cancer 1 (AIB1) Uncovers Functionally Distinct Subpopulations in Triple-Negative Breast Cancer. Neoplasia 21, 963–973. [PMID: 31437536]
• Selvaraj, S., Mondragon-Gonzalez, R., Xu, B., Magli, A., Kim, H., Lainé, J., Kiley, J., Mckee, H., Rinaldi, F., Aho, J., Tabti, N., Shen, W., Perlingeiro, R.C., n.d. Screening identifies small molecules that enhance the maturation of human pluripotent stem cell-derived myotubes. eLife 8. [PMID: 31710288]
• Takei, Y., Nemoto, Y., Morikawa, R., Tanaka, S., Oshima, S., Nagaishi, T., Okamoto, R., Tsuchiya, K., Nakamura, T., Watanabe, M., 2019. CD8αα+ T cells show amoeboid shape and frequent morphological change in vitro, and localize to small intestinal intraepithelial region in vivo. Biochem. Biophys. Res. Commun. [PMID: 31864702]
• Tan, M.S.Y., Sandanaraj, E., Chong, Y.K., Lim, S.W., Koh, L.W.H., Ng, W.H., Tan, N.S., Tan, P., Ang, B.T., Tang, C., 2019. A STAT3-based gene signature stratifies glioma patients for targeted therapy. Nat Commun 10. [PMID: 31399589]
• Torres Chavez, A., McKenna, M.K., Canestrari, E., Dann, C.T., Ramos, C.A., Lulla, P., Leen, A.M., Vera, J.F., Watanabe, N., 2019. Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity. J Immunother Cancer 7. [PMID: 31779709]
• Ursu, S., Majid, S., Garger, C., de Semir, D., Bezrookove, V., Desprez, P.-Y., McAllister, S., Soroceanu, L., Nosrati, M., Yimam, K., Hassoun, A., Osorio, R., Kashani-Sabet, M., Dar, A.A., 2019. Novel tumor suppressor role of miRNA-876 in cholangiocarcinoma. Oncogenesis 8. [PMID: 31409772]
• Vela, M., Bueno, D., González-Navarro, P., Brito, A., Fernández, L., Escudero, A., Valentín, J., Mestre-Durán, C., Arranz-Álvarez, M., Pérez de Diego, R., Mendiola, M., Pozo-Kreilinger, J.J., Pérez-Martínez, A., 2019. Anti-CXCR4 Antibody Combined With Activated and Expanded Natural Killer Cells for Sarcoma Immunotherapy. Front Immunol 10. [PMID: 31428099]
• Ventura, J.D., Beloor, J., Allen, E., Zhang, T., Haugh, K.A., Uchil, P.D., Ochsenbauer, C., Kieffer, C., Kumar, P., Hope, T.J., Mothes, W., 2019. Longitudinal bioluminescent imaging of HIV-1 infection during antiretroviral therapy and treatment interruption in humanized mice. PLoS Pathog 15. [PMID: 31805155]
• Voets, E., Paradé, M., Lutje Hulsik, D., Spijkers, S., Janssen, W., Rens, J., Reinieren-Beeren, I., van den Tillaart, G., van Duijnhoven, S., Driessen, L., Habraken, M., van Zandvoort, P., Kreijtz, J., Vink, P., van Elsas, A., van Eenennaam, H., 2019. Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint. J Immunother Cancer 7. [PMID: 31801627]
• Wagenblast, E., Azkanaz, M., Smith, S.A., Shakib, L., McLeod, J.L., Krivdova, G., Araújo, J., Shultz, L.D., Gan, O.I., Dick, J.E., Lechman, E.R., 2019. Functional profiling of single CRISPR/Cas9-edited human long-term hematopoietic stem cells. Nat Commun 10. [PMID: 31628330]
• Weishaupt, C., Steinert, M., Brunner, G., Schulze, H.-J., Fuhlbrigge, R.C., Goerge, T., Loser, K., n.d. Activation of human vascular endothelium in melanoma metastases induces ICAM-1 and E-selectin expression and results in increased infiltration with effector lymphocytes. Experimental Dermatology 0. [PMID: 31444891]
• Xie, S.Z., Garcia-Prat, L., Voisin, V., Ferrari, R., Gan, O.I., Wagenblast, E., Kaufmann, K.B., Zeng, A.G.X., Takayanagi, S., Patel, I., Lee, E.K., Jargstorf, J., Holmes, G., Romm, G., Pan, K., Shoong, M., Vedi, A., Luberto, C., Minden, M.D., Bader, G.D., Laurenti, E., Dick, J.E., 2019. Sphingolipid Modulation Activates Proteostasis Programs to Govern Human Hematopoietic Stem Cell Self-Renewal. Cell Stem Cell 25, 639-653.e7. [PMID: 31631013]
• Yun, H.D., Schirm, D.K., Felices, M., Miller, J.S., Eckfeldt, C.E., 2019. Dinaciclib enhances natural killer cell cytotoxicity against acute myelogenous leukemia. Blood Adv 3, 2448–2452. [PMID: 31416822]
• Zhang, X., Feng, J., Chen, S., Yang, H., Dong, Z., 2019. Synergized regulation of NK cell education by NKG2A and specific Ly49 family members. Nat Commun 10. [PMID: 31676749]

• An, Q., Hu, Y., Li, Q., Chen, X., Huang, J., Pellegrini, M., Zhou, X.J., Rettig, M., Fan, G., 2019. The size of cell-free mitochondrial DNA in blood is inversely correlated with tumor burden in cancer patients. Precis Clin Med 2, 131–139. [PMID: 31598384] 
• Andrews, A.R., Wang, Z., Wilkinson, R.A., Fishman, J.A., Sachs, D.H., Navarro-Alvarez, N., Huang, C.A., 2019. Development of transplantable B-cell lymphomas in the MHC-defined miniature swine model. Cancer Cell Int 19. [PMID: 31516393]
• Bi, J., Yang, S., Li, L., Dai, Q., Borcherding, N., Wagner, B.A., Buettner, G.R., Spitz, D.R., Leslie, K.K., Zhang, J., Meng, X., 2019. Metadherin enhances vulnerability of cancer cells to ferroptosis. Cell Death Dis 10. [PMID: 31527591]
• Caeser, R., Di Re, M., Krupka, J.A., Gao, J., Lara-Chica, M., Dias, J.M.L., Cooke, S.L., Fenner, R., Usheva, Z., Runge, H.F.P., Beer, P.A., Eldaly, H., Pak, H.-K., Park, C.-S., Vassiliou, G.S., Huntly, B.J.P., Mupo, A., Bashford-Rogers, R.J.M., Hodson, D.J., 2019. Genetic modification of primary human B cells to model high-grade lymphoma. Nat Commun 10. [PMID: 31586074]
• Cai, D., Wang, J., Gao, B., Li, J., Wu, F., Zou, J.X., Xu, J., Jiang, Y., Zou, H., Huang, Z., Borowsky, A.D., Bold, R.J., Lara, P.N., Li, J.J., Chen, X., Lam, K.S., To, K.-F., Kung, H.-J., Fiehn, O., Zhao, R., Evans, R.M., Chen, H.-W., 2019. RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype. Nat Commun 10. [PMID: 31604910]
• Cen, B., Lang, J.D., Du, Y., Wei, J., Xiong, Y., Bradley, N., Wang, D., DuBois, R.N., 2019. Prostaglandin E2 Induces MIR675-5p to Promote Colorectal Tumor Metastasis via Modulation of p53 Expression. Gastroenterology. [PMID: 31734182]
• Chahal, K.K., Li, J., Kufareva, I., Parle, M., Durden, D.L., Wechsler-Reya, R.J., Chen, C.C., Abagyan, R., 2019. Nilotinib, an approved leukemia drug, inhibits smoothened signaling in Hedgehog-dependent medulloblastoma. PLoS One 14. [PMID: 31539380]
• Cournoyer, S., Addioui, A., Belounis, A., Beaunoyer, M., Nyalendo, C., Le Gall, R., Teira, P., Haddad, E., Vassal, G., Sartelet, H., 2019. GX15–070 (Obatoclax), a Bcl-2 family proteins inhibitor engenders apoptosis and pro-survival autophagy and increases Chemosensitivity in neuroblastoma. BMC Cancer 19. [PMID: 31664947]
• Crawford, L.B., Caposio, P., Kreklywich, C., Pham, A.H., Hancock, M.H., Jones, T.A., Smith, P.P., Yurochko, A.D., Nelson, J.A., Streblow, D.N., 2019. Human Cytomegalovirus US28 Ligand Binding Activity Is Required for Latency in CD34+ Hematopoietic Progenitor Cells and Humanized NSG Mice. mBio 10. [PMID: 31431555]
• Dandawate, P., Kaushik, G., Ghosh, C., Standing, D., Sayed, A.A.A., Choudhury, S., Subramaniam, D., Manzardo, A., Banerjee, T., Santra, S., Ramamoorthy, P., Butler, M., Padhye, S.B., Baranda, J., Kasi, A., Sun, W., Tawfik, O., Coppola, D., Malafa, M., Umar, S., Soares, M.J., Saha, S., Weir, S.J., Dhar, A., Jensen, R.A., Thomas, S.M., Anant, S., 2019. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice. Gastroenterology. [PMID: 31786131]
• Ding, L., Su, Y., Fassl, A., Hinohara, K., Qiu, X., Harper, N.W., Huh, S.J., Bloushtain-Qimron, N., Jovanović, B., Ekram, M., Zi, X., Hines, W.C., Alečković, M., Gil del Alcazar, C., Caulfield, R.J., Bonal, D.M., Nguyen, Q.-D., Merino, V.F., Choudhury, S., Ethington, G., Panos, L., Grant, M., Herlihy, W., Au, A., Rosson, G.D., Argani, P., Richardson, A.L., Dillon, D., Allred, D.C., Babski, K., Kim, E.M.H., McDonnell, C.H., Wagner, J., Rowberry, R., Bobolis, K., Kleer, C.G., Hwang, E.S., Blum, J.L., Cristea, S., Sicinski, P., Fan, R., Long, H.W., Sukumar, S., Park, S.Y., Garber, J.E., Bissell, M., Yao, J., Polyak, K., 2019. Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ. Nat Commun 10. [PMID: 31519911]
• Eyre, R., Alférez, D.G., Santiago-Gómez, A., Spence, K., McConnell, J.C., Hart, C., Simões, B.M., Lefley, D., Tulotta, C., Storer, J., Gurney, A., Clarke, N., Brown, M., Howell, S.J., Sims, A.H., Farnie, G., Ottewell, P.D., Clarke, R.B., 2019. Microenvironmental IL1β promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling. Nat Commun 10. [PMID: 31676788]
• Farr Zuend, C., Nomellini, J.F., Smit, J., Horwitz, M.S., 2019. A Caulobacter crescentus Microbicide Protects from Vaginal Infection with HIV-1JR-CSF in Humanized Bone Marrow-Liver-Thymus Mice. J Virol 93. [PMID: 31243127]
• Gooding, S., Olechnowicz, S.W.Z., Morris, E.V., Armitage, A.E., Arezes, J., Frost, J., Repapi, E., Edwards, J.R., Ashley, N., Waugh, C., Gray, N., Martinez-Hackert, E., Lim, P.J., Pasricha, S.-R., Knowles, H., Mead, A.J., Ramasamy, K., Drakesmith, H., Edwards, C.M., 2019. Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease. Nat Commun 10. [PMID: 31586071]
• Green, R., Howell, M., Khalil, R., Nair, R., Yan, J., Foran, E., Katiri, S., Banerjee, J., Singh, M., Bharadwaj, S., Mohapatra, S.S., Mohapatra, S., 2019. Actinomycin D and Telmisartan Combination Targets Lung Cancer Stem Cells Through the Wnt/Beta Catenin Pathway. Sci Rep 9. [PMID: 31796785]
• Hayashi, Y., Goyama, S., Liu, X., Tamura, M., Asada, S., Tanaka, Y., Fukuyama, T., Wunderlich, M., O’Brien, E., Mizukawa, B., Yamazaki, S., Matsumoto, A., Yamasaki, S., Shibata, T., Matsuda, K., Sashida, G., Takizawa, H., Kitamura, T., 2019. Antitumor immunity augments the therapeutic effects of p53 activation on acute myeloid leukemia. Nat Commun 10. [PMID: 31653912]
• Heather, J.M., Myers, P.T., Shi, F., Aziz-Zanjani, M.O., Mahoney, K.E., Perez, M., Morin, B., Brittsan, C., Shabanowitz, J., Hunt, D.F., Cobbold, M., 2019. Murine xenograft bioreactors for human immunopeptidome discovery. Sci Rep 9. [PMID: 31811195][PMID: 31811195]
• Huang, M., Tailor, J., Zhen, Q., Gillmor, A.H., Miller, M.L., Weishaupt, H., Chen, J., Zheng, T., Nash, E.K., McHenry, L.K., An, Z., Ye, F., Takashima, Y., Clarke, J., Ayetey, H., Cavalli, F.M.G., Luu, B., Moriarity, B.S., Ilkhanizadeh, S., Chavez, L., Yu, C., Kurian, K.M., Magnaldo, T., Sevenet, N., Koch, P., Pollard, S.M., Dirks, P., Snyder, M.P., Largaespada, D.A., Cho, Y.J., Phillips, J.J., Swartling, F.J., Morrissy, A.S., Kool, M., Pfister, S.M., Taylor, M.D., Smith, A., Weiss, W.A., 2019. Engineering Genetic Predisposition in Human Neuroepithelial Stem Cells Recapitulates Medulloblastoma Tumorigenesis. Cell Stem Cell 25, 433-446.e7. [PMID: 31204176]
• Kierkels, G.J.J., Scheper, W., Meringa, A.D., Johanna, I., Beringer, D.X., Janssen, A., Schiffler, M., Aarts-Riemens, T., Kramer, L., Straetemans, T., Heijhuurs, S., Leusen, J.H.W., San José, E., Fuchs, K., Griffioen, M., Falkenburg, J.H., Bongiovanni, L., de Bruin, A., Vargas-Diaz, D., Altelaar, M., Heck, A.J.R., Shultz, L.D., Ishikawa, F., Nishimura, M.I., Sebestyén, Z., Kuball, J., 2019. Identification of a tumor-specific allo-HLA–restricted γδTCR. Blood Adv 3, 2870–2882. [PMID: 31585951]
• Kohart, N.A., Elshafae, S.M., Supsahvad, W., Alasonyalilar-Demirer, A., Panfil, A.R., Xiang, J., Dirksen, W.P., Veis, D.J., Green, P.L., Weilbaecher, K.N., Rosol, T.J., 2019. Mouse model recapitulates the phenotypic heterogeneity of human adult T-cell leukemia/lymphoma in bone. J Bone Oncol 19, 100257. [PMID: 31871882]

• Kowolik, C.M., Lin, M., Xie, J., Overman, L.E., Horne, D.A., 2019. Attenuation of hedgehog/GLI signaling by NT1721 extends survival in pancreatic cancer. Journal of Experimental & Clinical Cancer Research : CR 38. [PMID: 31661013]

• Kuznetsov, J.N., Aguero, T.H., Owens, D.A., Kurtenbach, S., Field, M.G., Durante, M.A., Rodriguez, D.A., King, M.L., Harbour, J.W., 2019. BAP1 regulates epigenetic switch from pluripotency to differentiation in developmental lineages giving rise to BAP1-mutant cancers. Sci Adv 5. [PMID: 31555735]
• Lang, L., Shay, C., Zhao, X., Xiong, Y., Wang, X., Teng, Y., 2019. Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma. J Hematol Oncol 12. [PMID: 31805962]
• Li, J., Chen, Y., Xu, X., Jones, J., Tiwari, M., Ling, J., Wang, Y., Harismendy, O., Sen, G.L., 2019. HNRNPK maintains epidermal progenitor function through transcription of proliferation genes and degrading differentiation promoting mRNAs. Nat Commun 10. [PMID: 31519929]
• Li, X., Su, Y., Madlambayan, G., Edwards, H., Polin, L., Kushner, J., Dzinic, S.H., White, K., Ma, J., Knight, T., Wang, G., Wang, Y., Yang, J., Taub, J.W., Lin, H., Ge, Y., 2019. Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemia. Haematologica 104, 2225–2240. [PMID: 30819918]
• Lin, Q., Chen, X., Meng, F., Ogawa, K., Li, M., Song, R., Zhang, S., Zhang, Z., Kong, X., Xu, Q., He, F., Bai, X., Sun, B., Hung, M.-C., Liu, L., Wands, J., Dong, X., 2019. ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis. Mol Cancer 18. [PMID: 31694640]
• Li, Q., Liu, B., Chao, H.-P., Ji, Y., Lu, Y., Mehmood, R., Jeter, C., Chen, T., Moore, J.R., Li, W., Liu, C., Rycaj, K., Tracz, A., Kirk, J., Calhoun-Davis, T., Xiong, J., Deng, Q., Huang, J., Foster, B.A., Gokhale, A., Chen, X., Tang, D.G., 2019. LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer. Nat Commun 10. [PMID: 31792211]
• Ma, G., Yasunaga, J.-I., Ohshima, K., Matsumoto, T., Matsuoka, M., 2019. Pentosan Polysulfate Demonstrates Anti-human T-Cell Leukemia Virus Type 1 Activities In Vitro and In Vivo. J. Virol. 93. [PMID: 31167921]
• Malvi, P., Janostiak, R., Nagarajan, A., Cai, G., Wajapeyee, N., 2019. Loss of thymidine kinase 1 inhibits lung cancer growth and metastatic attributes by reducing GDF15 expression. PLoS Genet 15. [PMID: 31589613]
• Menzl, I., Zhang, T., Berger-Becvar, A., Grausenburger, R., Heller, G., Prchal-Murphy, M., Edlinger, L., Knab, V.M., Uras, I.Z., Grundschober, E., Bauer, K., Roth, M., Skucha, A., Liu, Y., Hatcher, J.M., Liang, Y., Kwiatkowski, N.P., Fux, D., Hoelbl-Kovacic, A., Kubicek, S., Melo, J.V., Valent, P., Weichhart, T., Grebien, F., Zuber, J., Gray, N.S., Sexl, V., 2019. A kinase-independent role for CDK8 in BCR-ABL1+ leukemia. Nat Commun 10. [PMID: 31628323]
• Morales, M.L., Arenas, A., Ortiz-Ruiz, A., Leivas, A., Rapado, I., Rodríguez-García, A., Castro, N., Zagorac, I., Quintela-Fandino, M., Gómez-López, G., Gallardo, M., Ayala, R., Linares, M., Martínez-López, J., 2019. MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia. Sci Rep 9. [PMID: 31819100]
• Nagatani, M., Kodera, T., Suzuki, D., Igura, S., Fukunaga, Y., Kanemitsu, H., Nakamura, D., Mochizuki, M., Kemi, M., Tamura, K., Kasahara, K., 2019. Comparison of biological features between severely immuno-deficient NOD/Shi-scid Il2rgnull and NOD/LtSz-scid Il2rgnull mice. Exp. Anim. 68, 471–482. [PMID: 31118345]
• Ogawa, K., Lin, Q., Li, L., Bai, X., Chen, X., Chen, H., Kong, R., Wang, Y., Zhu, H., He, F., Xu, Q., Liu, L., Li, M., Zhang, S., Nagaoka, K., Carlson, R., Safran, H., Charpentier, K., Sun, B., Wands, J., Dong, X., 2019. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway. J Hematol Oncol 12 [PMID: 31888763]
• Ojo, E.O., Sharma, A.A., Liu, R., Moreton, S., Checkley-Luttge, M.-A., Gupta, K., Lee, G., Lee, D.A., Otegbeye, F., Sekaly, R.-P., de Lima, M., Wald, D.N., 2019. Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells. Sci Rep 9. [PMID: 31624330]
• Phi, L.T.H., Wijaya, Y.T., Sari, I.N., Kim, K.S., Yang, Y.-G., Lee, M.-W., Kwon, H.Y., 2019. 20(R)-Ginsenoside Rg3 Influences Cancer Stem Cell Properties and the Epithelial-Mesenchymal Transition in Colorectal Cancer via the SNAIL Signaling Axis. Onco Targets Ther 12, 10885–10895. [PMID: 31849492]
• Porter, R.L., Magnus, N.K.C., Thapar, V., Morris, R., Szabolcs, A., Neyaz, A., Kulkarni, A.S., Tai, E., Chougule, A., Hillis, A., Golczer, G., Guo, H., Yamada, T., Kurokawa, T., Yashaswini, C., Ligorio, M., Vo, K.D., Nieman, L., Liss, A.S., Deshpande, V., Lawrence, M.S., Maheswaran, S., Fernandez-Del Castillo, C., Hong, T.S., Ryan, D.P., O’Dwyer, P.J., Drebin, J.A., Ferrone, C.R., Haber, D.A., Ting, D.T., 2019. Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma. Proc Natl Acad Sci U S A 116, 26835–26845. [PMID: 31843922]
• Punzi, S., Balestrieri, C., D’Alesio, C., Bossi, D., Dellino, G.I., Gatti, E., Pruneri, G., Criscitiello, C., Lovati, G., Meliksetyan, M., Carugo, A., Curigliano, G., Natoli, G., Pelicci, P.G., Lanfrancone, L., 2019. WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells. Breast Cancer Res 21. [PMID: 31752957]
• Qi, J., Hymel, D., Nelson, C.G., Burke, T.R., Rader, C., 2019. Conventional and Chemically Programmed Asymmetric Bispecific Antibodies Targeting Folate Receptor 1. Front Immunol 10. [PMID: 31497024]
• Rokita, J.L., Rathi, K.S., Cardenas, M.F., Upton, K.A., Jayaseelan, J., Cross, K.L., Pfeil, J., Egolf, L.E., Way, G.P., Farrel, A., Kendsersky, N.M., Patel, K., Gaonkar, K.S., Modi, A., Berko, E.R., Lopez, G., Vaksman, Z., Mayoh, C., Nance, J., McCoy, K., Haber, M., Evans, K., McCalmont, H., Bendak, K., Böhm, J.W., Marshall, G.M., Tyrrell, V., Kalletla, K., Braun, F.K., Qi, L., Du, Y., Zhang, H., Lindsay, H.B., Zhao, S., Shu, J., Baxter, P., Morton, C., Kurmashev, D., Zheng, S., Chen, Y., Bowen, J., Bryan, A.C., Leraas, K.M., Coppens, S.E., Doddapaneni, H., Momin, Z., Zhang, W., Sacks, G.I., Hart, L.S., Krytska, K., Mosse, Y.P., Gatto, G.J., Sanchez, Y., Greene, C.S., Diskin, S.J., Vaske, O.M., Haussler, D., Gastier-Foster, J.M., E. Anders, K., Gorlick, R., Li, X.-N., Reynolds, C.P., Kurmasheva, R.T., Houghton, P.J., Smith, M.A., Lock, R.B., Raman, P., Wheeler, D.A., Maris, J.M., 2019. Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design. Cell Rep 29, 1675-1689.e9. [PMID: 31693904]
• Sachdeva, R., Wu, M., Johnson, K., Kim, H., Celebre, A., Shahzad, U., Graham, M.S., Kessler, J.A., Chuang, J.H., Karamchandani, J., Bredel, M., Verhaak, R., Das, S., 2019. BMP signaling mediates glioma stem cell quiescence and confers treatment resistance in glioblastoma. Sci Rep 9. [PMID: 31602000]
• Salgado, M., Martinez-Picado, J., Gálvez, C., Rodríguez-Mora, S., Rivaya, B., Urrea, V., Mateos, E., Alcamí, J., Coiras, M., 2019. Dasatinib protects humanized mice from acute HIV-1 infection. Biochem. Pharmacol. 113625. [PMID: 31476293]
• Straughn, A.R., Kakar, S.S., 2019. Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signaling. J Ovarian Res 12. [PMID: 31767036]
• Tatum, J.L., Kalen, J.D., Jacobs, P.M., Ileva, L.V., Riffle, L.A., Hollingshead, M.G., Doroshow, J.H., 2019. A spontaneously metastatic model of bladder cancer: imaging characterization. J Transl Med 17. [PMID: 31878948]
• Trigg, R.M., Lee, L.C., Prokoph, N., Jahangiri, L., Reynolds, C.P., Amos Burke, G.A., Probst, N.A., Han, M., Matthews, J.D., Kai Lim, H., Manners, E., Martinez, S., Pastor, J., Blanco-Aparicio, C., Merkel, O., de los Fayos Alonso, I.G., Kodajova, P., Tangermann, S., Högler, S., Luo, J., Kenner, L., Turner, S.D., 2019. The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status. Nat Commun 10. [PMID: 31780656]
• Tsuji, T., Ozasa, H., Aoki, W., Aburaya, S., Yamamoto Funazo, T., Furugaki, K., Yoshimura, Y., Yamazoe, M., Ajimizu, H., Yasuda, Y., Nomizo, T., Yoshida, H., Sakamori, Y., Wake, H., Ueda, M., Kim, Y.H., Hirai, T., 2020. YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation. Nat Commun 11. [PMID: 31900393]
• Ulbar, F., Montemurro, T., Jofra, T., Capri, M., Comai, G., Bertuzzo, V., Lavazza, C., Mandelli, A., Viganò, M., Budelli, S., Bacalini, M.G., Pirazzini, C., Garagnani, P., Giudice, V., Sollazzo, D., Curti, A., Arpinati, M., La Manna, G., Cescon, M., Pinna, A.D., Franceschi, C., Battaglia, M., Giordano, R., Catani, L., Lemoli, R.M., 2019. Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function. J Transl Med 17. [PMID: 31383037]
• Wang, Dongdong, Naydenov, N.G., Dozmorov, M.G., Koblinski, J.E., Ivanov, A.I., 2020. Anillin regulates breast cancer cell migration, growth, and metastasis by non-canonical mechanisms involving control of cell stemness and differentiation. Breast Cancer Res 22. [PMID: 31910867]
• Wang, M., Law, M.E., Davis, B.J., Yaaghubi, E., Ghilardi, A.F., Ferreira, R.B., Chiang, C.-W., Guryanova, O.A., Kopinke, D., Heldermon, C.D., Castellano, R.K., Law, B.K., 2019. Disulfide bond-disrupting agents activate the tumor necrosis family-related apoptosis-inducing ligand/death receptor 5 pathway. Cell Death Discov 5. [PMID: 31839995]
• Watson, Z.L., Yamamoto, T.M., McMellen, A., Kim, H., Hughes, C.J., Wheeler, L.J., Post, M.D., Behbakht, K., Bitler, B.G., 2019. Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma. Clin Epigenetics 11. [PMID: 31775874]
• Weber, S., Koschade, S.E., Hoffmann, C.M., Dubash, T.D., Giessler, K.M., Dieter, S.M., Herbst, F., Glimm, H., Ball, C.R., 2019. The notch target gene HEYL modulates metastasis forming capacity of colorectal cancer patient-derived spheroid cells in vivo. BMC Cancer 19, 1181. [PMID: 31796022]
• Weinberg, B.H., Cho, J.H., Agarwal, Y., Pham, N.T.H., Caraballo, L.D., Walkosz, M., Ortega, C., Trexler, M., Tague, N., Law, B., Benman, W.K.J., Letendre, J., Beal, J., Wong, W.W., 2019. High-performance chemical- and light-inducible recombinases in mammalian cells and mice. Nat Commun 10. [PMID: 31649244]
• Wunderlich, M., Manning, N., Sexton, C., Sabulski, A., Byerly, L., O’Brien, E., Perentesis, J.P., Mizukawa, B., Mulloy, J.C., 2019. Improved chemotherapy modeling with RAG-based immune deficient mice. PLoS ONE 14, e0225532. [PMID: 31747424]
• Yang, D., Qu, F., Cai, H., Chuang, C.-H., Lim, J.S., Jahchan, N., Grüner, B.M., S Kuo, C., Kong, C., Oudin, M.J., Winslow, M.M., Sage, J., n.d. Axon-like protrusions promote small cell lung cancer migration and metastasis. eLife 8. [PMID: 31833833]
• Zhang, K., Yang, L., Wang, J., Sun, T., Guo, Y., Nelson, R., Tong, T.R., Pangeni, R., Salgia, R., Raz, D.J., 2019. Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer. Cell Commun Signal 17. [PMID: 31842906]
• Zhang, Y., Roos, M., Himburg, H., Termini, C.M., Quarmyne, M., Li, M., Zhao, L., Kan, J., Fang, T., Yan, X., Pohl, K., Diers, E., Jin Gim, H., Damoiseaux, R., Whitelegge, J., McBride, W., Jung, M.E., Chute, J.P., 2019. PTPσ inhibitors promote hematopoietic stem cell regeneration. Nat Commun 10. [PMID: 31413255]
• Zhao, B., Lin, J., Rong, L., Wu, S., Deng, Z., Fatkhutdinov, N., Zundell, J., Fukumoto, T., Liu, Q., Kossenkov, A., Jean, S., Cadungog, M.G., Borowsky, M.E., Drapkin, R., Lieberman, P.M., Abate-Shen, C.T., Zhang, R., 2019. ARID1A promotes genomic stability through protecting telomere cohesion. Nat Commun 10. [PMID: 31492885]
• Zucchini, C., Manara, M.C., Cristalli, C., Carrabotta, M., Greco, S., Pinca, R.S., Ferrari, C., Landuzzi, L., Pasello, M., Lollini, P.-L., Gambarotti, M., Donati, D.M., Scotlandi, K., 2019a. ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity. J. Exp. Clin. Cancer Res. 38, 503. [PMID: 31878963]
• Zurlo, G., Liu, X., Takada, M., Fan, C., Simon, J.M., Ptacek, T.S., Rodriguez, J., von Kriegsheim, A., Liu, J., Locasale, J.W., Robinson, A., Zhang, J., Holler, J.M., Kim, B., Zikánová, M., Bierau, J., Xie, L., Chen, X., Li, M., Perou, C.M., Zhang, Q., 2019. Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer. Nat Commun 10. [PMID: 31729379]

• Beheshti, A., Stevenson, K., Vanderburg, C., Ravi, D., McDonald, J.T., Christie, A.L., Shigemori, K., Jester, H., Weinstock, D.M., Evens, A.M., 2019. Identification of Circulating Serum Multi-MicroRNA Signatures in Human DLBCL Models. Sci Rep 9. [PMID: 31748664]
• Cardin, S., Bilodeau, M., Roussy, M., Aubert, L., Milan, T., Jouan, L., Rouette, A., Laramée, L., Gendron, P., Duchaine, J., Decaluwe, H., Spinella, J.-F., Mourad, S., Couture, F., Sinnett, D., Haddad, É., Landry, J.-R., Ma, J., Humphries, R.K., Roux, P.P., Hébert, J., Gruber, T.A., Wilhelm, B.T., Cellot, S., 2019. Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities. Blood Adv 3, 3307–3321. [PMID: 31698461]
• Choi, B.D., Yu, X., Castano, A.P., Darr, H., Henderson, D.B., Bouffard, A.A., Larson, R.C., Scarfò, I., Bailey, S.R., Gerhard, G.M., Frigault, M.J., Leick, M.B., Schmidts, A., Sagert, J.G., Curry, W.T., Carter, B.S., Maus, M.V., 2019. CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma. J Immunother Cancer 7. [PMID: 31727131] 
• Ioannidou, K., Randin, O., Semilietof, A., Maby-El Hajjami, H., Baumgaertner, P., Vanhecke, D., Speiser, D.E., 2019. Low Avidity T Cells Do Not Hinder High Avidity T Cell Responses Against Melanoma. Front Immunol 10. [PMID: 31555299]
• Jin, L., Tao, H., Karachi, A., Long, Y., Hou, A.Y., Na, M., Dyson, K.A., Grippin, A.J., Deleyrolle, L.P., Zhang, W., Rajon, D.A., Wang, Q.J., Yang, J.C., Kresak, J.L., Sayour, E.J., Rahman, M., Bova, F.J., Lin, Z., Mitchell, D.A., Huang, J., 2019. CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors. Nat Commun 10 [PMID: 31488817]
• Kametani, Y., Ohno, Y., Ohshima, S., Tsuda, B., Yasuda, A., Seki, T., Ito, R., Tokuda, Y., 2019. Humanized Mice as an Effective Evaluation System for Peptide Vaccines and Immune Checkpoint Inhibitors. Int J Mol Sci 20. [PMID: 31888191]
• Musa, J., Cidre-Aranaz, F., Aynaud, M.-M., Orth, M.F., Knott, M.M.L., Mirabeau, O., Mazor, G., Varon, M., Hölting, T.L.B., Grossetête, S., Gartlgruber, M., Surdez, D., Gerke, J.S., Ohmura, S., Marchetto, A., Dallmayer, M., Baldauf, M.C., Stein, S., Sannino, G., Li, J., Romero-Pérez, L., Westermann, F., Hartmann, W., Dirksen, U., Gymrek, M., Anderson, N.D., Shlien, A., Rotblat, B., Kirchner, T., Delattre, O., Grünewald, T.G.P., 2019. Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes. Nat Commun 10. [PMID: 31511524]
• Ravanpay, A.C., Gust, J., Johnson, A.J., Rolczynski, L.S., Cecchini, M., Chang, C.A., Hoglund, V.J., Mukherjee, R., Vitanza, N.A., Orentas, R.J., Jensen, M.C., 2019. EGFR806-CAR T cells selectively target a tumor-restricted EGFR epitope in glioblastoma. Oncotarget 10, 7080–7095. [PMID: 31903167]
• Riegler, J., Gill, H., Ogasawara, A., Hedehus, M., Javinal, V., Oeh, J., Ferl, G.Z., Marik, J., Williams, S., Sampath, D., Schartner, J., Carano, R.A.D., 2019. VCAM-1 Density and Tumor Perfusion Predict T-cell Infiltration and Treatment Response in Preclinical Models. Neoplasia 21, 1036–1050. [PMID: 31521051]
• Sureban, S.M., Berahovich, R., Zhou, H., Xu, S., Wu, L., Ding, K., May, R., Qu, D., Bannerman-Menson, E., Golubovskaya, V., Houchen, C.W., 2019. DCLK1 Monoclonal Antibody-Based CAR-T Cells as a Novel Treatment Strategy against Human Colorectal Cancers. Cancers (Basel) 12. [PMID: 31878090]
• Tarumoto, Y., Lin, S., Wang, J., Milazzo, J.P., Xu, Y., Lu, B., Yang, Z., Wei, Y., Polyanskaya, S., Wunderlich, M., Gray, N.S., Stegmaier, K., Vakoc, C.R., 2020. Salt-inducible kinase inhibition suppresses acute myeloid leukemia progression in vivo. Blood 135, 56–70. [PMID: 31697837]
• Thomas, S., Mohammed, F., Reijmers, R.M., Woolston, A., Stauss, T., Kennedy, A., Stirling, D., Holler, A., Green, L., Jones, D., Matthews, K.K., Price, D.A., Chain, B.M., Heemskerk, M.H.M., Morris, E.C., Willcox, B.E., Stauss, H.J., 2019. Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function. Nat Commun 10. [PMID: 31575864]
• Wang, Dawei, Shao, Y., Zhang, X., Lu, G., Liu, B., 2020. IL-23 and PSMA-targeted duo-CAR T cells in Prostate Cancer Eradication in a preclinical model. J Transl Med 18. [PMID: 31937346]
• Xiang, J., Rauch, D.A., Huey, D.D., Panfil, A.R., Cheng, X., Esser, A.K., Su, X., Harding, J.C., Xu, Y., Fox, G.C., Fontana, F., Kobayashi, T., Su, J., Sundaramoorthi, H., Wong, W.H., Jia, Y., Rosol, T.J., Veis, D.J., Green, P.L., Niewiesk, S., Ratner, L., Weilbaecher, K.N., 2019. HTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemia. JCI Insight 4. [PMID: 31578308]

Humanized immune system: hematopoiesis and stem cell engraftment

• Abraham A, Kim YS, Zhao H, Humphries K, Persons DA.  Increased Engraftment of Human Short Term Repopulating Hematopoietic Cells in NOD/SCID/IL2rγnull Mice by Lentiviral Expression of NUP98-HOXA10HD. PLoS One. 2016 Jan 13;11(1):e0147059. doi: 10.1371/journal.pone.0147059. eCollection 2016. [PMID: 26761813]
• Amabile G; Welner RS; Nombela-Arrieta C; D'Alise AM; Di Ruscio A; Ebralidze AK; Kraytsberg Y; Ye M; Kocher O; Neuberg DS; Khrapko K; Silberstein LE; Tenen DG. 2013. In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. Blood. Feb 21;121(8):1255-64. [PMID: 23212524]
• André MC; Erbacher A; Gille C; Schmauke V; Goecke B; Hohberger A; Mang P; Wilhelm A; Mueller I; Herr W; Lang P; Handgretinger R; Hartwig UF. 2010. Long-Term Human CD34+ Stem Cell-Engrafted Nonobese Diabetic/SCID/IL-2 gamma-null Mice Show Impaired CD8+ T Cell Maintenance and a Functional Arrest of Immature NK Cells. J Immunol Sep 1;185(5):2710-20. [PMID: 20668220]
• Arulmozhivarman, G., Kräter, M., Wobus, M., Friedrichs, J., Bejestani, E.P., Müller, K., Lambert, K., Alexopoulou, D., Dahl, A., Stöter, M., Bickle, M., Shayegi, N., Hampe, J., Stölzel, F., Brand, M., von Bonin, M., Bornhäuser, M., 2017. Zebrafish In-Vivo Screening for Compounds Amplifying Hematopoietic Stem and Progenitor Cells: - Preclinical Validation in Human CD34+ Stem and Progenitor Cells. Sci. Rep. 7, 12084. doi:10.1038/s41598-017-12360-0. [PMID: 28935977]
• Baerenwaldt A; Lux A; Danzer H; Spriewald BM; Ullrich E; Heidkamp G; Dudziak D; Nimmerjahn F. 2011. Fcγ receptor IIB (FcγRIIB) maintains humoral tolerance in the human immune system in vivo. Proc Natl Acad Sci U S A Nov 15;108(46):18772-7. [PMID: 22065769] 
• Baird, A., Deng, C., Eliceiri, M.H., Haghi, F., Dang, X., Coimbra, R., Costantini, T.W., Torbett, B.E., Eliceiri, B.P., 2016. Mice engrafted with human hematopoietic stem cells support a human myeloid cell inflammatory response in vivo. Wound Repair Regen. Off. Publ. Wound Heal. Soc. Eur. Tissue Repair Soc. doi:10.1111/wrr.12471 [PMID: 27663454]
• Bartee E; Meacham A; Wise E; Cogle CR; McFadden G. 2012 Virotherapy Using Myxoma Virus Prevents Lethal Graft-versus-Host Disease following Xeno-Transplantation with Primary Human Hematopoietic Stem Cells. PLoS One.7(8):e43298. [PMID: 22905251]
• Baudet A; Karlsson C; Safaee Talkhoncheh M; Galeev R; Magnusson M; Larsson J. 2012. RNAi screen identifies MAPK14 as a druggable suppressor of human hematopoietic stem cell expansion. Blood. Jun 28;119(26):6255-8. [PMID: 22555972]
• Belle L; Bruck F; Foguenne J; Gothot A; Beguin Y; Baron F; Briquet A. 2012. Imatinib and Nilotinib Inhibit Hematopoietic Progenitor Cell Growth, but Do Not Prevent Adhesion, Migration and Engraftment of Human Cord Blood CD34(+) Cells. PLoS One. 7(12):e52564. [PMID: 23285088]
• Bernink JH; Peters CP; Munneke M; Te Velde AA; Meijer SL; Weijer K; Hreggvidsdottir HS; Heinsbroek SE; Legrand N; Buskens CJ; Bemelman WA; Mjösberg JM; Spits H. 2013. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol  Mar;14(3):221-9. [PMID: 23334791]
• Boitano AE; Wang J; Romeo R; Bouchez LC; Parker AE; Sutton SE; Walker JR; Flaveny CA; Perdew GH; Denison MS; Schultz PG; Cooke MP. 2010. Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells. Science Sep 10;329(5997):1345-58. [PMID: 20688981]
• Bryce PJ, Falahati R, Kenney LL, Leung J, Bebbington C, Tomasevic N, Krier RA, Hsu CL, Shultz LD, Greiner DL, Brehm MA. Humanized mouse model of mast cell-mediated passive cutaneous anaphylaxis and passive systemic anaphylaxis.  J Allergy Clin Immunol. 2016 Apr 6. pii: S0091-6749(16)30008-2. doi: 10.1016/j.jaci.2016.01.049. [PMID: 27139822]
• Broxmeyer HE; Lee MR; Hangoc G; Cooper S; Prasain N; Kim YJ; Mallett C; Ye Z; Witting S; Cornetta K; Cheng L; Yoder MC. 2011. Hematopoietic stem/progenitor cells; generation of induced pluripotent stem cells; and isolation of endothelial progenitors from 21-23.5 year cryopreserved cord blood. Blood May 5;117(18):4773-7. [PMID: 21393480]
• Bueno C; Montes R; de la Cueva T; Gutierrez-Aránda I; Menendez P. 2010. Intra-bone marrow transplantation of human CD34(+) cells into NOD/LtSz-scid IL-2rgamma(null) mice permits multilineage engraftment without previous irradiation. Cytotherapy 12(1):45-9. [PMID: 19929453]
• Butler JM; Gars EJ; James DJ; Nolan DJ; Scandura JM; Rafii S. 2012. Development of a vascular platform for expansion of repopulating human cord blood stem and progenitor cells. Blood. Aug 9;120(6):1344-7 [PMID: 22709690]
• Cai S; Wang H; Bailey B; Ernstberger A; Juliar BE; Sinn AL; Chan RJ; Jones DR; Mayo LD; Baluyut AR; Goebel WS; Pollok KE. 2011. Humanized Bone Marrow Mouse Model as a Preclinical Tool to Assess Therapy-Mediated Hematotoxicity. Clin Cancer Res Apr 15;17(8):2195-2206. [PMID: 21487065]
• Cany J,; van der Waart AB,; Spanholtz J,; Tordoir M,; Jansen JH,; van der Voort R,; Schaap NM,; Dolstra H. Combined IL-15 and IL-12 drives the generation of CD34+-derived natural killer cells with superior maturation and alloreactivity potential following adoptive transfer. Oncoimmunology. 2015 Apr 1;4(7):e1017701. [PMID: 26140247]
• Capitano ML; Hangoc G; Cooper S; Broxmeyer HE. Mild heat treatment primes human CD34+ cord blood cells for migration towards SDF-1α and enhances engraftment in an NSG mouse model. Stem Cells. 2015 Mar 5. Epub ahead of print. [PMID: 25753525]
• Ceccaldi R; Parmar K; Mouly E; Delord M; Kim JM; Regairaz M; Pla M; Vasquez N; Zhang QS; Pondarre C; Peffault de Latour R; Gluckman E; Cavazzana-Calvo M; Leblanc T; Larghero J; Grompe M; Socié G; D'Andrea AD; Soulier J. 2012. Bone Marrow Failure in Fanconi Anemia Is Triggered by an Exacerbated p53/p21 DNA Damage Response that Impairs Hematopoietic Stem and Progenitor Cells. Cell Stem Cell Jul 6;11(1):36-49. [PMID: 22683204]
• Chatterjee S, Lesniak WG, Gabrielson M, Lisok A, Wharram B, Sysa-Shah P, Azad BB, Pomper MG, Nimmagadda S. A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors. Oncotarget. 2016 Feb 2. doi: 10.18632/oncotarget.7143. [PMID: 26848870]
• Chen Q; He F; Kwang J; Chan JK; Chen J. 2012. GM-CSF and IL-4 Stimulate Antibody Responses in Humanized Mice by Promoting T, B, and Dendritic Cell Maturation. J Immunol. Dec 1;189(11):5223-9. [PMID: 23089398]
• Coughlan AM, Harmon C, Whelan S, O'Brien E, O'Reilly V, Crotty P, Kelly P, Ryan M, Hickey F, O'Farrelly C, Little MA. Myeloid engraftment in humanized mice: impact of GCSF treatment and transgenic mouse strain. Stem Cells Dev. 2016 Feb 16. [PMID: 26879149]
• Csaszar E; Kirouac DC; Yu M; Wang W; Qiao W; Cooke MP; Boitano AE; Ito C; Zandstra PW. 2012. Rapid expansion of human hematopoietic stem cells by automated control of inhibitory feedback signaling. Cell Stem Cell Feb 3;10(2):218-29. [PMID: 22305571]
• Drake AC; Khoury M; Leskov I; Iliopoulou BP; Fragoso M; Lodish H; Chen J. 2011. Human CD34+ CD133+ Hematopoietic Stem Cells Cultured with Growth Factors Including Angptl5 Efficiently Engraft Adult NOD-SCID Il2rγ-/- (NSG) Mice. PLoS One Apr 29;6(4):e18382. [PMID: 21559522]
• Doulatov S; Notta F; Eppert K; Nguyen LT; Ohashi PS; Dick JE. 2010. Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nat Immunol Jul;11(7):585-93. [PMID: 20543838]
• Eldjerou LK; Chaudhury S; Baisre-de Leon A; He M; Arcila ME; Heller G; O'Reilly RJ; Barker JN; Moore MA. 2010. An in vivo model of double unit cord blood transplantation that correlates with clinical engraftment. Blood Nov 11;116(19):3999-4006. [PMID: 20587781]
• Galli, V., Nixon, C.C., Strbo, N., Artesi, M., de Castro-Amarante, M.F., McKinnon, K., Fujikawa, D., Omsland, M., Washington-Parks, R., Romero, L., Caruso, B., Durkin, K., Brown, S., Karim, B., Vaccari, M., Jacobson, S., Zack, J.A., Van den Broeke, A., Pise-Masison, C., Franchini, G., 2019. Essential Role of HTLV-1 orf-I in Lethal Proliferation of CD4+ Cells in Humanized Mice. J. Virol. [PMID: 31315992]
• Gao H; Wu X; Sun Y; Zhou S; Silberstein LE; Zhu Z. 2012. Suppression of Homeobox Transcription Factor VentX Promotes Expansion of Human Hematopoietic Stem/Multipotent Progenitor Cells. J Biol Chem Aug 24;287(35):29979-87. [PMID: 22791709]
• Giassi LJ; Pearson T; Shultz LD; Laning J; Biber K; Kraus M; Woda BA; Schmidt MR; Woodland RT; Rossini AA; Greiner DL. 2008. Expanded CD34+ human umbilical cord blood cells generate multiple lymphohematopoietic lineages in NOD-scid IL2rgamma(null) mice. Exp Biol Med (Maywood) 233(8):997-1012. [PMID: 18653783]
• Görgens A; Beckmann J; Ludwig AK; Möllmann M; Dürig J; Horn PA; Rajendran L; Giebel B. 2012. Lipid raft redistribution and morphological cell polarization are separable processes providing a basis for hematopoietic stem and progenitor cell migration. Int J Biochem Cell Biol Jul;44(7):1121-32. [PMID: 22504287]
• Guo, B., Huang, X., Broxmeyer, H.E., 2018. Enhancing human cord blood hematopoietic stem cell engraftment by targeting nuclear hormone receptors. Curr. Opin. Hematol. 25, 245–252. [PMID: 29608487]
• Halim TY; Maclaren A; Romanish MT; Gold MJ; McNagny KM; Takei F. 2012. Retinoic-Acid-Receptor-Related Orphan Nuclear Receptor Alpha Is Required for Natural Helper Cell Development and Allergic Inflammation. Immunity. Sep 21;37(3):463-74. [PMID: 22981535]
• Hayakawa J; Hsieh MM; Uchida N; Phang O; Tisdale JF. 2009. Busulfan produces efficient human cell engraftment in NOD/LtSz-Scid IL2Rgamma(null) mice. Stem Cells 27(1):175-82. [PMID: 18927475]
• Herndler-Brandstetter, D., Shan, L., Yao, Y., Stecher, C., Plajer, V., Lietzenmayer, M., Strowig, T., de Zoete, M.R., Palm, N.W., Chen, J., Blish, C.A., Frleta, D., Gurer, C., Macdonald, L.E., Murphy, A.J., Yancopoulos, G.D., Montgomery, R.R., Flavell, R.A., 2017. Humanized mouse model supports development, function, and tissue residency of human natural killer cells. Proc. Natl. Acad. Sci. U.S.A. [PMID: 29078283]
• Himburg HA; Harris JR; Ito T; Daher P; Russell JL; Quarmyne M; Doan PL; Helms K; Nakamura M; Fixsen E; Herradon G; Reya T; Chao NJ; Harroch S; Chute JP. 2012. Pleiotrophin Regulates the Retention and Self-Renewal of Hematopoietic Stem Cells in the Bone Marrow Vascular Niche. Cell Rep Oct 25;2(4):964-75.[PMID: 23084748]
• Hoffend NC, Magner WJ, Tomasi TB. 2016. The modulation of Dicer regulates tumor immunogenicity in melanoma. Oncotarget. Jun 23. doi: 10.18632/oncotarget.10273. [Epub ahead of print] [PMID: 27356752]
• Huang J; Nguyen-McCarty M; Hexner EO; Danet-Desnoyers G; Klein PS. 2012. Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways. Nat Med. Dec 6;18(12):1778-85. [PMID: 23142822]
• Huang, X., Guo, B., Liu, S., Wan, J., Broxmeyer, H.E., 2018. Neutralizing negative epigenetic regulation by HDAC5 enhances human haematopoietic stem cell homing and engraftment. Nat Commun 9, 2741. [PMID: 30013077]
• Huang X, Lee MR, Cooper S, Hangoc G, Hong KS, Chung HM, Broxmeyer HE. Activation of OCT4 enhances ex vivo expansion of human cord blood hematopoietic stem and progenitor cells by regulating HOXB4 expression. Leukemia. 2015 Jul 23. Epub ahead of print. [PMID:26202933]
• Huang Y, Elliott MJ, Yolcu ES, Miller TO, Ratajczak J, Bozulic LD, Wen Y, Xu H, Ratajczak MZ, Ildstad ST. Characterization of Human CD8+ TCR- Facilitating Cells In Vitro and In Vivo in a NOD/SCID/IL2rγnull Mouse Model. Am J Transplant. 2015 Nov 9. [PMID: 26550777]
• Isern J; Martín-Antonio B; Ghazanfari R; Martín AM; López JA; Del Toro R; Sánchez-Aguilera A; Arranz L; Martín-Pérez D; Suárez-Lledó M; Marín P; Van Pel M; Fibbe WE; Vázquez J; Scheding S; Urbano-Ispizúa A; Méndez-Ferrer S. 2013. Self-Renewing Human Bone Marrow Mesenspheres Promote Hematopoietic Stem Cell Expansion. Cell Rep. May 30;3(5):1714-24. [PMID: 23623496]
• Ishikawa F; Shimazu H; Shultz LD; Fukata M; Nakamura R; Lyons B; Shimoda K; Shimoda S; Kanemaru T; Nakamura K; Ito H; Kaji Y; Perry AC; Harada M. 2006. Purified human hematopoietic stem cells contribute to the generation of cardiomyocytes through cell fusion. FASEB J 20(7):950-2. [PMID: 16585061]
• Ishikawa F; Yasukawa M; Lyons B; Yoshida S; Miyamoto T; Yoshimoto G; Watanabe T; Akashi K; Shultz LD; Harada M. 2005. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 106(5):1565-73. [PMID: 15920010]
• Ivanovs A; Rybtsov S; Welch L; Anderson RA; Turner ML; Medvinsky A. 2011. Highly potent human hematopoietic stem cells first emerge in the intraembryonic aorta-gonad-mesonephros region. J Exp Med Nov 21;208(12):2417-27. [PMID: 22042975]
• Kalscheuer H; Danzl N; Onoe T; Faust T; Winchester R; Goland R; Greenberg E; Spitzer TR; Savage DG; Tahara H; Choi G; Yang YG; Sykes M. 2012. A model for personalized in vivo analysis of human immune responsiveness. Sci Transl Med. Mar 14;4(125):125ra30. [PMID: 22422991]
• Kim I; Kim YJ; Métais JY; Dunbar CE; Larochelle A. 2012. Transient silencing of PTEN in human CD34(+) cells enhances their proliferative potential and ability to engraft immunodeficient mice. Exp Hematol Jan;40(1):84-91 [PMID: 22019626]
• Kohn LA; Hao QL; Sasidharan R; Parekh C; Ge S; Zhu Y; Mikkola HK; Crooks GM 2012. Lymphoid priming in human bone marrow begins before expression of CD10 with upregulation of L-selectin. Nat Immunol. Oct;13(10):963-71.[PMID: 22941246]
• Kundu, K., Ghosh, S., Sarkar, R., Edri, A., Brusilovsky, M., Gershoni-Yahalom, O., Yossef, R., Shemesh, A., Soria, J.-C., Lazar, V., Joshua, B.-Z., S Campbell, K., Elkabets, M., Porgador, A., 2019. Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA. Cancer Immunol Res. [PMID: 31164357]
• Larochelle A; Savona M; Wiggins M; Anderson S; Ichwan B; Keyvanfar K; Morrison SJ; Dunbar CE. 2011. Human and rhesus macaque hematopoietic stem cells cannot be purified based only upon SLAM family markers. Blood Feb 3;117(5):1550-4. [PMID: 21163926]
• Larochelle A; Gillette JM; Desmond R; Ichwan B; Cantilena A; Cerf A; Barrett AJ; Wayne AS; Lippincott-Schwartz J; Dunbar CE. 2012. Bone marrow homing and engraftment of human hematopoietic stem and progenitor cells is mediated by a polarized membrane domain. Blood Feb 23;119(8):1848-55. [PMID: 22228628]
• Laurenti E; Doulatov S; Zandi S; Plumb I; Chen J; April C; Fan JB; Dick JE. 2013. The transcriptional architecture of early human hematopoiesis identifies multilevel control of lymphoid commitment. Nat Immunol. Jul;14(7):756-63. [PMID: 23708252]
• Lecourt S; Mouly E; Freida D; Cras A; Ceccaldi R; Heraoui D; Chomienne C; Marolleau JP; Arnulf B; Porcher R; Caillaud C; Vanneaux V; Belmatoug N; Larghero J. 2013. A prospective study of bone marrow hematopoietic and mesenchymal stem cells in type 1 Gaucher disease patients. PLoS One. Jul 25;8(7):e69293. [PMID: 23935976]
• Lee J; Li M; Milwid J; Dunham J; Vinegoni C; Gorbatov R; Iwamoto Y; Wang F; Shen K; Hatfield K; Enger M; Shafiee S; McCormack E; Ebert BL; Weissleder R; Yarmush ML; Parekkadan B. 2012. Implantable microenvironments to attract hematopoietic stem/cancer cells. Proc Natl Acad Sci U S A. Nov 27;109(48):19638-43. [PMID: 23150542]
• Levy, E., Reger, R., Segerberg, F., Lambert, M., Leijonhufvud, C., Baumer, Y., Carlsten, M., Childs, R., 2019. Enhanced Bone Marrow Homing of Natural Killer Cells Following mRNA Transfection With Gain-of-Function Variant CXCR4R334X. Front Immunol 10, 1262. [PMID: 31231387]
• Li L; Modi H; McDonald T; Rossi J; Yee JK; Bhatia R. 2011. A critical role for SHP2 in STAT5 activation and growth factor mediated proliferation; survival and differentiation of human CD34+ cells. Blood Aug 11;118(6):1504-15. [PMID: 21670473]
• Li, X., Liu, Z., Zhang, A., Han, C., Shen, A., Jiang, L., Boothman, D.A., Qiao, J., Wang, Y., Huang, X., Fu, Y.-X., 2019. NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance. Nat Commun 10. [PMID: 31324798]
• Ling, L., Tang, X., Huang, X., Li, J., Wang, H., Chen, Z., 2018. AAV-Vectored Fms-Related Tyrosine Kinase 3 Ligand Inhibits CD34+ Progenitor Cell Engraftment in Humanized Mice. J Neuroimmune Pharmacol. [PMID: 30377944]
• Liu C; Chen BJ; Deoliveira D; Sempowski GD; Chao NJ; Storms RW. 2010. Progenitor cell dose determines the pace and completeness of engraftment in a xenograft model for cord blood transplantation. Blood Dec 16;116(25):5518-27. [PMID: 20833978]
• Magnusson M; Sierra MI; Sasidharan R; Prashad SL; Romero M; Saarikoski P; Van Handel B; Huang A; Li X; Mikkola HK. 2013. Expansion on stromal cells preserves the undifferentiated state of human hematopoietic stem cells despite compromised reconstitution ability. PLoS One. 2013;8(1):e53912. [PMID: 23342037]
• Majeti R; Park CY; Weissman IL. 2007. Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell 1(6):635-45. [PMID: 18371405]
• Masuda H; Anwar SS; Bühring HJ; Rao JR; Gargett CE. 2012. A novel marker of human endometrial mesenchymal stem-like cells. Cell Transplant 21(10):2201-14. [PMID: 22469435]
• Matsuzaki, J., Tsuji, T., Chodon, T., Ryan, C., Koya, R.C., Odunsi, K., 2019. A rare population of tumor antigen-specific CD4+CD8+ double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells. J Immunother Cancer 7, 7. [PMID: 30626427]
• McIntosh BE; Brown ME; Duffin BM; Maufort JP; Vereide DT; Slukvin II; Thomson JA. 2015. Nonirradiated NOD;B6.SCID Il2rγ-/-KitW41/W41 (NBSGW) Mice Support Multilineage Engraftment of Human Hematopoietic Cells. Stem Cell Reports. Epub ahead of print. [PMID: 25601207]
• Miller, P.H., Rabu, G., MacAldaz, M., Knapp, D.J., Cheung, A.M., Dhillon, K., Nakamichi, N., Beer, P.A., Shultz, L.D., Humphries, R.K., Eaves, C.J., 2017. Analysis of parameters that affect human hematopoietic cell outputs in mutant c-kit immunodeficient mice. Exp. Hematol. [PMID: 28087429]
• Minn, I., Huss, D.J., Ahn, H.-H., Chinn, T.M., Park, A., Jones, J., Brummet, M., Rowe, S.P., Sysa-Shah, P., Du, Y., Levitsky, H.I., Pomper, M.G., 2019. Imaging CAR T cell therapy with PSMA-targeted positron emission tomography. Sci Adv 5. [PMID: 31281894]
• Misharin AV; Haines GK 3rd; Rose S; Gierut AK; Hotchkiss RS; Perlman H. 2012. Development of a new humanized mouse model to study acute inflammatory arthritis. J Transl Med. Sep 13;10:190. [PMID: 22974474]
• Montano Almendras, C.P., Thudium, C.S., Löfvall, H., Moscatelli, I., Schambach, A., Henriksen, K., Richter, J., 2017. Forced expression of human macrophage colony-stimulating factor in CD34(+) cells promotes monocyte differentiation in vitro and in vivo but blunts osteoclastogenesis in vitro. Eur. J. Haematol. 98, 517–526. doi:10.1111/ejh.12867. [PMID: 28160330]
• Nada, M.H., Wang, H., Workalemahu, G., Tanaka, Y., Morita, C.T., 2017. Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation. J. Immunother. Cancer 5, 9. doi:10.1186/s40425-017-0209-6. [PMID: 28239463]
• Notta F; Doulatov S; Dick JE. 2010. Engraftment of human hematopoietic stem cells is more efficient in female NOD/SCID/IL-2Rgcnull recipients. Blood May 115(18): 3704-7 [PMID: 20207983]
• Olmedillas López S, Garcia-Arranz M, Garcia-Olmo D, Liras A. Preliminary study on non-viral transfection of F9 (factor IX) gene by nucleofection in human adipose-derived mesenchymal stem cells. PeerJ. 2016 Apr 14;4:e1907. doi: 10.7717/peerj.1907. [PMID: 27114871]
• Oyer JL, Pandey V, Igarashi RY, Somanchi SS, Zakari A, Solh M, Lee DA, Altomare DA, Copik AJ. 2016. Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: Clinical implications for cancer treatment. Cytotherapy. May;18(5):653-63. doi: 10.1016/j.jcyt.2016.02.006. [PMID: 27059202]
• Pang WW; Price EA; Sahoo D; Beerman I; Maloney WJ; Rossi DJ; Schrier SL; Weissman IL. 2011. Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci U S A. Dec 13;108(50):20012-7. [PMID: 22123971]
• Parcelier A; Maharzi N; Delord M; Robledo-Sarmiento M; Nelson E; Belakhdar-Mekid H; Pla M; Kuranda K; Parietti V; Goodhardt M; Legrand N; Bernstein ID; Gluckman JC; Sigaux F; Canque B. 2011. AF1q/MLLT11 regulates the emergence of human prothymocytes through cooperative interaction with the Notch signaling pathway. Blood Aug 18;118(7):1784-96 [PMID: 21715312]
• Patton J; Vuyyuru R; Siglin A; Root M; Manser T. Evaluation of the efficiency of human immune system reconstitution in NSG mice and NSG mice containing a human HLA.A2 transgene using hematopoietic stem cells purified from different sources. J Immunol Methods. 2015 Mar 14. Epub ahead of print. [PMID: 25776756]
• Petit Cocault L, Fleury M, Clay D, Larghero J, Vanneaux V, Souyri M. Monoclonal antibody 1.6.1. against human MPL receptor allows HSCs enrichment of CB and BM CD34+CD38- population. Exp Hematol. 2015 Dec 27. pii: S0301-472X(15)00801-2. doi: 10.1016/j.exphem.2015.12.004. [PMID: 26733047]
• Psatha, N., Georgolopoulos, G., Phelps, S., Papayannopoulou, T., 2017. Brief Report: A Differential Transcriptomic Profile of Ex Vivo Expanded Adult Human Hematopoietic Stem Cells Empowers them for Engraftment Better than Their Surface Phenotype. Stem Cells Transl. Med. doi:10.1002/sctm.17-0048. [PMID: 28801972]
• Robinson SN; Simmons PJ; Thomas MW; Brouard N; Javni JA; Trilok S; Shim JS; Yang H; Steiner D; Decker WK; Xing D; Shultz LD; Savoldo B; Dotti G; Bollard CM; Miller L; Champlin RE; Shpall EJ; Zweidler-McKay PA. 2013. Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rγ(null) mice. Exp Hematol. Jun;40(6):445-56. [PMID: 22306295]
• Risueño RM; Sachlos E; Lee JH; Lee JB; Hong SH; Szabo E; Bhatia M. 2012. Inability of human induced pluripotent stem cell-hematopoietic derivatives to downregulate microRNAs in vivo reveals a block in xenograft hematopoietic regeneration. Stem Cells Feb;30(2):131-9. [PMID: 22131151]
• Rohrabaugh SL; Campbell TB; Hangoc G; Broxmeyer HE. 2011. Ex vivo rapamycin treatment of human cord blood CD34(+) cells enhances their engraftment of NSG mice. Blood Cells Mol Dis Apr 15;46(4):318-20. [PMID: 21411351]
• Rörby E; Nifelt Hägerström M; Blank U; Karlsson G; Karlsson S. 2012. Human hematopoietic stem/progenitor cells overexpressing Smad4 exhibit impaired reconstitution potential in vivo. Blood. Nov 22;120(22):4343-51. [PMID: 23018642]
• Scholbach J; Schulz A; Westphal F; Egger D; Wege AK; Patties I; Köberle M; Sack U; Lange F. 2012. Comparison of hematopoietic stem cells derived from fresh and cryopreserved whole cord blood in the generation of humanized mice. PLoS One. 7(10):e46772. [PMID: 23071634]
• Seré K; Baek JH; Ober-Blöbaum J; Müller-Newen G; Tacke F; Yokota Y; Zenke M; Hieronymus T. 2012. Two Distinct Types of Langerhans Cells Populate the Skin during Steady State and Inflammation. Immunity. Nov 16;37(5):905-16. [PMID: 23159228]
• Smith, D.J., Lin, L.J., Moon, H., Pham, A.T., Wang, X., Liu, S., Ji, S., Rezek, V., Shimizu, S., Ruiz, M., Lam, J., Janzen, D.M., Memarzadeh, S., Kohn, D.B., Zack, J., Kitchen, S.G., An, D.S., Yang, L., 2016. Propagating Humanized BLT Mice for the Study of Human Immunology and Immunotherapy. Stem Cells Dev. doi:10.1089/scd.2016.0193 [PMID: 27608727]
• Song L; Li X; Jayandharan GR; Wang Y; Aslanidi GV; Ling C; Zhong L; Gao G; Yoder MC; Ling C; Tan M; Srivastava A. 2013. High-Efficiency Transduction of Primary Human Hematopoietic Stem Cells and Erythroid Lineage-Restricted Expression by Optimized AAV6 Serotype Vectors In Vitro and in a Murine Xenograft Model In Vivo. PLoS One. 8(3):e58757. [PMID: 23516552]
• Tormin A; Li O; Brune JC; Walsh S; Schütz B; Ehinger M; Ditzel N; Kassem M; Scheding S. 2011. CD146 expression on primary non-hematopoietic bone marrow stem cells correlates to in situ localization. Blood May 12;117(19):5067-77. [PMID: 21415267]
• Tran, H.C., Wan, Z., Sheard, M.A., Sun, J., Jackson, J.R., Malvar, J., Xu, Y., Wang, L., Sposto, R., Kim, E.S., Asgharzadeh, S., Seeger, R.C., 2016. TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. doi:10.1158/1078-0432.CCR-16-1743. [PMID: 27756784]
• Tuckett, A.Z., Thornton, R.H., O’Reilly, R.J., van den Brink, M.R.M., Zakrzewski, J.L., 2017. Intrathymic injection of hematopoietic progenitor cells establishes functional T cell development in a mouse model of severe combined immunodeficiency. J. Hematol. Oncol.J Hematol Oncol 10, 109. doi:10.1186/s13045-017-0478-z. [PMID: 28511686]
• Vedvyas, Y., McCloskey, J.E., Yang, Y., Min, I.M., Fahey, T.J., Zarnegar, R., Hsu, Y.-M.S., Hsu, J.-M., Besien, K.V., Gaudet, I., Law, P., Kim, N.J., Hofe, E. von, Jin, M.M., 2019. Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy. Sci Rep 9. [PMID: 31337787]

• Vivier, D., Sharma, S.K., Adumeau, P., Rodriguez, C., Fung, K., Zeglis, B., 2019. The Impact of FcγRI Binding on ImmunoPET. J. Nucl. Med. [PMID: 30733320]

• van der Garde M; van Hensbergen Y; Brand A; Slot MC; de Graaf-Dijkstra A; Mulder A; Watt SM; Zwaginga JJ. 2014. Thrombopoietin Treatment of One Graft in a Double Cord Blood Transplant Provides Early Platelet Recovery While Contributing to Long-Term Engraftment in NSG Mice. Stem Cells Dev. Sep; Epub ahead of print. [PMID: 25137252]
• Wang, Q.J., Yu, Z., Hanada, K.-I., Patel, K., Kleiner, D., Restifo, N.P., Yang, J.C., 2017. Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing Cancers. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 23, 2267–2276. doi:10.1158/1078-0432.CCR-16-1421. [PMID: 27803044]
• Wen, D., Peng, Y., Liu, D., Weizmann, Y., Mahato, R.I., 2016. Mesenchymal stem cell and derived exosome as small RNA carrier and Immunomodulator to improve islet transplantation. J. Control. Release Off. J. Control. Release Soc. 238, 166–175. doi:10.1016/j.jconrel.2016.07.044 [PMID: 27475298]
• Witt, R.G., Kreger, E.M., Buckman, L.B., Moradi, P.W., Ho, P.T., Derderian, S.C., Tsai, P., Baker, C., Schramm, N., Cleary, R., Garcia, J.V., MacKenzie, T.C., 2018. Systemic multilineage engraftment in mice after in utero transplantation with human hematopoietic stem cells. Blood Adv 2, 69–74. [PMID: 29344586]
• Wong WM; Sigvardsson M; Astrand-Grundström I; Hogge D; Larsson J; Qian H; Ekblom M. 2012. Expression of Integrin A2 Receptor in Human Cord Blood Cd34+Cd38-Cd90+ Stem Cells Engrafting Long-Term in Nod/Scid-Il2rγ(C) Null Mice. Stem Cells. Feb;31(2):360-71. [PMID: 23165626]
• Zhang J; Barefoot BE; Mo W; Deoliveira D; Son J; Cui X; Ramsburg E; Chen BJ. 2012. CD62L- memory T cells enhance T-cell regeneration after allogeneic stem cell transplantation by eliminating host resistance in mice. Blood. Jun 28;119(26):6344-53. [PMID: 22596261]
• Zibara K; Hamdan R; Dib L; Sindet-Pedersen S; Kharfan-Dabaja M; Bazarbachi A; El-Sabban M. 2012. Acellular bone marrow extracts significantly enhance engraftment levels of human hematopoietic stem cells in mouse xeno-transplantation models. PLoS One 7(7):e40140. [PMID: 22768336]
• Zou J; Sweeney CL; Chou BK; Choi U; Pan J; Wang H; Dowey SN; Cheng L; Malech HL. Oxidase deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease mediated safe harbor targeting. Blood May 26;117(21):5561-72 [PMID: 21411759]

Humanized immune system: T cell function

• Abraham S; Pahwa R; Ye C; Choi JG; Pahwa S; Jaggaiahgari S; Raut A; Chen S; Manjunath N; Shankar P. 2012. Long-Term Engraftment of Human Natural T Regulatory Cells in NOD/SCID IL2rγc(null) Mice by Expression of Human IL-2. PLoS One. 7(12):e51832. [PMID: 23272176]
• Baeuerle, P.A., Ding, J., Patel, E., Thorausch, N., Horton, H., Gierut, J., Scarfo, I., Choudhary, R., Kiner, O., Krishnamurthy, J., Le, B., Morath, A., Baldeviano, G.C., Quinn, J., Tavares, P., Wei, Q., Weiler, S., Maus, M.V., Getts, D., Schamel, W.W., Hofmeister, R., 2019. Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response. Nat Commun 10. [PMID: 31064990]
• Chicaybam, L., Abdo, L. de M., Carneiro, M., Peixoto, B.C., Viegas, M.D., Ferreira, P. de S., Fornazim, M., Spago, M., Albertoni Laranjeira, A.B., de Campos-Lima, P.O., Nowill, A., Barros, L.R.C., Bonamino, M., 2019. CAR T cells generated using Sleeping Beauty transposon vectors and expanded with an EBV-transformed lymphoblastoid cell line (LCL) display antitumor activity in vitro and in vivo. Hum. Gene Ther. [PMID: 30793967]
• Choi B; Chun E; Kim M; Kim SY; Kim ST; Yoon K; Lee KY; Kim SJ. 2011. Human T cell development in the liver of humanized NOD/SCID/IL-2Rγ(null)(NSG) mice generated by intrahepatic injection of CD34(+) human (h) cord blood (CB) cells. Clin Immunol. Jun;139(3):321-35. [PMID: 21429805]
• Di Tullio, A., Passaro, D., Rouault-Pierre, K., Purewal, S., Bonnet, D., 2017. Nuclear Factor Erythroid 2 Regulates Human HSC Self-Renewal and T Cell Differentiation by Preventing NOTCH1 Activation. Stem Cell Rep. 9, 5–11. doi:10.1016/j.stemcr.2017.05.027. [PMID: 28648895]
• Fischer A, Zundler S, Atreya R, Rath T, Voskens C, Hirschmann S, López-Posadas R, Watson A, Becker C, Schuler G, Neufert C, Atreya I, Neurath MF. Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo. Gut. 2015 Jul 24. Epub ahead of print. [PMID: 26209553]
• Galli, V., Nixon, C.C., Strbo, N., Artesi, M., de Castro-Amarante, M.F., McKinnon, K., Fujikawa, D., Omsland, M., Washington-Parks, R., Romero, L., Caruso, B., Durkin, K., Brown, S., Karim, B., Vaccari, M., Jacobson, S., Zack, J.A., Van den Broeke, A., Pise-Masison, C., Franchini, G., 2019. Essential Role of HTLV-1 orf-I in Lethal Proliferation of CD4+ Cells in Humanized Mice. J. Virol. [PMID: 31315992]
• Gattinoni L; Lugli E; Ji Y; Pos Z; Paulos CM; Quigley MF; Almeida JR; Gostick E; Yu Z; Carpenito C; Wang E; Douek DC; Price DA; June CH; Marincola FM; Roederer M; Restifo NP. 2011. A human memory T cell subset with stem cell-like properties. Nat Med Sep 18;17(10):1290-7. [PMID: 21926977]
• Harui A; Kiertscher SM; Roth MD. 2010. Reconstitution of huPBL-NSG Mice with Donor-Matched Dendritic Cells Enables Antigen-Specific T cell Activation. J Neuroimmune Pharmacol Mar;6(1):148-57. [PMID: 20532647]
• Hippen KL; Merkel SC; Schirm DK; Nelson C; Tennis NC; Riley JL; June CH; Miller JS; Wagner JE; Blazar BR. 2011. Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease. Am J Transplant. Jun;11(6):1148-57. [PMID: 21564534]
• Hippen KL; Bucher C; Schirm DK; Bearl AM; Brender T; Mink KA; Waggie KS; Peffault de Latour R; Janin A; Curtsinger JM; Dillon SR; Miller JS; Socie G; Blazar BR. 2012. Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes. Blood. Jan 12;119(2):619-28. [PMID: 22077059]
• Hof-Nahor I; Leshansky L; Shivtiel S; Eldor L; Aberdam D; Itskovitz-Eldor J; Berrih-Aknin S. 2012. Human mesenchymal stem cells shift CD8+ T cells towards a suppressive phenotype by inducing tolerogenic monocytes. J Cell Sci. Oct 1;125(Pt 19):4640-50. [PMID: 22767507]
• Huang, D., Wang, Y., Hawthorne, W.J., Hu, M., Hawkes, J., Burns, H., Davies, S., Gao, F., Chew, Y.V., Yi, S., O’Connell, P.J., 2017. Ex vivo-expanded baboon CD39 + regulatory T cells prevent rejection of porcine islet xenografts in NOD-SCID IL-2rγ(-/-) mice reconstituted with baboon peripheral blood mononuclear cells. Xenotransplantation. doi:10.1111/xen.12344. [PMID: 28963731]
• Hunter MR; Prosser ME; Mahadev V; Wang X; Aguilar B; Brown CE; Forman SJ; Jensen MC. 2013. Chimeric γc cytokine receptors confer cytokine independent engraftment of human T lymphocytes. Mol Immunol. Apr 26;56(1-2):1-11. [PMID: 23628622]
• Kim KD; Srikanth S; Yee MK; Mock DC; Lawson GW; Gwack Y. 2011. ORAI1 Deficiency Impairs Activated T Cell Death and Enhances T Cell Survival. J Immunol Oct 1;187(7):3620-30. [PMID: 21873530]
• Kueberuwa, G., Gornall, H., Alcantar-Orozco, E.M., Bouvier, D., Kapacee, Z.A., Hawkins, R.E., Gilham, D.E., 2017. CCR7(+) selected gene-modified T cells maintain a central memory phenotype and display enhanced persistence in peripheral blood in vivo. J. Immunother. Cancer 5, 14. doi:10.1186/s40425-017-0216-7. [PMID: 28239467]
• Kundu, K., Ghosh, S., Sarkar, R., Edri, A., Brusilovsky, M., Gershoni-Yahalom, O., Yossef, R., Shemesh, A., Soria, J.-C., Lazar, V., Joshua, B.-Z., S Campbell, K., Elkabets, M., Porgador, A., 2019. Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA. Cancer Immunol Res. [PMID: 31164357]
• Künkele, A., Brown, C., Beebe, A., Mgebroff, S., Johnson, A.J., Taraseviciute, A., Rolczynski, L.S., Chang, C.A., Finney, O.C., Park, J.R., Jensen, M.C., 2018. Manufacture of Chimeric Antigen Receptor T Cells from Mobilized Cyropreserved Peripheral Blood Stem Cell Units Depends on Monocyte Depletion. Biol. Blood Marrow Transplant. [PMID: 30315942]
• Lee, Y.G., Chu, H., Lu, Y., Leamon, C.P., Srinivasarao, M., Putt, K.S., Low, P.S., 2019. Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters. Nat Commun 10. [PMID: 31213606]
• Lee, Y.G., Marks, I., Srinivasarao, M., Kanduluru, A.K., Mahalingam, S.M., Liu, X., Chu, H., Low, P.S., 2018. Use of a single CAR T cell and several bispecific adapters facilitates eradication of multiple antigenically different solid tumors. Cancer Res. [PMID: 30482775]
• Li, X., Liu, Z., Zhang, A., Han, C., Shen, A., Jiang, L., Boothman, D.A., Qiao, J., Wang, Y., Huang, X., Fu, Y.-X., 2019. NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance. Nat Commun 10. [PMID: 31324798]
• Li, Y., Teteloshvili, N., Tan, S., Rao, S., Han, A., Yang, Y.-G., Creusot, R.J., 2019. Humanized Mice Reveal New Insights Into the Thymic Selection of Human Autoreactive CD8+ T Cells. Front Immunol 10, 63. [PMID: 30778347] [PMID: 30778347]
• Lockridge JL; Chen X; Zhou Y; Rajesh D; Roenneburg DA; Hegde S; Gerdts S; Cheng TY; Anderson RJ; Painter GF; Moody DB; Burlingham WJ; Gumperz JE. 2011. Analysis of the CD1 Antigen Presenting System in Humanized SCID Mice.PLoS One 6(6):e21701. [PMID: 21738769]
• Magnani CF, Turazzi N, Benedicenti F, Calabria A, Tenderini E, Tettamanti S, Giordano Attianese GM, Cooper LJ, Aiuti A, Montini E, Biondi A, Biagi E. 2016. Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform. Oncotarget. Jun 13. doi: 10.18632/oncotarget.9955. [Epub ahead of print] [PMID: 27323395]
• Maharzi N; Parietti V; Nelson E; Denti S; Robledo-Sarmiento M; Setterblad N; Parcelier A; Pla M; Sigaux F; Gluckman JC; Canque B. 2013. Identification of TMEM131L as a novel regulator of thymocyte proliferation in humans. J Immunol. Jun 15;190(12):6187-97. [PMID: 23690469]
• Marodon G; Desjardins D; Mercey L; Baillou C; Parent P; Manuel M; Caux C; Bellier B; Pasqual N; Klatzmann D; 2009. High diversity of the immune repertoire in humanized NOD.SCID.gammac(-/-) mice. Eur J Immunol Aug;39(8):2136-45 [PMID: 19572320]
• Mato, N., Hirahara, K., Ichikawa, T., Kumagai, J., Nakayama, M., Yamasawa, H., Bando, M., Hagiwara, K., Sugiyama, Y., Nakayama, T., 2017. Memory-type ST2(+)CD4(+) T cells participate in the steroid-resistant pathology of eosinophilic pneumonia. Sci. Rep. 7, 6805. doi:10.1038/s41598-017-06962-x. [PMID: 28754914]
• Matsuzaki, J., Tsuji, T., Chodon, T., Ryan, C., Koya, R.C., Odunsi, K., 2019. A rare population of tumor antigen-specific CD4+CD8+ double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells. J Immunother Cancer 7, 7. [PMID: 30626427]
• Melzer, M.K., Zeitlinger, L., Mall, S., Steiger, K., Schmid, R.M., Ebert, O., Krackhardt, A., Altomonte, J., 2019. Enhanced Safety and Efficacy of Oncolytic VSV Therapy by Combination with T Cell Receptor Transgenic T Cells as Carriers. Mol Ther Oncolytics 12, 26—40. [PMID: 30662938] 
• Menger L, Gouble A, Marzolini MA, Pachnio A, Bergerhoff K, Henry JY, Smith J, Pule M, Moss P, Riddell SR, Quezada SA, Peggs KS. TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells. Blood. 2015 Oct 27. [PMID: 26508783]
• Minn, I., Huss, D.J., Ahn, H.-H., Chinn, T.M., Park, A., Jones, J., Brummet, M., Rowe, S.P., Sysa-Shah, P., Du, Y., Levitsky, H.I., Pomper, M.G., 2019. Imaging CAR T cell therapy with PSMA-targeted positron emission tomography. Sci Adv 5. [PMID: 31281894]
• Najima Y, Tomizawa-Murasawa M, Saito Y, Watanabe T, Ono R, Ochi T, Suzuki N, Fujiwara H, Ohara O, Shultz LD, Yasukawa M, Ishikawa F. Induction of WT1 specific human CD8+ T cells from human HSCs in HLA class I Tg NOD/SCID/Il2rgKO mice. Blood. 2015 Dec 23. pii: blood-2014-10-604777. [PMID: 26702062]
• Oh, A.L., Mahmud, D., Nicolini, B., Mahmud, N., Senyuk, V., Patel, P.R., Bonetti, E., Arpinati, M., Ferrara, J., Rondelli, D., 2017. T Cell-Mediated Rejection of Human CD34+ Cells is Prevented by Costimulatory Blockade in a Xenograft Model. Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant. doi:10.1016/j.bbmt.2017.08.009. [PMID: 28818684]
• Parietti V; Nelson E; Telliam G; Le Noir S; Pla M; Delord M; Vanneaux V; Mohtashami M; Macintyre EA; Gluckman JC; Asnafi V; Zuniga-Pflücker JC; Larghero J; Canque B. 2012. Dynamics of Human Prothymocytes and Xenogeneic Thymopoiesis in Hematopoietic Stem Cell-Engrafted Nonobese Diabetic-SCID/IL-2rγnull Mice. J Immunol. Aug 15;189(4):1648-60 [PMID: 22798679]
• Pham HP; Manuel M; Petit N; Klatzmann D; Cohen-Kaminsky S; Six A; Marodon G. 2011. Half of the T-cell repertoire combinatorial diversity is genetically determined in humans and humanized mice. Eur J Immunol Mar;42(3):760-70 [PMID: 22105329]
• Picarda, E., Bézie, S., Boucault, L., Autrusseau, E., Kilens, S., Meistermann, D., Martinet, B., Daguin, V., Donnart, A., Charpentier, E., David, L., Anegon, I., Guillonneau, C., 2017. Transient antibody targeting of CD45RC induces transplant tolerance and potent antigen-specific regulatory T cells. JCI Insight 2, e90088. doi:10.1172/jci.insight.90088. [PMID: 28194440]
• Rajesh D; Zhou Y; Jankowska-Gan E; Renneburg DA; Dart ML; Torrealba J; Burlingham WJ. 2010. Th1 and Th17 immunocompetence in humanized NOD/SCID/IL2rg(null) mice. Hum Immunol Jun;71(6):551-9 [PMID: 20298731]
• Reimann C; Six E; Dal-Cortivo L; Schiavo A; Appourchaux K; Lagresle-Peyrou C; de Chappedelaine C; Ternaux B; Coulombel L; Beldjord K; Cavazzana-Calvo M; Andre-Schmutz I. 2012. Human T-lymphoid Progenitors Generated in a Feeder-cell-free DL- 4 Culture System Promote T-cell Reconstitution in NOD/SCID/γc(-/-) Mice. Stem Cells Aug;30(8):1771-80 [PMID: 22689616]
• Rosenzweig, M., Urak, R., Walter, M., Lim, L., Sanchez, J.F., Krishnan, A., Forman, S., Wang, X., 2017. Preclinical data support leveraging CS1 chimeric antigen receptor T-cell therapy for systemic light chain amyloidosis. Cytotherapy. doi:10.1016/j.jcyt.2017.03.077. [PMID: 28483281]
• Setoguchi R. IL-15 boosts function and migration of human terminally differentiated CD8+ T cells by inducing a unique gene signature. Int Immunol. 2016 Feb 8. [PMID: 26857736]
• Umeshappa, C.S., Singha, S., Blanco, J., Shao, K., Nanjundappa, R.H., Yamanouchi, J., Parés, A., Serra, P., Yang, Y., Santamaria, P., 2019. Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines. Nat Commun 10. [PMID: 31089130]
• Vedvyas, Y., McCloskey, J.E., Yang, Y., Min, I.M., Fahey, T.J., Zarnegar, R., Hsu, Y.-M.S., Hsu, J.-M., Besien, K.V., Gaudet, I., Law, P., Kim, N.J., Hofe, E. von, Jin, M.M., 2019. Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy. Sci Rep 9. [PMID: 31337787]
• Waldron-Lynch F; Deng S; Preston-Hurlburt P; Henegariu O; Herold KC. 2012. Analysis of Human Biologics With a Mouse Skin Transplant Model in Humanized Mice. Am J Transplant Oct;12(10):2652-62.  [PMID: 22900715]
• Zhang, B., Yeo, R.W.Y., Lai, R.C., Sim, E.W.K., Chin, K.C., Lim, S.K., 2018. Mesenchymal stromal cell exosome-enhanced regulatory T-cell production through an antigen-presenting cell-mediated pathway. Cytotherapy.  [PMID: 29622483]

Humanized immune system: B cell function

• Cantaert T, Schickel JN, Bannock JM, Ng YS, Massad C, Oe T, Wu R, Lavoie A, Walter JE, Notarangelo LD, Al-Herz W, Kilic SS, Ochs HD, Nonoyama S, Durandy A, Meffre E. Activation-Induced Cytidine Deaminase Expression in Human B Cell Precursors Is Essential for Central B Cell Tolerance. Immunity. 2015 Nov 2. [PMID: 26546282]
• Choi B; Chun E; Kim M; Kim ST; Yoon K; Lee KY; Kim SJ. 2010. Human B Cell Development and Antibody Production in Humanized NOD/SCID/IL-2Rγ(null) (NSG) Mice Conditioned by Busulfan. J Clin Immunol Apr;31(2):253-64 [PMID: 20981478]
• Chung YS, Son JK, Choi B, Park JB, Chang J, Kim SJ. Transplantation of human spleen into immunodeficient NOD/SCID IL2Rγnull mice generates humanized mice that improve functional B cell development. Clin Immunol. 2015 Sep 7. [PMID: 26360254]
• Ippolito GC; Hoi KH; Reddy ST; Carroll SM; Ge X; Rogosch T; Zemlin M; Shultz LD; Ellington AD; Vandenberg CL; Georgiou G. 2012. Antibody Repertoires in Humanized NOD-scid-IL2Rγ(null) Mice and Human B Cells Reveals Human-Like Diversification and Tolerance Checkpoints in the Mouse. PLoS One 7(4):e35497. [PMID: 22558161]
• Ishikawa Y; Usui T; Shiomi A; Shimizu M; Murakami K; Mimori T. 2014. Functional engraftment of human peripheral T and B cells and sustained production of autoantibodies in NOD/LtSzscid/IL-2Rγ(-/-) mice. Eur J Immunol. Nov;44(11):3453-63. [PMID: 25154613]
• Levy, C., Fusil, F., Amirache, F., Costa, C., Girard, A., Negre, D., Bernadin, O., Garaulet, G., Rodriguez, A., Nair, N., Vandendriessche, T., Chuah, M., Cosset, F.-L., Verhoeyen, E., 2016. Baboon envelope pseudotyped lentiviral vectors transduce efficiently human B cells and allow active factor IX B cell secretion in vivo in NOD/SCID mice. J. Thromb. Haemost. JTH. doi:10.1111/jth.13520 [PMID: 27685947]
• Deng J, Pennati A, Cohen JB, Wu Y, Ng S, Wu JH, Flowers CR, Galipeau J. 2016. GIFT4 fusokine converts leukemic B cells into immune helper cells. J Transl Med. Apr 27;14(1):106. doi: 10.1186/s12967-016-0865-1. [PMID: 27118475]

Humanized immune system: myeloerythroid lineages

• Chen P, Huang Y, Womer KL. Effects of mesenchymal stromal cells on human myeloid dendritic cell differentiation and maturation in a humanized mouse model.  J Immunol Methods. 2015 Oct 30. [PMID: 26522667]
• Cheung AM; Leung D; Rostamirad S; Dhillon K; Miller PH; Droumeva R; Brinkman RR; Hogge D; Roy DC; Eaves CJ. 2012. Distinct but phenotypically heterogeneous human cell populations produce rapid recovery of platelets and neutrophils post-transplant. Blood Apr 12;119(15):3431-9. [PMID: 22374695]
• Coughlan AM; Freeley SJ; Robson MG. 2012. Humanised mice have functional human neutrophils. J Immunol Methods. Nov 30;385(1-2):96-104 [PMID: 22917930]
• de Graaff MA, Yu JS, Beird HC, Ingram DR, Nguyen T, Juehui Liu J, Bolshakov S, Szuhai K, Åman P, Torres KE, Lev D, Nielsen TO, Bovée JV, Lazar AJ, Somaiah N. 2016. Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation. Lab Invest. Jun 6. doi: 10.1038/labinvest.2016.64. [Epub ahead of print] [PMID: 27270875]
• Duffy D; Perrin H; Abadie V; Benhabiles N; Boissonnas A; Liard C; Descours B; Reboulleau D; Bonduelle O; Verrier B; Van Rooijen N; Combadière C; Combadière B. 2012. Neutrophils transport antigen from the dermis to the bone marrow, initiating a source of memory CD8(+) T cells. Immunity. Nov 16;37(5):917-29. [PMID: 23142782]
• Gille C; Orlikowsky TW; Spring B; Hartwig UF; Wilhelm A; Wirth A; Goecke B; Handgretinger R; Poets CF; André MC. 2012. Monocytes derived from humanized neonatal NOD/SCID/IL2Rγ(null) mice are phenotypically immature and exhibit functional impairments. Hum Immunol Apr;73(4):346-54. [PMID: 22330087]
• Ghinassi B; Ferro L; Masiello F; Tirelli V; Sanchez M; Migliaccio G; Whitsett C; Kachala S; Riviere I; Saledain M; Migliaccio AR. 2011. Recovery and Biodistribution of Ex Vivo Expanded Human Erythroblasts Injected into NOD/SCID/IL2Rg(null) Mice. Stem Cells International. 673752 [PMID: 21912558]
• Hayakawa J; Hsieh MM; Anderson DE; Phang O; Uchida N; Washington K; Tisdale JF. 2010. The assessment of human erythroid output in NOD/SCID mice reconstituted with human hematopoietic stem cells. Cell Transplant Nov;19(11):1465-1473 [PMID: 20587140]
• Hu Z; Van Rooijen N; Yang YG. 2011. Macrophages prevent human red blood cell reconstitution in immunodeficient mice. Blood Nov 24;118(22):5938-46. [PMID: 21926352]
• Ishikawa F; Niiro H; Iino T; Yoshida S; Saito N; Onohara S; Miyamoto T; Minagawa H; Fujii S; Shultz LD; Harada M; Akashi K. 2007. The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathways. Blood 110(10):3591-660. [PMID: 17664352]
• Kundu, K., Ghosh, S., Sarkar, R., Edri, A., Brusilovsky, M., Gershoni-Yahalom, O., Yossef, R., Shemesh, A., Soria, J.-C., Lazar, V., Joshua, B.-Z., S Campbell, K., Elkabets, M., Porgador, A., 2019. Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA. Cancer Immunol Res. [PMID: 31164357]
• Lamarche, C., Orio, J., Georges-Tobar, V., Pincez, T., Goupil, M., Dahmani, A., Carli C, C., Brasey, A., Busque, L., Delisle, J.-S., 2017. Clinical-scale Rapid Autologous BK-virus Specific T Cell Line generation from Kidney Transplant Recipients with Active Viremia for Adoptive Immunotherapy. Transplantation. doi:10.1097/TP.0000000000001698. [PMID: 28230645]
• Larson, S.M., Truscott, L.C., Chiou, T.-T., Patel, A., Kao, R., Tu, A., Tyagi, T., Lu, X., Elashoff, D., De Oliveira, S.N., 2017. Pre-clinical development of gene modification of hematopoietic stem cells with chimeric antigen receptors for cancer immunotherapy. Hum. Vaccines Immunother. 0. doi:10.1080/21645515.2016.1268745. [PMID: 28059624]
• Le, Y., Gao, H., Bleday, R., Zhu, Z., 2018. The homeobox protein VentX reverts immune suppression in the tumor microenvironment. Nat Commun 9, 2175. [PMID: 29872044]
• Li Y; Chen Q; Zheng D; Yin L; Chionh YH; Wong LH; Tan SQ; Tan TC; Chan JK; Alonso S; Dedon PC; Lim B; Chen J. 2013. Induction of Functional Human Macrophages from Bone Marrow Promonocytes by M-CSF in Humanized Mice. J Immunol.  Sep 15;191(6):3192-9.[PMID: 23935193]
• Luther C; Warner K; Takei F. 2011. Unique progenitors in mouse lymph node develop into CD127+ NK cells: thymus-dependent and thymus-independent pathways. Blood Apr 14;117(15):4012-21. [PMID:  21355093]
• Meixlsperger S; Leung CS; Rämer PC; Pack M; Vanoaica LD; Breton G; Pascolo S; Salazar AM; Dzionek A; Schmitz J; Steinman RM; Münz C. 2013. CD141+ dendritic cells produce prominent amounts of IFN-α after dsRNA recognition and can be targeted via DEC-205 in humanized mice. Blood. Jun 20;121(25):5034-44. [PMID: 23482932]
• Miller PH; Cheung AM; Beer PA; Knapp DJ; Dhillon K; Rabu G; Rostamirad S; Humphries RK; Eaves CJ. 2013. Enhanced normal short term human myelopoiesis in mice engineered to express human-specific myeloid growth factors. Blood. Jan 31;121(5):e1-4. [PMID: 23233660]
• Parekh C; Sahaghian A; Kim W; Scholes J; Ge S; Zhu Y; Asgharzadeh S; Hollis R; Kohn D; Ji L; Malvar J; Wang X; Crooks G. 2012. Novel pathways to erythropoiesis induced by dimerization of intracellular C-mpl in human hematopoietic progenitors. Stem Cells Apr;30(4):697-708. [PMID: 22290824]
• Shin JW; Swift J; Spinler KR; Discher DE. 2011. Myosin-II inhibition and soft 2D matrix maximize multinucleation and cellular projections typical of platelet-producing megakaryocytes. Proc Natl Acad Sci U S A. Jul 12;108(28):11458-63. [PMID: 21709232]
• Strowig T; Chijioke O; Carrega P; Arrey F; Meixlsperger S; Rämer PC; Ferlazzo G; Münz C. 2010. Human NK cells of mice with reconstituted human immune system components require pre-activation to acquire functional competence. Blood 2010 Nov 18;116(20):4158-67 [PMID: 20671122]
• Tanaka S; Saito Y; Kunisawa J; Kurashima Y; Wake T; Suzuki N; Shultz LD; Kiyono H; Ishikawa F. 2012. Development of Mature and Functional Human Myeloid Subsets in Hematopoietic Stem Cell-Engrafted NOD/SCID/IL2rγKO Mice. J Immunol. Jun 15;188(12):6145-55 [PMID: 22611244]
• Yang D; Zhang X; Dong Y; Liu X; Wang T; Wang X; Geng Y; Fang S; Zheng Y; Chen X; Chen J; Pan G; Wang J. 2015. Enforced expression of Hoxa5 in hematopoietic stem cells leads to aberrant erythropoiesis in vivo. Cell Cycle. Jan 15; Epub ahead of print. [PMID: 25590986]

NSG as a superior host for human immune system components

• Brehm MA; Cuthbert A; Yang C; Miller DM; DiIorio P; Laning J; Burzenski L; Gott B; Foreman O; Kavirayani A; Herlihy M; Rossini AA; Shultz LD; Greiner DL. 2010. Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation. Clin Immunol Apr;135(1):84-98. [PMID: 20096637]
• Carpenter RS, Kigerl KA, Marbourg JM, Gaudet AD, Huey D, Niewiesk S, Popovich PG. Traumatic spinal cord injury in mice with human immune systems. Exp Neurol. 2015 Jul 17;271:432-444. Epub ahead of print. [PMID: 26193167]
• Carriglio, N., Klapwijk, J., Hernandez, R.J., Vezzoli, M., Chanut, F., Lowe, R., Elena, D., Nord, M., Albertini, P., Cristofori, P., Richards, J., Staton, H., Appleby, J., Aiuti, A., Sauer, A.V., 2017. Good Laboratory Practice Preclinical Safety Studies for GSK2696273 (MLV Vector-Based Ex Vivo Gene Therapy for Adenosine Deaminase Deficiency Severe Combined Immunodeficiency) in NSG Mice. Hum. Gene Ther. Clin. Dev. 28, 17–27. [PMID: 28319446]
• Durost, P., Aryee, K.-E., Manzoor, F., Tisch, R., Mueller, C., Jurczyk, A., Shultz, L., Brehm, M., 2017. Gene therapy with an AAV vector expressing human IL-2 alters immune system homeostasis in humanized mice. Hum. Gene Ther. doi:10.1089/hum.2017.072. [PMID: 28826231]
• Knibbe-Hollinger JS, Fields NR, Chaudoin TR, Epstein AA, Makarov E, Akhter SP, Gorantla S, Bonasera SJ, Gendelman HE, Poluektova LY. Influence of age, irradiation and humanization on NSG mouse phenotypes. Biol Open. 2015 Sep 9. [PMID: 26353862]
• Liu, H., Xu, Y., Xiang, J., Long, L., Green, S., Yang, Z., Zimdahl, B., Lu, J., Cheng, N., Horan, L.H., Liu, B., Yan, S., Wang, P., Diaz, J., Jin, L., Nakano, Y., Morales, J.F., Zhang, P., Liu, L.-X., Staley, B.K., Priceman, S.J., Brown, C.E., Forman, S.J., Chan, V.W., Liu, C., 2017. Targeting Alpha-Fetoprotein (AFP)-MHC Complex with CAR T-Cell Therapy for Liver Cancer. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 23, 478–488. doi:10.1158/1078-0432.CCR-16-1203. [PMID: 27535982]
• McDermott SP; Eppert K; Lechman E; Doedens M; Dick JE. 2010. Comparison of human cord blood engraftment between immunocompromised mouse strains. Blood Jul 15;116(2):193-200 [PMID: 20404133]
• Pearson, F.E., Chang, K., Minoda, Y., Rojas, I.M.L., Haigh, O.L., Daraj, G., Tullett, K.M., Radford, K.J., 2018. Activation of human CD141+ and CD1c+ dendritic cells in vivo with combined TLR3 and TLR7/8 ligation. Immunol. Cell Biol. 96, 390–400. [PMID: 20404133]
• Roy L. Maute, Sydney R. Gordon, Aaron T. Mayer, Melissa N. McCracken, Arutselvan Natarajan, Nan Guo Ring, Richard Kimura, Jonathan M. Tsai, Aashish Manglik, Andrew C. Kruse, Sanjiv S. Gambhir, Irving L. Weissman, Aaron M. Ring. Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging. PNAS Early Edition. http://www.pnas.org/content/early/2015/11/09/1519623112
• Shultz LD; Lyons BL; Burzenski LM; Gott B; Chen X; Chaleff S; Kotb M; Gillies SD; King M; Mangada J; Greiner DL; Handgretinger R. 2005. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174(10):6477-89. [PMID: 15879151]
• Valentinuzzi, D., Simoncic, U., Ursic, K., Vrankar, M., Turk, M., Jeraj, R., 2018. Predicting tumour response to anti-PD-1 immunotherapy with computational modelling. Phys Med Biol. [PMID:30561383
• Wang, M., Yao, L.-C., Cheng, M., Cai, D., Martinek, J., Pan, C.-X., Shi, W., Ma, A.-H., De Vere White, R.W., Airhart, S., Liu, E.T., Banchereau, J., Brehm, M.A., Greiner, D.L., Shultz, L.D., Palucka, K., Keck, J.G., 2017. Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy. FASEB J. [PMID: 29146734]
• Wunderlich, M., Chou, F.-S., Sexton, C., Presicce, P., Chougnet, C.A., Aliberti, J., Mulloy, J.C., 2018. Improved multilineage human hematopoietic reconstitution and function in NSGS mice. PLoS ONE 13, e0209034. [PMID: 30540841]

NSG strains expressing human cytokine transgenes

• Ali R, Babad J, Follenzi A, Gebe JA, Brehm MA, Nepom GT, Shultz LD, Greiner DL, DiLorenzo TP. 2016. Genetically Modified Human CD4+ T Cells Can Be Evaluated In Vivo Without Lethal Graft Versus Host Disease. Immunology. Apr 28. doi: 10.1111/imm.12613. [PMID: 27124592]
• Billerbeck E; Barry WT; Mu K; Dorner M; Rice CM; Ploss A. 2011. Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor, GM-CSF and interleukin 3 expressing NOD SCID IL2R{gamma}NULL humanized mice. Blood Mar 17;117(11):3076-86. [PMID: 21252091]
• Brehm MA; Racki WJ; Leif J; Burzenski L; Hosur V; Wetmore A; Gott B; Herlihy M; Ignotz R; Dunn R; Shultz LD; Greiner DL. 2012. Engraftment of human HSCs in nonirradiated newborn NOD-scid IL2rγnull mice is enhanced by transgenic expression of membrane-bound human SCF. Blood Mar 22;119(12):2778-88. [PMID: 22246028]
• Montano Almendras, C.P., Thudium, C.S., Löfvall, H., Moscatelli, I., Schambach, A., Henriksen, K., Richter, J., 2017. Forced expression of human M-CSF in CD34+ cells promotes monocyte differentiation in vitro and in vivo but blunts osteoclastogenesis in vitro. Eur. J. Haematol. doi:10.1111/ejh.12867. [PMID: 28160330]
• Takagi S; Saito Y; Hijikata A; Tanaka S; Watanabe T; Hasegawa T; Mochizuki S; Kunisawa J; Kiyono H; Koseki H; Ohara O; Saito T; Taniguchi S; Shultz LD; Ishikawa F. 2012. Membrane-bound human SCF/KL promotes in vivo human hematopoietic engraftment and myeloid differentiation. Blood Mar 22;119(12):2768-77. [PMID: 22279057]

NSG strains expressing HLA transgenes

• Herr, W., Eichinger, Y., Beshay, J., Bloetz, A., Vatter, S., Mirbeth, C., Distler, E., Hartwig, U.F., Thomas, S., 2017. HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation. Leukemia 31, 434–445. doi:10.1038/leu.2016.210. [PMID: 27479183]
• Huang Y, Elliott MJ, Yolcu ES, Miller TO, Ratajczak J, Bozulic LD, Wen Y, Xu H, Ratajczak MZ, Ildstad ST. Characterization of Human CD8(+) TCR(-) Facilitating Cells In Vitro and In Vivo in a NOD/SCID/IL2rγ(null) Mouse Model. Am J Transplant. 2016 Feb;16(2):440-53. doi: 10.1111/ajt.13511. Epub 2015 Nov 9. [PMID: 26550777]
• Pearson, F.E., Chang, K., Minoda, Y., Leal Rojas, I.M., Haigh, O.L., Daraj, G., Tullett, K.M., Radford, K.J., 2018. Activation of human CD141+ and CD1c+ dendritic cells in vivo with combined TLR 3 and TLR 7/8 ligation. Immunol. Cell Biol. [PMID: 29344995]
• Shultz LD; Saito Y; Najima Y; Tanaka S; Ochi T; Tomizawa M; Doi T; Sone A; Suzuki N; Fujiwara H; Yasukawa M; Ishikawa F. 2010. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma-null humanized mice. Proc Natl Acad Sci U S A Jul 20;107(29):13022-7. [PMID: 20615947]
• Sun YQ, Zhang Y, Li X, Deng MX, Gao WX, Yao Y, Chiu SM, Liang X, Gao F, Chan CW, Tse HF, Shi J, Fu QL, Lian Q. Insensitivity of Human iPS Cells-Derived Mesenchymal Stem Cells to Interferon-γ-induced HLA Expression Potentiates Repair Efficiency of Hind Limb Ischemia in Immune Humanized NOD Scid Gamma Mice. Stem Cells. 2015 Jul 14. [PMID: 26175298]

Reviews and protocols

• Duchez, P., Rodriguez, L., Chevaleyre, J., De La Grange, P.B., Ivanovic, Z., 2016. Clinical-scale validation of a new efficient procedure for cryopreservation of ex vivo expanded cord blood hematopoietic stem and progenitor cells. Cytotherapy 18, 1543–1547. [PMID: 27592406]
• Hosur, V., Low, B.E., Avery, C., Shultz, L.D., Wiles, M.V., 2017. Development of Humanized Mice in the Age of Genome Editing. J. Cell. Biochem. [PMID: 28332231]
• Ishikawa F; Saito Y; Yoshida S; Harada M; Shultz LD. 2008. The differentiative and regenerative properties of human hematopoietic stem/progenitor cells in NOD-SCID/IL2rgamma(null) mice. Curr Top Microbiol Immunol 324:87-94. [PMID: 18481454]
• Li, F., Ulrich, M.L., Shih, V.F.-S., Cochran, J.H., Hunter, J.H., Westendorf, L., Neale, J., Benjamin, D.R., 2019. Mouse Strains Influence Clearance and Efficacy of Antibody and Antibody-Drug Conjugate Via Fc-FcγR Interaction. Mol. Cancer Ther. 18, 780—787. [PMID: 30824607
• Pearson T; Greiner DL; Shultz LD. 2008. Creation of "humanized" mice to study human immunity. Curr Protoc Immunol May;Chapter 15:Unit 15.21. [PMID: 18491294]
• Shultz LD; Ishikawa F; Greiner DL. 2007. Humanized mice in translational biomedical research. Nat Rev Immunol 7(2):118-30. [PMID: 17259968]
• Shultz LD; Brehm MA; Garcia-Martinez JV; Greiner DL. 2012. Humanized mice for immune system investigation: progress; promise and challenges. Nat Rev Immunol. Nov;12(11):786-98. [PMID: 23059428]
• Skelton, J.K., Ortega-Prieto, A.M., Dorner, M., 2018. A Hitchhiker’s Guide to Humanized Mice: new pathways to studying viral infections. Immunology. [PMID: 29446074]

Transplantation research / graft-versus-host disease (GVHD) / PBMC engraftment

• Abraham, M., Pereg, Y., Bulvik, B., Klein, S., Mishalian, I., Wald, H., Eizenberg, O., Beider, K., Nagler, A., Golan, R., Vainstein, A., Aharon, A., Galun, E., Caraco, Y., Or, R., Peled, A., 2017. Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34(+) Cells in Healthy Volunteers. Clin. Cancer Res. 23, 6790–6801.  [PMID: 28835380]
• Abraham, S., Guo, H., Choi, J.-G., Ye, C., Thomas, M.B., Ortega, N., Dwivedi, A., Manjunath, N., Yi, G., Shankar, P., 2017. Combination of IL-10 and IL-2 induces oligoclonal human CD4 T cell expansion during xenogeneic and allogeneic GVHD in humanized mice. Heliyon 3, e00276. doi:10.1016/j.heliyon.2017.e00276.  [PMID: 28409183]
• Ali N; Flutter B; Sanchez Rodriguez R; Sharif-Paghaleh E; Barber LD; Lombardi G; Nestle FO. 2012. Xenogeneic Graft-versus-Host-Disease in NOD-scid IL-2Rγ(null) Mice Display a T-Effector Memory Phenotype. PLoS One 7(8):e44219.  [PMID: 22937164]
• Bohana-Kashtan O; Morisot S; Hildreth R; Brayton C; Levitsky HI; Civin CI. 2009. Selective reduction of graft-versus-host disease-mediating human T cells by ex vivo treatment with soluble Fas ligand. J Immunol Jul 1;183(1):696-705. [PMID:19535642]
• Borel, F., Tang, Q., Gernoux, G., Greer, C., Wang, Z., Barzel, A., Kay, M.A., Shultz, L.D., Greiner, D.L., Flotte, T.R., Brehm, M.A., Mueller, C., 2017. Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency. Mol. Ther. 25, 2477–2489. [PMID: 29032169]
• Brehm, M.A., Kenney, L.L., Wiles, M.V., Low, B.E., Tisch, R.M., Burzenski, L., Mueller, C., Greiner, D.L., Shultz, L.D., 2018. Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression. FASEB J. fj201800636R. [PMID: 30383447]
• Bruck F; Belle L; Lechanteur C; De Leval L; Hannon M; Dubois S; Castermans E; Humblet-Baron S; Rahmouni S; Beguin Y; Briquet A; Baron F. 2013. Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease. Cytotherapy. Mar;15(3):267-79. [PMID: 23265769]
• Burger, D.R., Parker, Y., Guinta, K., Lindner, D., 2017. PRO 140 Monoclonal Antibody to CCR5 Prevents Acute Xenogeneic Graft-Versus-Host Disease in NOD-Scid IL-2Ry(null) Mice. Biol. Blood Marrow Transplant. [PMID: 29128556]
• Chandra, S., Cristofori, P., Fonck, C., O'Neill, C.A., 2019. Ex Vivo Gene Therapy: Graft-versus-host Disease (GVHD) in NSG™ (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ) Mice Transplanted with CD34+ Human Hematopoietic Stem Cells. Toxicol Pathol 192623319844484. [PMID: 31064282]
• Chu CC; Ali N; Karagiannis P; Di Meglio P; Skowera A; Napolitano L; Barinaga G; Grys K; Sharif-Paghaleh E; Karagiannis SN; Peakman M; Lombardi G; Nestle FO. 2012 Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation. J Exp Med May 7;209(5):935-45. [PMID: 22547651]
• Cimbro R; Vassena L; Arthos J; Cicala C; Kehrl JH; Park C; Sereti I; Lederman MM; Fauci AS; Lusso P. 2012. Interleukin-7 induces expression and activation of integrin α4β7 promoting naive T-cell homing to the intestinal mucosa. Blood.Sep 27;120(13):2610-9.[PMID: 22896005]
• Covassin L; Jangalwe S; Jouvet N; Laning J; Burzenski L; Shultz LD; Brehm MA. 2013. Human immune system development and survival of NOD-scid IL2rγnull (NSG) mice engrafted with human thymus and autologous hematopoietic stem cells. Clin Exp Immunol. Dec;174(3):372-88. [PMID: 23869841]
• Delens, L., Ehx, G., Somja, J., Vrancken, L., Belle, L., Seidel, L., Grégoire, C., Fransolet, G., Ritacco, C., Hannon, M., Dubois, S., Beguin, Y., Baron, F., Servais, S., 2018. In vitro Th17-polarized human CD4+ T cells exacerbate xenogeneic graft-versus-host disease. Biol. Blood Marrow Transplant.[PMID: 30326279]
• Del Papa, B., Ruggeri, L., Urbani, E., Baldoni, S., Cecchini, D., Zei, T., Iacucci Ostini, R., Crescenzi, B., Carotti, A., Pierini, A., Sportoletti, P., Di Bartolomeo, P., Falzetti, F., Mecucci, C., Velardi, A., Martelli, M.F., Di Ianni, M., 2017. Clinical-Grade Expanded Tregs Prevent GvHD While Allowing a Powerful T-Cell Dependent GvL Effect in Murine Models. Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant. doi:10.1016/j.bbmt.2017.07.009. [PMID: 28729148]
• Fujii H; Luo ZJ; Kim HJ; Newbigging S; Gassas A; Keating A; Egeler RM. Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation. PLoS One. 2015 Jul 15;10(7):e0133216. [PMID: 26176698]
• Geraghty, N.J., Belfiore, L., Ly, D., Adhikary, S.R., Fuller, S.J., Varikatt, W., Sanderson-Smith, M.L., Sluyter, V., Alexander, S.I., Sluyter, R., Watson, D., 2017. The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon-γ in a humanized mouse model of graft-versus-host disease. Clin. Exp. Immunol. doi:10.1111/cei.13005. [PMID: 28665482]
• Geraghty, N.J., Belfiore, L., Adhikary, S.R., Alexander, S.I., Sluyter, R., Watson, D., 2019. Increased splenic human CD4+:CD8+ T cell ratios, serum human interferon-γ and intestinal human interleukin-17 are associated with clinical graft-versus-host disease in humanized mice. Transpl. Immunol. [PMID: 30743002]
• Grégoire, C., Ritacco, C., Hannon, M., Seidel, L., Delens, L., Belle, L., Dubois, S., Vériter, S., Lechanteur, C., Briquet, A., Servais, S., Ehx, G., Beguin, Y., Baron, F., 2019. Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model. Front Immunol 10, 619. [PMID: 31001253]
• Gregoire-Gauthier J; Durrieu L; Duval A; Fontaine F; Dieng MM; Bourgey M; Patey-Mariaud de Serre N; Louis I; Haddad E. 2012. Use of immunoglobulins in the prevention of GvHD in a xenogeneic NOD/SCID/γc- mouse model. Bone Marrow Transplant. Mar;47(3):439-50. [PMID: 21572464]
• Gregoire-Gauthier J; Fontaine F; Benchimol L; Nicoletti S; Selleri S; Dieng MM; Haddad E. 2015. Role of Natural Killer Cells in Intravenous Immunoglobulin-Induced Graft-versus-Host Disease Inhibition in NOD/LtSz-scidIL2rg-/- (NSG) Mice. Biol Blood Marrow Transplant. Jan 14; Epub ahead of print. [PMID: 25596424]
• Hemmerling J; Wegner-Kops J; von Stebut E; Wolff D; Wagner EM; Hartwig UF; André MC; Theobald M; Schopf RE; Herr W; Meyer RG. 2011. Human Epidermal Langerhans Cells Replenish Skin Xenografts and Are Depleted by Alloreactive T Cells In Vivo. J Immunol Aug 1;187(3):1142-9. [PMID: 21697461]
• Ito S; Barrett AJ; Dutra A; Pak E; Miner S; Keyvanfar K; Hensel NF; Rezvani K; Muranski P; Liu P; Melenhorst JJ; Larochelle A. 2015. Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells. Stem Cell Res. Jan;14(1):95-104. [PMID: 25535865]
• Janikashvili N; Trad M; Gautheron A; Samson M; Lamarthée B; Bonnefoy F; Lemaire-Ewing S; Ciudad M; Rekhviashvili K; Seaphanh F; Gaugler B; Perruche S; Bateman A; Martin L; Audia S; Saas P; Larmonier N; Bonnotte B. 2015. Human monocyte-derived suppressor cells control graft-versus-host disease by inducing regulatory forkhead box protein 3-positive CD8+ T lymphocytes. J Allergy Clin Immunol. Jan 25; Epub ahead of print. [PMID: 25630940]
• King MA; Covassin L; Brehm MA; Racki W; Pearson T; Leif J; Laning J; Fodor W; Foreman O; Burzenski L; Chase TH; Gott B; Rossini AA; Bortell R; Shultz LD; Greiner DL. 2009. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin Exp Immunol Jul;157(1):104-18. [PMID: 19659776]
• Kirkiles-Smith NC; Harding MJ; Shepherd BR; Fader SA; Yi T; Wang Y; McNiff JM; Snyder EL; Lorber MI; Tellides G; Pober JS. 2010. Development of a humanized mouse model to study the role of macrophages in allograft injury. Transplantation Jan 27;87(2):189-97. [PMID: 19155972]
• Laing ST; Griffey SM; Moreno ME; Stoddart CA. J Comp Pathol. CD8-positive Lymphocytes in Graft-Versus-Host Disease of Humanized NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ Mice.  2015 Feb 7. Epub ahead of print.  [PMID: 25670669]
• McIntosh BE; Brown ME; Duffin BM; Maufort JP; Vereide DT; Slukvin II; Thomson JA. 2015. Nonirradiated NOD;B6.SCID Il2rγ-/-KitW41/W41 (NBSGW) Mice Support Multilineage Engraftment of Human Hematopoietic Cells. Stem Cell Reports. Epub ahead of print. [PMID: 25601207]
• Nolte T; Zadeh-Khorasani M; Safarov O; Rueff F; Varga R; Herbach N; Wanke R; Wollenberg A; Mueller T; Gropp R; Wolf E; Siebeck M. 2013. Induction of oxazolone-mediated features of atopic dermatitis in NOD-scid IL2Rγnull mice engrafted with human peripheral blood mononuclear cells. Dis Model Mech. Jan;6(1):125-34. [PMID: 22822046]
• Ono, R., Watanabe, T., Kawakami, E., Iwasaki, M., Tomizawa-Murasawa, M., Matsuda, M., Najima, Y., Takagi, S., Fujiki, S., Sato, R., Mochizuki, Y., Yoshida, H., Sato, K., Yabe, H., Kato, S., Saito, Y., Taniguchi, S., Shultz, L.D., Ohara, O., Amagai, M., Koseki, H., Ishikawa, F., 2019. Co-activation of macrophages and T cells contribute to chronic GVHD in human IL-6 transgenic humanised mouse model. EBioMedicine. [PMID: 30772305]
• Pino S; Brehm MA; Covassin-Barberis L; King M; Gott B; Chase TH; Wagner J; Burzenski L; Foreman O; Greiner DL; Shultz LD. 2010. Development of Novel Major Histocompatibility Complex Class I and Class II-Deficient NOD-SCID IL2R Gamma Chain Knockout Mice for Modeling Human Xenogeneic Graft-Versus-Host Disease. Methods Mol Biol 602:105-17. [PMID: 20012395]
• Racki WJ; Covassin L; Brehm M; Pino S; Ignotz R; Dunn R; Laning J; Graves SK; Rossini AA; Shultz LD; Greiner DL. 2010 NOD-scid IL2rgamma(null) mouse model of human skin transplantation and allograft rejection. Transplantation Mar 15;89(5):527-36. [PMID: 20134397]
• Ranjan, S., Goihl, A., Kohli, S., Gadi, I., Pierau, M., Shahzad, K., Gupta, D., Bock, F., Wang, H., Shaikh, H., Kähne, T., Reinhold, D., Bank, U., Zenclussen, A.C., Niemz, J., Schnöder, T.M., Brunner-Weinzierl, M., Fischer, T., Kalinski, T., Schraven, B., Luft, T., Huehn, J., Naumann, M., Heidel, F.H., Isermann, B., 2017. Activated protein C protects from GvHD via PAR2/PAR3 signalling in regulatory T-cells. Nat. Commun. 8, 311. doi:10.1038/s41467-017-00169-4. [PMID: 28827518]
• Scalley-Kim ML; Hess BW; Kelly RL; Krostag AR; Lustig KH; Marken JS; Ovendale PJ; Posey AR; Smolak PJ; Taylor JD; Wood CL; Bienvenue DL; Probst P; Salmon RA; Allison DS; Foy TM; Raport CJ. 2012. A novel highly potent therapeutic antibody neutralizes multiple human chemokines and mimics viral immune modulation. PLoS One. 7(8):e43332. [PMID: 22912856]
• Sonntag K; Eckert F; Welker C; Müller H, Müller F; Zips D; Sipos B; Klein R; Blank G; Feuchtinger T; Schumm M; Handgretinger R; Schilbach K. Chronic graft-versus-host-disease in CD34+-humanized NSG mice is associated with human susceptibility HLA haplotypes for autoimmune disease. J Autoimmun. 2015 Jul 2. Epub ahead of print. [PMID: 26143958]
• Tobin LM; Healy ME; English K; Mahon BP. 2013. Human mesenchymal stem cells suppress donor CD4(+) T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host disease. Clin Exp Immunol. May;172(2):333-48. [PMID: 23574329]
• Touil S; Rosenzwajg M; Landau DA; Le Corvoisier P; Frédéric C; Klatzmann D; Maury S; Cohen JL. 2012. Depletion of T regulatory cells through selection of CD127-positive cells results in a population enriched in memory T cells: implications for anti-tumor cell therapy. Haematologica. Nov;97(11):1678-85. [PMID: 22581007]
• Van Elssen, C.H.M.J., Rashidian, M., Vrbanac, V., Wucherpfennig, K.W., El Habre, Z., Sticht, J., Freund, C., Jacobsen, J., Cragnolini, J., Ingram, J., Plaisier, L., Spierings, E., Tager, A.M., Ploegh, H., 2017. Noninvasive imaging of human immune responses in a human xenograft model of graft-versus-host disease. J. Nucl. Med. Off. Publ. Soc. Nucl. Med. doi:10.2967/jnumed.116.186007. [PMID: 28209904]
• Vlad G; Stokes MB; Liu Z; Chang CC; Sondermeijer H; Vasilescu ER; Colovai AI; Berloco P; D'Agati VD; Ratner L; Cortesini R; Suciu-Foca N. 2009. Suppression of xenogeneic graft-versus-host disease by treatment with immunoglobulin-like transcript 3-Fc. Hum Immunol Sep;70(9):663-9. PMID: 19501624]
• Walcher, L., Müller, C., Hilger, N., Kretschmer, A., Stahl, L., Wigge, S., Rengelshausen, J., Müller, A.M., Fricke, S., 2018. Effect of combined sublethal X-ray irradiation and cyclosporine A treatment in NOD scid gamma (NSG) mice. Exp. Anim. [PMID:30078790]
• Zadeh-Khorasani M; Nolte T; Mueller TD; Pechlivanis M; Rueff F; Wollenberg A; Fricker G; Wolf E; Siebeck M; Gropp R. 2013. NOD-scid IL2R γnull mice engrafted with human peripheral blood mononuclear cells as a model to test therapeutics targeting human signaling pathways. J Transl Med. Jan 7;11:4. [PMID: 23294516]
• Zhou F, Fortin J, Chen H, Martinez-Diaz H, Chang L, Reynolds B, Roper S. Functional integration of human neural precursor cells in mouse cortex. Plos One. 2015 Mar 12; 10(3): e0120281. [PMID: 25763840]

Vaccines

• Ivanova, I.I., Mihaylova, N.M., Manoylov, I.K., Makatsori, D., Lolov, S., Nikolova, M.H., Mamalaki, A., Prechl, J., Tchorbanov, A.I., 2018. Targeting of Influenza Viral Epitopes to Antigen-Presenting Cells by Genetically Engineered Chimeric Molecules in a Humanized NOD SCID Gamma Transfer Model. Hum. Gene Ther. 29, 1056–1070. [PMID: 30191743] 
• Khalaf, O.H., Chaki, S.P., Garcia-Gonzalez, D.G., Ficht, T.A., Arenas-Gamboa, A.M., 2019. The NOD-scid IL2rγnull Mouse Model Is Suitable for the Study of Osteoarticular Brucellosis and Vaccine Safety. Infect. Immun. 87. [PMID: 30936160]
• Pagovich, O.E., Wang, B., Chiuchiolo, M.J., Kaminsky, S.M., Sondhi, D., Jose, C.L., Price, C.C., Brooks, S.F., Mezey, J.G., Crystal, R.G., 2016. Anti-hIgE gene therapy of peanut-induced anaphylaxis in a humanized murine model of peanut allergy. J. Allergy Clin. Immunol. 138, 1652–1662.e7. [PMID: 27372563]
• Spranger S; Frankenberger B; Schendel DJ. 2012. NOD/scid IL-2Rgnull mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo. J Transl Med Feb 25;10:30. [PMID: 22364226]

Autoimmunity

• Ishikawa Y; Usui T; Shiomi A; Shimizu M; Murakami K; Mimori T. 2014. Functional engraftment of human peripheral T and B cells and sustained production of autoantibodies in NOD/LtSzscid/IL-2Rgamma mice. Eur J Immunol. Aug 22. [PMID: 25154613] [PMID: 25154613]
• Little MA; Al-Ani B; Ren S; Al-Nuaimi H; Leite M Jr; Alpers CE; Savage CO; Duffield JS. 2012. Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system. PLoS One 7(1):e28626. [PMID: 22247758]
• Nishime C, Kawai K, Yamamoto T, Katano I, Monnai M, Goda N, Mizushima T, Suemizu H, Nakamura M, Murata M, Suematsu M, Wakui M. Innate Response to Human Cancer Cells with or without IL-2 Receptor Common γ-Chain Function in NOD Background Mice Lacking Adaptive Immunity. J Immunol. 2015 Aug 15;195(4):1883-90. [PMID: 26170385]

Inflammation

• Goettel, J., Kotlarz, D., Illig, D., Canavan, J., Allegretti, J., Hamilton, M., Kelly, R., Griffith, A., Carellas, M., Nelina, A., Bousvaros, A., Korzenik, J., Snapper, S., 2017. O-011 Low-dose IL-2 Administration Expands Human Regulatory T Cells in Patients with UC and Humanized Mice and Protects Against Experimental Colitis. Inflamm. Bowel Dis. 23 Suppl 1, S4. doi:10.1097/01.MIB.0000512521.84210.0b. [PMID: 28125559]
• Jodeleit, H., Palamides, P., Beigel, F., Mueller, T., Wolf, E., Siebeck, M., Gropp, R., 2017. Design and validation of a disease network of inflammatory processes in the NSG-UC mouse model. J Transl Med 15, 265. [PMID: 29282132]
• Lee, J.S., Jeong, S.-J., Kim, S., Chalifour, L., Yun, T.J., Miah, M.A., Li, B., Majdoubi, A., Sabourin, A., Keler, T., Guimond, J.V., Haddad, E., Choi, E.-Y., Epelman, S., Choi, J.-H., Thibodeau, J., Oh, G.T., Cheong, C., 2018. Conventional Dendritic Cells Impair Recovery after Myocardial Infarction. J. Immunol. [PMID: 30097529]
• Li-Ping Thio, C., Chuan-Ying Lai, A., Chi, P.-Y., Webster, G., Chang, Y.-J., 2019. TLR9-dependent interferon production prevents group 2 innate lymphoid cell-driven airway hyperreactivity. J. Allergy Clin. Immunol.[PMID: 30914379]
• Manocha, G.D., Floden, A.M., Puig, K.L., Nagamoto-Combs, K., Scherzer, C.R., Combs, C.K., 2017. Defining the contribution of neuroinflammation to Parkinson’s disease in humanized immune system mice. Mol. Neurodegener. 12, 17. doi:10.1186/s13024-017-0158-z. [PMID: 28196514]
• Vizzardelli, C., Gindl, M., Roos, S., Möbs, C., Nagl, B., Zimmann, F., Sexl, V., Kenner, L., Neunkirchner, A., Zlabinger, G.J., Pickl, W.F., Pfützner, W., Bohle, B., 2018. Blocking antibodies induced by allergen-specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric model. Allergy 73, 851–861. [PMID: 29159964]

Malaria

• Arnold L; Tyagi RK; Meija P; Swetman C; Gleeson J; Pérignon JL; Druilhe P. 2011 Further Improvements of the P. falciparum Humanized Mouse Model. PLoS ONE Mar 31;6(3):e18045. [PMID: 21483851]
• Jiménez-Díaz MB; Viera S; Ibáñez J; Mulet T; Magán-Marchal N; Garuti H; Gómez V; Cortés-Gil L; Martínez A; Ferrer S; Fraile MT; Calderón F; Fernández E; Shultz LD; Leroy D; Wilson DM; García-Bustos JF; Gamo FJ; Angulo-Barturen I. 2013. A new in vivo screening paradigm to accelerate antimalarial drug discovery. PLoS One. Jun 25;8(6):e66967. [PMID: 23825598]
• Jiménez-Díaz MB; Mulet T; Viera S; Gómez V; Garuti H; Ibáñez J; Alvarez-Doval A; Shultz LD; Martínez A; Gargallo-Viola D; Angulo-Barturen I. 2009. Improved murine model of malaria using P. falciparum competent strains and non-myelodepleted NOD-scid IL2R{gamma}null mice engrafted with human erythrocytes. Antimicrob Agents Chemother Oct;53(10):4533-6 [PMID: 19596869]
• McCarthy JS, Marquart L, Sekuloski S, Trenholme K, Elliott S, Griffin P, Rockett R, O'Rourke P, Sloots T, Angulo-Barturen I, Ferrer S, Jiménez-Díaz MB, Martínez MS, van Huijsduijnen RH, Duparc S, Leroy D, Wells TN, Baker M, Möhrle JJ. 2016. Linking murine and human Plasmodium falciparum challenge models in a translational path for antimalarial drug development. Antimicrob Agents Chemother. Apr 4. pii: AAC.02883-15. [PMID: 27044554]
• Tyagi, R.K., Gleeson, P.J., Arnold, L., Tahar, R., Prieur, E., Decosterd, L., Pérignon, J.-L., Olliaro, P., Druilhe, P., 2018. High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure. BMC Med 16, 181. [PMID: 30269689]

Candida albicans

• Quintin J; Voigt J; van der Voort R; Jacobsen ID; Verschueren I; Hube B; Giamarellos-Bourboulis EJ; van der Meer JW; Joosten LA; Kurzai O; Netea MG. 2014. Differential role of NK cells against Candida albicans infection in immunocompetent or immunocompromised mice. Eur J Immunol. May 27; 44(8):2405-14. [PMID: 24802993]

Cytomegalovirus

• Dogra, P., Miller-Kittrell, M., Pitt, E., Jackson, J.W., Masi, T., Copeland, C., Wu, S., Miller, W., Sparer, T., 2016. A Little Cooperation Helps Murine Cytomegalovirus Go a Long Way - Co-infection Between MCMVs Rescues A Viral Chemokine Salivary Gland Defect. J. Gen. Virol. doi:10.1099/jgv.0.000603 [PMID: 27638684]
• Livingston-Rosanoff D; Daley-Bauer LP; Garcia A; McCormick AL; Huang J; Mocarski ES. 2012. Antiviral T cell response triggers cytomegalovirus hepatitis in mice. J Virol. Dec;86(23):12879-90. [PMID: 22993151]
• Smith MS; Goldman DC; Bailey AS; Pfaffle DL; Kreklywich CN; Spencer DB; Othieno FA; Streblow DN; Garcia JV; Fleming WH; Nelson JA. 2010. Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model. Cell Host Microbe Sep 16;8(3):284-91. [PMID: 20833379]

Dengue virus

• Cox J; Mota J; Sukupolvi-Petty S; Diamond MS; Rico-Hesse R. 2012. Mosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice. J Virol Jul;86(14):7637-49.[PMID: 22573866]
• Jaiswal S; Pearson T; Friberg H; Shultz LD; Greiner DL; Rothman A; Mathew A. 2009. Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice. PLoS One 2009 Oct 5;4(10):e7251.  [PMID: 19802382]
• Mota J; Rico-Hesse R. 2009. Humanized mice show clinical signs of dengue fever according to infecting virus genotype. J Virol Sep;83(17):8638-45. [PMID: 19535452]
• Subramanya S; Kim SS; Abraham S; Yao J; Kumar M; Kumar P; Haridas V; Lee SK; Shultz L; Greiner D; N M; Shankar P. 2009. Targeted delivery of siRNA to human dendritic cells to suppress Dengue viral infection and associated proinflammatory cytokine production. J Virol Mar;84(5):2490-501. [PMID: 20015996]
• Sridharan A; Chen Q; Tang KF; Ooi EE; Hibberd ML; Chen J. 2013. Inhibition of Megakaryocyte Development in the Bone Marrow Underlies Dengue Virus-induced Thrombocytopenia in Humanized Mice. J Virol. [Epub ahead of print][PMID:23966397]

Ebola Virus

• Lüdtke A, Oestereich L, Ruibal P, Wurr S, Pallasch E, Bockholt S, Ip WH, Rieger T, Gómez-Medina S, Stocking C, Rodríguez E, Günther S, Muñoz-Fontela C. Ebola virus disease in mice with transplanted human hematopoietic stem cells. J Virol. 2015 Apr;89(8):4700-4. [PMID: 25673711]
• Spengler, J.R., Saturday, G., Lavender, K.J., Martellaro, C., Keck, J.G., Nichol, S.T., Spiropoulou, C.F., Feldmann, H., Prescott, J., 2017. Severity of Disease in Humanized Mice Infected with Ebola Virus or Reston Virus is Associated with Magnitude of Early Viral Replication in Liver. J. Infect. Dis. [PMID: 29087482]

Epstein Barr virus

• Kraus, R.J., Yu, X., Cordes, B.-L.A., Sathiamoorthi, S., Iempridee, T., Nawandar, D.M., Ma, S., Romero-Masters, J.C., McChesney, K.G., Lin, Z., Makielski, K.R., Lee, D.L., Lambert, P.F., Johannsen, E.C., Kenney, S.C., Mertz, J.E., 2017. Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus’s natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter. PLoS Pathog. 13, e1006404. doi:10.1371/journal.ppat.1006404 [PMID: 28617871]
• Lai J, Tan WJ, Too CT, Choo JA, Wong LH Bte Mustafa F, Srinivasan N, Lim AP, Zhong Y, Gascoigne NR, Hanson BJ, Chan SH, Chen J, MacAry PA. 2016. Targeting Epstein-Barr virus transformed B lymphoblastoid cells using antibodies with T cell receptor-like specificities. Blood. Jun 23. pii: blood-2016-03-707836. [Epub ahead of print] [PMID: 27338099]
• Ma SD, Xu X, Jones R, Delecluse HJ, Zumwalde NA, Sharma A, Gumperz JE, Kenney SC. 2016. PD-1/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse Model. PLoS Pathog. May 17;12(5):e1005642. doi: 10.1371/journal.ppat.1005642. [PMID: 27186886]
• Ma SD; Yu X; Mertz JE; Gumperz JE; Reinheim E; Zhou Y; Tang W; Burlingham WJ; Gulley ML; Kenney SC. 2012. An Epstein-Barr virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model. J Virol Aug;86(15):7976-87. [PMID: 22623780]
• Strowig T; Gurer C; Ploss A; Liu YF; Arrey F; Sashihara J; Koo G; Rice CM; Young JW; Chadburn A; Cohen JI; Münz C. 2009. Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J Exp Med Jun 8;206(6):1423-34. [PMID: 19487422]
• Wahl A; Linnstaedt SD; Esoda C; Krisko JF; Martinez-Torres F; Delecluse HJ; Cullen BR; Garcia JV. 2013. A Cluster of Virus-encoded microRNAs Accelerates Acute Systemic Epstein-Barr Virus Infection but does not Significantly Enhance Virus-induced Oncogenesis In Vivo. J Virol. May;87(10):5437-46. [PMID: 23468485]
• White RE; Rämer PC; Naresh KN; Meixlsperger S; Pinaud L; Rooney C; Savoldo B; Coutinho R; Bödör C; Gribben J; Ibrahim HA; Bower M; Nourse JP; Gandhi MK; Middeldorp J; Cader FZ; Murray P; Münz C; Allday MJ. 2012. EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. J Clin Invest Apr 2;122(4):1487-502. [PMID: 22406538]

Hepatitis

• Bility MT; Cheng L; Zhang Z; Luan Y; Li F; Chi L; Zhang L; Tu Z; Gao Y; Fu Y; Niu J; Wang F; Su L. 2014. Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages. PLoS Pathog. Mar 20; 10(3):e1004032. [PMID: 24651854]
• Billerbeck E; Horwitz JA; Labitt RN; Donovan BM; Vega K; Budell WC; Koo GC; Rice CM; Ploss A. 2013. Characterization of Human Antiviral Adaptive Immune Responses during Hepatotropic Virus Infection in HLA-Transgenic Human Immune System Mice. J Immunol. Aug 15;191(4):1753-64. [PMID: 23833235]
• Sonntag K, Eckert F, Welker C, Müller H, Müller F, Zips D, Sipos B, Klein R, Blank G, Feuchtinger T, Schumm M, Handgretinger R, Schilbach K. Chronic graft-versus-host-disease in CD34+-humanized NSG mice is associated with human susceptibility HLA haplotypes for autoimmune disease. J Autoimmun. 2015 Jul 2. Epub ahead of print. [PMID: 26143958]

HIV modeling

• Akkina RK, Allam A, Balazs AB, Blankson J, Burnett JC, Casares S, Garcia JV, Hasenkrug K, Kashanchi F, Kitchen S, Klein F, Kumar P, Luster AD, Poluektova LY, Rao M, Sanders BE, Shultz LD, Zack JA. Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop Summary. AIDS Res Hum Retroviruses. 2015 Dec 16. [PMID: 26670361]
• Bhargavan, B., Kanmogne, G.D., 2019. Epigenetics, N-myrystoyltransferase-1 and casein kinase-2-alpha modulates the increased replication of HIV-1 CRF02_AG, compared to subtype-B viruses. Sci Rep 9. [PMID: 31337802]
• Boska MD; Dash PK; Knibbe J; Epstein AA; Akhter SP; Fields N; High R; Makarov E; Bonasera S; Gelbard HA; Poluektova LY; Gendelman HE; Gorantla S. 2015. Associations between brain microstructures; metabolites; and cognitive deficits during chronic HIV-1 infection of humanized mice. Mol Neurodegener. Dec 18;9(1):58. [PMID: 25523287]
• Dagur, R.S., Branch-Woods, A., Mathews, S., Joshi, P.S., Quadros, R.M., Harms, D.W., Cheng, Y., Miles, S.M., Pirruccello, S.J., Gurumurthy, C.B., Gorantla, S., Poluektova, L.Y., 2019. Human-like NSG mouse glycoproteins sialylation pattern changes the phenotype of human lymphocytes and sensitivity to HIV-1 infection. BMC Immunol. 20, 2. [PMID: 30616506]
• Dash PK; Gorantla S; Gendelman HE; Knibbe J; Casale GP; Makarov E; Epstein AA; Gelbard HA; Boska MD; Poluektova LY. 2011. Loss of Neuronal Integrity during Progressive HIV-1 Infection of Humanized Mice. J Neurosci Mar 2;31(9):3148-57. [PMID: 21368026]
• Dash, P.K., Kaminski, R., Bella, R., Su, H., Mathews, S., Ahooyi, T.M., Chen, C., Mancuso, P., Sariyer, R., Ferrante, P., Donadoni, M., Robinson, J.A., Sillman, B., Lin, Z., Hilaire, J.R., Banoub, M., Elango, M., Gautam, N., Mosley, R.L., Poluektova, L.Y., McMillan, J., Bade, A.N., Gorantla, S., Sariyer, I.K., Burdo, T.H., Young, W.-B., Amini, S., Gordon, J., Jacobson, J.M., Edagwa, B., Khalili, K., Gendelman, H.E., 2019. Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice. Nat Commun 10. [PMID: 31266936]
• Garg H; Joshi A; Ye C; Shankar P; Manjunath N. 2011. Single amino acid change in gp41 region of HIV-1 alters bystander apoptosis and CD4 decline in humanized mice. Virol J Jan 21;8(1):34. [PMID: 21255440]
• Gorantla S; Makarov E; Finke-Dwyer J; Castanedo A; Holguin A; Gebhart CL; Gendelman HE; Poluektova L. 2010. Links between Progressive HIV-1 Infection of Humanized Mice and Viral Neuropathogenesis. Am J Pathol Dec;177(6):2938-49 [PMID: 21088215]
• Latinovic, O.S., Neal, L.M., Tagaya, Y., Heredia, A., Medina-Moreno, S., Zapata, J.C., Reitz, M., Bryant, J., Redfield, R.R., 2019. Suppression of Active HIV-1 Infection in CD34+ Hematopoietic Humanized NSG Mice by a Combination of cART Therapy and CCR5 Targeting Drugs. AIDS Res. Hum. Retroviruses. [PMID: 31099257]
• Li, W., Gorantla, S., Gendelman, H.E., Poluektova, L.Y., 2017. Systemic HIV-1 infection produces a unique glial footprint in humanized mouse brains. Dis Model Mech. [PMID: 29084769]
• Llewellyn, G.N., Alvarez-Carbonell, D., Chateau, M., Karn, J., Cannon, P.M., 2017. HIV-1 infection of microglial cells in a reconstituted humanized mouse model and identification of compounds that selectively reverse HIV latency. J. Neurovirol. [PMID: 29256041]
• Lu R; Wu S; Zhang Y; Xia Y; Huelsmann EJ; Lacek AT; Nabatiyan A; Richards MH; Narasipura SD; Lutgen V; Chen H; Kaufman HL; Chen D; Al-Harthi L; Zloza A; Sun J. 2014. HIV Infection Accelerates Gastrointestinal Tumor Outgrowth in NSG-HuPBL Mice. AIDS Res Hum Retroviruses. Apr 3. [PMID: 24593860]
• Kovarova M, Swanson MD, Sanchez RI, Baker CE, Steve J, Spagnuolo RA, Howell BJ, Hazuda DJ, Garcia JV. 2016. A long-acting formulation of the integrase inhibitor raltegravir protects humanized BLT mice from repeated high-dose vaginal HIV challenges. J Antimicrob Chemother. Mar 21. pii: dkw042. [PMID: 27002074]
• Nixon CC; Vatakis DN; Reichelderfer SN; Dixit D; Kim SG; Uittenbogaart CH; Zack JA. 2013. HIV-1 Infection of hematopoietic progenitor cells in vivo in humanized mice. Blood. [Epub ahead of print] [PMID: 23886835]
• Sampey GC, Saifuddin M, Schwab A, Barclay R, Punya S, Chung MC, Hakami RM, Asad Zadeh M, Lepene B, Klase ZA, El-Hage N, Young M, Iordanskiy S, Kashanchi F. Exosomes from HIV-1 infected cells stimulate production of pro-inflammatory cytokines through TAR RNA. J Biol Chem. 2015 Nov 9. [PMID: 26553869]
• Schmitt, K., Akkina, R., 2018. Ultra-Sensitive HIV-1 Latency Viral Outgrowth Assays Using Humanized Mice. Front Immunol 9, 344. [PMID: 29556230]
• Sharma A, Wu W, Sung B, Huang J, Tsao T, Li X, Gomi R, Tsuji M, Worgall S. 2016. RSV Pulmonary Infection in Humanized Mice Induces Human Anti-RSV Immune Responses and Pathology. J Virol. 2016 Mar 9. pii: JVI.00259-16. [PMID: 26962219]
• Thomas T, Seay K, Zheng JH, Zhang C, Ochsenbauer C, Kappes JC, Goldstein H. High-Throughput Humanized Mouse Models for Evaluation of HIV-1 Therapeutics and Pathogenesis. Methods Mol Biol. 2016; 1354:221-35. [PMID: 26714715]
• Xu, S.X., Leontyev, D., Kaul, R., Gray-Owen, S.D., 2018. Neisseria gonorrhoeae co-infection exacerbates vaginal HIV shedding without affecting systemic viral loads in human CD34+ engrafted mice. PLoS ONE 13, e0191672. [PMID: 29360873]
• Yu, C., Narasipura, S.D., Richards, M.H., Hu, X.-T., Yamamoto, B., Al-Harthi, L., 2017. HIV and drug abuse mediate astrocyte senescence in a β-catenin-dependent manner leading to neuronal toxicity. Aging Cell. doi:10.1111/acel.12593 [PMID: 28612507]

HIV therapies

• Balazs AB; Chen J; Hong CM; Rao DS; Yang L; Baltimore D. 2011. Antibody-based protection against HIV infection by vectored immunoprophylaxis. Nature Nov 30;481(7379):81-4. [PMID: 22139420]
• Dubrovsky L; Duyne RV; Senina S; Guendel I; Pushkarsky T; Sviridov D; Kashanchi F; Bukrinsky M. 2012. Liver X receptor agonist inhibits HIV-1 replication and prevents HIV-induced reduction of plasma HDL in humanized mouse model of HIV infection. Biochem Biophys Res Commun Mar 2;419(1):95-8. [PMID: 22326260]
• Falkenhagen, A., Singh, J., Asad, S., Leontyev, D., Read, S., Zúñiga-Pflücker, J.C., Joshi, S., 2017. Control of HIV Infection In Vivo Using Gene Therapy with a Secreted Entry Inhibitor. Mol Ther Nucleic Acids 9, 132–144. [PMID: 29246292]
• Gorantla S; Makarov E; Finke-Dwyer J; Gebhart CL; Domm W; Dewhurst S; Gendelman HE; Poluektova LY. 2010. CD8+ Cell Depletion Accelerates HIV-1 Immunopathology in Humanized Mice. J Immunol Jun 15 184(12):7082-91. [PMID: 20495069]
• Heredia, A., Hassounah, S., Medina-Moreno, S., Zapata, J.C., Le, N.M., Han, Y., Foulke, J.S., Davis, C., Bryant, J., Redfield, R.R., Wainberg, M.A., 2017. Monotherapy with either dolutegravir or raltegravir fails to durably suppress HIV viraemia in humanized mice. J. Antimicrob. Chemother. doi:10.1093/jac/dkx195 [PMID: 28637235]
• Holt N; Wang J; Kim K; Friedman G; Wang X; Taupin V; Crooks GM; Kohn DB; Gregory PD; Holmes MC; Cannon PM. 2010. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol Aug;28(8):839-47 [PMID: 20601939]
• Hur EM; Patel SN; Shimizu S; Rao DS; Gnanapragasam PN; An DS; Yang L; Baltimore D. 2012. Inhibitory effect of HIV-specific neutralizing IgA on mucosal transmission of HIV in humanized mice. Blood Nov 29;120(23):4571-82. [PMID: 23065154]
• Joseph A; Zheng JH; Chen K; Dutta M; Chen C; Stiegler G; Kunert R; Follenzi A; Goldstein H. 2010. Inhibition of In Vivo HIV Infection In Humanized Mice By Gene Therapy of Human Hematopoietic Stem Cells with a Lentiviral Vector Encoding a Broadly Neutralizing Anti-HIV Antibody. J Virol Jul;84(13):6645-53. [PMID: 20410262]
• Joshi P, Maidji E, Stoddart CA. 2016. Inhibition of Heat Shock Protein 90 Prevents HIV Rebound. J Biol Chem. 2016 Mar 8. pii: jbc.M116.717538. [PMID: 26957545]
• Kiem HP; Jerome KR; Deeks SG; McCune JM. 2012. Hematopoietic-stem-cell-based gene therapy for HIV disease. Cell Stem Cell Feb 3;10(2):137-47. [PMID: 22305563]
• Kitchen SG; Levin BR; Bristol G; Rezek V; Kim S; Aguilera-Sandoval C; Balamurugan A; Yang OO; Zack JA. 2012. In vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cells. PLoS Pathog Apr;8(4):e1002649. [PMID: 22511873]
• Kumar P; Ban HS; Kim SS; Wu H; Pearson T; Greiner DL; Laouar A; Yao J; Haridas V; Habiro K; Yang YG; Jeong JH; Lee KY; Kim YH; Kim SW; Peipp M; Fey GH; Manjunath N; Shultz LD; Lee SK; Shankar P. 2008. T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 134(4):577-86. [PMID: 18691745]
• Li L; Krymskaya L; Wang J; Henley J; Rao A; Cao LF; Tran CA; Torres-Coronado M; Gardner A; Gonzalez N; Kim K; Liu PQ; Hofer U; Lopez E; Gregory PD; Liu Q; Holmes MC; Cannon PM; Zaia JA; Digiusto DL. 2013. Genomic Editing of the HIV-1 Coreceptor CCR5 in Adult Hematopoietic Stem and Progenitor Cells Using Zinc Finger Nucleases. Mol Ther. Jun;21(6):1259-69. [PMID: 23587921]
• Mandal, S., Kang, G., Prathipati, P.K., Zhou, Y., Fan, W., Li, Q., Destache, C.J., 2018. Nanoencapsulation introduces long-acting phenomenon to tenofovir alafenamide and emtricitabine drug combination: A comparative pre-exposure prophylaxis efficacy study against HIV-1 vaginal transmission. J Control Release 294, 216–225. [PMID: 30576746 ]
• Medina-Moreno, S., Dowling, T.C., Zapata, J.C., Le, N.M., Sausville, E., Bryant, J., Redfield, R.R., Heredia, A., 2017. Targeting of CDK9 with indirubin 3’-monoxime safely and durably reduces HIV viremia in chronically infected humanized mice. PloS One 12, e0183425. doi:10.1371/journal.pone.0183425 [PMID: 28817720]
• Mukherjee R; Plesa G; Sherrill-Mix S; Richardson MW; Riley JL; Bushman FD. 2010. HIV sequence variation associated with env antisense adoptive T-cell therapy in the hNSG mouse model. Mol Ther Apr;18(4):803-11. [PMID: 20104212]
• Perdomo-Celis, F., Medina-Moreno, S., Davis, H., Bryant, J., Zapata, J.C., 2019. HIV Replication in Humanized IL-3/GM-CSF-Transgenic NOG Mice. Pathogens 8. [PMID: 30871027]
• Poonia B. 2016. Adoptive transfer of aminobisphonate-expanded Vγ9Vδ2+ T cells does not control HIV replication in a humanized mouse model. Immunotherapy. 2016 May;8(5):521-6. doi: 10.2217/imt-2015-0003. [PMID: 27140407]
• Prathipati, P.K., Mandal, S., Pon, G., Vivekanandan, R., Destache, C.J., 2017. Pharmacokinetic and Tissue Distribution Profile of Long Acting Tenofovir Alafenamide and Elvitegravir Loaded Nanoparticles in Humanized Mice Model. Pharm. Res. doi:10.1007/s11095-017-2255-7 [PMID: 28905173]
• Quispe Calla, N.E., Vicetti Miguel, R.D., Glick, M.E., Kwiek, J.J., Gabriel, J.M., Cherpes, T.L., 2018. Exogenous oestrogen inhibits genital transmission of cell-associated HIV-1 in DMPA-treated humanized mice. J Int AIDS Soc 21. [PMID: 29334191]
• Satheesan, S., Li, H., Burnett, J.C., Takahashi, M., Li, S., Wu, S.X., Synold, T.W., Rossi, J.J., Zhou, J., 2018. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy. J. Virol. 92. [PMID: 29343582]
• Seay K; Church C; Zheng JH; Deneroff K; Ochsenbauer C; Kappes JC; Liu B; Jeng EK; Wong HC; Goldstein H. In Vivo Activation of Human NK cells by Treatment with an IL-15 Superagonist Potently Inhibits Acute In Vivo HIV-1 Infection in Humanized Mice. J Virol. 2015 Apr 1. Epub ahead of print. [PMID: 25833053]
• Singh M; Singh P; Gaudray G; Musumeci L; Thielen C; Vaira D; Vandergeeten C; Delacroix L; Van Gulck E; Vanham G; de Leval L; Rahmouni S; Moutschen M. 2012. An Improved Protocol for Efficient Engraftment in NOD/LTSZ-SCIDIL-2Rγ(NULL) Mice Allows HIV Replication and Development of Anti-HIV Immune Responses. PLoS One 7(6):e38491. [PMID: 22675567]
• Wilen CB; Wang J; Tilton JC; Miller JC; Kim KA; Rebar EJ; Sherrill-Mix SA; Patro SC; Secreto AJ; Jordan AP; Lee G; Kahn J; Aye PP; Bunnell BA; Lackner AA; Hoxie JA; Danet-Desnoyers GA; Bushman FD; Riley JL; Gregory PD; June CH; Holmes MC; Doms RW. 2011. HIV-Resistant Human CD4+ T Cells with CXCR4-Specific Zinc-Finger Nucleases. PLoS Pathog Apr;7(4):e1002020. [PMID: 21533216]
• Wu X, Liu L, Cheung KW, Wang H, Lu X, Cheung AK, Liu W, Huang X, Li Y, Chen ZW, Chen SM, Zhang T, Wu H, Chen Z. Brain Invasion by CD4+ T Cells Infected with a Transmitted/Founder HIV-1BJZS7 During Acute Stage in Humanized Mice. J Neuroimmune Pharmacol. 2016 Feb 2. [PMID: 26838362]
• Yu, C., Narasipura, S.D., Richards, M.H., Hu, X.-T., Yamamoto, B., Al-Harthi, L., 2017. HIV and drug abuse mediate astrocyte senescence in a β-catenin-dependent manner leading to neuronal toxicity. Aging Cell 16, 956–965. doi:10.1111/acel.12593 [PMID: 28612507]
• Yuan J; Wang J; Crain K; Fearns C; Kim KA; Hua KL; Gregory PD; Holmes MC; Torbett BE. 2012. Zinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4(+) T cell resistance and enrichment. Mol Ther. Apr;20(4):849-59. [PMID:22273578]
• Zhang J; Mulvenon A; Makarov E; Wagoner J; Knibbe J; Kim JO; Osna N; Bronich TK; Poluektova LY. 2013. Antiviral peptide nanocomplexes as a potential therapeutic modality for HIV/HCV co-infection. Biomaterials. May;34(15):3846-57. [PMID: 23403120]

HIV review articles

• Gorantla S; Poluektova L; Gendelman HE. 2012. Rodent models for HIV-associated neurocognitive disorders. Trends Neurosci Mar;35(3):197-208. Review [PMID: 22305769]
• Sato K; Koyanagi Y. The mouse is out of the bag: insights and perspectives on HIV-1-infected humanized mouse models.Exp Biol Med (Maywood) Aug 1;236(8):977-85. [PMID: 21750016]
• Zhang L; Su L. 2012. HIV-1 immunopathogenesis in humanized mouse models. Cell Mol Immunol May;9(3):237-44. Review [PMID: 22504952]

Influenza

• Balazs AB; Bloom JD; Hong CM; Rao DS; Baltimore D. 2013. Broad protection against influenza infection by vectored immunoprophylaxis in mice. Nat Biotechnol. Jul;31(7):647-52. [PMID: 23728362]

Leishmaniasis

• Wege AK; Florian C; Ernst W; Zimara N; Schleicher U; Hanses F; Schmid M; Ritter U. 2012. Leishmania major Infection in Humanized Mice Induces Systemic Infection and Provokes a Nonprotective Human Immune Response. PLoS Negl Trop Dis. Jul;6(7):e1741. [PMID: 22848771]

Measles

• Boussaad I; Varagnolo L; Hornich V; Rieger L; Krockenberger M; Stuehmer T; Kranzfelder D; Mueller AM; Schneider-Schaulies S. 2011. Wild-type Measles Virus (MV) interferes with short term engraftment of human CD34+ hematopoietic progenitor cells. J Virol Aug;85(15):7710-8 [PMID: 21593150]

Pneumonia

• Prince, A., Wang, H., Kitur, K., Parker, D., 2016. Humanized mice exhibit increased susceptibility to Staphylococcus aureus pneumonia. J. Infect. Dis. doi:10.1093/infdis/jiw425 [PMID: 27638942]

Review articles

• Akkina R. 2013. New generation humanized mice for virus research: Comparative aspects and future prospects. Virology. Jan 5;435(1):14-28. [PMID: 23217612]
• Akkina R. 2013. Human immune responses and potential for vaccine assessment in humanized mice. Curr Opin Immunol. Jun;25(3):403-9. [PMID: 23628166]
• Rämer PC; Chijioke O; Meixlsperger S; Leung CS; Münz C. 2011. Mice with human immune system components as in vivo models for infections with human pathogens. Immunol Cell Biol Mar;89(3):408-16. [PMID: 21301484]
• Xiang J, Zhang S, Leclercq G, Nauwynck H. 2016. Difference in replication of low-passage MCMV HaNa1 in BALB/c, C57BL/6 and NOD mice and role of different branches of immunity in susceptibility. Virus Res. May 9. pii: S0168-1702(16)30097-1. doi: 10.1016/j.virusres.2016.05.006. [PMID: 27173788]

Sepsis

• Ernst W; Zimara N; Hanses F; Männel DN; Seelbach-Göbel B; Wege AK. 2013. Humanized Mice- a new Model to Study the Influence of Drug Treatment on Neonatal Sepsis. Infect Immun. May;81(5):1520-31. [PMID: 23439310]
• Skirecki T, Kawiak J, Machaj E, Pojda Z, Wasilewska D, Czubak J, Hoser G. Early severe impairment of hematopoietic stem and progenitor cells from the bone marrow caused by CLP sepsis and endotoxemia in a humanized mice model. Stem Cell Res Ther. 2015 Aug 14;6(1):142. [PMID: 26272069]
• Unsinger J; McDonough JS; Shultz LD; Ferguson TA; Hotchkiss RS. 2009. Sepsis-induced human lymphocyte apoptosis and cytokine production in "humanized" mice. J Leukoc Biol Aug;86(2):219-27. [PMID: 19369639]
• Ye C; Choi JG; Abraham S; Wu H; Diaz D; Terreros D; Shankar P; Manjunath N. 2012. Human macrophage and dendritic cell-specific silencing of high-mobility group protein B1 ameliorates sepsis in a humanized mouse model. Proc Natl Acad Sci U S A. Dec 18;109(51):21052-7. [PMID: 23213216]

Tuberculosis

• Calderon VE; Valbuena G; Goez Y; Judy BM; Huante MB; Sutjita P; Johnston RK; Estes DM; Hunter RL; Actor JK; Cirillo JD; Endsley JJ. 2013. A humanized mouse model of tuberculosis. PLoS One. May 17;8(5):e63331. [PMID: 23691024]
• Heuts F; Gavier-Widén D; Carow B; Juarez J; Wigzell H; Rottenberg ME. 2013. CD4+ cell-dependent granuloma formation in humanized mice infected with mycobacteria. Proc Natl Acad Sci U S A. Apr 16;110(16):6482-7. [PMID: 23559373]
• Lee J; Brehm MA; Greiner D; Shultz LD; Kornfeld H. 2013. Engrafted human cells generate adaptive immune responses to Mycobacterium bovis BCG infection in humanized mice. BMC Immunol. Dec 7; 14:53. [PMID: 24313934]

Typhoid fever

• Libby SJ; Brehm MA; Greiner DL; Shultz LD; McClelland M; Smith KD; Cookson BT; Karlinsey JE; Kinkel TL; Porwollik S; Canals R; Cummings LA; Fang FC. 2010. Humanized nonobese diabetic-scid IL2r{gamma}null mice are susceptible to lethal Salmonella Typhi infection. Proc Natl Acad Sci U S A Aug 31;107(35):15589-94. [PMID: 20713716]

Varicella-zoster virus

• Rowe J; Greenblatt RJ; Liu D; Moffat JF. 2010. Compounds that target host cell proteins prevent varicella-zoster virus replication in culture, ex vivo, and in SCID-Hu mice. Antiviral Res Jun;86(3):276-85. [PMID: 20307580]

Other infectious disease

• Altamirano-Lagos, M.J., Díaz, F.E., Mansilla, M.A., Rivera-Pérez, D., Soto, D., McGill, J.L., Vasquez, A.E., Kalergis, A.M., 2019. Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus. Front Microbiol 10.[PMID: 31130923] 
• Bakkour, S., Chafets, D.M., Wen, L., Muench, M.O., Telford, S.R., Erwin, J.L., Levin, A.E., Self, D., Brès, V., Linnen, J.M., Lee, T.-H., Busch, M.P., 2018. Minimal infectious dose and dynamics of Babesia microti parasitemia in a murine model. Transfusion. [PMID: 30264498]
• Lindquist, M.E., Zeng, X., Altamura, L.A., Daye, S.P., Delp, K.L., Blancett, C., Coffin, K.M., Koehler, J.W., Coyne, S., Shoemaker, C.J., Garrison, A.R., Golden, J.W., 2018. Exploring Crimean-Congo hemorrhagic fever virus-induced hepatic injury using antibody-mediated type I interferon blockade in mice. J. Virol. [PMID: 30111561]
• Lopez-Gordo, E., Doszpoly, A., Duffy, M.R., Coughlan, L., Bradshaw, A.C., White, K.M., Denby, L., Nicklin, S.A., Baker, A.H., 2017. Defining a novel role for the coxsackie and adenovirus receptor in human adenovirus serotype 5 transduction in vitro in the presence of mouse serum. J. Virol. doi:10.1128/JVI.02487-16 [PMID: 28381574]
• Ma, G., Yasunaga, J.-I., Ohshima, K., Matsumoto, T., Matsuoka, M., 2019. Pentosan polysulfate demonstrates anti-HTLV-1 activities in vitro and in vivo. J. Virol. [PMID: 31167921]
• Patton, J.B., Bennuru, S., Eberhard, M.L., Hess, J.A., Torigian, A., Lustigman, S., Nutman, T.B., Abraham, D., 2018. Development of Onchocerca volvulus in humanized NSG mice and detection of parasite biomarkers in urine and serum. PLoS Negl Trop Dis 12, e0006977. [PMID: 30540742 ]
• Spengler, J.R., Keating, M.K., McElroy, A.K., Zivcec, M., Coleman-McCray, J.D., Harmon, J.R., Bollweg, B.C., Goldsmith, C.S., Bergeron, É., Keck, J.G., Zaki, S.R., Nichol, S.T., Spiropoulou, C.F., 2017. Crimean-Congo Hemorrhagic Fever in Humanized Mice Reveals Glial Cells as Primary Targets of Neurological Infection. J. Infect. Dis. doi:10.1093/infdis/jix215 [PMID: 28482001]
• Spengler, J.R., McElroy, A.K., Harmon, J.R., Coleman-McCray, J.D., Welch, S.R., Keck, J.G., Nichol, S.T., Spiropoulou, C.F., 2018. Human immune cell engraftment does not alter development of severe acute Rift Valley fever in mice. PLoS ONE 13, e0201104. [PMID: 30028878]
• Zhao, J., Lee, E.E., Kim, J., Yang, R., Chamseddin, B., Ni, C., Gusho, E., Xie, Y., Chiang, C.-M., Buszczak, M., Zhan, X., Laimins, L., Wang, R.C., 2019. Transforming activity of an oncoprotein-encoding circular RNA from human papillomavirus. Nat Commun 10.[PMID: 31127091]

Adrenal gland cancer

• Cournoyer S; Nyalendo C; Addioui A; Belounis A; Beaunoyer M; Aumont A; Teira P; Duval M; Fernandes K; Fetni R; Haddad E; Sartelet H. 2012. Genotype analysis of tumor-initiating cells expressing CD133 in neuroblastoma. Genes Chromosomes Cancer Aug;51(8):792-804. [PMID: 22514116]
• Sartelet H; Durrieu L; Fontaine F; Nyalendo C; Haddad E. 2012. Description of a new xenograft model of metastatic neuroblastoma using NOD/SCID/Il2rg null (NSG) mice. In Vivo. Jan-Feb;26(1):19-29. [PMID: 22210712]
• Schlitter AM; Dorneburg C; Barth TF; Wahl J; Schulte JH; Brüderlein S; Debatin KM; Beltinger C. 2012. CD57(high) Neuroblastoma Cells Have Aggressive Attributes Ex Situ and an Undifferentiated Phenotype in Patients. PLoS One. 7(8):e42025. [PMID: 22900004]
• Singh N; Liu X; Hulitt J; Jiang S; June C; Grupp S; Barrett D;  Zhao Y. 2014. Nature of Tumor Control by Permanently and Transiently Modified GD2 Chimeric Antigen Receptor T Cells in Xenograft Models of Neuroblastoma. Cancer Immunol Res. Nov;2(11):1059-70 [PMID: 25104548]

Bladder cancer

• Lin TY; Li YP; Zhang H; Luo J; Goodwin N; Gao T; White RD; Lam KS; Pan CX. 2012. Tumor-targeting multifunctional micelles for imaging and chemotherapy of advanced bladder cancer.Nanomedicine (Lond). Aug;8(8):1239-51. [PMID: 23199207]
• Pan CX, Zhang H, Tepper CG, Lin TY, Davis RR, Keck J, Ghosh PM, Gill P, Airhart S, Bult C, Gandara DR, Liu E, de Vere White RW. Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy. PLoS One. 2015 Aug 13;10(8):e0134346. [PMID: 26270481]
• Peek EM; Li DR; Zhang H; Kim HP; Zhang B; Garraway IP; Chin AI. 2012. Stromal modulation of bladder cancer-initiating cells in a subcutaneous tumor model. Am J Cancer Res. 2(6):745-51. [PMID: 23226620]
• Seki, T., Liu, J., Brutkiewicz, R.R., Tsuji, M., 2019. A Potent CD1d-binding Glycolipid for iNKT-Cell-based Therapy Against Human Breast Cancer. Anticancer Res. 39, 549–555. [PMID: 30711929]
• Wang, F., Zhang, H., Ma, A.-H., Yu, W., Zimmermann, M., Yang, J., Hwang, S.H., Zhu, D., Lin, T.-Y., Malfatti, M., Turteltaub, K.W., Henderson, P.T., Airhart, S., Hammock, B.D., Yuan, J., de Vere White, R.W., Pan, C.-X., 2017. COX-2/sEH Dual Inhibitor PTUPB Potentiates the Anti-tumor Efficacy of Cisplatin. Mol. Cancer Ther. [PMID: 29284644]
• Wang, M., Yao, L.-C., Cheng, M., Cai, D., Martinek, J., Pan, C.-X., Shi, W., Ma, A.-H., De Vere White, R.W., Airhart, S., Liu, E.T., Banchereau, J., Brehm, M.A., Greiner, D.L., Shultz, L.D., Palucka, K., Keck, J.G., 2018. Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy. FASEB J. fj201700740R. [PMID: 29146734]

Breast cancer

• Baccelli I; Schneeweiss A; Riethdorf S; Stenzinger A; Schillert A; Vogel V; Klein C; Saini M; Bäuerle T; Wallwiener M; Holland-Letz T; Höfner T; Sprick M; Scharpff M; Marmé F; Sinn HP; Pantel K; Weichert W; Trumpp A. 2013. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol. Jun;31(6):539-44. [PMID: 23609047]
• Bacci, M., Lorito, N., Ippolito, L., Ramazzotti, M., Luti, S., Romagnoli, S., Parri, M., Bianchini, F., Cappellesso, F., Virga, F., Gao, Q., Simões, B.M., Marangoni, E., Martin, L.-A., Comito, G., Ferracin, M., Giannoni, E., Mazzone, M., Chiarugi, P., Morandi, A., 2019. Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer. Cell Rep 28, 104-118.e8. [PMID: 31269432]
• Bernascone, I., González, T., Barea, M.D., Carabaña, C., Hachimi, M., Bosch-Fortea, M., Santamaria, S., Martin, R., Tarnick, J., Garcia-Sanz, J.A., Martín-Belmonte, F., 2019. Sfrp3 modulates stromal–epithelial crosstalk during mammary gland development by regulating Wnt levels. Nat Commun 10. [PMID: 31171792]
• Buijs, J.T., Laghmani, E.H., van den Akker, R.F.P., Tieken, C., Vletter, E.M., van der Molen, K.M., Crooijmans, J.J., Kroone, C., Le Dévédec, S.E., van der Pluijm, G., Versteeg, H.H., 2019. The Direct Oral Anticoagulants Rivaroxaban and Dabigatran do not Inhibit Orthotopic Growth and Metastasis of Human Breast Cancer in Mice. J. Thromb. Haemost. [PMID: 30929299]
• Chen MC; Zhou B; Zhang K; Yuan YC; Un F; Hu S; Chou CM; Chen CH; Wu J; Wang Y; Liu X; Smith L; Warden CD; Liu Z; Li H; Su L; Malkas LH; Chung YM; Hu MC; Yen Y. The Novel Ribonucleotide Reductase Inhibitor COH29 Inhibits DNA Repair In Vitro. Mol Pharmacol. 2015 Mar 26. Epub ahead of print. [PMID: 25814515]
• Chu, T.L.H., Connell, M., Zhou, L., He, Z., Won, J., Chen, H., Rahavi, S.M.R., Mohan, P., Nemirovsky, O., Fotovati, A., Pujana, M.A., Reid, G.S.D., Nielsen, T.O., Pante, N., Maxwell, C.A., 2018. Cell Cycle-Dependent Tumor Engraftment and Migration Are Enabled by Aurora-A. Mol. Cancer Res. 16, 16–31. [PMID: 28993511]
• DeRose YS; Wang G; Lin YC; Bernard PS; Buys SS; Ebbert MT; Factor R; Matsen C; Milash BA; Nelson E; Neumayer L; Randall RL; Stijleman IJ; Welm BE; Welm AL. 2011. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology; growth; metastasis and disease outcomes. Nat Med Oct 23;17(11):1514-20. [PMID: 22019887]
• Devarakonda CV, Kita D, Phoenix KN, Claffey KP. Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors. BMC Cancer. 2015 Sep 3;15(1):614. [PMID: 26334999]
• Dhawan A, von Bonin M, Bray LJ, Freudenberg U, Bejestani EP, Werner C, Hofbauer LC, Wobus M, Bornhäuser M. 2016. Functional interference in the bone marrow microenvironment by disseminated breast cancer cells. Stem Cells. Apr 19. doi: 10.1002/stem.2384. [PMID: 27090603]
• Goel HL; Pursell B; Chang C; Shaw LM; Mao J; Simin K; Kumar P; Kooi CW; Shultz LD; Greiner DL; Norum JH; Toftgard R; Kuperwasser C; Mercurio AM. 2013. GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation. EMBO Mol Med. Apr;5(4):488-508. [PMID: 23436775]
• Harrison H; Simoes BM; Rogerson L; Howell SJ; Landberg G; Clarke RB. 2013. Oestrogen increases the activity of oestrogen receptor-negative breast cancer stem cells through paracrine EGFR and Notch signaling. Breast Cancer Res. 2013 Mar 8;15(2):R21. [PMID: 23497505]
• Hu, W.-F., Krieger, K.L., Lagundžin, D., Li, X., Cheung, R.S., Taniguchi, T., Johnson, K.R., Bessho, T., Monteiro, A.N.A., Woods, N.T., 2019. CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. Cell Death Discov 5. [PMID: 31240132]
• Iorns E; Drews-Elger K; Ward TM; Dean S; Clarke J; Berry D; Ashry DE; Lippman M. 2012. A new mouse model for the study of human breast cancer metastasis. PLoS One. 7(10):e47995. [PMID: 23118918]
• Kai M; Kanaya N; Wu SV; Mendez C; Nguyen D; Luu T; Chen S. Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin. Breast Cancer Res Treat. 2015. Epub ahead of print. [PMID: 25904215]
• Kim J; Villadsen R; Sørlie T; Fogh L; Grønlund SZ; Fridriksdottir AJ; Kuhn I; Rank F; Wielenga VT; Solvang H; Edwards PA; Børresen-Dale AL; Rønnov-Jessen L; Bissell MJ; Petersen OW. 2012. Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity. Proc Natl Acad Sci U S A Apr 17;109(16):6124-9. [PMID: 22454501]
• Kim RS; Avivar-Valderas A; Estrada Y; Bragado P; Sosa MS; Aguirre-Ghiso JA; Segall JE. 2012. Dormancy signatures and metastasis in estrogen receptor positive and negative breast cancer. PLoS One 2012;7(4):e35569. [PMID: 22530051]
• Kumar, A., Tripathy, M.K., Pasquereau, S., Al Moussawi, F., Abbas, W., Coquard, L., Khan, K.A., Russo, L., Algros, M.-P., Valmary-Degano, S., Adotevi, O., Morot-Bizot, S., Herbein, G., 2018. The Human Cytomegalovirus Strain DB Activates Oncogenic Pathways in Mammary Epithelial Cells. EBioMedicine 30, 167–183. [PMID: 29628341]
• Mandriota, S.J., Tenan, M., Ferrari, P., Sappino, A.-P., 2016. Aluminium chloride promotes tumorigenesis and metastasis in normal murine mammary gland epithelial cells. Int. J. Cancer 139, 2781–2790. [PMID: 27541736]
• Martin-Padura I; Gregato G; Marighetti P; Mancuso P; Calleri A; Corsini C; Pruneri G; Manzotti M; Lohsiriwat V; Rietjens M; Petit JY; Bertolini F. 2012. The white adipose tissue used in lipotransfer procedures is a rich reservoir of CD34+ progenitors able to promote cancer progression. Cancer Res Jan 1;72(1):325-34. [PMID: 22052460]
• Orecchioni S; Gregato G; Martin-Padura I; Reggiani F; Braidotti P; Mancuso P; Calleri A; Quarna J; Marighetti P; Aldeni C; Pruneri G; Martella S; Manconi A; Petit JY; Rietjens M; Bertolini F. 2013. Complementary populations of human adipose CD34+ progenitor cells promote growth; angiogenesis and metastasis of breast cancer. Cancer Res. [Epub ahead of print] [PMID: 23918796]
• Park DH; Jung BK; Lee YS; Jang JY; Kim MK; Lee JK; Park H; Seo J; Kim CW. 2015. Evaluation of in vivo antitumor effects of ANT2 shRNA delivered using PEI and ultrasound with microbubbles. Gene Ther. Epub ahead of print. [PMID: 25588739]
• Prud'homme GJ; Glinka Y; Toulina A; Ace O; Subramaniam V; Jothy S. 2010 Breast Cancer Stem-Like Cells Are Inhibited by a Non-Toxic Aryl Hydrocarbon Receptor Agonist. PLoS ONE 5(11): e13831. [PMID: 21072210]
• Quail DF; Zhang G; Findlay SD; Hess DA; Postovit LM. 2013. Nodal promotes invasive phenotypes via a mitogen-activated protein kinase-dependent pathway. Oncogene. [Epub ahead of print] [PMID: 23334323]
• Rowson-Hodel AR, Manjarin R, Trott JF, Cardiff RD, Borowsky AD, Hovey RC. Neoplastic transformation of porcine mammary epithelial cells in vitro and tumor formation in vivo. BMC Cancer. 2015 Jul 31;15:562. [PMID: 26228788]
• Shafiee, A., McGovern, J.A., Lahr, C.A., Meinert, C., Moi, D., Wagner, F., Landgraf, M., De-Juan-Pardo, E., Mazzieri, R., Hutmacher, D.W., 2018. Immune system augmentation via humanization using stem/progenitor cells and bioengineering in a breast cancer model study. Int. J. Cancer. [PMID: 29659011]
• Shen, Y., Zhang, W., Liu, J., He, J., Cao, R., Chen, X., Peng, X., Xu, H., Zhao, Q., Zhong, J., Ding, W., Lei, X., Jiang, Y., Zu, X., 2018. Therapeutic Activity of DCC-2036, a Novel Tyrosine Kinase Inhibitor, against Triple-Negative Breast Cancer Patient-Derived Xenografts by Targeting AXL/MET. Int. J. Cancer. [PMID: 30289981]
• Smith, H.W., Hirukawa, A., Sanguin-Gendreau, V., Nandi, I., Dufour, C.R., Zuo, D., Tandoc, K., Leibovitch, M., Singh, S., Rennhack, J.P., Swiatnicki, M., Lavoie, C., Papavasiliou, V., Temps, C., Carragher, N.O., Unciti-Broceta, A., Savage, P., Basik, M., van Hoef, V., Larsson, O., Cooper, C.L., Vargas Calderon, A.C., Beith, J., Millar, E., Selinger, C., Giguère, V., Park, M., Harris, L.N., Varadan, V., Andrechek, E.R., O’Toole, S.A., Topisirovic, I., Muller, W.J., 2019. An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis. Nat Commun 10. [PMID: 31263101]
• Sossey-Alaoui, K., Pluskota, E., Szpak, D., Plow, E.F., 2019. The Kindlin2-p53-SerpinB2 signaling axis is required for cellular senescence in breast cancer. Cell Death Dis 10. [PMID: 31308359]
• Tonsing-Carter E, Bailey BJ, Saadatzadeh MR, Ding J, Wang H, Sinn AL, Peterman KM, Spragins TK, Silver JM, Sprouse AA, Georgiadis TM, Gunter TZ, Long EC, Minto RE, Marchal CC, Batuello CN, Safa AR, Hanenberg H, Territo PR, Sandusky GE, Mayo LD, Eischen CM, Shannon HE, Pollok KE. Potentiation of carboplatin-mediated DNA damage by the Mdm2 modulator Nutlin-3a in a humanized orthotopic breast-to-lung metastatic model. Mol Cancer Ther. 2015 Oct 22. [PMID: 26494859]
• Valdez KE; Fan F; Smith W; Allred DC; Medina D; Behbod F. 2011. Human primary ductal carcinoma in situ (DCIS) subtype-specific pathology is preserved in a mouse intraductal (MIND) xenograft model. J Pathol Dec;225(4):565-73. [PMID: 22025213]
• Wagenblast E; Soto M; Gutiérrez-Ángel S; Hartl CA; Gable AL; Maceli AR; Erard N; Williams AM; Kim SY; Dickopf S; Harrell JC; Smith AD; Perou CM; Wilkinson JE; Hannon GJ; Knott SR. A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis. Nature. 2015 Apr 16;520(7547):358-62. [PMID: 25855289]
• Wang, M., Yao, L.-C., Cheng, M., Cai, D., Martinek, J., Pan, C.-X., Shi, W., Ma, A.-H., De Vere White, R.W., Airhart, S., Liu, E.T., Banchereau, J., Brehm, M.A., Greiner, D.L., Shultz, L.D., Palucka, K., Keck, J.G., 2018. Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy. FASEB J. fj201700740R. [PMID: 29146734]
• Zibara K, Awada Z, Dib L, El-Saghir J, Al-Ghadban S, Ibrik A, El-Zein N, El-Sabban M. Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast cancer cell invasion and metastasis in vitro and in vivo. Sci Rep. 2015 Jul 28;5:12598. [PMID: 26218768]

Brain cancer

• Arora, P., Adams, C.H., Gudelsky, G., DasGupta, B., Desai, P.B., 2018. Plasma and brain pharmacokinetics of letrozole and drug interaction studies with temozolomide in NOD-scid gamma mice and sprague dawley rats. Cancer Chemother. Pharmacol. [PMID: 30357450]
• Babic I; Anderson ES; Tanaka K; Guo D; Masui K; Li B; Zhu S; Gu Y; Villa GR; Akhavan D; Nathanson D; Gini B; Mareninov S; Li R; Camacho CE; Kurdistani SK; Eskin A; Nelson SF; Yong WH; Cavenee WK; Cloughesy TF; Christofk HR; Black DL; Mischel PS. 2013. EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer. Cell Metab. Jun 4;17(6):1000-8. [PMID: 23707073]
• Bandopadhayay, P., Piccioni, F., O'Rourke, R., Ho, P., Gonzalez, E.M., Buchan, G., Qian, K., Gionet, G., Girard, E., Coxon, M., Rees, M.G., Brenan, L., Dubois, F., Shapira, O., Greenwald, N.F., Pages, M., Balboni Iniguez, A., Paolella, B.R., Meng, A., Sinai, C., Roti, G., Dharia, N.V., Creech, A., Tanenbaum, B., Khadka, P., Tracy, A., Tiv, H.L., Hong, A.L., Coy, S., Rashid, R., Lin, J.-R., Cowley, G.S., Lam, F.C., Goodale, A., Lee, Y., Schoolcraft, K., Vazquez, F., Hahn, W.C., Tsherniak, A., Bradner, J.E., Yaffe, M.B., Milde, T., Pfister, S.M., Qi, J., Schenone, M., Carr, S.A., Ligon, K.L., Kieran, M.W., Santagata, S., Olson, J.M., Gokhale, P.C., Jaffe, J.D., Root, D.E., Stegmaier, K., Johannessen, C.M., Beroukhim, R., 2019. Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma. Nat Commun 10. [PMID: 31160565]
• Bayer M, Schmitt J, Dittmann H, Handgretinger R, Bruchelt G, Sauter AW. 2016. Improved selectivity of mIBG uptake into neuroblastoma cells in vitro and in vivo by inhibition of organic cation transporter 3 uptake using clinically approved corticosteroids. Nucl Med Biol. May 27;43(9):543-551. doi: 0.1016/j.nucmedbio.2016.05.013. [Epub ahead of print] [PMID: 27376201]
• Bijangi-Vishehsaraei, K., Reza Saadatzadeh, M., Wang, H., Nguyen, A., Kamocka, M.M., Cai, W., Cohen-Gadol, A.A., Halum, S.L., Sarkaria, J.N., Pollok, K.E., Safa, A.R., 2017. Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell-like spheroids, and tumor xenografts through multiple cell signaling pathways. J. Neurosurg. 1–12. doi:10.3171/2016.8.JNS161197 [PMID: 28059653]
• Braekeveldt N, Wigerup C, Tadeo I, Beckman S, Sandén C, Jönsson J, Erjefält JS, Berbegall AP, Börjesson A, Backman T, Øra I, Navarro S, Noguera R, Gisselsson D, Påhlman S, Bexell D. 2016. Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours. Cancer Lett. 2016 Mar 18. pii: S0304-3835(16)30124-0. [PMID: 27000989]
• Brown, C.E., Aguilar, B., Starr, R., Yang, X., Chang, W.-C., Weng, L., Chang, B., Sarkissian, A., Brito, A., Sanchez, J.F., Ostberg, J.R., D’Apuzzo, M., Badie, B., Barish, M.E., Forman, S.J., 2018. Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma. Mol. Ther. 26, 31–44. [PMID: 29103912]
• Brown CE; Starr R; Aguilar B; Shami A; Martinez C; D'Apuzzo M; Barish ME; Forman SJ; Jensen MC. 2012. Stem-like tumor initiating cells isolated from IL13Ra2-expressing gliomas are targeted and killed by IL13-zetakine redirected T cells. Clin Cancer Res Apr 15;18(8):2199-209 [PMID: 22407828]
• Buchstaller J; McKeever PE; Morrison SJ. 2012. Tumorigenic cells are common in mouse MPNSTs but their frequency depends upon tumor genotype and assay conditions. Cancer Cell Feb 14;21(2):240-52. [PMID: 22340596]
• Chan XH; Nama S; Gopal F; Rizk P; Ramasamy S; Sundaram G; Ow GS; Vladimirovna IA; Tanavde V; Haybaeck J; Kuznetsov V; Sampath P. 2012. Targeting Glioma Stem Cells by Functional Inhibition of a Prosurvival OncomiR-138 in Malignant Gliomas. Cell Rep. Sep 27;2(3):591-602. [PMID: 22921398]
• Chandramohan V; Bao X; Keir ST; Pegram CN; Szafranski SE; Piao H; Wikstrand CJ; McLendon RE; Kuan CT; Pastan IH; Bigner DD. 2013. Construction of an Immunotoxin; D2C7-(scdsFv)-PE38KDEL; Targeting EGFRwt and EGFRvIII for Brain Tumor Therapy. Clin Cancer Res  Sep 1;19(17):4717-27. [PMID: 23857604]
• Chaturvedi NK, McGuire TR, Coulter DW, Shukla A, McIntyre EM, Sharp JG, Joshi SS. Improved therapy for neuroblastoma using a combination approach: superior efficacy with vismodegib and topotecan. Oncotarget. 2016 Feb 25. doi: 10.18632/oncotarget.7714. [PMID: 26934655]
• Choi BD; Kuan CT; Cai M; Archer GE; Mitchell DA; Gedeon PC; Sanchez-Perez L; Pastan I; Bigner DD; Sampson JH. 2013. Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma. Proc Natl Acad Sci U S A. Jan 2;110(1):270-5. [PMID: 23248284]
• Chong YK, Sandanaraj E, Koh L, Thangaveloo M, Tan MS, Koh GR, Toh TB, Lim GG1, Holbrook JD, Kon OL1, Nadarajah M, Ng I, Ng WH, Tan NS, Lim KL, Tang C, Ang BT. ST3GAL1-Associated Transcriptomic Program in Glioblastoma Tumor Growth, Invasion, and Prognosis. J Natl Cancer Inst. 2015 Nov 7;108(2). [PMID: 26547933]
• Doloff JC; Waxman DJ. 2012. VEGF receptor inhibitors block the ability of metronomically dosed cyclophosphamide to activate innate immunity-induced tumor regression. Cancer Res Mar 1;72(5):1103-15. [PMID: 22237627]
• Jeitany M; Pineda JR; Liu Q; Porreca RM; Hoffschir F; Desmaze C; Silvestre DC; Mailliet P; Junier MP; Londoño-Vallejo A; Ségal-Bendirdjian E; Chneiweiss H; Boussin FD. 2014. A preclinical mouse model of glioma with an alternative mechanism of telomere maintenance (ALT). Int J Cancer. Aug 30. [PMID: 25175359]
• Lal, S., Carrera, D., Phillips, J.J., Weiss, W.A., Raffel, C., 2018. An oncolytic measles virus-sensitive Group 3 medulloblastoma model in immune-competent mice. Neuro-oncology. [PMID: 29912438]
• Lang MF; Yang S; Zhao C; Sun G; Murai K; Wu X; Wang J; Gao H; Brown CE; Liu X; Zhou J; Peng L; Rossi JJ; Shi Y. 2012. Genome-Wide Profiling Identified a Set of miRNAs that Are Differentially Expressed in Glioblastoma Stem Cells and Normal Neural Stem Cells. PLoS One 7(4):e36248. [PMID: 22558405]
• Lee SJ, Kang WY, Yoon Y, Jin JY, Song HJ, Her JH, Kang SM, Hwang YK, Kang KJ, Joo KM, Nam DH. Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain. BMC Cancer. 2015 Dec 24;15(1):1011. doi: 10.1186/s12885-015-2034-y. [PMID: 26704632]
• Lim CY; Solter D; Knowles BB; Damjanov I. Development Of Teratocarcinomas And Teratomas In Severely Immunodeficient NOD.Cg-Prkdc^scid Il2rg^tm1Wjl/SzJ (NSG) Mice. Stem Cells Dev. 2015. Epub ahead of print [PMID: 25897827]
• Liu C; Pham K; Luo D; Reynolds BA; Hothi P; Foltz G; Harrison JK. 2013. Expression and Functional Heterogeneity of Chemokine Receptors CXCR4 and CXCR7 in Primary Patient-Derived Glioblastoma Cells. PLoS One. 8(3):e59750. [PMID: 23555768]
• Nellan, A., Rota, C., Majzner, R., Lester-McCully, C.M., Griesinger, A.M., Mulcahy Levy, J.M., Foreman, N.K., Warren, K.E., Lee, D.W., 2018. Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells. J Immunother Cancer 6, 30. [PMID: 29712574]
• Pei Y; Moore CE; Wang J; Tewari AK; Eroshkin A; Cho YJ; Witt H; Korshunov A; Read TA; Sun JL; Schmitt EM; Miller CR; Buckley AF; McLendon RE; Westbrook TF; Northcott PA; Taylor MD; Pfister SM; Febbo PG; Wechsler-Reya RJ. 2012. An animal model of MYC-driven medulloblastoma. Cancer Cell Feb 14;21(2):155-67. [PMID: 22340590]
• Pierce, A.M., Witt, D.A., Donson, A.M., Gilani, A., Sanford, B., Sill, M., Van Court, B., Oweida, A., Prince, E.W., Steiner, J., Danis, E., Dorris, K., Hankinson, T., Handler, M.H., Jones, K.L., Karam, S.D., Serkova, N.J., Vibhakar, R., Foreman, N.K., Griesinger, A.M., 2019. Establishment of patient-derived orthotopic xenograft model of 1q+ posterior fossa group A ependymoma. Neuro-oncology. [PMID: 31276586]
• Pirovano, G., Roberts, S., Brand, C., Donabedian, P.L., Mason, C., de Souza, P.D., Higgins, G.S., Reiner, T., 2018. [18F]FE-OTS964: a Small Molecule Targeting TOPK for In Vivo PET Imaging in a Glioblastoma Xenograft Model. Mol Imaging Biol. [PMID: 30357568]
• Rampazzo E; Persano L; Pistollato F; Moro E; Frasson C; Porazzi P; Della Puppa A; Bresolin S; Battilana G; Indraccolo S; Te Kronnie G; Argenton F; Tiso N; Basso G. 2013. Wnt activation promotes neuronal differentiation of Glioblastoma. Cell Death Dis. Feb 21;4:e500. [PMID: 23429286]
• Rivera M; Wu Q; Hamerlik P; Hjelmeland AB; Bao S; Rich JN. Acquisition of meiotic DNA repair regulators maintain genome stability in glioblastoma. Cell Death Dis. 2015 Apr 23;6:e1732. [PMID: 25906155]
• Sciorra VA; Sanchez MA; Kunibe A; Wurmser AE. 2012. Suppression of glioma progression by egln3.  PLoS One. 7(8):e40053. [PMID: 22905089]
• Silvestre DC; Pineda JR; Hoffschir F; Studler JM; Mouthon MA; Pflumio F; Junier MP; Chneiweiss H; Boussin FD. 2011. Alternative lengthening of telomeres in human glioma stem cells. Stem Cells Mar;29(3):440-51. [PMID: 21425407]
• Venkatesh HS; Johung TB; Caretti V; Noll A; Tang Y; Nagaraja S; Gibson EM; Mount CW; Polepalli J; Mitra SS; Woo PJ; Malenka RC; Vogel H; Bredel M; Mallick P; Monje M. Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion. Cell. 2015 Apr 21. Epub ahead of print. [PMID: 25913192]
• Wang, H., Cai, S., Bailey, B.J., Reza Saadatzadeh, M., Ding, J., Tonsing-Carter, E., Georgiadis, T.M., Zachary Gunter, T., Long, E.C., Minto, R.E., Gordon, K.R., Sen, S.E., Cai, W., Eitel, J.A., Waning, D.L., Bringman, L.R., Wells, C.D., Murray, M.E., Sarkaria, J.N., Gelbert, L.M., Jones, D.R., Cohen-Gadol, A.A., Mayo, L.D., Shannon, H.E., Pollok, K.E., 2017. Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist. J. Neurosurg. 126, 446–459. doi:10.3171/2016.1.JNS152513 [PMID: 27177180]
• Webb, M.W., Sun, J., Sheard, M.A., Liu, W.-Y., Wu, H.-W., Jackson, J.R., Malvar, J., Sposto, R., Daniel, D., Seeger, R.C., 2018. Colony stimulating factor 1 receptor blockade improves the efficacy of chemotherapy against human neuroblastoma in the absence of T lymphocytes. Int. J. Cancer. [PMID: 29665011]
• Yost SE; Pastorino S; Rozenzhak S; Smith EN; Chao YS; Jiang P; Kesari S; Frazer KA; Harismendy O. 2013. High-resolution mutational profiling suggests the genetic validity of glioblastoma patient-derived pre-clinical models. PLoS One. 2013;8(2):e56185. [PMID: 23441165]
• Zhai, L., Ladomersky, E., Lauing, K.L., Wu, M., Genet, M., Gritsina, G., Győrffy, B., Brastianos, P.K., Binder, D., Sosman, J.A., Giles, F.J., James, C.D., Horbinski, C., Stupp, R., Wainwright, D.A., 2017. Infiltrating T cells increase IDO1 expression in glioblastoma and contribute to decreased patient survival. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. doi:10.1158/1078-0432.CCR-17-0120 [PMID: 28751450]

Cancer stem cells

• Ames E, Canter RJ, Grossenbacher SK, Mac S, Chen M, Smith RC, Hagino T, Perez-Cunningham J, Sckisel GD, Urayama S, Monjazeb AM, Fragoso RC, Sayers TJ, Murphy WJ. NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype. J Immunol. 2015 Sep 11. [PMID: 26363055]
• Ishizawa K; Rasheed ZA; Karisch R; Wang Q; Kowalski J; Susky E; Pereira K; Karamboulas C; Moghal N; Rajeshkumar NV; Hidalgo M; Tsao M; Ailles L; Waddell TK; Maitra A; Neel BG; Matsui W. 2010. Tumor-Initiating Cells Are Rare in Many Human Tumors.  Cell Stem Cell Sep 3;7(3):279-282. [PMID: 20804964]
• Kumar SM; Liu S; Lu H; Zhang H; Zhang PJ; Gimotty PA; Guerra M; Guo W; Xu X. 2012. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene. Nov 22;31(47):4898-911. [PMID: 22286766]
• Sachlos E; Risueño RM; Laronde S; Shapovalova Z; Lee JH; Russell J; Malig M; McNicol JD; Fiebig-Comyn A; Graham M; Levadoux-Martin M; Lee JB; Giacomelli AO; Hassell JA; Fischer-Russell D; Trus MR; Foley R; Leber B; Xenocostas A; Brown ED; Collins TJ; Bhatia M. 2012. Identification of Drugs Including a Dopamine Receptor Antagonist that Selectively Target Cancer Stem Cells. Cell Jun 8;149(6):1284-97. [PMID: 22632761]
• Scaffidi P; Misteli T. 2011. In vitro generation of human cells with cancer stem cell properties. Nat Cell Biol Aug 21;13(9):1051-61. [PMID: 21857669]
• Thirant C; Bessette B; Varlet P; Puget S; Cadusseau J; Tavares Sdos R; Studler JM; Silvestre DC; Susini A; Villa C; Miquel C; Bogeas A; Surena AL; Dias-Morais A; Léonard N; Pflumio F; Bieche I; Boussin FD; Sainte-Rose C; Grill J; Daumas-Duport C; Chneiweiss H; Junier MP. 2011. Clinical Relevance of Tumor Cells with Stem-Like Properties in Pediatric Brain Tumors. PLoS One 2011 Jan 28;6(1):e16375. [PMID: 21297991]

Colon cancer

• Calon A; Espinet E; Palomo-Ponce S; Tauriello DV; Iglesias M; Céspedes MV; Sevillano M; Nadal C; Jung P; Zhang XH; Byrom D; Riera A; Rossell D; Mangues R; Massagué J; Sancho E; Batlle E. 2012. Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis Initiation. Cancer Cell. Nov 13;22(5):571-84. [PMID: 23153532]
• Dieter SM; Ball CR; Hoffmann CM; Nowrouzi A; Herbst F; Zavidij O; Abel U; Arens A; Weichert W; Brand K; Koch M; Weitz J; Schmidt M; von Kalle C; Glimm H. 2011. Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. Cell Stem Cell Oct 4;9(4):357-65. [PMID: 21982235]
• Lo, Y.-H., Noah, T.K., Chen, M.-S., Zou, W., Borras, E., Vilar, E., Shroyer, N.F., 2017. SPDEF Induces Quiescence of Colorectal Cancer Cells by Changing the Transcriptional Targets of β-catenin. Gastroenterology. doi:10.1053/j.gastro.2017.03.048 [PMID: 28390865]
• Maykel J; Liu JH; Li H; Shultz LD; Greiner DL; Houghton J. 2014. NOD-scidIl2rg (tm1Wjl) and NOD-Rag1 (null) Il2rg (tm1Wjl) : a model for stromal cell-tumor cell interaction for human colon cancer. Dig Dis Sci. June; 59(6):1169-79. [PMID: 24798995]
• Merhautová, J., Vychytilová-Faltejsková, P., Demlová, R., Slabý, O., 2016. Systemic administration of miRNA mimics by liposomal delivery system in animal model of colorectal carcinoma. Physiol. Res. [PMID: 28006930]
• Prall, F., Maletzki, C., Hühns, M., Krohn, M., Linnebacher, M., 2017. Colorectal carcinoma tumour budding and podia formation in the xenograft microenvironment. PLoS ONE 12, e0186271. [PMID: 29040282]
• Vychytilova-Faltejskova, P., Merhautova, J., Machackova, T., Gutierrez-Garcia, I., Garcia-Solano, J., Radova, L., Brchnelova, D., Slaba, K., Svoboda, M., Halamkova, J., Demlova, R., Kiss, I., Vyzula, R., Conesa-Zamora, P., Slaby, O., 2017. MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9. Oncogenesis 6, 5. [PMID: 29199273]
• Wang D, Fu L, Sun H, Guo L, DuBois RN. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice. Gastroenterology. 2015 Aug 7. [PMID: 26261008]
• Wimsatt, J.H., Montgomery, C., Thomas, L.S., Savard, C., Tallman, R., Innes, K., Jrebi, N., 2018. Assessment of a mouse xenograft model of primary colorectal cancer with special reference to perfluorooctane sulfonate. PeerJ 6, e5602. [PMID: 30405966]
• Xu, H., Li, J., Chen, H., Ghishan, F.K., 2019. NHE8 Deficiency Promotes Colitis-Associated Cancer in Mice via Expansion of Lgr5-Expressing Cells. Cell Mol Gastroenterol Hepatol 7, 19—31. [PMID: 30465020]

Endometrial cancer

• Winder, A., Unno, K., Yu, Y., Lurain, J., Kim, J.J., 2017. The allosteric AKT inhibitor, MK2206, decreases tumor growth and invasion in patient derived xenografts of endometrial cancer. Cancer Biol. Ther. 0. doi:10.1080/15384047.2017.1281496 [PMID: 28112582]

Esophageal cancer

• Ahn J; Bishop JA; Akpeng B; Pai SI; Best SR. 2014. Xenograft Model for Therapeutic Drug Testing in Recurrent Respiratory Papillomatosis. Ann Otol Rhinol Laryngol. Aug; pii: 0003489414546400. [PMID: 25124839]
• Ebbing, E.A., Steins, A., Fessler, E., Stathi, P., Lesterhuis, W.J., Krishnadath, K.K., Vermeulen, L., Medema, J.P., Bijlsma, M.F., van Laarhoven, H.W.M., 2017. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition. Gastroenterology. [PMID: 28286209]
• Predina JD; Judy B; Aliperti LA; Fridlender ZG; Blouin A; Kapoor V; Laguna B; Nakagawa H; Rustgi AK; Aguilar L; Aguilar-Cordova E; Albelda SM; Singhal S. 2011. Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models. Cancer Gene Ther. Dec;18(12):871-83. [PMID: 21869822]

Gastrointestinal cancer

• Dieter, S.M., Giessler, K.M., Kriegsmann, M., Dubash, T.D., Möhrmann, L., Schulz, E.R., Siegl, C., Weber, S., Strakerjahn, H., Oberlack, A., Heger, U., Gao, J., Hartinger, E.-M., Oppel, F., Hoffmann, C.M., Ha, N., Brors, B., Lasitschka, F., Ulrich, A., Strobel, O., Schmidt, M., von Kalle, C., Schneider, M., Weichert, W., Ehrenberg, K.R., Glimm, H., Ball, C.R., 2016. Patient-derived Xenografts of Gastrointestinal Cancers Are Susceptible to Rapid and Delayed B-Lymphoproliferation. Int. J. Cancer. [PMID: 27935045]
• Edris B; Willingham SB; Weiskopf K; Volkmer AK; Volkmer JP; Mühlenberg T; Montgomery KD; Contreras-Trujillo H; Czechowicz A; Fletcher JA; West RB; Weissman IL; van de Rijn M. 2013. Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growth. Proc Natl Acad Sci U S A.  Feb 26;110(9):3501-6. [PMID: 23382202]
• Liu K; Jiang M; Lu Y; Chen H; Sun J; Wu S; Ku WY; Nakagawa H; Kita Y; Natsugoe S; Peters JH; Rustgi A; Onaitis MW; Kiernan A; Chen X; Que J. 2013. Sox2 cooperates with inflammation-mediated stat3 activation in the malignant transformation of foregut Basal progenitor cells. Cell Stem Cell. Mar 7;12(3):304-15. [PMID: 23472872]
• Rad R; Cadiñanos J; Rad L; Varela I; Strong A; Kriegl L; Constantino-Casas F; Eser S; Hieber M; Seidler B; Price S; Fraga MF; Calvanese V; Hoffman G; Ponstingl H; Schneider G; Yusa K; Grove C; Schmid RM; Wang W; Vassiliou G; Kirchner T; McDermott U; Liu P; Saur D; Bradley A. 2013. A Genetic Progression Model of Braf(V600E)-Induced Intestinal Tumorigenesis Reveals Targets for Therapeutic Intervention. Cancer Cell. Jul 8;24(1):15-29. [PMID: 23845441]
• Zhu, G., Foletti, D., Liu, X., Ding, S., Melton Witt, J., Hasa-Moreno, A., Rickert, M., Holz, C., Aschenbrenner, L., Yang, A.H., Kraynov, E., Evering, W., Obert, L., Lee, C., Sai, T., Mistry, T., Lindquist, K.C., Van Blarcom, T., Strop, P., Chaparro-Riggers, J., Liu, S.-H., 2019. Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer. Sci Rep 9, 8420. [PMID: 31182754]

Head and neck cancer

• Baik FM, Hansen S, Knoblaugh SE, Sahetya D, Mitchell RM, Xu C, Parrish-Novak J, Méndez E. Fluorescence Identification of Head and Neck Squamous Cell Carcinoma and High-Risk Oral Dysplasia With BLZ-100, a Chlorotoxin-Indocyanine Green Conjugate. JAMA Otolaryngol Head Neck Surg. 2016 Feb 18. doi: 10.1001/jamaoto.2015.3617. [PMID: 26892902]
• Behera, A.K., Kumar, M., Shanmugam, M.K., Bhattacharya, A., Rao, V.J., Bhat, A., Vasudevan, M., Gopinath, K.S., Mohiyuddin, A., Chatterjee, A., Sethi, G., Kundu, T.K., 2019. Functional interplay between YY1 and CARM1 promotes oral carcinogenesis. Oncotarget 10, 3709—3724. [PMID: 31217904]
• Bragado P; Estrada Y; Sosa MS; Avivar-Valderas A; Cannan D; Genden E; Teng M; Ranganathan AC; Wen HC; Kapoor A; Bernstein E; Aguirre-Ghiso JA. 2012. Analysis of marker-defined HNSCC subpopulations reveals a dynamic regulation of tumor initiating properties. PLoS One 7(1):e29974. [PMID: 22276135]
• Facompre, N.D., Sahu, V., Montone, K.T., Harmeyer, K.M., Nakagawa, H., Rustgi, A.K., Weinstein, G.S., Gimotty, P.A., Basu, D., 2017. Barriers to generating PDX models of HPV-related head and neck cancer. Laryngoscope 127, 2777–2783. [PMID: 28561270]
• Kimple RJ; Harari P; Torres AD; Yang RZ; Soriano BJ; Yu M; Armstrong EA; Blitzer GC; Smith MA; Lorenz LD; Lee D; Yang D; McCulloch TM; Hartig GK; Lambert PF. 2012. Development and characterization of HPV-positive and HPV-negative head and neck squamous cell carcinoma tumorgrafts. Clin Cancer Res. Feb 15;19(4):855-64. [PMID: 23251001]
• Martens-de Kemp SR; Brink A; Stigter-van Walsum M; Damen JM; Rustenburg F; Wu T; van Wieringen WN; Schuurhuis GJ; Braakhuis BJ; Slijper M; Brakenhoff RH. 2013. CD98 marks a subpopulation of head and neck squamous cell carcinoma cells with stem cell properties. Stem Cell Res. May;10(3):477-88. [PMID: 23523931]
• Shrivastava S; Steele R; Sowadski M; Crawford SE; Varvares M; Ray RB. 2015. Identification of molecular signature of head and neck cancer stem-like cells. Sci Rep. Epub ahead of print. [PMID: 25588898]

Hepatoblastoma

• Ellerkamp V; Armeanu-Ebinger S; Wenz J; Warmann SW; Schafer J; Ruck P; Fuchs J. 2011. Successful Establishment of an Orthotopic Hepatoblastoma In Vivo Model in NOD/LtSz-scid IL2Rγnull Mice. PLoS One. 6(8):e23419. [PMID: 21853130]
• Harmon, J.S., Kabinejadian, F., Seda, R., Fabiilli, M.L., Kuruvilla, S., Kuo, C.C., Greve, J.M., Fowlkes, J.B., Bull, J.L., 2019. Minimally invasive gas embolization using acoustic droplet vaporization in a rodent model of hepatocellular carcinoma. Sci Rep 9. [PMID: 31363130]
• Lieber J; Eicher C; Wenz J; Kirchner B; Warmann SW; Fuchs J; Armeanu-Ebinger S. 2011. The BH3 mimetic ABT-737 increases treatment efficiency of paclitaxel against hepatoblastoma. BMC Cancer. Aug 19;11(1):362. [PMID: 21854558]

Hepatocellular carcinoma

• Chen K; Ahmed S; Adeyi O; Dick JE; Ghanekar A. 2012. Human solid tumor xenografts in immunodeficient mice are vulnerable to lymphomagenesis associated with epstein-barr virus. PLoS One. 7(6):e39294. [PMID: 22723990]
• Colombo F; Baldan F; Mazzucchelli S; Martin-Padura I; Marighetti P; Cattaneo A; Foglieni B; Spreafico M; Guerneri S; Baccarin M; Bertolini F; Rossi G; Mazzaferro V; Cadamuro M; Maggioni M; Agnelli L; Rebulla P; Prati D; Porretti L. 2011. Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma. PLoS One 6(6):e21369. [PMID: 21731718]
• Guo, X., Jiang, H., Shi, B., Zhou, M., Zhang, H., Shi, Z., Du, G., Luo, H., Wu, X., Wang, Y., Sun, R., Li, Z., 2018. Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma. Front Pharmacol 9, 1118. [PMID: 30327605]
• Kumar, D.P., Santhekadur, P.K., Seneshaw, M., Mirshahi, F., Tuculescu, C.U., Sanyal, A.J., 2018. A Novel Regulatory Role of Apoptosis Antagonizing Transcription Factor in the Pathogenesis of NAFLD and HCC. Hepatology. [PMID: 30394550]
• Martin-Padura I; Marighetti P; Agliano A; Colombo F; Larzabal L; Redrado M; Bleau AM; Prior C; Bertolini F; Calvo A. 2012. Residual dormant cancer stem-cell foci are responsible for tumor relapse after antiangiogenic metronomic therapy in hepatocellular carcinoma xenografts. Lab Invest Jul;92(7):952-66. [PMID: 22546866]
• Tahtouh R; Azzi AS; Alaaeddine N; Chamat S; Bouharoun-Tayoun H; Wardi L; Raad I; Sarkis R; Antoun NA; Hilal G. Telomerase Inhibition Decreases Alpha-Fetoprotein Expression and Secretion by Hepatocellular Carcinoma Cell Lines: In Vitro and In Vivo Study. Plos One. 2015 Mar 30;10(3):e0119512. [PMID: 25822740]
• Tischfield, D.J., Ackerman, D., Noji, M., Chen, J.X., Johnson, O., Perkons, N.R., Nadolski, G.J., Hunt, S.J., Soulen, M.C., Furth, E.E., Gade, T.P., 2019. Establishment of hepatocellular carcinoma patient-derived xenografts from image-guided percutaneous biopsies. Sci Rep 9. [PMID: 31332214]
• Zhao, J., Wozniak, A., Adams, A., Cox, J., Vittal, A., Voss, J., Bridges, B., Weinman, S.A., Li, Z., 2019. SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway. J Exp Clin Cancer Res 38. [PMID: 31196136]
• Zhao, Y., Shuen, T.W.H., Toh, T.B., Chan, X.Y., Liu, M., Tan, S.Y., Fan, Y., Yang, H., Lyer, S.G., Bonney, G.K., Loh, E., Chang, K.T.E., Tan, T.C., Zhai, W., Chan, J.K.Y., Chow, E.K.-H., Chee, C.E., Lee, G.H., Dan, Y.Y., Chow, P.K.-H., Toh, H.C., Lim, S.G., Chen, Q., 2018. Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy. Gut. [PMID: 29602780]
• Zhu, W., Peng, Y., Wang, L., Hong, Y., Jiang, X., Li, Q., Liu, H., Huang, L., Wu, J., Celis, E., Merchen, T., Kruse, E., He, Y., 2018. Identification of α-fetoprotein-specific T cell receptors for hepatocellular carcinoma immunotherapy. Hepatology. [PMID: 29443377]

Lung cancer

• Basak SK; Veena MS; Oh S; Lai C; Vangala S; Elashoff D; Fishbein MC; Sharma S; Rao NP; Rao D; Phan R; Srivatsan ES; Batra RK. 2013. The CD44(high) Tumorigenic Subsets in Lung Cancer Biospecimens Are Enriched for Low miR-34a Expression. PLoS One. Sep 3;8(9):e73195. [PMID: 24019906]
• Gandara DR; Mack PC; Bult C; Li T; Lara PN Jr; Riess JW; Astrow SH; Gandour-Edwards R; Cooke DT; Yoneda KY; Moore EH; Pan CX; Burich RA; David EA; Keck JG; Airhart S; Goodwin N; de Vere White RW; Liu ET. Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platform. Clin Lung Cancer. 2015 May;16(3):165-72. [PMID: 25838158]
• Guerrera F, Tabbò F, Bessone L, Maletta F, Gaudiano M, Ercole E, Annaratone L, Todaro M, Boita M, Filosso PL, Solidoro P, Delsedime L, Oliaro A, Sapino A, Ruffini E, Inghirami G. The Influence of Tissue Ischemia Time on RNA Integrity and Patient-Derived Xenografts (PDX) Engraftment Rate in a Non-Small Cell Lung Cancer (NSCLC) Biobank. PLoS One. 2016 Jan 5;11(1):e0145100. doi: 10.1371/journal.pone.0145100. [PMID: 26731692]
• Habiel, D.M., Espindola, M.S., Coelho, A.L., Hogaboam, C.M., 2018. Modeling Idiopathic Pulmonary Fibrosis in Humanized SCID Mice. Am. J. Pathol. [PMID: 29378172]
• Holopainen T; Saharinen P; D'Amico G; Lampinen A; Eklund L; Sormunen R; Anisimov A; Zarkada G; Lohela M; Heloterä H; Tammela T; Benjamin LE; Ylä-Herttuala S; Leow CC; Koh GY; Alitalo K. 2012. Effects of Angiopoietin-2-Blocking Antibody on Endothelial Cell–Cell Junctions and Lung Metastasis. J Natl Cancer Inst Mar 21;104(6):461-75. [PMID: 22343031]
• Hung, W.-Y., Chang, J.-H., Cheng, Y., Chen, C.-K., Chen, J.-Q., Hua, K.-T., Cheng, C.-W., Hsiao, M., Chung, C.-L., Lee, W.-J., Chien, M.-H., 2018. Leukocyte Cell-Derived Chemotaxin 2 Retards Non-Small Cell Lung Cancer Progression Through Antagonizing MET and EGFR Activities. Cell. Physiol. Biochem. 51, 337–355. [PMID: 30453282]
• Kalber TL; Campbell-Washburn AE; Siow BM; Sage E; Price AN; Ordidge KL; Walker-Samuel S; Janes SM; Lythgoe MF. 2013. Primed Infusion with Delayed Equilibrium of Gd.DTPA for Enhanced Imaging of Small Pulmonary Metastases. PLoS One. 8(1):e54903. [PMID: 23382996]
• Morrison BJ; Steel JC; Morris JC. 2012. Sphere culture of murine lung cancer cell lines are enriched with cancer initiating cells. PLoS One. 7(11):e49752. [PMID: 23152931]
• Pyo, K.H., Kim, J.H., Lee, J.-M., Kim, S.E., Cho, J.S., Lim, S.M., Cho, B.C., 2019. Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models. Lung Cancer 127, 112—121. [PMID: 30642538]
• Serrano-Tejero D; Bleau AM; Fernandez-Garcia I; Fernandez-Marcelo T; Iniesta P; Ortiz-de-Solorzano C; Calvo A. 2011. Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer. Mol Cancer. Aug 9;10(1):96. [PMID: 21827695]
• Simpson-Abelson MR; Sonnenberg GF; Takita H; Yokota SJ; Conway TF Jr; Kelleher RJ Jr; Shultz LD; Barcos M; Bankert RB. 2008. Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. J Immunol 180(10):7009-18. [PMID: 18453623]
• Tavassoly, I., Hu, Y., Zhao, S., Mariottini, C., Boran, A., Chen, Y., Li, L., Tolentino, R.E., Jayaraman, G., Goldfarb, J., Gallo, J., Iyengar, R., 2019. Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses. Mol Oncol 13, 1725–1743. [PMID: 31116490<]
• Toma, W., Kyte, S.L., Bagdas, D., Jackson, A., Meade, J.A., Rahman, F., Chen, Z.-J., Del Fabbro, E., Cantwell, L., Kulkarni, A., Thakur, G.A., Papke, R.L., Bigbee, J.W., Gewirtz, D.A., Damaj, M.I., 2019. The α7 nicotinic receptor silent agonist R-47 prevents and reverses paclitaxel-induced peripheral neuropathy in mice without tolerance or altering nicotine reward and withdrawal. Exp. Neurol. 320, 113010. [PMID: 31299179]
• Tsai HY; Yang YF; Wu AT; Yang CJ; Liu YP; Jan YH; Lee CH; Hsiao YW; Yeh CT; Shen CN; Lu PJ; Huang MS; Hsiao M. 2013. Endoplasmic reticulum ribosome-binding protein 1 (RRBP1) overexpression is frequently found in lung cancer patients and alleviates intracellular stress-induced apoptosis through the enhancement of GRP78. Oncogene [Epub ahead of print] [PMID: 23318055]
• Vaughan AE; Halbert CL; Wootton SK; Miller AD. 2012. Lung cancer in mice induced by the jaagsiekte sheep retrovirus envelope protein is not maintained by rare cancer stem cells; but tumorigenicity does correlate with Wnt pathway activation. Mol Cancer Res Jan;10(1):86-95. [PMID: 22064658]
• Wang, D., Pham, N.-A., Tong, J., Sakashita, S., Allo, G., Kim, L., Yanagawa, N., Raghavan, V., Wei, Y., To, C., Trinh, Q.M., Starmans, M.H.W., Chan-Seng-Yue, M.A., Chadwick, D., Li, L., Zhu, C.-Q., Liu, N., Li, M., Lee, S., Ignatchenko, V., Strumpf, D., Taylor, P., Moghal, N., Liu, G., Boutros, P.C., Kislinger, T., Pintilie, M., Jurisica, I., Shepherd, F.A., McPherson, J.D., Muthuswamy, L., Moran, M.F., Tsao, M.-S., 2017. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors. Int. J. Cancer 140, 662–673. doi:10.1002/ijc.30472 [PMID: 27177180]
• Wang H, Wang L, Zhang Y, Wang J, Deng Y, Lin D. Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth. Cancer Cell Int. 2016 Feb 16;16:9. doi: 10.1186/s12935-016-0280-y. [PMID: 26884725]
• Wang, X.-D., Hu, R., Ding, Q., Savage, T.K., Huffman, K.E., Williams, N., Cobb, M.H., Minna, J.D., Johnson, J.E., Yu, Y., 2019. Subtype-specific secretomic characterization of pulmonary neuroendocrine tumor cells. Nat Commun 10. [PMID: 31324758]
• Wu, L., Zhang, H., Jiang, Y., Gallo, R.C., Cheng, H., 2018. Induction of antitumor cytotoxic lymphocytes using engineered human primary blood dendritic cells. Proc. Natl. Acad. Sci. U.S.A. [PMID: 29674449]
• Yeddula N, Xia Y, Ke E, Beumer J, Verma IM. Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenic KRas in promoting lung adenocarcinoma. Proc Natl Acad Sci U S A. 2015 Nov 5.  [PMID: 26542681]
• Zhang, L., Singh, A., Plaisier, C., Pruett, N., Ripley, R.T., Schrump, D.S., Hoang, C.D., 2019. Metadherin Is a Prognostic Apoptosis Modulator in Mesothelioma Induced via NF-κB-Mediated Signaling. Transl Oncol 12, 859—870. [PMID: 31054476]
• Zhang WC; Shyh-Chang N; Yang H; Rai A; Umashankar S; Ma S; Soh BS; Sun LL; Tai BC; Nga ME; Bhakoo KK; Jayapal SR; Nichane M; Yu Q; Ahmed DA; Tan C; Sing WP; Tam J; Thirugananam A; Noghabi MS; Pang YH; Ang HS; Mitchell W; Robson P; Kaldis P; Soo RA; Swarup S; Lim EH; Lim B. 2012. Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell Jan 20;148(1-2):259-72. [PMID: 22225612]
• Zheng Y; de la Cruz CC; Sayles LC; Alleyne-Chin C; Vaka D; Knaak TD; Bigos M; Xu Y; Hoang CD; Shrager JB; Fehling HJ; French D; Forrest W; Jiang Z; Carano RA; Barck KH; Jackson EL; Sweet-Cordero EA. 2013. A Rare Population of CD24(+)ITGB4(+)Notch(hi) Cells Drives Tumor Propagation in NSCLC and Requires Notch3 for Self-Renewal. Cancer Cell. Jul 8;24(1):59-74. [PMID: 23845442]

Immunotherapy

• Alatrash, G., Qiao, N., Zhang, M., Zope, M., Perakis, A.A., Sukhumalchandra, P., Philips, A.V., Garber, H.R., Kerros, C., John, L.S.S., Khouri, M.R., Khong, H., Clise-Dwyer, K., Miller, L.P., Wolpe, S.D., Overwijk, W.W., Molldrem, J.J., Ma, Q., Shpall, E.J., Mittendorf, E.A., 2019. Fucosylation enhances the efficacy of adoptively transferred antigen-specific cytotoxic T lymphocytes. Clin Cancer Res clincanres.1527.2018. [PMID: 30647079]
• Barrett DM; Liu X; Jiang S; June CH; Grupp SA; Zhao Y. 2013. Regimen-Specific Effects of RNA-Modified Chimeric Antigen Receptor T Cells in Mice with Advanced Leukemia. Hum Gene Ther. Aug;24(8):717-27. [PMID: 23883116]
• Braumüller H; Wieder T; Brenner E; Aßmann S; Hahn M; Alkhaled M; Schilbach K; Essmann F; Kneilling M; Griessinger C; Ranta F; Ullrich S; Mocikat R; Braungart K; Mehra T; Fehrenbacher B; Berdel J; Niessner H; Meier F; van den Broek M; Häring HU; Handgretinger R; Quintanilla-Martinez L; Fend F; Pesic M; Bauer J; Zender L; Schaller M; Schulze-Osthoff K; Röcken M. 2013. T-helper-1-cell cytokines drive cancer into senescence. Nature. Feb 21;494(7437):361-5. [PMID: 23376950]
• Canale S; Cocco C; Frasson C; Seganfreddo E; Di Carlo E; Ognio E; Sorrentino C; Ribatti D; Zorzoli A; Basso G; Dufour C; Airoldi I. 2011. Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model.Leukemia Dec;25(12):1815-24.[PMID: 21701492]
• Chang DK, Peterson E, Sun J, Goudie C, Drapkin RI, Liu JF, Matulonis U, Zhu Q, Marasco WA. 2015. Anti-CCR4 monoclonal antibody enhances antitumor immunity by modulating tumor-infiltrating Tregs in an ovarian cancer xenograft humanized mouse model. Oncoimmunology. Dec 10;5(3):e1090075. [PMID: 27141347]
• Edris B; Weiskopf K; Volkmer AK; Volkmer JP; Willingham SB; Contreras-Trujillo H; Liu J; Majeti R; West RB; Fletcher JA; Beck AH; Weissman IL; van de Rijn M. 2012. Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma. Proc Natl Acad Sci U S A Apr 24;109(17):6656-61 [PMID: 22451919]
• Ferretti E; Montagna D; Di Carlo E; Cocco C; Ribatti D; Ognio E; Sorrentino C; Lisini D; Bertaina A; Locatelli F; Pistoia V; Airoldi I. 2011. Absence of IL-12Rβ2 in CD33(+)CD39(+) pediatric acute myeloid leukemia cells favours progression in NOD/SCID/IL2RγC-deficient mice. Leukemia Feb;26(2):225-35. [PMID: 21844875]
• Fisher TS; Kamperschroer C; Oliphant T; Love VA; Lira PD; Doyonnas R; Bergqvist S; Baxi SM; Rohner A; Shen AC; Huang C; Sokolowski SA; Sharp LL. 2012. Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity. Cancer Immunol Immunother. Oct;61(10):1721-33. [PMID: 22406983]
• Habiel, D.M., Espindola, M.S., Kitson, C., Azzara, A.V., Coelho, A.L., Stripp, B., Hogaboam, C.M., 2018. Characterization of CD28null T cells in idiopathic pulmonary fibrosis. Mucosal Immunol. [PMID: 30315241]
• Hudecek M; Lupo Stanghellini MT; Kosasih PL; Sommermeyer D; Jensen M; Rader C; Riddell S. 2013. Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T-cells. Clin Cancer Res. Jun 15;19(12):3153-64. [PMID: 23620405]
• Kloss CC; Condomines M; Cartellieri M; Bachmann M; Sadelain M. 2012. Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells.  Nat Biotechnol. Dec 16;31(1):71-5. [PMID: 23242161]
• Liu D; Song L; Wei J; Courtney AN; Gao X; Marinova E; Guo L; Heczey A; Asgharzadeh S; Kim E; Dotti G; Metelitsa LS. 2012. IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity. J Clin Invest Jun 1;122(6):2221-33. [PMID: 22565311]
• Markley JC; Sadelain M. 2010. Interleukin (IL)-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice. Blood Apr 29;115(17):3508-19. [PMID: 20190192]
• Mayer, A.T., Natarajan, A., Gordon, S., Maute, R., McCracken, M., Ring, A., Weissman, I., Gambhir, S.S., 2016. Practical ImmunoPET radiotracer design considerations for human immune checkpoint imaging. J. Nucl. Med. Off. Publ. Soc. Nucl. Med. [PMID: 27980047]
• McCormack E; Adams KJ; Hassan NJ; Kotian A; Lissin NM; Sami M; Mujić M; Osdal T; Gjertsen BT; Baker D; Powlesland AS; Aleksic M; Vuidepot A; Morteau O; Sutton DH; June CH; Kalos M; Ashfield R; Jakobsen BK. 2012. Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors. Cancer Immunol Immunother. Apr;62(4):773-85. [PMID: 23263452]
• Milone MC; Fish JD; Carpenito C; Carroll RG; Binder GK; Teachey D; Samanta M; Lakhal M; Gloss B; Danet-Desnoyers G; Campana D; Riley JL; Grupp SA; June CH. 2009.  Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo. Mol Ther. Aug;17(8):1453-64. [PMID: 19384291]
• Moon EK; Carpenito C; Sun J; Wang LC; Kapoor V; Predina JD; Powell DJ Jr; Riley J; June CH; Albelda SM. 2011. Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Eradication by Human T Cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor. Clin Cancer Res Jul 15;17(14):4719-30. [PMID: 21610146]
• Orienti, I., Francescangeli, F., De Angelis, M.L., Fecchi, K., Bongiorno-Borbone, L., Signore, M., Peschiaroli, A., Boe, A., Bruselles, A., Costantino, A., Eramo, A., Salvati, V., Sette, G., Contavalli, P., Zolla, L., Oki, T., Kitamura, T., Spada, M., Giuliani, A., Baiocchi, M., La Torre, F., Melino, G., Tartaglia, M., De Maria, R., Zeuner, A., 2019. A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors. Cell Death Dis 10. [PMID: 31332161]
• Otáhal P, Průková D, Král V, Fabry M, Vočková P, Latečková L, Trněný M, Klener P. 2016. Lenalidomide enhances antitumor functions of chimeric antigen receptor modified T cells. Oncoimmunology. 2015 Dec 3;5(4):e1115940. [PMID: 27141398]
• Park J, Kim S, Joh J, Remick SC, Miller DM, Yan J, Kanaan Z, Chao JH, Krem MM, Basu SK, Hagiwara S, Kenner L, Moriggl R, Bunting KD, Tse W. 2016. MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling. Oncotarget. Jun 1. doi: 10.18632/oncotarget.9759. [Epub ahead of print] [PMID: 27259262]
• Piccione EC, Juarez S, Tseng S, Liu J, Stafford M, Narayanan C, Wang L, Weiskopf K, Majeti R. 2016. SIRPα-Antibody Fusion Proteins Selectively Bind and Eliminate Dual Antigen-Expressing Tumor Cells. Clin Cancer Res. 2016 Apr 28. pii: clincanres.2503.2015. [PMID: 27126995]
• Provasi E; Genovese P; Lombardo A; Magnani Z; Liu PQ; Reik A; Chu V; Paschon DE; Zhang L; Kuball J; Camisa B; Bondanza A; Casorati G; Ponzoni M; Ciceri F; Bordignon C; Greenberg PD; Holmes MC; Gregory PD; Naldini L; Bonini C. 2012. Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer.  Nat Med May;18(5):807-15 [PMID: 22466705]
• Reid GS; Shan X; Coughlin CM; Lassoued W; Pawel BR; Wexler LH; Thiele CJ; Tsokos M; Pinkus JL; Pinkus GS; Grupp SA; Vonderheide RH. 2009. Interferon-gamma-dependent infiltration of human T cells into neuroblastoma tumors in vivo.Clin Cancer Res 15(21):6602-8. [PMID: 19825945]
• Song DG; Ye Q; Carpenito C; Poussin M; Wang LP; Ji C; Figini M; June CH; Coukos G; Powell DJ Jr. 2011. In Vivo Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB). Cancer Res. Jul 1;71(13):4617-27. [PMID: 21546571]
• Song DG; Ye Q; Poussin M; Harms GM; Figini M; Powell DJ Jr. 2012. CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo. Blood Jan 19;119(3):696-706. [PMID: 22117050]
• Spranger S; Jeremias I; Wilde S; Leisegang M; Stärck L; Mosetter B; Uckert W; Heemskerk MH; Schendel DJ; Frankenberger B. 2012. T-cell receptor-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo. Blood Apr 12;119(15):3440-9 [PMID: 22371883]
• Stadler CR, Bähr-Mahmud H, Plum LM, Schmoldt K, Kölsch AC, Türeci Ö, Sahin U. 2015. Characterization of the first-in-class T-cell-engaging bispecific single-chain antibody for targeted immunotherapy of solid tumors expressing the oncofetal protein claudin 6. Oncoimmunology. Oct 29;5(3):e1091555. [PMID: 27141353]
• Tian G, Courtney AN, Jena B, Heczey A, Liu D, Marinova E, Guo L, Xu X, Torikai H, Mo Q, Dotti G, Cooper LJ, Metelitsa LS. 2016. CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo. J Clin Invest. 2016 May 16. pii: 83476. doi: 10.1172/JCI83476. [Epub ahead of print] [PMID: 27183388]
• Urbanska K; Lanitis E; Poussin M; Lynn RC; Gavin BP; Kelderman S; Yu J; Scholler N; Powell DJ Jr. 2012. A Universal Strategy for Adoptive Immunotherapy of Cancer through Use of a Novel T-cell Antigen Receptor. Cancer Res Apr 1;72(7):1844-52. [PMID: 22315351]
• Wang QJ, Yu Z, Griffith K, Hanada KI, Restifo NP, Yang JC. Identification of T-cell Receptors Targeting KRAS-mutated Human Tumors. Cancer Immunol Res. 2015 Dec 23. pii: canimm.0188.2015. [PMID: 26701267]
• Wege AK; Ernst W; Eckl J; Frankenberger B; Vollmann-Zwerenz A; Mannel DN; Ortmann O; Kroemer A; Brockhoff G. 2011. Humanized tumor mice - a new model to study and manipulate the immune response in advanced cancer therapy. Int J Cancer  Nov 1;129(9):2194-206 [PMID: 21544806]
• Wege A; Schmidt MUeberham E; Ponnath M; Ortmann; Brockhoff G; Lehmann J. Co-transplantation of human hematopoietic stem cells and human breast cancer cells in NSG mice: a novel approach to generate tumor cell specific human antibodies.MAbs. 2014 Jul-Aug;6(4):968-77. [PMID: 24870377]
• Willingham SB; Volkmer JP; Gentles AJ; Sahoo D; Dalerba P; Mitra SS; Wang J; Contreras-Trujillo H; Martin R; Cohen JD; Lovelace P; Scheeren FA; Chao MP; Weiskopf K; Tang C; Volkmer AK; Naik TJ; Storm TA; Mosley AR; Edris B; Schmid SM; Sun CK; Chua MS; Murillo O; Rajendran P; Cha AC; Chin RK; Kim D; Adorno M; Raveh T; Tseng D; Jaiswal S; Enger PO; Steinberg GK; Li G; So SK; Majeti R; Harsh GR; van de Rijn M; Teng NN; Sunwoo JB; Alizadeh AA; Clarke MF; Weissman IL. 2012. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A Apr 24;109(17):6662-6667. [PMID: 22451913]
• Yoshida T, Jin K, Song H, Park S, Huso DL, Zhang Z, Liangfeng H, Zhu C, Bruchertseifer F, Morgenstern A, Sgouros G, Sukumar S. 2016. Effective treatment of ductal carcinoma in situ with a HER-2- targeted alpha-particle emitting radionuclide in a preclinical model of human breast cancer. Oncotarget. Apr 23. doi: 10.18632/oncotarget.8949. [PMID: 27119227]
• Zhao Y; Moon E; Carpenito C; Paulos C; Liu X; Brennan A; Chew A; Scholler J; Carroll RG; Levine BL; Albelda SM; June CH. Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor. Cancer Res. Nov 15;70(22):9053-61. [PMID: 20926399]
• Zheng, Q., Wang, Zhaohui, Zhang, H., Huang, Q., Madsen, J.C., Sachs, D.H., Huang, C.A., Wang, Zhirui, 2017. Diphtheria toxin-based anti-human CD19 immunotoxin for targeting human CD19(+) tumors. Mol. Oncol. [PMID: 28306193]
• Zorzoli A; Di Carlo E; Cocco C; Ognio E; Ribatti D; Ferretti E; Dufour C; Locatelli F; Montagna D; Airoldi I. 2012. Interleukin-27 Inhibits the Growth of Pediatric Acute Myeloid Leukemia in NOD/SCID/Il2rg-/- Mice. Clin Cancer Res Mar 15;18(6):1630-1640. [PMID: 22383738]

Melanoma

• Benito-Jardón, L., Díaz-Martínez, M., Arellano-Sánchez, N., Vaquero-Morales, P., Esparís-Ogando, A., Teixidó, J., 2019. Resistance to MAPK inhibitors in melanoma involves activation of the IGF-1R-MEK5-Erk5 pathway. Cancer Res. [PMID: 30833419] 
• Boiko AD; Razorenova OV; van de Rijn M; Swetter SM; Johnson DL; Ly DP; Butler PD; Yang GP; Joshua B; Kaplan MJ; Longaker MT; Weissman IL. 2010. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature Jul 1;466(7302):133-7. [PMID: 19052619]
• Boonyaratanakornkit JB; Yue L; Strachan LR; Scalapino KJ; Leboit PE; Lu Y; Leong SP; Smith JE; Ghadially R. 2010. Selection of Tumorigenic Melanoma Cells Using ALDH. J Invest Dermatol Dec;130(12):2799-808. [PMID: 20739950]
• Chen Y; Soong J; Mohanty S; Xu L; Scott G. 2012. The neural guidance receptor Plexin C1 delays melanoma progression. Oncogene. [Epub ahead of print] [PMID: 23160370]
• Costea DE; Hills A; Osman AH; Thurlow J; Kalna G; Huang X; Pena Murillo C; Parajuli H; Suliman S; Keerthi KK; Johannessen AC; Partridge M. 2013. Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma. Cancer Res. Jul 1;73(13):3888-901. [PMID: 23598279]
• Deng, W., McLaughlin, S.L., Klinke, D.J., 2017. Quantifying spontaneous metastasis in a syngeneic mouse melanoma model using real time PCR. The Analyst. doi:10.1039/c7an00623c [PMID: 28725894]
• Deng, W., Fernandez, A., McLaughlin, S.L., Klinke, D.J., 2019. WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial - mesenchymal transition. J. Biol. Chem. [PMID: 30723155]
• Dobos J; Mohos A; Tóvári J; Rásó E; Lőrincz T; Zádori G; Tímár J; Ladányi A. 2012. Sex-dependent liver colonization of human melanoma in SCID mice-role of host defense mechanisms. Clin Exp Metastasis. Apr;30(4):497-506. [PMID: 23203681]
• Du, Y., Shao, H., Moller, M., Prokupets, R., Tse, Y.T., Liu, Z.-J., 2019. Intracellular Notch1 Signaling in Cancer-Associated Fibroblasts Dictates the Plasticity and Stemness of Melanoma Stem/Initiating Cells. Stem Cells. [PMID: 30941836]
• Gunnarsdóttir, F.B., Kiessling, R., Pico de Coaña, Y., 2019. Establishment of Melanoma Tumor Xenograft Using Single Cell Line Suspension and Co-injection of Patient-Derived T Cells in Immune-Deficient NSG Mice. Methods Mol. Biol. 1913, 207—215. [PMID: 30666609]
• Jenkins MH; Brinckerhoff CE; Mullins DW. CXCR3 Signaling in BRAFWT Melanoma Increases IL-8 Expression and Tumorigenicity. PLoS One. 2015 Mar 23;10(3):e0121140. [PMID: 25798946]
• Karagiannis P; Gilbert AE; Josephs DH; Ali N; Dodev T; Saul L; Correa I; Roberts L; Beddowes E; Koers A; Hobbs C; Ferreira S; Geh JL; Healy C; Harries M; Acland KM; Blower PJ; Mitchell T; Fear DJ; Spicer JF; Lacy KE; Nestle FO; Karagiannis SN. 2013. IgG4 subclass antibodies impair antitumor immunity in melanoma. J Clin Invest. Apr 1;123(4):1457-74. [PMID: 23454746]
• Kumar SM; Dai J; Li S; Yang R; Yu H; Nathanson KL; Liu S; Zhou H; Guo J; Xu X. 2013. Human skin neural crest progenitor cells are susceptible to BRAF(V600E)-induced transformation. Oncogene. [Epub ahead of print] [PMID: 23334329]
• Lian CG; Xu Y; Ceol C; Wu F; Larson A; Dresser K; Xu W; Tan L; Hu Y; Zhan Q; Lee CW; Hu D; Lian BQ; Kleffel S; Yang Y; Neiswender J; Khorasani AJ; Fang R; Lezcano C; Duncan LM; Scolyer RA; Thompson JF; Kakavand H; Houvras Y; Zon LI; Mihm MC Jr; Kaiser UB; Schatton T; Woda BA; Murphy GF; Shi YG. 2012. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell. Sep 14;150(6):1135-46. [PMID: 22980977]
• Matatall KA; Agapova OA; Onken MD; Worley LA; Bowcock AM; Harbour JW. 2013. BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma. BMC Cancer. Aug 5;13(1):371. [Epub ahead of print] [PMID: 23915344]
• Natarajan, A., Mayer, A.T., Reeves, R.E., Nagamine, C.M., Gambhir, S.S., 2017. Development of Novel ImmunoPET Tracers to Image Human PD-1 Checkpoint Expression on Tumor-Infiltrating Lymphocytes in a Humanized Mouse Model. Mol Imaging Biol 19, 903–914. [PMID: 28247187]
• Natarajan, A., Patel, C.B., Habte, F., Gambhir, S.S., 2018. Dosimetry Prediction for Clinical Translation of 64Cu-Pembrolizumab ImmunoPET Targeting Human PD-1 Expression. Sci Rep 8, 633. [PMID: 29330552]
• Penna E; Orso F; Cimino D; Vercellino I; Grassi E; Quaglino E; Turco E; Taverna D. 2013. miR-214 Coordinates Melanoma Progression by Upregulating ALCAM through TFAP2 and miR-148b Downmodulation. Cancer Res. Jul 1;73(13):4098-111 . [PMID: 23667173]
• Roesch A; Vultur A; Bogeski I; Wang H; Zimmermann KM; Speicher D; Körbel C; Laschke MW; Gimotty PA; Philipp SE; Krause E; Pätzold S; Villanueva J; Krepler C; Fukunaga-Kalabis M; Hoth M; Bastian BC; Vogt T; Herlyn M. 2013. Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells. Cancer Cell. Jun 10;23(6):811-25. [PMID: 23764003]
• Quintana E; Shackleton M; Foster HR; Fullen DR; Sabel MS; Johnson TM; Morrison SJ. 2010. Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically Organized. Cancer Cell Nov 16;18(5):510-23. [PMID: 21075313]
• Quintana E; Shackleton M; Sabel MS; Fullen DR; Johnson TM; Morrison SJ. 2008. Efficient tumour formation by single human melanoma cells. Nature 456(7222):593-8. [PMID: 19052619]
• Shackleton M; Quintana E. 2010. Progress in understanding melanoma propagation. Mol Oncol Review Oct;4(5):451-7 [PMID: 20655286]
• Tian Y; Nam S; Liu L; Yakushijin F; Yakushijin K; Buettner R; Liang W; Yang F; Ma Y; Horne D; Jove R. 2012. Spirooxindole Derivative SOID-8 Induces Apoptosis Associated with Inhibition of JAK2/STAT3 Signaling in Melanoma Cells. PLoS One.7(11):e49306. [PMID: 23166634]
• Weber CE, Luo C, Hotz-Wagenblatt A, Gardyan A, Kordaß T, Holland-Letz T, Osen W, Eichmüller SB. 2016. miR-339-3p Is a Tumor Suppressor in Melanoma. Cancer Res. Apr 15. [Epub ahead of print] [PMID: 27197185]
• Yang CH; Pfeffer SR; Sims M; Yue J; Wang Y; Linga VG; Paulus E; Davidoff AM; Pfeffer LM. 2015. The oncogenic microRNA-21 inhibits the tumor suppressive activity of FBXO11 to promote tumorigenesis. J Biol Chem. Epub ahead of print. [PMID: 25589783]
• Yang, S., Wei, J., Cui, Y.-H., Park, G., Shah, P., Deng, Y., Aplin, A.E., Lu, Z., Hwang, S., He, C., He, Y.-Y., 2019. m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade. Nat Commun 10. [PMID: 31239444]

Melanoma metastasis

• Carreno BM; Garbow JR; Kolar GR; Jackson EN; Engelbach JA; Becker-Hapak M; Carayannopoulos LN; Piwnica-Worms D; Linette GP. 2009. Immunodeficient mouse strains display marked variability in growth of human melanoma lung metastases. Clin Cancer Res May 15;15(10):3277-86. [PMID: 19447870]
• Kokolus, K.M., Haley, J.S., Koubek, E.J., Gowda, R., Dinavahi, S.S., Sharma, A., Claxton, D.F., Helm, K.F., Drabick, J.J., Robertson, G.P., Neighbors, J.D., Hohl, R.J., Schell, T.D., 2019. Schweinfurthin natural products induce regression of murine melanoma and pair with anti-PD-1 therapy to facilitate durable tumor immunity. Oncoimmunology 8, e1539614. [PMID: 30713799]
• Kupas V; Weishaupt C; Siepmann D; Kaserer ML; Eickelmann M; Metze D; Luger TA; Beissert S; Loser K. 2011. RANK Is Expressed in Metastatic Melanoma and Highly Upregulated on Melanoma-Initiating Cells. J Invest DermatolApr;131(4):944-55. [PMID: 21270824]
• Ma J; Lin JY; Alloo A; Wilson BJ; Schatton T; Zhan Q; Murphy GF; Waaga-Gasser AM; Gasser M; Hodi FS; Frank NY; Frank MH. 2010. Isolation of tumorigenic circulating melanoma cells. Biochem Biophys Res Commun Nov 26;402(4):711-7. [PMID: 20977885]
• Quintana E; Piskounova E; Shackleton M; Weinberg D; Eskiocak U; Fullen DR; Johnson TM; Morrison SJ. 2012. Human Melanoma Metastasis in NSG Mice Correlates with Clinical Outcome in Patients. Sci Transl Med. Nov 7;4(159):159ra149. [PMID: 23136044]
• Ritthipichai, K., Haymaker, C., Martinez-Paniagua, M., Aschenbrenner, A., Yi, X., Zhang, M., Kale, C., Hailemichael, Y., Overwijk, W.W., Vence, L., Roszik, J., Varadarajan, N., Nurieva, R., Radvanyi, L.G., Hwu, P., Bernatchez, C., 2017. Multifaceted role of BTLA in the control of CD8+ T cell fate after antigen encounter. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. doi:10.1158/1078-0432.CCR-16-1217 [PMID: 28754817]
• Vishnoi, M., Boral, D., Liu, H., Sprouse, M.L., Yin, W., Goswami-Sewell, D., Tetzlaff, M.T., Davies, M.A., Glitza Oliva, I.C., Marchetti, D., 2018. Targeting USP7 identifies a metastasis-competent state within bone marrow-resident melanoma CTCs. Cancer Res. [PMID: 30026332]

Metastasis

• Abe, F., Kitadate, A., Ikeda, S., Yamashita, J., Nakanishi, H., Takahashi, N., Asaka, C., Teshima, K., Miyagaki, T., Sugaya, M., Tagawa, H., 2016. Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma. Oncotarget. [PMID: 27935859]
• Kang SA, Blache CA, Bajana S, Hasan N, Kamal M, Morita Y, Gupta V, Tsolmon B, Suh SK, Gorenstein DG, Razaq W, Rui H, Tanaka T. 2016. The effect of soluble E-selectin on tumor progression and metastasis. BMC Cancer. May 24;16(1):331. doi: 10.1186/s12885-016-2366-2. [PMID: 27220365]
• Lecomte N; Njardarson JT; Nagorny P; Yang G; Downey R; Ouerfelli O; Moore MA; Danishefsky SJ. 2011. Organic Synthesis Toward Small-Molecule Probes and Drugs Special Feature: Emergence of potent inhibitors of metastasis in lung cancer via syntheses based on migrastatin. Proc Natl Acad Sci U S A. Sep 13;108(37):15074-8. [PMID: 21808037]
• Liu H; Patel MR; Prescher JA; Patsialou A; Qian D; Lin J; Wen S; Chang YF; Bachmann MH; Shimono Y; Dalerba P; Adorno M; Lobo N; Bueno J; Dirbas FM; Goswami S; Somlo G; Condeelis J; Contag CH; Gambhir SS; Clarke MF. 2010. Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc Natl Acad Sci U S A Oct 19;107(42):18115-20 [PMID: 20921380]
• Sahu, S.K., Tiwari, N., Pataskar, A., Zhuang, Y., Borisova, M., Diken, M., Strand, S., Beli, P., Tiwari, V.K., 2017. FBXO32 promotes microenvironment underlying epithelial-mesenchymal transition via CtBP1 during tumour metastasis and brain development. Nat Commun 8, 1523. [PMID: 29142217]

Mouse cancer allografts

• Grim JE; Knoblaugh SE; Guthrie KA; Hagar A; Swanger J; Hespelt J; Delrow JJ; Small T; Grady WM; Nakayama KI; Clurman BE. 2012. Fbw7 and p53 cooperatively suppress advanced and chromosomally unstable intestinal cancer. Mol Cell Biol Jun;32(11):2160-7 [PMID: 22473991]
• Kuruvilla, S.P., Tiruchinapally, G., Crouch, A.C., ElSayed, M.E.H., Greve, J.M., 2017. Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model. PloS One 12, e0181944. doi:10.1371/journal.pone.0181944 [PMID: 28829785]

Neuroblastoma

• Barry, W.E., Jackson, J.R., Asuelime, G.E., Wu, H.-W., Sun, J., Wan, Z., Malvar, J., Sheard, M.A., Wang, L., Seeger, R.C., Kim, E.S., 2018. Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary Neuroblastoma. Clin. Cancer Res. [PMID: 30232225]
• Relation, T., Yi, T., Guess, A.J., La Perle, K., Otsuru, S., Hasgur, S., Dominici, M., Breuer, C., Horwitz, E.M., 2018. Intratumoral Delivery of Interferonγ-Secreting Mesenchymal Stromal Cells Repolarizes Tumor-Associated Macrophages and Suppresses Neuroblastoma Proliferation In Vivo. Stem Cells. [PMID: 29430789]

Ovarian Cancer

• Bankert RB; Balu-Iyer SV; Odunsi K; Shultz LD; Kelleher RJ Jr; Barnas JL; Simpson-Abelson M; Parsons R; Yokota SJ. 2011. Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression; ascites formation; and metastasis. PLoS One 6(9):e24420. [PMID: 21935406]
• Chen, M.-W., Yang, S.-T., Chien, M.-H., Hua, K.-T., Wu, C.-J., Hsiao, S.-M., Lin, H., Hsiao, M., Su, J.-L., Wei, L.-H., 2017. The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer. Cancer Res. doi:10.1158/0008-5472.CAN-16-1115 [PMID: 28196514]
• Felices, M., Chu, S., Kodal, B., Bendzick, L., Ryan, C., Lenvik, A.J., Boylan, K.L.M., Wong, H.C., Skubitz, A.P.N., Miller, J.S., Geller, M.A., 2017. IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer. Gynecol. Oncol. doi:10.1016/j.ygyno.2017.02.028 [PMID: 28236454]
• Flesken-Nikitin A; Hwang CI; Cheng CY; Michurina TV; Enikolopov G; Nikitin AY. 2013. Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche. Nature. Mar 14;495(7440):241-5. [PMID: 23467088]
• He Y; Wu AC; Harrington BS; Davies CM; Wallace SJ; Adams MN; Palmer JS; Roche DK; Hollier BG; Westbrook TF; Hamidi H; Konecny GE; Winterhoff B; Chetty NP; Crandon AJ; Oliveira NB; Shannon CM; Tinker AV; Gilks CB; Coward JI; Lumley JW; Perrin LC; Armes JE; Hooper JD. Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation; cell migration and chemoresistance. Oncogene. 2015 Apr 20. Epub ahead of print. [PMID: 25893298]
• Hoarau-Véchot, J., Touboul, C., Halabi, N., Blot-Dupin, M., Lis, R., Abi Khalil, C., Rafii, S., Rafii, A., Pasquier, J., 2019. Akt-activated endothelium promotes ovarian cancer proliferation through notch activation. J Transl Med 17. [PMID: 31182109]
• Khabele D; Fadare O; Liu AY; Wilson AJ; Wass E; Osteen K; Crispens MA. 2012. An orthotopic model of platinum-sensitive high grade serous fallopian tube carcinoma. Int J Clin Exp Pathol 5(1):37-45. [PMID: 22295145]
• Magnotti, E., Marasco, W.A., 2018. The latest animal models of ovarian cancer for novel drug discovery. Expert Opin Drug Discov 1–9. [PMID: 29338446]
• Mao, T.L., Miao, C.H., Liao, Y.J., Chen, Y.J., Yeh, C.Y., Liu, C.L., 2019. Ex Vivo Expanded Human Vγ9Vδ2 T-Cells Can Suppress Epithelial Ovarian Cancer Cell Growth. Int J Mol Sci 20. [PMID: 30845699]
• Monk, B.J., Facciabene, A., Brady, W.E., Aghajanian, C.A., Fracasso, P.M., Walker, J.L., Lankes, H.A., Manjarrez, K.L., Danet-Desnoyers, G.-Ä.H., Bell-McGuinn, K.M., McCourt, C.K., Malykhin, A., Hershberg, R.M., Coukos, G., 2017. Integrative Development of a TLR8 Agonist for Ovarian Cancer Chemoimmunotherapy. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 23, 1955–1966. doi:10.1158/1078-0432.CCR-16-1453 [PMID: 27702821]
• Stewart JM; Shaw PA; Gedye C; Bernardini MQ; Neel BG; Ailles LE. 2011. Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells. Proc Natl Acad Sci U S A Apr 19;108(16):6468-73. [PMID: 21451132]
• Ward Rashidi, M.R., Mehta, P., Bregenzer, M., Raghavan, S., Fleck, E.M., Horst, E.N., Harissa, Z., Ravikumar, V., Brady, S., Bild, A., Rao, A., Buckanovich, R.J., Mehta, G., 2019. Engineered 3D Model of Cancer Stem Cell Enrichment and Chemoresistance. Neoplasia 21, 822–836. [PMID: 31299607]

Pancreatic Cancer

• Almawash, S.A., Mondal, G., Mahato, R.I., 2018. Coadministration of Polymeric Conjugates of Docetaxel and Cyclopamine Synergistically Inhibits Orthotopic Pancreatic Cancer Growth and Metastasis. Pharm. Res. 35, 17. [PMID: 29305793]
• Bhagwandin VJ, Bishop JM, Wright WE, Shay JW. The Metastatic Potential and Chemoresistance of Human Pancreatic Cancer Stem Cells. PLoS One. 2016 Feb 9;11(2):e0148807. doi: 10.1371/journal.pone.0148807. [PMID: 26859746]
• Choi, S., Wang, D., Chen, X., Tang, L.H., Verma, A., Chen, Z., Kim, B.J., Selesner, L., Robzyk, K., Zhang, G., Pang, S., Han, T., Chan, C.S., Fahey, T.J., Elemento, O., Du, Y.-C.N., 2019. Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression. Mol Cancer 18. [PMID: 31072393]
• Eser S; Reiff N; Messer M; Seidler B; Gottschalk K; Dobler M; Hieber M; Arbeiter A; Klein S; Kong B; Michalski CW; Schlitter AM; Esposito I; Kind AJ; Rad L; Schnieke AE; Baccarini M; Alessi DR; Rad R; Schmid RM; Schneider G; Saur D. 2013. Selective Requirement of PI3K/PDK1 Signaling for Kras Oncogene-Driven Pancreatic Cell Plasticity and Cancer. Cancer Cell. Mar 18;23(3):406-20. [PMID: 23453624]
• Fredebohm J; Boettcher M; Eisen C; Gaida MM; Heller A; Keleg S; Tost J; Greulich-Bode KM; Hotz-Wagenblatt A; Lathrop M; Giese NA; Hoheisel JD. 2012. Establishment and characterization of a highly tumourigenic and cancer stem cell enriched pancreatic cancer cell line as a well defined model system. PLoS One. 7(11):e48503. [PMID: 23152778]
• Fujita, M., Somasundaram, V., Basudhar, D., Cheng, R.Y.S., Ridnour, L.A., Higuchi, H., Imadome, K., No, J.H., Bharadwaj, G., Wink, D.A., 2019. Role of nitric oxide in pancreatic cancer cells exhibiting the invasive phenotype. Redox Biol 22, 101158. [PMID: 30852389]
• Golubovskaya, V., Berahovich, R., Zhou, H., Xu, S., Harto, H., Li, L., Chao, C.-C., Mao, M.M., Wu, L., 2017. CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth. Cancers (Basel) 9. [PMID: 29065481]
• Hussain, S.M., Reed, L.F., Krasnick, B.A., Miranda-Carboni, G., Fields, R.C., Bi, Y., Elahi, A., Ajidahun, A., Dickson, P.V., Deneve, J.L., Hawkins, W.G., Shibata, D., Glazer, E.S., 2018. IL23 and TGF-ß diminish macrophage associated metastasis in pancreatic carcinoma. Sci Rep 8, 5808. [PMID: 29643359]
• Kattel, K., Mondal, G., Lin, F., Kumar, V., Mahato, R.I., 2017. Biodistribution of Self-Assembling Polymer-Gemcitabine Conjugate after Systemic Administration into Orthotopic Pancreatic Tumor Bearing Mice. Mol. Pharm. 14, 1365–1372. doi:10.1021/acs.molpharmaceut.6b00929 [PMID: 27798825]
• Kim J; Hoffman JP; Alpaugh RK; Rhimm AD; Reichert M; Stanger BZ; Furth EE; Sepulveda AR; Yuan CX; Won KJ; Donahue G; Sands J; Gumbs AA; Zaret KS. 2013. An iPSC Line from Human Pancreatic Ductal Adenocarcinoma Undergoes Early to Invasive Stages of Pancreatic Cancer Progression. Cell Rep. Jun 27;3(6):2088-99. [PMID: 23791528]
• Mondal, G., Almawash, S., Chaudhary, A.K., Mahato, R.I., 2017. EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancreatic Cancer. Mol. Pharm. doi:10.1021/acs.molpharmaceut.7b00355 [PMID: 28719220]
• Nostro MC; Sarangi F; Yang C; Holland A; Elefanty AG; Stanley EG; Greiner DL; Keller G. Efficient Generation of NKX6-1(+) Pancreatic Progenitors from Multiple Human Pluripotent Stem Cell Lines. Stem Cell Reports. 2015 Apr 14;4(4):591-604. [PMID: 25843049]
• Singh S; Chitkara D; Kumar V; Behrman SW; Mahato RI. 2012. miRNA profiling in pancreatic cancer and restoration of chemosensitivity. Cancer Lett. Jul 1;334(2):211-20. [PMID: 23073476]
• von Burstin J; Diersch S; Schneider G; Reichert M; Rustgi AK; Schmid RM. Detection of Tumor Suppressor Genes in Cancer Development by a Novel shRNA-based method.  Mol Cancer Res. 2015 Feb 27. Epub ahead of print. [PMID: 25724428]
• Zettlitz, K.A., Tsai, W.-T.K., Knowles, S.M., Kobayashi, N., Donahue, T.R., Reiter, R.E., Wu, A.M., 2018. Dual-modality immunoPET and near-infrared fluorescence (NIRF) imaging of pancreatic cancer using an anti-prostate cancer stem cell antigen (PSCA) cys-diabody. J. Nucl. Med. [PMID: 29602820]

Primary Myelofibrosis

• Wang X; Zhang W; Tripodi J; Lu M; Xu M; Najfeld V; Li Y; Hoffman R. 2010. Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin modifying agents eliminate JAK2V617F positive NOD/SCID marrow repopulating cells. Blood Dec 23;116(26):5972-82. [PMID: 20858855]

Prostate Cancer

• Chen X; Liu B; Li Q; Honorio S; Liu X; Liu C; Multani AS; Calhoun-Davis T; Tang DG. 2013. Dissociated Primary Human Prostate Cancer Cells Coinjected with the Immortalized Hs5 Bone Marrow Stromal Cells Generate Undifferentiated Tumors in NOD/SCID-γ Mice. PLoS One. 8(2):e56903. [PMID: 23451107]
• Domingo-Domenech J; Vidal SJ; Rodriguez-Bravo V; Castillo-Martin M; Quinn SA; Rodriguez-Barrueco R; Bonal DM; Charytonowicz E; Gladoun N; de la Iglesia-Vicente J; Petrylak DP; Benson MC; Silva JM; Cordon-Cardo C. 2012. Suppression of Acquired Docetaxel Resistance in Prostate Cancer through Depletion of Notch- and Hedgehog-Dependent Tumor-Initiating Cells. Cancer Cell. 2012 Sep 11;22(3):373-88. [PMID: 22975379]
• Goldstein AS; Huang J; Guo C; Garraway IP; Witte ON. 2010. Identification of a cell of origin for human prostate cancer. Science Jul 30;329(5991):568-71. [PMID: 20671189]
• Graham, M.K., Principessa, L., Antony, L., Meeker, A.K., Isaacs, J.T., 2017. Low p16(INK4a) Expression in Early Passage Human Prostate Basal Epithelial Cells Enables Immortalization by Telomerase Expression Alone. The Prostate 77, 374–384. [PMID: 27859428]
• Hori, S., Wadhwa, K., Pisupati, V., Zecchini, V., Ramos-Montoya, A., Warren, A.Y., Neal, D.E., Gnanapragasam, V.J., 2017. Loss of hSef promotes metastasis through upregulation of EMT in prostate cancer. Int. J. Cancer. doi:10.1002/ijc.30604 [PMID: 28073170]
• Hudson BD, Hum NR, Thomas CB, Kohlgruber A, Sebastian A, Collette NM, Coleman MA, Christiansen BA, Loots GG. SOST Inhibits Prostate Cancer Invasion. PLoS One. 2015 Nov 6;10(11):e0142058. [PMID: 26545120]
• Lange, T., Oh-Hohenhorst, S.J., Joosse, S.A., Pantel, K., Hahn, O., Gosau, T., Dyshlovoy, S.A., Wellbrock, J., Feldhaus, S., Maar, H., Gehrcke, R., Kluth, M., Simon, R., Schlomm, T., Huland, H., Schumacher, U., 2018. Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate Cancer. Sci Rep 8, 17535. [PMID: 30510249]
• Lawrence MG; Taylor RA; Toivanen R; Pedersen J; Norden S; Pook DW; Frydenberg M; Australian Prostate Cancer BioResource; Papargiris MM; Niranjan B; Richards MG; Wang H; Collins AT; Maitland NJ; Risbridger GP. 2013. A preclinical xenograft model of prostate cancer using human tumors. Nat Protoc. Apr 4;8(5):836-48. [PMID: 23558784]
• Lillo Osuna, M.A., Garcia-Lopez, J., El Ayachi, I., Fatima, I., Khalid, A.B., Kumpati, J., Slayden, A.V., Seagroves, T.N., Miranda-Carboni, G.A., Krum, S.A., 2018. Activation of Estrogen Receptor Alpha by Decitabine Inhibits Osteosarcoma Growth and Metastasis. Cancer Res. [PMID: 30593524]
• Lu, Z.H., Kaliberov, S., Sohn, R.E., Kaliberova, L., Du, Y., Prior, J.L., Leib, D.J., Chauchereau, A., Sehn, J.K., Curiel, D.T., Arbeit, J.M., 2017. A new model of multi-visceral and bone metastatic prostate cancer with perivascular niche targeting by a novel endothelial specific adenoviral vector. Oncotarget. doi:10.18632/oncotarget.14699 [PMID: 28103576]
• McGovern, J.A., Shafiee, A., Wagner, F., Lahr, C.A., Landgraf, M., Meinert, C., Williams, E.D., Russell, P.J., Clements, J.A., Loessner, D., Holzapfel, B.M., Risbridger, G.P., Hutmacher, D.W., 2018. Humanization of the Prostate Microenvironment Reduces Homing of PC3 Prostate Cancer Cells to Human Tissue-Engineered Bone. Cancers (Basel) 10. [PMID: 30428629]
• Mulholland DJ; Kobayashi N; Ruscetti M; Zhi A; Tran LM; Huang J; Gleave M; Wu H. 2012. Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells. Cancer Res Apr 1;72(7):1878-89. [PMID: 22350410]
• Mussawy, H., Viezens, L., Schroeder, M., Hettenhausen, S., Sündermann, J., Wellbrock, J., Kossow, K., Schaefer, C., 2018. The bone microenvironment promotes tumor growth and tissue perfusion compared with striated muscle in a preclinical model of prostate cancer in vivo. BMC Cancer 18, 979. [PMID: 30326868]
• Nanta R; Kumar D; Meeker D; Rodova M; Van Veldhuizen PJ; Shankar S; Srivastava RK. 2013. NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128. Oncogenesis. Apr 8;2:e42. [PMID: 23567619]
• Rivera A, Fu X, Tao L, Zhang X. Expression of mouse CD47 on human cancer cells profoundly increases tumor metastasis in murine models.BMC Cancer. 2015 Dec 16;15(1):964. doi: 10.1186/s12885-015-1980-8. [PMID: 26674012]
• Wang ZA; Mitrofanova A; Bergren SK; Abate-Shen C; Cardiff RD; Califano A; Shen MM. 2013. Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity. Nat Cell Biol. Feb 24;15(3):274-83. [PMID: 23434823]
• Wu, W., Tang, S.-N., Zhang, Y., Puppala, M., Cooper, T.K., Xing, C., Jiang, C., Lü, J., 2017. Prostate Cancer Xenograft Inhibitory Activity and Pharmacokinetics of Decursinol, a Metabolite of Angelica gigas Pyranocoumarins, in Mouse Models. Am. J. Chin. Med. 1–20. [PMID: 29121805]

Sarcoma

• Berlow, N.E., Rikhi, R., Geltzeiler, M., Abraham, J., Svalina, M.N., Davis, L.E., Wise, E., Mancini, M., Noujaim, J., Mansoor, A., Quist, M.J., Matlock, K.L., Goros, M.W., Hernandez, B.S., Doung, Y.C., Thway, K., Tsukahara, T., Nishio, J., Huang, E.T., Airhart, S., Bult, C.J., Gandour-Edwards, R., Maki, R.G., Jones, R.L., Michalek, J.E., Milovancev, M., Ghosh, S., Pal, R., Keller, C., 2019. Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma. BMC Cancer 19. [PMID: 31208434] 
• Bharathy, N., Berlow, N.E., Wang, E., Abraham, J., Settelmeyer, T.P., Hooper, J.E., Svalina, M.N., Bajwa, Z., Goros, M.W., Hernandez, B.S., Wolff, J.E., Pal, R., Davies, A.M., Ashok, A., Bushby, D., Mancini, M., Noakes, C., Goodwin, N.C., Ordentlich, P., Keck, J., Hawkins, D.S., Rudzinski, E.R., Mansoor, A., Perkins, T.J., Vakoc, C.R., Michalek, J.E., Keller, C., 2019. Preclinical rationale for entinostat in embryonal rhabdomyosarcoma. Skelet Muscle 9. [PMID: 31113472] 
• Charytonowicz E; Terry M; Coakley K; Telis L; Remotti F; Cordon-Cardo C; Taub RN; Matushansky I. 2012. PPARγ agonists enhance ET-743-induced adipogenic differentiation in a transgenic mouse model of myxoid round cell liposarcoma. J Clin Invest Mar 1;122(3):886-98 [PMID: 22293175]
• Edris B; Espinosa I; Mühlenberg T; Mikels A; Lee CH; Steigen SE; Zhu S; Montgomery KD; Lazar AJ; Lev D; Fletcher JA; Beck AH; West RB; Nusse R; van de Rijn M. 2012. ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour. J Pathol Jun;227(2):223-33. [PMID: 22294416]
• Herrero Martín D; Boro A; Schäfer BW. 2013. Cell-based small-molecule compound screen identifies fenretinide as potential therapeutic for translocation-positive rhabdomyosarcoma. PLoS One. 8(1):e55072. [PMID: 23372815]
• McManus, M., Kleinerman, E., Yang, Y., Livingston, J.A., Mortus, J., Rivera, R., Zweidler-McKay, P., Schadler, K., 2017. Hes4: A potential prognostic biomarker for newly diagnosed patients with high-grade osteosarcoma. Pediatr. Blood Cancer 64. doi:10.1002/pbc.26318 [PMID: 27786411]
• Ono M; Qiang W; Serna VA; Yin P; Coon JS 5th; Navarro A; Monsivais D; Kakinuma T; Dyson M; Druschitz S; Unno K; Kurita T; Bulun SE. 2012. Role of stem cells in human uterine leiomyoma growth. PLoS One 7(5):e36935. [PMID: 22570742]
• Rubio R; Gutierrez-Aranda I; Sáez-Castillo AI; Labarga A; Rosu-Myles M; Gonzalez-Garcia S; Toribio ML; Menendez P; Rodriguez R. 2012. The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development. Oncogene. [Epub ahead of print] [PMID: 23222711]
• Seitz G; Pfeiffer M; Fuchs J; Warmann SW; Leuschner I; Vokuhl C; Lang P; Handgretinger R; Armeanu-Ebinger S. 2010. Establishment of a rhabdomyosarcoma xenograft model in human-adapted mice. Oncol Rep. Oct;24(4):1067-72. [PMID: 23383095]
• Skoda J, Nunukova A, Loja T, Zambo I, Neradil J, Mudry P, Zitterbart K, Hermanova M, Hampl A, Sterba J, Veselska R. Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice. Tumour Biol. 2016 Jan 20. [Epub ahead of print]. [PMID: 26790443]
• Wagner, F., Holzapfel, B.M., McGovern, J.A., Shafiee, A., Baldwin, J.G., Martine, L.C., Lahr, C.A., Wunner, F.M., Friis, T., Bas, O., Boxberg, M., Prodinger, P.M., Shokoohmand, A., Moi, D., Mazzieri, R., Loessner, D., Hutmacher, D.W., 2018. Humanization of bone and bone marrow in an orthotopic site reveals new potential therapeutic targets in osteosarcoma. Biomaterials 171, 230–246. [PMID: 29705656]
• Wang, M., Yao, L.-C., Cheng, M., Cai, D., Martinek, J., Pan, C.-X., Shi, W., Ma, A.-H., De Vere White, R.W., Airhart, S., Liu, E.T., Banchereau, J., Brehm, M.A., Greiner, D.L., Shultz, L.D., Palucka, K., Keck, J.G., 2018. Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy. FASEB J. fj201700740R. [PMID: 29146734]
• Zhang X; Cruz FD; Terry M; Remotti F; Matushansky I. 2012. Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming. Oncogene. May 2;32(18):2249-60, 2260.e1-21 [PMID: 22777357]

Solid cancer cell line xenografts

• Bach P; Abel T; Hoffmann C; Gal Z; Braun G; Voelker I; Ball CR; Johnston IC; Lauer UM; Herold-Mende C; Mühlebach MD; Glimm H; Buchholz CJ. 2012. Specific Elimination of CD133+ Tumor Cells with Targeted Oncolytic Measles Virus. Cancer Res. Jan 15;73(2):865-74. [PMID: 23293278]
• Chikova A; Grando SA. 2011. Naturally occurring variants of human Α9 nicotinic receptor differentially affect bronchial cell proliferation and transformation. PLoS One 6(11):e27978. [PMID: 22125646]
• Chu, T.L.H., Connell, M., Zhou, L., He, Z., Won, J.R., Rahavi, S.M., Chen, H., Mohan, P., Nemirovsky, O., Fotovati, A., Pujana, M.A., Reid, G.S., Nielsen, T.O., Pante, N., Maxwell, C.A., 2017. Cell Cycle-dependent Tumor Engraftment and Migration are Enabled by Aurora A. Mol. Cancer Res. [PMID: 28993511]
• de Sostoa, J., Fajardo, C.A., Moreno, R., Ramos, M.D., Farrera-Sal, M., Alemany, R., 2019. Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager. J Immunother Cancer 7, 19. [PMID: 30683154]
• Escobar G; Moi D; Ranghetti A; Ozkal-Baydin P; Squadrito ML; Kajaste-Rudnitski A; Bondanza A; Gentner B; De Palma M; Mazzieri R; Naldini L. 2014. Genetic engineering of hematopoiesis for targeted IFN-&alpha; delivery inhibits breast cancer progression. Sci Transl Med. Jan 1; 6(217):217ra3.. [PMID: 24382895] 
• Hammerlindl, H., Ravindran Menon, D., Hammerlindl, S., Emran, A.A., Torrano, J., Sproesser, K., Thakkar, D., Xiao, M., Atkinson, V.G., Gabrielli, B., Haass, N.K., Herlyn, M., Krepler, C., Schaider, H., 2017. Acetylsalicylic Acid Governs the Effect of Sorafenib in RAS- Mutant Cancers. Clin. Cancer Res. [PMID: 29196297]
• Khaled WT; Choon Lee S; Stingl J; Chen X; Raza Ali H; Rueda OM; Hadi F; Wang J; Yu Y; Chin SF; Stratton M; Futreal A; Jenkins NA; Aparicio S; Copeland NG; Watson CJ; Caldas C; Liu P. 2015. BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells. Nat Commun. [PMID: 25574598]
• Kamiyama H; Rauenzahn S; Shim JS; Karikari C; Feldmann G; Hua L; Kamiyama M; Schuler W; Lin MT; Beaty R; Karanam B; Liang H; Mullendore M; Mo G; Hidalgo M; Jaffee EM; Hruban RH; Jinnah HA; Roden RB; Jimeno A; Liu JO; Maitra A; Eshleman JR. 2013. Personalized chemotherapy profiling using cancer cell lines from selectable mice. Clin Cancer Res. Mar 1;19(5):1139-46. [PMID: 23340293]
• Kaplon J; Zheng L; Meissl K; Chaneton B; Selivanov VA; Mackay G; van der Burg SH; Verdegaal EM; Cascante M; Shlomi T; Gottlieb E; Peeper DS. 2013. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature. Jun 6;498(7452):109-12. [PMID: 23685455]
• Larzabal L; Nguewa PA; Pio R; Blanco D; Sanchez B; Rodríguez MJ; Pajares MJ; Catena R; Montuenga LM; Calvo A. 2011. Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology. Br J Cancer Nov 8;105(10):1608-14 [PMID: 22067904]
• Liu X; Lai L; Wang X; Xue L; Leora S; Wu J; Hu S; Zhang K; Kuo ML; Zhou L; Zhang H; Wang Y; Wang Y; Zhou B; Nelson RA; Zheng S; Zhang S; Chu PG; Yen Y. 2011. Ribonucleotide reductase small subunit M2B prognoses better survival in colorectal cancer. Cancer Res May 1;71(9):3202-13. [PMID: 21415168]
• Powers, J.F., Pacak, K., Tischler, A.S., 2017. Pathology of Human Pheochromocytoma and Paraganglioma Xenografts in NSG Mice. Endocr. Pathol. 28, 2–6. [PMID: 27709415]
• Rivero, E.M., Piñero, C.P., Gargiulo, L., Entschladen, F., Zänker, K., Bruzzone, A., Lüthy, I.A., 2017. The β2-Adrenergic Agonist Salbutamol Inhibits Migration, Invasion and Metastasis of the Human Breast Cancer MDA-MB-231 Cell Line. Curr. Cancer Drug Targets. [PMID: 28359245]
• Rojas, J.D., Lin, F., Chiang, Y.-C., Chytil, A., Chong, D.C., Bautch, V.L., Rathmell, W.K., Dayton, P.A., 2018. Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy. Theranostics 8, 141–155. [PMID: 29290798]
• Schneider, D., Xiong, Y., Wu, D., Nӧlle, V., Schmitz, S., Haso, W., Kaiser, A., Dropulic, B., Orentas, R.J., 2017. A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines. J. Immunother. Cancer 5, 42. doi:10.1186/s40425-017-0246-1 [PMID: 28515942]
• Shim, S.H., Sur, S., Steele, R., Albert, C.J., Huang, C., Ford, D.A., Ray, R.B., 2018. Disrupting cholesterol esterification by bitter melon suppresses triple-negative breast cancer cell growth. Mol. Carcinog. [PMID: 30074275]
• Silden E; Hjelle SM; Wergeland L; Sulen A; Andresen V; Bourdon JC; Micklem DR; McCormack E; Gjertsen BT. 2013. Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53(null) Cell Lines. PLoS One. 8(2):e56276. [PMID: 23409163]
• Singhal, J., Singhal, P., Horne, D., Salgia, R., Awasthi, S., Singhal, S.S., 2018. Metastasis of breast tumor cells to brain is suppressed by targeting RLIP alone and in combination with 2’-Hydroxyflavanone. Cancer Lett. 438, 144–153. [PMID: 30223070]
• Tátrai P; Szepesi A; Matula Z; Szigeti A; Buchan G; Mádi A; Uher F; Német K. 2012. Combined introduction of Bmi-1 and hTERT immortalizes human adipose tissue-derived stromal cells with low risk of transformation. Biochem Biophys Res Commun May 25;422(1):28-35. [PMID: 22554522]
• Teow, S.-Y., Liew, K., Che Mat, M.F., Marzuki, M., Abdul Aziz, N., Chu, T.-L., Ahmad, M., Khoo, A.S.-B., 2019. Development of a luciferase/luciferin cell proliferation (XenoLuc) assay for real-time measurements of Gfp-Luc2-modified cells in a co-culture system. BMC Biotechnol 19. [PMID: 31200673]
• Wang, B., Li, X., Zhao, G., Yan, H., Dong, P., Watari, H., Sims, M., Li, W., Pfeffer, L.M., Guo, Y., Yue, J., 2018. miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway. J. Exp. Clin. Cancer Res. 37, 235. [PMID: 30241553]
• Wang H, Cai S, Bailey BJ, Reza Saadatzadeh M, Ding J, Tonsing-Carter E, Georgiadis TM, Zachary Gunter T, Long EC, Minto RE, Gordon KR, Sen SE, Cai W, Eitel JA, Waning DL, Bringman LR, Wells CD, Murray ME, Sarkaria JN, Gelbert LM, Jones DR, Cohen-Gadol AA, Mayo LD, Shannon HE, Pollok KE. 2016. Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist. J Neurosurg. 2016 May 13:1-14. [PMID: 27177180]
• Wang, M., Yao, L.-C., Cheng, M., Cai, D., Martinek, J., Pan, C.-X., Shi, W., Ma, A.-H., De Vere White, R.W., Airhart, S., Liu, E.T., Banchereau, J., Brehm, M.A., Greiner, D.L., Shultz, L.D., Palucka, K., Keck, J.G., 2018. Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy. FASEB J. fj201700740R. [PMID: 29146734]
• Wei T; Chen C; Liu J; Liu C; Posocco P; Liu X; Cheng Q; Huo S; Liang Z; Fermeglia M; Pricl S; Liang XJ; Rocchi P; Peng L. Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance. Proc Natl Acad Sci U S A. 2015 Feb 23. Epub ahead of print. [PMID: 25713374]
• Williams KJ; Argus JP; Zhu Y; Wilks MQ; Marbois BN; York AG; Kidani Y; Pourzia AL; Akhavan D; Lisiero DN; Komisopoulou E; Henkin AH; Soto H; Chamberlain BT; Vergnes L; Jung ME; Torres JZ; Liau LM; Christofk HR; Prins RM; Mischel PS; Reue K; Graeber TG; Bensinger S. 2013. An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicity. Cancer Res. May 1;73(9):2850-62 [PMID: 23440422]
• Yan, H., Li, H., Li, P., Li, X., Lin, J., Zhu, L., Silva, M.A., Wang, X., Wang, P., Zhang, Z., 2018. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis. J. Exp. Clin. Cancer Res. 37, 237. [PMID: 30249278]
• Zhang, Y., Dong, Y., Melkus, M.W., Yin, S., Tang, S.-N., Jiang, P., Pramanik, K., Wu, W., Kim, S., Ye, M., Hu, H., Lu, J., Jiang, C., 2018. Role of P53-Senescence Induction in Suppression of LNCaP Prostate Cancer Growth by Cardiotonic Compound Bufalin. Mol. Cancer Ther. [PMID: 30166403]

Acute megakaryocytic leukemia (AMKL)

• Thiollier C; Lopez CK; Gerby B; Ignacimouttou C; Poglio S; Duffourd Y; Guégan J; Rivera-Munoz P; Bluteau O; Mabialah V; Diop M; Wen Q; Petit A; Bauchet AL; Reinhardt D; Bornhauser B; Gautheret D; Lecluse Y; Landman-Parker J; Radford I; Vainchenker W; Dastugue N; de Botton S; Dessen P; Bourquin JP; Crispino JD; Ballerini P; Bernard OA; Pflumio F; Mercher T. 2012. Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models. J Exp Med. Oct 22;209(11):2017-31. [PMID: 23045605]
• Wen Q; Goldenson B; Silver SJ; Schenone M; Dancik V; Huang Z; Wang LZ; Lewis TA; An WF; Li X; Bray MA; Thiollier C; Diebold L; Gilles L; Vokes MS; Moore CB; Bliss-Moreau M; Verplank L; Tolliday NJ; Mishra R; Vemula S; Shi J; Wei L; Kapur R; Lopez CK; Gerby B; Ballerini P; Pflumio F; Gilliland DG; Goldberg L; Birger Y; Izraeli S; Gamis AS; Smith FO; Woods WG; Taub J; Scherer CA; Bradner JE; Goh BC; Mercher T; Carpenter AE; Gould RJ; Clemons PA; Carr SA; Root DE; Schreiber SL; Stern AM; Crispino JD. 2012. Identification of Regulators of Polyploidization Presents Therapeutic Targets for Treatment of AMKL. Cell Aug 3;150(3):575-89. [PMID: 22655268]

Acute myeloid leukemia (AML)

• Aigner, P., Mizutani, T., Horvath, J., Eder, T., Heber, S., Lind, K., Just, V., Moll, H.P., Yeroslaviz, A., Fischer, M.J.M., Kenner, L., Győrffy, B., Sill, H., Grebien, F., Moriggl, R., Casanova, E., Stoiber, D., 2019. STAT3β is a tumor suppressor in acute myeloid leukemia. Blood Adv 3, 1989–2002. [PMID: 31270081] 
• Ågerstam H, Karlsson C, Hansen N, Sandén C, Askmyr M, von Palffy S, Högberg C, Rissler M, Wunderlich M, Juliusson G, Richter J, Sjöström K, Bhatia R, Mulloy JC, Järås M, Fioretos T. 2015. Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia. Proc Natl Acad Sci U S A. 112(34):10786-91. [PMID:  26261316]
• Agliano A; Martin-Padura I; Mancuso P; Marighetti P; Rabascio C; Pruneri G; Shultz LD; Bertolini F. 2008. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains. Int J Cancer 123(9):2222-7. [PMID: 18688847]
• Alberich-Jordà M; Wouters B; Balastik M; Shapiro-Koss C; Zhang H; Diruscio A; Radomska HS; Ebralidze AK; Amabile G; Ye M; Zhang J; Lowers I; Avellino R; Melnick A; Figueroa ME; Valk PJ; Delwel R; Tenen DG. 2012. C/EBPγ deregulation results in differentiation arrest in acute myeloid leukemia. J Clin Invest. Dec 3;122(12):4490-504. [PMID: 23160200]
• Alachkar H; Santhanam R; Harb JG; Lucas DM; Oaks JJ; Hickey CJ; Pan L; Kinghorn AD; Caligiuri MA; Perrotti D; Byrd JC; Garzon R; Grever MR; Marcucci G. 2013. Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia. J Hematol Oncol. Mar 16;6:21. [PMID: 23497456]
• Arteaga MF; Mikesch JH; Qiu J; Christensen J; Helin K; Kogan SC; Dong S; So CW. 2013. The Histone Demethylase PHF8 Governs Retinoic Acid Response in Acute Promyelocytic Leukemia. Cancer Cell. Mar 18;23(3):376-89. [PMID: 23518351]
• Banerji V; Frumm SM; Ross KN; Li LS; Schinzel AC; Hahn CK; Kakoza RM; Chow KT; Ross L; Alexe G; Tolliday N; Inguilizian H; Galinsky I; Stone RM; DeAngelo DJ; Roti G; Aster JC; Hahn WC; Kung AL; Stegmaier K.2012. The intersection of genetic and chemical genomic screens identifies GSK-3a; as a target in human acute myeloid leukemia. J Clin Invest Mar 1;122(3):935-47. [PMID: 22326953]
• Barve, A., Casson, L., Krem, M., Wunderlich, M., Mulloy, J.C., Beverly, L.J., 2018. Comparative utility of NRG and NRGS mice for the study of normal hematopoiesis, leukemogenesis, and therapeutic response. Exp. Hematol. [PMID: 30125602]
• Bonnet, D., 2017. Acute myeloid leukemia including favorable-risk group samples engraft in NSG mice: just be patient. Haematologica 102, 805–806. doi:10.3324/haematol.2017.165159. [PMID: 28458252]
• Buettner, R., Nguyen, L.X.T., Kumar, B., Morales, C., Liu, C., Chen, L.S., Pemovska, T., Synold, T.W., Palmer, J., Thompson, R., Li, L., Hoang, D.H., Zhang, B., Ghoda, L., Kowolik, C., Kontro, M., Leitch, C., Wennerberg, K., Xu, X., Chen, C.-C., Horne, D., Gandhi, V., Pullarkat, V., Marcucci, G., Rosen, S.T., 2019. 8-chloro-adenosine activity in FLT3-ITD acute myeloid leukemia. J. Cell. Physiol. [PMID: 30770553]
• Cany J; van der Waart AB; Tordoir M; Franssen GM; Hangalapura BN; de Vries J; Boerman O; Schaap N; van der Voort R; Spanholtz J; Dolstra H. 2013. Natural killer cells generated from cord blood hematopoietic progenitor cells efficiently target bone marrow-residing human leukemia cells in NOD/SCID/IL2Rg(null) mice. PLoS One. Jun 5;8(6):e64384. [PMID: 23755121]
• Carter-Cooper, B.A., Fletcher, S., Ferraris, D., Choi, E.Y., Kronfli, D., Dash, S., Truong, P., Sausville, E.A., Lapidus, R.G., Emadi, A., 2017. Synthesis, characterization and antineoplastic activity of bis-aziridinyl dimeric naphthoquinone - A novel class of compounds with potent activity against acute myeloid leukemia cells. Bioorg. Med. Chem. Lett. 27, 6–10. doi:10.1016/j.bmcl.2016.11.045. [PMID: 27890379]
• Casucci M; Nicolis di Robilant B; Falcone L; Camisa B; Norelli M; Genovese P; Gentner B; Gullotta F; Ponzoni M; Bernardi M; Marcatti M; Saudemont A; Bordignon C; Savoldo B; Ciceri F; Naldini L; Dotti G; Bonini C; Bondanza A. 2013. CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma. Blood [Epub ahead of print] [PMID: 24016461]
• Chen Y; Jacamo R; Konopleva M; Garzon R; Croce C; Andreeff M. 2013. CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia. J Clin Invest. Jun 3;123(6):2395-407. [PMID: 23676502]
• Chou FS; Wunderlich M; Griesinger A; Mulloy JC. 2011. N-RasG12D induces features of stepwise transformation in preleukemic human umbilical cord blood cultures expressing the AML1-ETO fusion gene. Blood Feb 17;117(7):2237-2240. [PMID: 21200020]
• Distler E; Wolfel C; Kohler S; Nonn M; Kaus N; Schnurer E; Meyer RG; Wehler TC; Huber C; Wolfel T; Hartwig UF; Herr W. 2008. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice. Exp Hematol 36(4):451-63. [PMID: 18261837]
• Dos Santos C; McDonald T; Ho YW; Liu H; Lin A; Forman SJ; Kuo YH; Bhatia R. 2013. The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cell by chemotherapeutic agents. Blood. Sep 12;122(11):1900-13. [PMID: 23896410]
• Drenberg, C.D., Shelat, A., Dang, J., Cotton, A., Orwick, S.J., Li, M., Jeon, J.Y., Fu, Q., Buelow, D.R., Pioso, M., Hu, S., Inaba, H., Ribeiro, R.C., Rubnitz, J.E., Gruber, T.A., Guy, R.K., Baker, S.D., 2019. A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML. Nat Commun 10. [PMID: 31097698]
• Du W, Li XE, Sipple J, Pang Q. 2011. Overexpression of IL-3 Rα on CD34+CD38- stem cells defines leukemia-initiating cells in Fanconic anemia AML. Blood. Apr 21;117(16):4243-52. [PMID: 21330473]
• Endo, A., Tomizawa, D., Aoki, Y., Morio, T., Mizutani, S., Takagi, M., 2016. EWSR1/ELF5 induces acute myeloid leukemia by inhibiting p53/p21 pathway. Cancer Sci. doi:10.1111/cas.13080 [PMID: 27627705]
• Etchin J, Montero J, Berezovskaya A, Le BT, Kentsis A, Christie AL, Conway AS, Chen WC, Reed C, Mansour MR, Ng CE, Adamia S, Rodig SJ, Galinsky IA, Stone RM, Klebanov B, Landesman Y, Kauffman M, Shacham S, Kung AL, Wang JC, Letai A, Look AT. Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG mice. Leukemia. 2015 Jul 23. Epub ahead of print. [PMID: 26202935]
• Folkerts, H., Hilgendorf, S., Wierenga, A.T.J., Jaques, J., Mulder, A.B., Coffer, P.J., Schuringa, J.J., Vellenga, E., 2017. Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia. Cell Death Dis. 8, e2927. doi:10.1038/cddis.2017.317. [PMID: 28703806]
• Fox JM, Moynihan JR, Mott BT, Mazzone JR, Anders NM, Brown PA, Rudek MA, Liu JO, Arav-Boger R, Posner GH, Civin CI, Chen X. Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs. Oncotarget. 2016 Jan 12. doi: 10.18632/oncotarget.6896. [Epub ahead of print] [PMID: 26771236]
• Gao, S., Zhou, B., Li, H., Huang, X., Wu, Y., Xing, C., Yu, X., Ji, Y., 2018. Long non-coding RNA HOTAIR promotes the self-renewal of leukemia stem cell through epigenetic silencing of p15. Exp. Hematol. [PMID: 30172749]
• Gausdal G; Wergeland A; Skavland J; Nguyen E; Pendino F; Rouhee N; McCormack E; Herfindal L; Kleppe R; Havemann U; Schwede F; Bruserud O; Gjertsen BT; Lanotte M; Ségal-Bendirdjian E; Døskeland SO. 2013. Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis. Cell Death Dis. Feb 28;4:e516. [PMID: 23449452]
• Gerber JM; Smith BD; Ngwang B; Zhang H; Vala MS; Morsberger L; Galkin S; Collector MI; Perkins B; Levis MJ; Griffin CA; Sharkis SJ; Borowitz MJ; Karp JE; Jones RJ. 2012. A clinically relevant population of leukemic CD34+CD38- cells in acute myeloid leukemia. Blood Apr 12;119(15):3571-7. [PMID: 22262762]
• Goardon N; Marchi E; Atzberger A; Quek L; Schuh A; Soneji S; Woll P; Mead A; Alford KA; Rout R; Chaudhury S; Gilkes A; Knapper S; Beldjord K; Begum S; Rose S; Geddes N; Griffiths M; Standen G; Sternberg A; Cavenagh J; Hunter H; Bowen D; Killick S; Robinson L; Price A; Macintyre E; Virgo P; Burnett A; Craddock C; Enver T; Jacobsen SE; Porcher C; Vyas P. 2011. Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia. Cancer Cell Jan 18;19(1):138-52. [PMID: 21251617]
• Griessinger E, Anjos-Afonso F, Vargaftig J, Taussig D, Lassailly F, Prebet T, Imbert V, Nebout M, Vey N, Chabannon C, Filby A, Bollet-Quivogne F, Gribben JG, Peyron JF, Bonnet D. 2016. Frequency and dynamics of leukemia-initiating cells during short-term ex vivo culture informs outcomes in acute myeloid leukemia patients. Cancer Res. 2016 Mar 9. pii: canres.2063.2015. [PMID: 26960976]
• Griessinger, E., Vargaftig, J., Horswell, S., Taussig, D.C., Gribben, J., Bonnet, D., 2017. Acute myeloid leukemia xenograft success prediction: saving time. Exp. Hematol. [PMID: 29253573]
• Gunasekara, D.C., Zheng, M.M., Mojtahed, T., Woods, J.R., Fandy, T.E., Riofski, M.V., Glackin, C.A., Hassan, H.E., Kirshner, J., Colby, D.A., 2016. 15-Methylene-Eburnamonine Kills Leukemic Stem Cells and Reduces Engraftment in a Humanized Bone Marrow Xenograft Mouse Model of Leukemia. ChemMedChem. doi:10.1002/cmdc.201600334 [PMID: 27677525]
• Han, L., Jorgensen, J.L., Brooks, C., Shi, C., Zhang, Q., Nogueras González, G.M., Cavazos, A., Pan, R., Mu, H., Wang, S., Zhou, J., Alatrash, G., Ciurea, S.O., Rettig, M., DiPersio, J.F., Cortes, J.E., Huang, X., Kantarjian, H., Andreeff, M., Ravandi-Kashani, F., Konopleva, M., 2017. Anti-leukemia efficacy and mechanisms of action of SL-101, a novel anti-CD123 antibody-conjugate, in acute myeloid leukemia. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. doi:10.1158/1078-0432.CCR-16-1904. [PMID: 28096272]
• Harris WJ; Huang X; Lynch JT; Spencer GJ; Hitchin JR; Li Y; Ciceri F; Blaser JG; Greystoke BF; Jordan AM; Miller CJ; Ogilvie DJ; Somervaille TC. 2012. The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells. Cancer Cell Apr 17;21(4):473-87. [PMID: 22464800]
• Her, Z., Yong, K.S.M., Paramasivam, K., Tan, W.W.S., Chan, X.Y., Tan, S.Y., Liu, M., Fan, Y., Linn, Y.C., Hui, K.M., Surana, U., Chen, Q., 2017. An improved pre-clinical patient-derived liquid xenograft mouse model for acute myeloid leukemia. J Hematol Oncol 10, 162. [PMID: 28985760]
• Hu S; Niu H; Inaba H; Orwick S; Rose C; Panetta JC; Yang S; Pounds S; Fan Y; Calabrese C; Rehg JE; Campana D; Rubnitz JE; Baker SD. 2011. Activity of the Multikinase Inhibitor Sorafenib in Combination With Cytarabine in Acute Myeloid Leukemia. J Natl Cancer Inst Jun 8;103(11):893-905. [PMID: 21487100]
• Jacque N, Ronchetti AM, Larrue C, Meunier G, Birsen R, Willems L, Saland E, Decroocq J, Trovati Maciel T, Lambert M, Poulain L, Hospital MA, Sujobert P, Joseph L, Chapuis N, Lacombe C, Cruz Moura I, Demo S, Sarry JE, Recher C, Mayeux P, Tamburini J, Bouscary D. Targeting glutaminolysis has anti-leukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition. Blood. 2015 Jul 17. Epub ahead of print. [PMID: 26186940]
• Jaiswal S; Jamieson CH; Pang WW; Park CY; Chao MP; Majeti R; Traver D; van Rooijen N; Weissman IL. 2009. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell Jul 23;138(2):271-85. [PMID: 19632178]
• Johanna, I., Straetemans, T., Heijhuurs, S., Aarts-Riemens, T., Norell, H., Bongiovanni, L., de Bruin, A., Sebestyen, Z., Kuball, J., 2019. Evaluating in vivo efficacy - toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells. J Immunother Cancer 7, 69. [PMID: 30871629 ]
• Kannan S; Sutphin RM; Hall MG; Golfman LS; Fang W; Nolo RM; Akers LJ; Hammitt RA; McMurray JS; Kornblau SM; Melnick AM; Figueroa ME; Zweidler-McKay PA. 2013. Notch activation inhibits AML growth and survival: a potential therapeutic approach.  J Exp Med Feb 11;210(2):321-37. [PMID: 23359069]
• Kawahara M; Pandolfi A; Bartholdy B; Barreyro L; Will B; Roth M; Okoye-Okafor UC; Todorova TI; Figueroa ME; Melnick A; Mitsiades CS; Steidl U. 2012. H2.0-like Homeobox Regulates Early Hematopoiesis and Promotes Acute Myeloid Leukemia. Cancer Cell Aug 14;22(2):194-208. [PMID: 22897850]
• Klco JM, Spencer DH, Miller CA, Griffith M, Lamprecht TL, O'Laughlin M, Fronick C, Magrini V, Demeter RT, Fulton RS, Eades WC, Link DC, Graubert TA, Walter MJ, Mardis ER, Dipersio JF, Wilson RK, Ley TJ. 2014. Functional heterogeneity of genetically defined subclones in acute myeloid leukemia. Cancer Cell. 25(3):379–392. [PMID: 24613412]
• Krevvata, M., Shan, X., Zhou, C., Dos Santos, C., Habineza Ndikuyeze, G., Secreto, A., Glover, J., Trotman, W., Brake-Silla, G., Nunez-Cruz, S., Wertheim, G., Ra, H.-J., Griffiths, E., Papachristou, C., Danet-Desnoyers, G., Carroll, M., 2018. Cytokines increase engraftment of human acute myeloid leukemia cells in immunocompromised mice but not engraftment of human myelodysplastic syndrome cells. Haematologica. [PMID: 29545344]
• Labelle JL; Katz SG; Bird GH; Gavathiotis E; Stewart ML; Lawrence C; Fisher JK; Godes M; Pitter K; Kung AL; Walensky LD. 2012. A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers. J Clin Invest Jun 1;122(6):2018-31. [PMID: 22622039]
• Lagadinou ED; Sach A; Callahan K; Rossi RM; Neering SJ; Minhajuddin M; Ashton JM; Pei S; Grose V; O'Dwyer KM; Liesveld JL; Brookes PS; Becker MW; Jordan CT. 2013. BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells. Cell Stem Cell. Mar 7;12(3):329-41. [PMID: 23333149]
• Leclerc, G.M., Zheng, S., Leclerc, G.J., DeSalvo, J., Swords, R.T., Barredo, J.C., 2016. The NEDD8-activating enzyme inhibitor pevonedistat activates the eIF2α and mTOR pathways inducing UPR-mediated cell death in acute lymphoblastic leukemia. Leuk. Res. 50, 1–10. doi:10.1016/j.leukres.2016.09.007. [PMID: 27626202]
• Lee-Sherick AB; Eisenman KM; Sather S; McGranahan A; Armistead PM; McGary CS; Hunsucker SA; Schlegel J; Martinson H; Cannon C; Keating AK; Earp HS; Liang X; Deryckere D; Graham DK. 2013. Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia. Cytotherapy. [Epub ahead of print] [PMID: 23474756]
• Madlambayan GJ; Bartee E; Kim M; Rahman MM; Meacham A; Scott EW; McFadden G; Cogle CR. 2012. Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitro. Leuk Res May;36(5):619-24. [PMID: 22341701]
• Majeti R; Chao MP; Alizadeh AA; Pang WW; Jaiswal S; Gibbs KD Jr; van Rooijen N; Weissman IL. 2009. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell Jul 23;138(2):286-99. [PMID: 19632179]
• Marlein, C.R., Zaitseva, L., Piddock, R.E., Robinson, S., Edwards, D., Shafat, M.S., Zhou, Z., Lawes, M., Bowles, K.M., Rushworth, S.A., 2017. NADPH oxidase-2 derived superoxide drives mitochondrial transfer from bone marrow stromal cells to leukemic blasts. Blood. doi:10.1182/blood-2017-03-772939. [PMID: 28733324]
• Martin-Padura I; Marighetti P; Gregato G; Agliano A; Malazzi O; Mancuso P; Pruneri G; Viale A; Bertolini F. 2012. Spontaneous cell fusion of acute leukemia cells and macrophages observed in cells with leukemic potential. Neoplasia. Nov;14(11):1057-66. [PMID: 23226099]
• Miraki-Moud F; Anjos-Afonso F; Hodby KA; Griessinger E; Rosignoli G; Lillington D; Jia L; Davies JK; Cavenagh J; Smith M; Oakervee H; Agrawal S; Gribben JG; Bonnet D; Taussig DC. 2013. Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation. Proc Natl Acad Sci U S A. Aug 13;110(33):13576-81. [PMID: 23901108]
• Morisot S; Wayne AS; Bohana-Kashtan O; Kaplan IM; Gocke CD; Hildreth R; Stetler-Stevenson M; Walker RL; Davis S; Meltzer PS; Wheelan SJ; Brown P; Jones RJ; Shultz LD; Civin CI. 2010. High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias. Leukemia Nov;24(11):1859-66. [PMID: 20739953]
• Moschoi R, Imbert V, Nebout M, Chiche J, Mary D, Prebet T, Saland E, Castellano R, Pouyet L, Collette Y, Vey N, Chabannon C, Recher C, Sarry JE, Alcor D, Peyron JF, Griessinger E. 2016. Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy. Blood. Jun 2. pii: blood-2015-07-655860. [Epub ahead of print] [PMID: 27257182]
• Paczulla, A.M., Dirnhofer, S., Konantz, M., Medinger, M., Salih, H.R., Rothfelder, K., Tsakiris, D.A., Passweg, J.R., Lundberg, P., Lengerke, C., 2017. Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice. Haematologica. doi:10.3324/haematol.2016.153528. [PMID: 28183848]
• Paris, J., Morgan, M., Campos, J., Spencer, G.J., Shmakova, A., Ivanova, I., Mapperley, C., Lawson, H., Wotherspoon, D.A., Sepulveda, C., Vukovic, M., Allen, L., Sarapuu, A., Tavosanis, A., Guitart, A.V., Villacreces, A., Much, C., Choe, J., Azar, A., van de Lagemaat, L.N., Vernimmen, D., Nehme, A., Mazurier, F., Somervaille, T.C.P., Gregory, R.I., O’Carroll, D., Kranc, K.R., 2019. Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia. Cell Stem Cell 25, 137-148.e6. [PMID: 31031138]
• Pigazzi M; Manara E; Bresolin S; Tregnago C; Beghin A; Baron E; Giarin E; Cho EC; Masetti R; Rao DS; Sakamoto KM; Basso G. 2012. MiR-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation. Haematologica. Apr;98(4):602-10. [PMID: 23100280]
• Potter, N., Miraki-Moud, F., Ermini, L., Titley, I., Vijayaraghavan, G., Papaemmanuil, E., Campbell, P., Gribben, J., Taussig, D., Greaves, M., 2018. Single cell analysis of clonal architecture in acute myeloid leukaemia. Leukemia. [PMID: 30568172 ]
• Ranganathan P; Yu X; Na C; Santhanam R; Shacham S; Kauffman M; Walker A; Klisovic R; Blum W; Caligiuri M; Croce CM; Marcucci G; Garzon R. 2012. Pre-clinical activity of a novel CRM1 inhibitor in acute myeloid leukemia. Blood  Aug 30;120(9):1765-73 [PMID: 22677130]
• Ranganathan P; Yu X; Santhanam R; Hofstetter J; Walker A; Walsh K; Bhatnagar B; Klisovic R; Vasu S; Phelps MA; Devine S; Shacham S; Kauffman M; Marcucci G; Blum W; Garzon R. Decitabine priming enhances the anti-leukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemia. Blood. 2015 Feb 25. Epub ahead of print.  [PMID: 25716206]
• Rettinger E; Meyer V; Kreyenberg H; Volk A; Kuçi S; Willasch A; Koscielniak E; Fulda S; Wels WS; Boenig H; Klingebiel T; Bader P. 2012. Cytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models. Front Oncol. 2012;2:32. [PMID: 22655268]
• Richter, A., Roolf, C., Hamed, M., Gladbach, Y.S., Sender, S., Konkolefski, C., Knübel, G., Sekora, A., Fuellen, G., Vollmar, B., Murua Escobar, H., Junghanss, C., 2019. Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia. BMC Cancer 19, 202. [PMID: 30841886]
• Saenz, D.T., Fiskus, W., Qian, Y., Manshouri, T., Rajapakshe, K., Raina, K., Coleman, K.G., Crew, A.P., Shen, A., Mill, C.P., Sun, B., Qiu, P., Kadia, T.M., Pemmaraju, N., DiNardo, C., Kim, M.-S., Nowak, A.J., Coarfa, C., Crews, C.M., Verstovsek, S., Bhalla, K.N., 2017. Novel BET protein proteolysis targeting chimera (BET-PROTAC) exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm (MPN) secondary (s) AML cells. Leukemia. doi:10.1038/leu.2016.393. [PMID: 28042144]
• Saito, Y., Mochizuki, Y., Ogahara, I., Watanabe, T., Hogdal, L., Takagi, S., Sato, K., Kaneko, A., Kajita, H., Uchida, N., Fukami, T., Shultz, L.D., Taniguchi, S., Ohara, O., Letai, A.G., Ishikawa, F., 2017. Overcoming mutational complexity in acute myeloid leukemia by inhibition of critical pathways. Sci Transl Med 9. [PMID: 29070697]
• Saito Y; Uchida N; Tanaka S; Suzuki N; Tomizawa-Murasawa M; Sone A; Najima Y; Takagi S; Aoki Y; Wake A; Taniguchi S; Shultz LD; Ishikawa F. 2010. Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. Nat Biotechnol Mar;28(3):275-80. [PMID: 20160717]
• Saito Y; Yuki H; Kuratani M; Hashizume Y; Takagi S; Honma T; Tanaka A; Shirouzu M; Mikuni J; Handa N; Ogahara I; Sone A; Najima Y; Tomabechi Y; Wakiyama M; Uchida N; Tomizawa-Murasawa M; Kaneko A; Tanaka S; Suzuki N; Kajita H; Aoki Y; Ohara O; Shultz LD; Fukami T; Goto T; Taniguchi S; Yokoyama S; Ishikawa F. 2013. A Pyrrolo-Pyrimidine Derivative Targets Human Primary AML Stem Cells in Vivo. Sci Transl Med. Apr 17;5(181):181ra52. [PMID: 23596204]
• Saland E; Boutzen H; Castellano R; Pouyet L; Griessinger E; Larrue C; de Toni F; Scotland S; David M; Danet-Desnoyers G; Vergez F; Barreira Y; Collette Y; Récher C; Sarry JE. A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia. Blood Cancer J. 2015 Mar 20. Epub ahead of print. [PMID: 25794133]
• Sanchez PV; Perry RL; Sarry JE; Perl AE; Murphy K; Swider CR; Bagg A; Choi JK; Biegel JA; Danet-Desnoyers G; Carroll M. 2009. A robust xenotransplantation model for acute myeloid leukemia. Leukemia Nov;23(11):2109-17.[PMID: 19626050]
• Sarry JE; Murphy K; Perry R; Sanchez PV; Secreto A; Keefer C; Swider CR; Strzelecki AC; Cavelier C; Récher C; Mansat-De Mas V; Delabesse E; Danet-Desnoyers G; Carroll M. 2011. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice. J Clin Invest Jan 4;121(1):384-95 [PMID: 21157036]
• Schenk T; Chen WC; Göllner S; Howell L; Jin L; Hebestreit K; Klein HU; Popescu AC; Burnett A; Mills K; Casero RA Jr; Marton L; Woster P; Minden MD; Dugas M; Wang JC; Dick JE; Müller-Tidow C; Petrie K; Zelent A. 2012. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia. Nat Med Mar 11;18(4):605-11 [PMID: 22406747]
• Sergeeva A, He H, Ruisaard K, St John L, Alatrash G, Clise-Dwyer K, Li D, Patenia R, Hong R, Sukhumalchandra P, You MJ, Gagea M, Ma Q, Molldrem JJ. 2016. Activity of 8F4, a T-cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivo. Leukemia. Mar 8. doi: 10.1038/leu.2016.57. [PMID: 27055866]
• Siegers GM; Felizardo TC; Mathieson AM; Kosaka Y; Wang XH; Medin JA; Keating A. 2011. Anti-leukemia activity of in vitro-expanded human gamma delta T cells in a xenogeneic Ph+ leukemia model. PLoS One Feb 3;6(2):e16700. [PMID: 21304898]
• Sivagnanalingam U, Balys M, Eberhardt A, Wang N, Myers JR, Ashton JM, Becker MW, Calvi LM, Mendler JH. Residual Disease in a Novel Xenograft Model of RUNX1-Mutated, Cytogenetically Normal Acute Myeloid Leukemia. PLoS One. 2015 Jul 15;10(7):e0132375. [PMID: 26177509]
• Täger, M., Horn, S., Latuske, E., Ehm, P., Schaks, M., Nalaskowski, M., Fehse, B., Fiedler, W., Stocking, C., Wellbrock, J., Jücker, M., 2017. SHIP1, but not an AML-derived SHIP1 mutant, suppresses myeloid leukemia growth in a xenotransplantation mouse model. Gene Ther. [PMID: 29143813]
• Taussig DC; Miraki-Moud F; Anjos-Afonso F; Pearce DJ; Allen K; Ridler C; Lillington D; Oakervee H; Cavenagh J; Agrawal SG; Lister TA; Gribben JG; Bonnet D. 2008. Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood Aug 1;112(3):568-75. [PMID: 18523148]
• Tuszynski GP; Rothman VL. 2013. Angiocidin Induces Differentiation of Acute Myeloid Leukemia Cells. Exp Mol Pathol. [Epub ahead of print] [PMID: 24036285]
• von Bonin M; Wermke M; Cosgun KN; Thiede C; Bornhauser M; Wagemaker G; Waskow C. 2013. In Vivo Expansion of Co-Transplanted T Cells Impacts on Tumor Re-Initiating Activity of Human Acute Myeloid Leukemia in NSG Mice. PLoS One. Apr 9;8(4):e60680. [PMID: 23585844]
• Vargaftig J; Taussig DC; Griessinger E; Anjos-Afonso F; Lister TA; Cavenagh J; Oakervee H; Gribben J; Bonnet D. 2011. Frequency of leukemic initiating cells does not depend on the xenotransplantation model used. Leukemia Apr;26(4):858-60 [PMID: 21926966]

• Wu Q, Bhole A, Qin H, Karp J, Malek S, Cowell JK, Ren M.  2016. SCLLTargeting FGFR1 to suppress leukemogenesis in syndromic and de novo AML in murine models. Oncotarget. Jul 6. doi: 10.18632/oncotarget.10438. [Epub ahead of print] [PMID: 27391347]

• Wunderlich M; Chou FS; Link KA; Mizukawa B; Perry RL; Carroll M; Mulloy JC. 2010. AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF; GM-CSF and IL-3. LeukemiaOct;24(10):1785-8. [PMID: 20686503]
• Yea, K., Jones, T.M., Jung, D., Shin, S., Arlian, B.M., Han, K.H., Zha, Z., Kim, M.S., Oh, Y.-S., Zhang, H., Lerner, R.A., 2019. An agonist antibody prefers relapsed AML for induction of cells that kill each other. Sci Rep 9, 3494. [PMID: 30837591]

Acute lymphoblastic leukemia (ALL)

• Banerjee P; Tripp A; Lairmore MD; Crawford L; Sieburg M; Ramos JC; Harrington W Jr; Beilke MA; Feuer G. 2010. Adult T-cell leukemia/lymphoma development in HTLV-1-infected humanized SCID mice. Blood Apr 1;115(13):2640-8. [PMID: 20124219]
• Benito J; Shi Y; Szymanska B; Carol H; Boehm I; Lu H; Konoplev S; Fang W; Zweidler-McKay PA; Campana D; Borthakur G; Bueso-Ramos C; Shpall E; Thomas DA; Jordan CT; Kantarjian H; Wilson WR; Lock R; Andreeff M; Konopleva M. 2011. Pronounced Hypoxia in Models of Murine and Human Leukemia: High Efficacy of Hypoxia-Activated Prodrug PR-104.  PLoS One 6(8):e23108. [PMID: 21853076]
• Bomken S; Buechler L; Rehe K; Ponthan F; Elder A; Blair H; Bacon CM; Vormoor J; Heidenreich O. 2012. Lentiviral marking of patient-derived acute lymphoblastic leukaemic cells allows in vivo tracking of disease progression. Leukemia. Mar;27(3):718-21. [PMID: 22858908]
• Bonapace L; Bornhauser BC; Schmitz M; Cario G; Ziegler U; Niggli FK; Schäfer BW; Schrappe M; Stanulla M; Bourquin JP. 2010. Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance. J Clin Invest Apr 1;120(4):1310-23. [PMID: 20200450]
• Castro Alves C; Terziyska N; Grunert M; Gündisch S; Graubner U; Quintanilla-Martinez L; Jeremias I. 2012. Leukemia-initiating cells of patient-derived acute lymphoblastic leukemia xenografts are sensitive towards TRAIL. Blood May 3;119(18):4224-7 [PMID: 22408264]
• Chan, W.K., Horvath, T.D., Tan, L., Link, T., Harutyunyan, K.G., Pontikos, M.A., Anishkin, A., Du, D., Martin, L.A., Yin, E., Rempe, S.B., Sukharev, S., Konopleva, M., Weinstein, J.N., Lorenzi, P.L., 2019. Glutaminase activity of L-asparaginase contributes to durable preclinical activity against acute lymphoblastic leukemia. Mol. Cancer Ther. [PMID: 31209181]
• Chiu PP; Jiang H; Dick JE. 2010. Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance. Blood Dec 9;116(24):5268-79. [PMID: 20810926]
• Choi YJ; Li X; Hydbring P; Sanda T; Stefano J; Christie AL; Signoretti S; Look AT; Kung AL; von Boehmer H; Sicinski P. 2012. The requirement for cyclin d function in tumor maintenance. Cancer Cell. Oct 16;22(4):438-51. [PMID: 23079655]
• Clappier E; Gerby B; Sigaux F; Delord M; Touzri F; Hernandez L; Ballerini P; Baruchel A; Pflumio F; Soulier J. 2011. Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse. J Exp Med Apr 11;208(4):653-61. [PMID: 21464223]
• Cleveland SM; Smith S; Tripathi R; Mathias EM; Goodings C; Elliott N; Peng D; El-Rifai W; Yi D; Chen X; Li L; Mullighan C; Downing JR; Love P; Davé UP. 2013. Lmo2 induces Hematopoietic Stem Cell like Features in T-cell Progenitor Cells Prior to Leukemia. Stem Cells. May;31(5):882-94. [PMID: 23378057]
• Dao T; Yan S; Veomett N; Pankov D; Zhou L; Korontsvit T; Scott A; Whitten J; Maslak P; Casey E; Tan T; Liu H; Zakhaleva V; Curcio M; Doubrovina E; O'Reilly RJ; Liu C; Scheinberg DA. 2013. Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody. Sci Transl Med. Mar 13;5(176):176ra33. [PMID: 23486779]
• Diamanti P; Cox CV; Blair A. 2012. Comparison of childhood leukemia initiating cell populations in NOD/SCID and NSG mice. Leukemia Feb;26(2):376-80. [PMID: 21860430]
• Diamanti P; Cox CV; Moppett JP; Blair A. 2012. Parthenolide eliminates leukemia initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic leukemia. Blood. Feb 21;121(8):1384-93. [PMID: 23264600]
• Diamanti, P., Cox, C.V., Moppett, J.P., Blair, A., 2018. Dual targeting of Hsp90 in childhood acute lymphoblastic leukaemia. Br. J. Haematol. 180, 147–149. [PMID: 27503106]
• Etchin J; Sanda T; Mansour MR; Kentsis A; Montero J; Le BT; Christie AL; McCauley D; Rodig SJ; Kauffman M; Shacham S; Stone R; Letai A; Kung AL; Thomas Look A. 2013. KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia. Br J Haematol. Apr;161(1):117-27. [PMID: 23373539]
• Fidyt, K., Pastorczak, A., Goral, A., Szczygiel, K., Fendler, W., Muchowicz, A., Bartlomiejczyk, M.A., Madzio, J., Cyran, J., Graczyk-Jarzynka, A., Jansen, E., Patkowska, E., Lech-Maranda, E., Pal, D., Blair, H., Burdzinska, A., Pedzisz, P., Glodkowska-Mrowka, E., Demkow, U., Gawle-Krawczyk, K., Matysiak, M., Winiarska, M., Juszczynski, P., Mlynarski, W., Heidenreich, O., Golab, J., Firczuk, M., 2019. Targeting the thioredoxin system as a novel strategy against B-cell acute lymphoblastic leukemia. Mol Oncol. [PMID: 30861284]
• Gang EJ; Hsieh YT; Pham J; Zhao Y; Nguyen C; Huantes S; Park E; Naing K; Klemm L; Swaminathan S; Conway EM; Pelus LM; Crispino J; Mullighan CG; McMillan M; Müschen M; Kahn M; Kim YM. 2013. Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia. Oncogene. [Epub ahead of print] [PMID: 23728349]
• George AA, Paz H, Fei F, Kirzner J, Kim YM, Heisterkamp N, Abdel-Azim H. Phosphoflow-Based Evaluation of Mek Inhibitors as Small-Molecule Therapeutics for B-Cell Precursor Acute Lymphoblastic Leukemia. PLoS One. 2015 Sep 11;10(9):e0137917. [PMID: 26360058]
• Goossens S; Radaelli E; Blanchet O; Durinck K; Van der Meulen J; Peirs S; Taghon T; Tremblay CS; Costa M; Farhang Ghahremani M; De Medts J; Bartunkova S; Haigh K; Schwab C; Farla N; Pieters T; Matthijssens F; Van Roy N; Best JA; Deswarte K; Bogaert P; Carmichael C; Rickard A; Suryani S; Bracken LS; Alserihi R; Canté-Barrett K; Haenebalcke L; Clappier E; Rondou P; Slowicka K; Huylebroeck D; Goldrath AW; Janzen V; McCormack MP; Lock RB; Curtis DJ; Harrison C; Berx G; Speleman F; Meijerink JP; Soulier J; Van Vlierberghe P; Haigh JJ. 2015. ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signaling. Nat Commun. Jan 7;6:5794. [PMID: 25565005]
• Greystoke BF; Huang X; Wilks DP; Atkinson S; Somervaille TC. 2013. Very high frequencies of leukaemia-initiating cells in precursor T-acute lymphoblastic leukaemia may be obscured by cryopreservation. Br J Haematol. [Epub ahead of print] [PMID: 23927465]
• Guo W; Schubbert S; Chen JY; Valamehr B; Mosessian S; Shi H; Dang NH; Garcia C; Theodoro MF; Varella-Garcia M; Wu H. 2011. Suppression of leukemia development caused by PTEN loss. Proc Natl Acad Sci U S A Jan 25;108(4):1409-14. [PMID: 21212363]
• Inuzuka H; Shaik S; Onoyama I; Gao D; Tseng A; Maser RS; Zhai B; Wan L; Gutierrez A; Lau AW; Xiao Y; Christie AL; Aster J; Settleman J; Gygi SP; Kung AL; Look T; Nakayama KI; DePinho RA; Wei W. 2011. SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature. Mar 3;471(7336):104-9. [PMID: 21368833]
• Janes MR; Limon JJ; So L; Chen J; Lim RJ; Chavez MA; Vu C; Lilly MB; Mallya S; Ong ST; Konopleva M; Martin MB; Ren P; Liu Y; Rommel C; Fruman DA. 2010. Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor. Nat Med. Feb;16(2):205-13. [PMID: 20072130]
• Janes MR; Vu C; Mallya S; Shieh MP; Limon JJ; Li LS; Jessen KA; Martin MB; Ren P; Lilly MB; Sender LS; Liu Y; Rommel C; Fruman DA. 2012. Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia. Leukemia. Dec 1;189(11):5223-9. [PMID: 23089398]
• Karol, S.E., Janke, L.J., Panetta, J.C., Ramsey, L.B., Cai, X., Payton, M.A., Jenkins, D.A., Evans, W.E., Relling, M.V., 2019. Asparaginase combined with discontinuous dexamethasone improves antileukemic efficacy without increasing osteonecrosis in preclinical models. PLoS One 14. [PMID: 31059548]
• Khandanpour C; Phelan JD; Vassen L; Schütte J; Chen R; Horman SR; Gaudreau MC; Krongold J; Zhu J; Paul WE; Dührsen U; Göttgens B; Grimes HL; Möröy T. 2013 Growth Factor Independence 1 Antagonizes a p53-Induced DNA Damage Response Pathway in Lymphoblastic Leukemia. Cancer Cell. Feb 11;23(2):200-14. [PMID: 23410974]
• Konantz M; Andre MC; Ebinger M; Grauer M; Wang H; Grzywna S; Rothfuss OC; Lehle S; Kustikova OS; Salih HR; Handgretinger R; Fend F; Baum C; Kanz L; Quintanilla-Martinez L; Schulze-Osthoff K; Essmann F; Lengerke C. 2013. EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia. Leukemia. Jan;27(1):56-65. [PMID: 22828445]
• Kong Y; Yoshida S; Saito Y; Doi T; Nagatoshi Y; Fukata M; Saito N; Yang SM; Iwamoto C; Okamura J; Liu KY; Huang XJ; Lu DP; Shultz LD; Harada M; Ishikawa F. 2008. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL. Leukemia 22(6):1207-13. [PMID: 18418410]
• Kübler A; Woiterski J; Witte KE; Bühring HJ; Hartwig UF; Ebinger M; Oevermann L; Mezger M; Herr W; Lang P; Handgretinger R; Münz C; André MC. 2014. Both mature KIR+ and immature KIR- NK cells control pediatric acute B-cell precursor leukemia in NOD.Cg-Prkdcscid IL2rgtmWjl/Sz mice. Blood. Dec 18;124(26):3914-23. [PMID: 25359989]
• Kusy S; Gerby B; Goardon N; Gault N; Ferri F; Gérard D; Armstrong F; Ballerini P; Cayuela JM; Baruchel A; Pflumio F; Roméo PH. 2010. NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia. J Exp Med Sep 27;207(10):2141-56. [PMID: 20855495]
• le Viseur C; Hotfilder M; Bomken S; Wilson K; Rottgers S; Schrauder A; Rosemann A; Irving J; Stam RW; Shultz LD; Harbott J; Jurgens H; Schrappe M; Pieters R; Vormoor J. 2008. In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties. Cancer Cell 14(1):47-58. [PMID: 18598943]
• Leclerc, G.M., Zheng, S., Leclerc, G.J., DeSalvo, J., Swords, R.T., Barredo, J.C., 2016. The NEDD8-activating enzyme inhibitor pevonedistat activates the eIF2α and mTOR pathways inducing UPR-mediated cell death in acute lymphoblastic leukemia. Leuk. Res. 50, 1–10. doi:10.1016/j.leukres.2016.09.007. [PMID: 27626202]
• Lin, S., Luo, R.T., Shrestha, M., Thirman, M.J., Mulloy, J.C., 2017. The full transforming capacity of MLL-Af4 is interlinked with lymphoid lineage commitment. Blood. doi:10.1182/blood-2017-04-777185. [PMID: 28637661]
• Mangolini M; de Boer J; Walf-Vorderwülbecke V; Pieters R; den Boer ML; Williams O. 2013. STAT3 mediates oncogenic addiction to TEL-AML1 in t(12;21) acute lymphoblastic leukemia. Blood. Jul 25;122(4):542-9.[PMID: 23741012]
• Maude SL; Dolai S; Delgado-Martin C; Vincent T; Robbins A; Selvanathan A; Ryan T; Hall J; Wood AC; Tasian SK; Hunger SP; Loh ML; Mullighan CG; Wood BL; Hermiston ML; Grupp SA; Lock RB; Teachey DT. Blood. Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia. 2015 Feb 2. Epub ahead of print.  [PMID: 25645356]
• Medyouf H; Gao X; Armstrong F; Gusscott S; Liu Q; Gedman AL; Matherly LH; Schultz KR; Pflumio F; You MJ; Weng AP. 2010. Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss. Blood  Feb 11;115(6):1175-84. [PMID: 20008304]
• Notta F; Mullighan CG; Wang JC; Poeppl A; Doulatov S; Phillips LA; Ma J; Minden MD; Downing JR; Dick JE. 2011. Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature 2011 Jan 20;469(7330):362-7. [PMID: 21248843]
• Müller, F., Cunningham, T., Stookey, S., Tai, C.-H., Burkett, S., Jailwala, P., Stetler Stevenson, M., Cam, M.C., Wayne, A.S., Pastan, I., 2018. 5-Azacytidine prevents relapse and produces long-term complete remissions in leukemia xenografts treated with Moxetumomab pasudotox. Proc. Natl. Acad. Sci. U.S.A. 115, E1867–E1875. [PMID: 29432154]
• Parameswaran R; Lim M; Arutyunyan A; Abdel-Azim H; Hurtz C; Lau K; Müschen M; Yu RK; von Itzstein M; Heisterkamp N; Groffen J. 2013. O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia. J Exp Med. Apr 8;210(4):805-19. [PMID: 23478187]
• Park E; Gang EJ; Hsieh YT; Schaefer P; Chae S; Klemm L; Huantes S; Loh M; Conway EM; Kang ES; Koo HH; Hofmann WK; Heisterkamp N; Pelus L; Keerthivasan G; Crispino J; Kahn M; Müschen M; Kim YM. 2011. Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia. Blood Aug 25;118(8):2191-9. [PMID: 21715311]
• Rehe K; Wilson K; Bomken S; Williamson D; Irving J; den Boer ML; Stanulla M; Schrappe M; Hall AG; Heidenreich O; Vormoor J. 2013. Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations. EMBO Mol Med. Jan;5(1):38-51. [PMID: 23229821]
• Roberts KG; Morin RD; Zhang J; Hirst M; Zhao Y; Su X; Chen SC; Payne-Turner D; Churchman ML; Harvey RC; Chen X; Kasap C; Yan C; Becksfort J; Finney RP; Teachey DT; Maude SL; Tse K; Moore R; Jones S; Mungall K; Birol I; Edmonson MN; Hu Y; Buetow KE; Chen IM; Carroll WL; Wei L; Ma J; Kleppe M; Levine RL; Garcia-Manero G; Larsen E; Shah NP; Devidas M; Reaman G; Smith M; Paugh SW; Evans WE; Grupp SA; Jeha S; Pui CH; Gerhard DS; Downing JR; Willman CL; Loh M; Hunger SP; Marra MA; Mullighan CG. 2012. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell. Aug 14;22(2):153-66. [PMID: 22897847]
• Roti G; Carlton A; Ross KN; Markstein M; Pajcini K; Su AH; Perrimon N; Pear WS; Kung AL; Blacklow SC; Aster JC; Stegmaier K. 2013. Complementary Genomic Screens Identify SERCA as a Therapeutic Target in NOTCH1 Mutated Cancer. Cancer Cell. Mar 18;23(3):390-405 [PMID: 23434461]
• Schewe, D.M., Alsadeq, A., Sattler, C., Lenk, L., Vogiatzi, F., Cario, G., Vieth, S., Valerius, T., Rosskopf, S., Meyersieck, F., Alten, J., Schrappe, M., Gramatzki, M., Peipp, M., Kellner, C., 2017. An Fc engineered CD19 antibody eradicates MRD in patient-derived MLL-rearranged acute lymphoblastic leukemia xenografts. Blood. doi:10.1182/blood-2017-01-764316. [PMID: 28698205]
• Schmitz M; Breithaupt P; Scheidegger N; Cario G; Bonapace L; Meissner B; Mirkowska P; Tchinda J; Niggli FK; Stanulla M; Schrappe M; Schrauder A; Bornhauser BC; Bourquin JP. 2011. Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment. Blood Aug 18;118(7):1854-64. [PMID: 21670474]
• Seif AE; Barrett DM; Milone M; Brown VI; Grupp SA; Reid GS. 2009. Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responses. Blood Sep 17;114(12):2459-66. [PMID: 19636062]
• Watanabe, A., Inukai, T., Kagami, K., Abe, M., Takagi, M., Fukushima, T., Fukushima, H., Nanmoku, T., Terui, K., Ito, T., Toki, T., Ito, E., Fujimura, J., Goto, H., Endo, M., Look, T., Kamps, M., Minegishi, M., Takita, J., Inaba, T., Takahashi, H., Ohara, A., Harama, D., Shinohara, T., Somazu, S., Oshiro, H., Akahane, K., Goi, K., Sugita, K., 2019. Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to multiagents in induction therapy. Cancer Med. [PMID: 31305009]
• Weigert O; Lane AA; Bird L; Kopp N; Chapuy B; van Bodegom D; Toms AV; Marubayashi S; Christie AL; McKeown M; Paranal RM; Bradner JE; Yoda A; Gaul C; Vangrevelinghe E; Romanet V; Murakami M; Tiedt R; Ebel N; Evrot E; De Pover A; Régnier CH; Erdmann D; Hofmann F; Eck MJ; Sallan SE; Levine RL; Kung AL; Baffert F; Radimerski T; Weinstock DM. 2012. Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition. J Exp Med Feb 13;209(2):259-73. [PMID: 22271575] 
• Woiterski J; Ebinger M; Witte KE; Goecke B; Heininger V; Philippek M; Bonin M; Schrauder A; Röttgers S; Herr W; Lang P; Handgretinger R; Hartwig UF; André MC. 2013. Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcome. Int J. Cancer. Oct 1;133(7):1547-56. [PMID: 23526331]

Chronic lymphocytic leukemia (CLL)

• Bagnara D; Kaufman MS; Calissano C; Marsilio S; Patten P; Simone R; Chum P; Yan XJ; Allen SL; Kolitz JE; Baskar S; Rader C; Mellstedt H; Rabbani H; Lee A; Gregersen PK; Rai KR; Chiorazzi N. 2011. A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease. Blood May 19;117(20):5463-72. [PMID: 21385850]
• Chang DK, Kurella VB, Biswas S, Avnir Y, Sui J, Wang X, Sun J, Wang Y, Panditrao M, Peterson E, Tallarico A, Fernandes S, Goodall M, Zhu Q, Brown JR, Jefferis R, Marasco WA. 2016. Humanized mouse G6 anti-idiotypic monoclonal antibody has therapeutic potential against IGHV1-69 germline gene-based B-CLL. MAbs. 2016 Mar 10:0. [PMID: 2696373]
• Cutrona, G., Matis, S., Colombo, M., Massucco, C., Baio, G., Valdora, F., Emionite, L., Fabris, S., Recchia, A.G., Gentile, M., Neumaier, C.E., Reverberi, D., Massara, R., Boccardo, S., Basso, L., Salvi, S., Rosa, F., Cilli, M., Zupo, S., Truini, M., Tassone, P., Calabrese, M., Negrini, M., Neri, A., Morabito, F., Fais, F., Ferrarini, M., 2017. Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: Implication for therapy. Leukemia. doi:10.1038/leu.2016.394. [PMID: 28053325]
• Decker WK; Shah N; Xing D; Lapushin R; Li S; Robinson SN; Yang H; Parmar S; Halpert MM; Keating MJ; Gribben JG; Molldrem JJ; Shpall EJ; Wierda WG. 2012. Generation of Functional CLL-Specific Cord Blood CTL Using CD40-Ligated CLL APC. PLoS One. 7(12):e51390. [PMID: 23284688]
• Herman SE; Sun X; McAuley EM; Hsieh MM; Pittaluga S; Raffeld M; Liu D; Keyvanfar K; Chapman CM; Chen J; Buggy JJ; Aue G; Tisdale JF; Pérez-Galán P; Wiestner A. 2013. Modeling tumor-host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapy. Leukemia. [Epub ahead of print] [PMID:23619564]
• Herman, S.E.M., Montraveta, A., Niemann, C.U., Mora-Jensen, H., Gulrajani, M., Krantz, F., Mantel, R., Smith, L.L., McClanahan, F., Harrington, B.K., Colomer, D., Covey, T., Byrd, J.C., Izumi, R., Kaptein, A., Ulrich, R., Johnson, A.J., Lannutti, B.J., Wiestner, A., Woyach, J.A., 2017. The Bruton Tyrosine Kinase (BTK) Inhibitor Acalabrutinib Demonstrates Potent On-Target Effects and Efficacy in Two Mouse Models of Chronic Lymphocytic Leukemia. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 23, 2831–2841. doi:10.1158/1078-0432.CCR-16-0463. [PMID:27903679]
• Kaucka M; Plevova K; Pavlova S; Janovska P; Mishra A; Verner J; Prochazkova J; Krejci P; Kotaskova J; Ovesna P; Tichy B; Brychtova Y; Doubek M; Kozubik A; Mayer J; Pospisilova S; Bryja V. 2013. The planar cell polarity pathway drives pathogenesis of chronic lymphocytic leukemia by the regulation of B-lymphocyte migration. Cancer Res. Mar 1;73(5):1491-501. [PMID: 23338609]
• Kellner J, Wierda W, Shpall E, Keating M, McNiece I. Isolation of a novel chronic lymphocytic leukemic (CLL) cell line and development of an in vivo mouse model of CLL. Leuk Res. 2016 Jan;40:54-9. doi: 10.1016/j.leukres.2015.10.008. [PMID: 26601610]
• Kikushige Y; Ishikawa F; Miyamoto T; Shima T; Urata S; Yoshimoto G; Mori Y; Iino T; Yamauchi T; Eto T; Niiro H; Iwasaki H; Takenaka K; Akashi K. 2011. Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell Aug 16;20(2):246-59. [PMID: 21840488]
• Marini, C., Bruno, S., Fiz, F., Campi, C., Piva, R., Cutrona, G., Matis, S., Nieri, A., Miglino, M., Ibatici, A., Maria Orengo, A., Maria Massone, A., Neumaier, C.E., Totero, D. de, Giannoni, P., Bauckneht, M., Pennone, M., Tenca, C., Gugiatti, E., Bellini, A., Borra, A., Tedone, E., Efetürk, H., Rosa, F., Emionite, L., Cilli, M., Bagnara, D., Brucato, V., Bruzzi, P., Piana, M., Fais, F., Sambuceti, G., 2017. Functional Activation of Osteoclast Commitment in Chronic Lymphocytic Leukaemia: a Possible Role for RANK/RANKL Pathway. Sci Rep 7, 14159. [PMID: 29074954]
• Matas-Céspedes, A., Vidal-Crespo, A., Rodriguez, V., Villamor, N., Delgado, J., Giné, E., Roca-Ho, H., Menéndez, P., Campo, E., López-Guillermo, A., Colomer, D., Roué, G., Wiestner, A., Parren, P.W.H.I., Doshi, P., van Bueren, J.L., Pérez-Galán, P., 2017. The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia-Microenvironment Interactions in Chronic Lymphocytic Leukemia. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 23, 1493–1505. [PMID: 27637890]
• Os A; Bürgler S; Ribes AP; Funderud A; Wang D; Thompson KM; Tjønnfjord GE; Bogen B; Munthe LA. 2013. Chronic Lymphocytic Leukemia Cells Are Activated and Proliferate in Response to Specific T Helper Cells. Cell Rep. Aug 15;4(3):566-77. [PMID: 23933259]
• Verner J; Trbusek M; Chovancova J; Jaskova Z; Moulis M; Folber F; Halouzka R; Mayer J; Pospisilova S; Doubek M. NOD/SCID IL2Rγ-null mouse xenograft model of human p53-mutated chronic lymphocytic leukemia and ATM-mutated mantle cell lymphoma using permanent cell lines. Leuk Lymphoma. 2015 Apr 1. Epub ahead of print. [PMID: 25827173]
• Wong K; Brenneman F; Chesney A; Spaner DE; Gorczynski RM. 2012. Soluble CD200 is critical to engraft Chronic Lymphocytic Leukemia cells in immunocompromised mice. Cancer Res. Oct 1;72(19):4931-43. [PMID: 22875025]
• Zhu, F., Khatri, I., Spaner, D., Gorczynski, R.M., 2018. An autologous tumor vaccine for CLL. Leuk. Res. 68, 40–47. [PMID: 29525600]

Chronic myeloid leukemia (CML)

• Chen M; Gallipoli P; Degeer D; Sloma I; Forrest DL; Chan M; Lai D; Jorgensen H; Ringrose A; Wang HM; Lambie K; Nakamoto H; Saw KM; Turhan A; Arlinghaus R; Paul J; Stobo J; Barnett MJ; Eaves A; Eaves CJ; Holyoake TL; Jiang X. 2013. Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1-BCR-ABL-JAK2 Complex. J Natl Cancer Inst. Mar 20;105(6):405-23. [PMID: 23446755]
• Heaney NB; Pellicano F; Zhang B; Crawford L; Chu S; Kazmi SM; Allan EK; Jorgensen HG; Irvine AE; Bhatia R; Holyoake TL. 2010. Bortezomib induces apoptosis in primitive chronic myeloid leukemia cells including LTC-IC and NOD/SCID repopulating cells. Blood Mar 18;115(11):2241-50. [PMID: 20068223]
• Herrmann H; Sadovnik I; Cerny-Reiterer S; Rülicke T; Stefanzl G; Willmann M; Hoermann G; Bilban M; Blatt K; Herndlhofer S; Mayerhofer M; Streubel B; Sperr WR; Holyoake TL; Mannhalter C; Valent P. 2014. Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia. Blood. Jun 19; 123(25):3951-62. [PMID:24778155]
• Irvine DA, Zhang B, Kinstrie R, Tarafdar A, Morrison H, Campbell VL, Moka HA, Ho Y, Nixon C, Manley PW, Wheadon H, Goodlad JR, Holyoake TL, Bhatia R, Copland M. 2016. Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia. Sci Rep. 2016 May 9;6:25476. doi: 10.1038/srep25476. [PMID: 27157927]
• Li L; Wang L; Li L; Wang Z; Ho Y; McDonald T; Holyoake TL; Chen W; Bhatia R. 2012. Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib. Cancer Cell Feb 14;21(2):266-81. [PMID: 22340598]
• Neviani P; Harb JG; Oaks JJ; Santhanam R; Walker CJ; Ellis JJ; Ferenchak G; Dorrance AM; Paisie CA; Eiring AM; Ma Y; Mao HC; Zhang B; Wunderlich M; May PC; Sun C; Saddoughi SA; Bielawski J; Blum W; Klisovic RB; Solt JA; Byrd JC; Volinia S; Cortes J; Huettner CS; Koschmieder S; Holyoake TL; Devine S; Caligiuri MA; Croce CM; Garzon R; Ogretmen B; Arlinghaus RB; Chen CS; Bittman R; Hokland P; Roy DC; Milojkovic D; Apperley J; Goldman JM; Reid A; Mulloy JC; Bhatia R; Marcucci G; Perrotti D. 2013. PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. J Clin Invest. [Epub ahead of print] [PPMID: 23999433]
• Sloma I; Jang X; Eaves AC; Eaves CJ. 2010. Insights into the stem cells of chronic myeloid leukemia. Leukemia Review Nov;24(11):1823-33 [PMID: 20861912]
• Sloma I; Beer PA; Saw KM; Chan M; Leung D; Raghuram K; Brimacombe C; Johnston B; Lambie K; Forrest D; Jiang X; Eaves CJ. 2013. Genotypic and functional diversity of phenotypically defined primitive hematopoietic cells in patients with chronic myeloid leukemia. Exp Hematol. [Epub ahead of print] [PMID: 23851302]
• Steinman RA; Yang Q; Gasparetto M; Robinson LJ; Liu X; Lenzner DE; Hou J; Smith C; Wang Q. 2012. Deletion of the RNA-editing enzyme ADAR1 causes regression of established chronic myelogenous leukemia in mice. Int J Cancer. Apr 15;132(8):1741-50. [PMID: 22987615]
• Willmann, M., Sadovnik, I., Eisenwort, G., Entner, M., Bernthaler, T., Stefanzl, G., Hadzijusufovic, E., Berger, D., Herrmann, H., Hoermann, G., Valent, P., Rülicke, T., 2017. Evaluation of cooperative anti-leukemic effects of nilotinib and vildagliptin in Ph(+) chronic myeloid leukemia. Exp. Hematol. [PMID: 29031704]
• Zhang B; Strauss AC; Chu S; Li M; Ho Y; Shiang K.-D; Snyder D.S; Huettner, C.S; Shultz L; Holyoake T; Bhatia, R. 2010. Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate. Cancer Cell May 18;17(5):427-42. [PMID: 20478526]
• Zhang B; Li M; McDonald T; Holyoake TL; Moon RT; Campana D; Shultz L; Bhatia R. 2013. Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-Cadherin and Wnt-β-catenin signaling. Blood. Mar 7;121(10):1824-38. [PMID: 23299311]
• Zhao Y, Masiello D, McMillian M, Nguyen C, Wu Y, Melendez E, Smbatyan G, Kida A, He Y, Teo JL, Kahn M. CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells.  Oncogene. 2015 Dec 14. doi: 10.1038/onc.2015.438. [PMID: 26657156]

Leukemia: Other

• Agliano A; Martin-Padura I; Marighetti P; Calleri A; Prior C; Redrado M; Calvo A; Bertolini F. 2011. Therapeutic effect of Lenalidomide in a novel xenograft mouse model of human Blastic NK cell lymphoma/blastic plasmacytoid dendritic cell neoplasm. Clin Cancer Res. Oct 1;17(19):6163-73. [PMID: 21856771]
• Andre MC, Witte KE, Hoerrmann RA, Schmitt A, Handgretinger R, Ebinger M. Hoechst 33342 Staining Identifies the Progenitor Side Population in NOD.Cg-PrkdcscidIL2rgtmWjl/Sz Mice Harboring Pediatric Leukemias. In Vivo. 2015 11-12;29(6):661-669. [PMID: 26546522]
• Borkin D; He S; Miao H; Kempinska K; Pollock J; Chase J; Purohit T; Malik B; Zhao T; Wang J; Wen B; Zong H; Jones M; Danet-Desnoyers G; Guzman ML; Talpaz M; Bixby DL; Sun D; Hess JL; Muntean AG; Maillard I; Cierpicki T; Grembecka J. Pharmacologic Inhibition of the Menin-MLL Interaction Blocks Progression of MLL Leukemia In Vivo. Cancer Cell. 2015 Mar 25. Epub ahead of print. [PMID: 25817203]
• Daigle SR; Olhava EJ; Therkelsen CA; Majer CR; Sneeringer CJ; Song J; Johnston LD; Scott MP; Smith JJ; Xiao Y; Jin L; Kuntz KW; Chesworth R; Moyer MP; Bernt KM; Tseng JC; Kung AL; Armstrong SA; Copeland RA; Richon VM; Pollock RM. 2011. Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor. Cancer Cell Jul 12;20(1):53-65. [PMID: 21741596]
• Gunasekara, D.C., Zheng, M.M., Mojtahed, T., Woods, J.R., Fandy, T.E., Riofski, M.V., Glackin, C.A., Hassan, H.E., Kirshner, J., Colby, D.A., 2016. 15-Methylene-Eburnamonine Kills Leukemic Stem Cells and Reduces Engraftment in a Humanized Bone Marrow Xenograft Mouse Model of Leukemia. ChemMedChem. doi:10.1002/cmdc.201600334 PMID: 27677525
• Hatcher CL, Mott TM, Muruato LA, Sbrana E, Torres AG. Burkholderia mallei CLH001 attenuated vaccine strain is immunogenic and protects against acute respiratory glanders. Infect Immun. 2016 Jun 6. pii: IAI.00328-16. [PMID: 27271739]
• Huey, D.D., Bolon, B., La Perle, K.M.D., Kannian, P., Jacobson, S., Ratner, L., Green, P.L., Niewiesk, S., 2018. Role of Wild-type and Recombinant Human T-cell Leukemia Viruses in Lymphoproliferative Disease in Humanized NSG Mice. Comp. Med. 68, 4–14. [PMID: 29460716]
• Kovacic B; Hoelbl A; Litos G; Alacakaptan M; Schuster C; Fischhuber KM; Kerenyi MA; Stengl G; Moriggl R; Sexl V; Beug H. 2012. Diverging fates of cells of origin in acute and chronic leukaemia. EMBO Mol Med Apr;4(4):283-97. [PMID: 22323443]
• Leiva-Juárez MM, Ware HH, Kulkarni VV, Zweidler-McKay PA, Tuvim MJ, Evans SE. 2016. Inducible epithelial resistance protects mice against leukemia-associated pneumonia. Blood. Jun 17. pii: blood-2016-03-708511. [PMID: 27317793]
• Meyer LH; Debatin KM. 2011. Diversity of human leukemia xenograft mouse models: implications for disease biology. Cancer Res Dec 1;71(23):7141-4. Review. [PMID: 22088964]
• Montes R; Ayllón; Gutierrez-Aranda I; Prat I; Hernandez-Lamas MC; Ponce L; Bresolin S; Te Kronnie G; Greaves M; Bueno C; Menendez P. 2011. Enforced expression of MLL-AF4 fusion in cord blood CD34+ cells enhances the hematopoietic repopulating cell function and clonogenic potential but is not sufficient to initiate leukemia. Blood May 5;117(18):4746-58. [PMID: 21389315]
• O'Callaghan K; Lee L; Nguyen N; Hsieh MY; Kaneider NC; Klein AK; Sprague K; Van Etten RA; Kuliopulos A; Covic L. 2012. Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia. Blood Feb 16;119(7):1717-25. [PMID: 22186993]
• Rhyasen GW; Bolanos L; Fang J; Jerez A; Wunderlich M; Rigolino C; Mathews L; Ferrer M; Southall N; Guha R; Keller J; Thomas C; Beverly LJ; Cortelezzi A; Oliva EN; Cuzzola M; Maciejewski JP; Mulloy JC; Starczynowski DT. 2013. Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic Syndrome. Cancer Cell. Jul 8;24(1):90-104. [PMID: 23845443]
• Sontakke P, Carretta M, Jaques J, Brouwers-Vos AZ, Lubbers-Aalders L, Yuan H, de Bruijn JD, Martens AC, Vellenga E, Groen RW, Schuringa JJ. Modeling BCR-ABL and MLL-AF9 leukemia in a human bone marrow-like scaffold-based xenograft model. Leukemia. 2016 May 17. doi: 10.1038/leu.2016.108. [PMID: 27125308]
• Tirado-Gonzalez, I., Czlonka, E., Nevmerzhitskaya, A., Soetopo, D., Bergonzani, E., Mahmoud, A., Contreras, A., Jeremias, I., Platzbecker, U., Bourquin, J.P., Kloz, U., Van der Hoeven, F., Medyouf, H., 2017. CRISPR/Cas9 edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC. Leukemia. [PMID: 29209043]

Lymphoma

• Arita K; Maeda-Kasugai Y; Ohshima K; Tsuzuki S; Suguro-Katayama M; Karube K; Yoshida N; Sugiyama T; Seto M. 2013. Generation of mouse models of lymphoid neoplasm using retroviral gene transduction of in vitro-induced germinal center B and T cells. Exp Hematol. Aug;41(8):731-741. [PMID: 23583576]
• Birkenmeier K, Moll K, Newrzela S, Hartmann S, Dröse S, Hansmann ML. 2016. Basal autophagy is pivotal for Hodgkin and Reed-Sternberg cells' survival and growth revealing a new strategy for Hodgkin lymphoma treatment. Oncotarget. Jun 27. doi: 10.18632/oncotarget.10300. [PMID: 27366944]
• Boss IW; Nadeau PE; Abbott JR; Yang Y; Mergia A; Renne R. 2011. A KSHV encoded ortholog of miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2R{gamma}null mice. J Virol. Oct;85(19):9877-86. [PMID: 21813606]
• Christoph S; Schlegel J; Alvarez-Calderon F; Kim YM; Brandao LN; Deryckere D; Graham DK. 2013. Bioluminescence imaging of leukemia cell lines in vitro and in mouse xenografts: effects of monoclonal and polyclonal cell populations on intensity and kinetics of photon emission. J Hematol Oncol. Jan 23;6:10. [PMID: 23343252]
• Chu, Y., Lee, S., Shah, T., Yin, C., Barth, M., Miles, R.R., Ayello, J., Morris, E., Harrison, L., Van de Ven, C., Galardy, P., Goldman, S.C., Lim, M.S., Hermiston, M., McAllister-Lucas, L.M., Giulino-Roth, L., Perkins, S.L., Cairo, M.S., 2019. Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model. Oncoimmunology 8, e1512455. [PMID: 30546948]
• Deutsch, A.J., Rinner, B., Pichler, M., Troppan, K., Pansy, K., Bischof, M., Fechter, K., Hatzl, S., Feichtinger, J., Wenzl, K., Frisch, M.-T., Stiegelbauer, V., Prokesch, A., Krogsdam, A.M., Sill, H., Thallinger, G.G., Greinix, H.T., Wang, C., Beham-Schmid, C., Neumeister, P., 2017. NR4A3 suppresses lymphomagenesis through induction of pro-apoptotic genes. Cancer Res. [PMID: 28249906]
• Kittipongdaja W; Wu X; Garner J; Liu X; Komas SM; Hwang ST; Schieke SM. Rapamycin Suppresses Tumor Growth and Alters the Metabolic Phenotype in T-Cell Lymphoma. J Invest Dermatol. 2015. doi: 10.1038/jid.2015.153. [Epub ahead of print. [PMID: 25897830]
• Luster TA; Mukherjee I; Carrell JA; Cho YH; Gill J; Kelly L; Garcia A; Ward C; Oh L; Ullrich SJ; Migone TS; Humphreys R. 2012. Fusion Toxin BLyS-Gelonin Inhibits Growth of Malignant Human B Cell Lines In Vitro and In Vivo. PLoS One. 7(10):e47361. [PMID: 23056634]
• Manfè V; Biskup E; Willumsgaard A; Skov AG; Palmieri D; Gasparini P; Laganá A; Woetmann A; Odum N; Croce CM; Gniadecki R. 2013. cMyc/miR-125b-5p Signaling Determines Sensitivity to Bortezomib in Preclinical Model of Cutaneous T-Cell Lymphomas. PLoS One. 8(3):e59390. [PMID: 23527180]
• M’kacher, R., Frenzel, M., Al Jawhari, M., Junker, S., Cuceu, C., Morat, L., Bauchet, A.-L., Stimmer, L., Lenain, A., Dechamps, N., Hempel, W.M., Pottier, G., Heidingsfelder, L., Laplagne, E., Borie, C., Oudrhiri, N., Jouni, D., Bennaceur-Griscelli, A., Colicchio, B., Dieterlen, A., Girinsky, T., Boisgard, R., Bourhis, J., Bosq, J., Mehrling, T., Jeandidier, E., Carde, P., 2018. Establishment and Characterization of a Reliable Xenograft Model of Hodgkin Lymphoma Suitable for the Study of Tumor Origin and the Design of New Therapies. Cancers (Basel) 10. [PMID: 30384446]
• Nagel D; Spranger S; Vincendeau M; Grau M; Raffegerst S; Kloo B; Hlahla D; Neuenschwander M; Peter von Kries J; Hadian K; Dörken B; Lenz P; Lenz G; Schendel DJ; Krappmann D. Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL. Cancer Cell. Dec 11;22(6):825-37. [PMID: 23238017]
• Ngai, H., Tian, G., Courtney, A.N., Ravari, S.B., Guo, L., Liu, B., Jin, J., Shen, E.T., Di Pierro, E.J., Metelitsa, L.S., 2018. IL-21 Selectively Protects CD62L+ NKT Cells and Enhances Their Effector Functions for Adoptive Immunotherapy. J. Immunol. [PMID: 30111631]
• Oelsner, S., Friede, M.E., Zhang, C., Wagner, J., Badura, S., Bader, P., Ullrich, E., Ottmann, O.G., Klingemann, H., Tonn, T., Wels, W.S., 2017. Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma. Cytotherapy 19, 235–249. doi:10.1016/j.jcyt.2016.10.009. [PMID: 27887866]
• Pham LV, Lu G, Tamayo AT, Chen J, Challagundla P, Jorgensen JL, Medeiros LJ, Ford RJ. Establishment and characterization of a novel MYC/BCL2 "double-hit" diffuse large B cell lymphoma cell line, RC. J Hematol Oncol. 2015 Oct 29;8(1):121. [PMID: 26515759]
• Pieters, T., T’Sas, S., Demoen, L., Almeida, A., Haenebalcke, L., Matthijssens, F., Lemeire, K., D’Hont, J., Van Rockeghem, F., Hochepied, T., Lintermans, B., Reunes, L., Lammens, T., Berx, G., Haigh, J.J., Goossens, S., Van Vlierberghe, P., 2019. Novel strategy for rapid functional in vivo validation of oncogenic drivers in haematological malignancies. Sci Rep 9. [PMID: 31332244]
• Spaccarotella E; Pellegrino E; Ferracin M; Ferreri C; Cuccuru G; Liu C; Iqbal J; Cantarella D; Taulli R; Provero P; Di Cunto F; Medico E; Negrini M; Chan WC; Inghirami G; Piva R. 2013. STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK positive anaplastic large cell lymphoma. Haematologica [PMID: 23975180]
• Våtsveen, T.K., Myhre, M.R., Steen, C.B., Wälchli, S., Lingjærde, O.C., Bai, B., Dillard, P., Theodossiou, T.A., Holien, T., Sundan, A., Inderberg, E.M., Smeland, E.B., Myklebust, J.H., Oksvold, M.P., 2018. Artesunate shows potent anti-tumor activity in B-cell lymphoma. J Hematol Oncol 11, 23. [PMID: 29458389]
• Vekaria, P.H., Kumar, A., Subramaniam, D., Dunavin, N., Vallurupalli, A., Schoenen, F., Ganguly, S., Anant, S., McGuirk, J.P., Jensen, R.A., Rao, R., 2019. Functional cooperativity of p97 and histone deacetylase 6 in mediating DNA repair in mantle cell lymphoma cells. Leukemia. [PMID: 30664664]
• Verma, M.K., Clemens, J., Burzenski, L., Sampson, S.B., Brehm, M.A., Greiner, D.L., Shultz, L.D., 2017. A novel hemolytic complement-sufficient NSG mouse model supports studies of complement-mediated antitumor activity in vivo. J. Immunol. Methods. doi:10.1016/j.jim.2017.03.021. [PMID: 28390927]
• Vicario, M., Mattiolo, A., Montini, B., Piano, M.A., Cavallari, I., Amadori, A., Chieco-Bianchi, L., Calabrò, M.L., 2018. A Preclinical Model for the ATLL Lymphoma Subtype With Insights Into the Role of Microenvironment in HTLV-1-Mediated Lymphomagenesis. Front Microbiol 9, 1215. [PMID: 29951044]
• Wang, Z., Zheng, Q., Zhang, H., Bronson, R.T., Madsen, J.C., Sachs, D.H., Huang, C.A., Wang, Zhirui, 2017. Ontak-like human IL-2 fusion toxin. J. Immunol. Methods. doi:10.1016/j.jim.2017.05.008. [PMID: 28551309]
• White RE; Rämer PC; Naresh KN; Meixlsperger S; Pinaud L; Rooney C; Savoldo B; Coutinho R; Bödör C; Gribben J; Ibrahim HA; Bower M; Nourse JP; Gandhi MK; Middeldorp J; Cader FZ; Murray P; Münz C; Allday MJ. 2012. EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. J Clin Invest Apr 2;122(4):1487-502 [PMID: 22406538]
• Zheng, L., Hu, P., Wolfe, B., Gonsalves, C., Ren, L., Khawli, L.A., Kaslow, H.R., Epstein, A.L., 2017. Lym-1 Chimeric Antigen Receptor T Cells Exhibit Potent Anti-Tumor Effects against B-Cell Lymphoma. Int J Mol Sci 18. [PMID: 29261129]

Non-Hodgkin Lymphoma 

• Ayello, J., Hochberg, J., Flower, A., Chu, Y., Baxi, L.V., Quish, W., van de Ven, C., Cairo, M.S., 2016. Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy. Exp. Hematol. doi:10.1016/j.exphem.2016.10.003. [PMID: 27765614]
• Chao MP; Alizadeh AA; Tang C; Myklebust JH; Varghese B; Gill S; Jan M; Cha AC; Chan CK; Tan BT; Park CY; Zhao F; Kohrt HE; Malumbres R; Briones J; Gascoyne RD; Lossos IS; Levy R; Weissman IL; Majeti R. 2010. Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma. Cell Sep 3;142(5):699-713. [PMID: 20813259]
• Chao MP; Tang C; Pachynski RK; Chin R; Majeti R; Weissman IL. 2011. Extra-nodal dissemination of non-Hodgkin's lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy. Blood Nov 3;118(18):4890-901. [PMID: 21828138]

Mastocytoma

• Blatt K, Cerny-Reiterer S, Schwaab J, Sotlar K, Eisenwort G, Stefanzl G, Hoermann G, Mayerhofer M, Schneeweiss M, Knapp S, Rülicke T, Hadzijusufovic E, Bauer K, Smiljkovic D, Willmann M, Reiter A, Horny HP, Valent P. Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis. Blood. 2015 Oct 20. [PMID: 26486787]
• Hadzijusufovic E; Peter B; Herrmann H; Rülicke T; Cerny-Reiterer S; Schuch K; Kenner L; Thaiwong T; Yuzbasiyan-Gurkan V; Pickl WF; Willmann M; Valent P. 2012. NI-1: a novel canine mastocytoma model for studying drug resistance and IgER-dependent mast cell activation. Allergy Jul;67(7):858-68. [PMID: 22583069]

Multiple Myeloma

• Bartee E; Chan WS; Moreb JS; Cogle CR; McFadden G. 2012. Selective Purging of Human Multiple Myeloma Cells from Autologous Stem Cell Transplant Grafts using Oncolytic Myxoma Virus. Biol Blood Marrow Transplant. Oct;18(10):1540-51.[PMID: 22516053]
• Carpenter RO; Evbuomwan MO; Pittaluga S; Rose JJ; Raffeld M; Yang S; Gress RE; Hakim FT; Kochenderfer JN. 2013. B-cell Maturation Antigen is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma. Clin Cancer Res. Apr 15;19(8):2048-60. [PMID: 23344265]
• Casucci M; Nicolis di Robilant B; Falcone L; Camisa B; Norelli M; Genovese P; Gentner B; Gullotta F; Ponzoni M; Bernardi M; Marcatti M; Saudemont A; Bordignon C; Savoldo B; Ciceri F; Naldini L; Dotti G; Bonini C; Bondanza A. 2013. CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma. Blood [Epub ahead of print][PMID: 24016461]
• Chaidos A; Barnes CP; Cowan G; May PC; Melo V; Hatjiharissi E; Papaioannou M; Harrington H; Doolittle H; Terpos E; Dimopoulos M; Abdalla S; Yarranton H; Naresh K; Foroni L; Reid A; Rahemtulla A; Stumpf M; Roberts I; Karadimitris A. 2013. Clinical drug resistance linked to inter-convertible phenotypic and functional states of tumor-propagating cells in multiple myeloma. Blood. Jan 10;121(2):318-28. [PMID: 23169779]
• Fuhler GM; Brooks R; Toms B; Iyer S; Gengo EA; Park MY; Gumbleton M; Viernes DR; Chisholm JD; Kerr WG. 2012. Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer. Mol Med Feb 10;18(1):65-75. [PMID: 22033675]
• Grigson ER; Ozerova M; Pisklakova A; Liu H; Sullivan DM; Nefedova Y. 2015. Canonical Wnt Pathway Inhibitor ICG-001 Induces Cytotoxicity of Multiple Myeloma Cells in Wnt-Independent Manner. PLoS One. Jan 30; 10(1):e0117693. [PMID: 25635944]
• Kim D; Park CY; Medeiros BC; Weissman IL. 2012. CD19(-)CD45(low/-)CD38(high)/CD138(+) plasma cells enrich for human tumorigenic myeloma cells. Leukemia Dec;26(12):2530-7. [PMID: 22733078]
• Koduru S; Wong E; Strowig T; Sundaram R; Zhang L; Strout MP; Flavell RA; Schatz DG; Dhodapkar KM; Dhodapkar MV. 2012. Dendritic cell-mediated activation-induced cytidine deaminase (AID)-dependent induction of genomic instability in human myeloma. Blood Mar 8;119(10):2302-9. [PMID: 22234692]
• Mastaglio, S., Genovese, P., Magnani, Z., Ruggiero, E., Landoni, E., Camisa, B., Schiroli, G., Provasi, E., Lombardo, A., Reik, A., Cieri, N., Rocchi, M., Oliveira, G., Escobar, G., Casucci, M., Gentner, B., Spinelli, A., Mondino, A., Bondanza, A., Vago, L., Ponzoni, M., Ciceri, F., Holmes, M.C., Naldini, L., Bonini, C., 2017. NY-ESO-1 TCR single edited central memory and memory stem T cells to treat multiple myeloma without inducing GvHD. Blood. doi:10.1182/blood-2016-08-732636. [PMID: 28637663]
• Piddock, R.E., Loughran, N., Marlein, C.R., Robinson, S.D., Edwards, D.R., Yu, S., Pillinger, G.E., Zhou, Z., Zaitseva, L., Auger, M.J., Rushworth, S.A., Bowles, K.M., 2017. PI3Kδ and PI3Kγ isoforms have distinct functions in regulating pro-tumoural signalling in the multiple myeloma microenvironment. Blood Cancer J. 7, e539. [PMID: 28282033]
• Shancer, Z., Liu, X.-F., Nagata, S., Zhou, Q., Bera, T.K., Pastan, I., 2019. Anti-BCMA immunotoxins produce durable complete remissions in two mouse myeloma models. Proc. Natl. Acad. Sci. U.S.A. [PMID: 30782819]
• Swift BE; Williams BA; Kosaka Y; Wang XH; Medin JA; Viswanathan S; Martinez-Lopez J; Keating A. 2012. Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model. Haematologica Jul;97(7):1020-8 [PMID: 22271890]
• Udi J; Schüler J; Wider D; Ihorst G; Catusse J; Waldschmidt J; Schnerch D; Follo M; Wäsch R; Engelhardt M.2013. Potent in vitro and in vivo activity of sorafenib in multiple myeloma: induction of cell death, CD138-downregulation and inhibition of migration through actin depolymerization. Br J Haematol. Apr;161(1):104-16. [PMID: 23384035]

Myelodysplastic Syndrome

• Li X; Marcondes AM; Ragoczy T; Telling A; Deeg HJ. 2013. Effect of intravenous coadministration of human stroma cell lines on engraftment of long-term repopulating clonal myelodysplastic syndrome cells in immunodeficient mice. Blood Cancer J. Apr 26;3:e113. [PMID: 23624784]
• Madan V; Kanojia D; Li J; Okamoto R; Sato-Otsubo A; Kohlmann A; Sanada M; Grossmann V; Sundaresan J; Shiraishi Y; Miyano S; Thol F; Ganser A; Yang H; Haferlach T; Ogawa S; Koeffler HP. 2015. Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome. Nat Commun. Jan 14;6:6042. [PMID: 25586593]
• Martin MG; Welch JS; Uy GL; Fehniger TA; Kulkarni S; Duncavage EJ; Walter MJ. 2010. Limited engraftment of low-risk myelodysplastic syndrome cells in NOD/SCID gamma-C chain knockout mice. Leukemia Sep;24(9):1662-4. [PMID: 20668474]
• Medyouf H, Mossner M, Jann JC, Nolte F, Raffel S, Herrmann C, Lier A, Eisen C, Nowak V, Zens B, Müdder K, Klein C, Obländer J, Fey S, Vogler J, Fabarius A, Riedl E, Roehl H, Kohlmann A, Staller M, Haferlach C, Müller N, John T, Platzbecker U, Metzgeroth G, Hofmann WK, Trumpp A, Nowak D. 2014. Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit. Cell Stem Cell. 14(6):824–837. [PMID: 24704494]
• Rouault-Pierre, K., Mian, S.A., Goulard, M., Abarrategi, A., Tullio, A.D., Smith, A.E., Mohamedali, A., Best, S., Nloga, A.-M., Kulasekararaj, A.G., Ades, L., Chomienne, C., Fenaux, P., Dosquet, C., Mufti, G.J., Bonnet, D., 2017. Preclinical modeling of myelodysplastic syndromes. Leukemia. doi:10.1038/leu.2017.172. [PMID: 28663577]
• Salari A, Thomay K, Himmler K, Vajen B, Schienke A, Hagedorn M, Ebersold J, Kreipe HH, Krüger A, Schambach A, Schlegelberger B, Göhring G. Establishing a murine xenograft-model for long-term analysis of factors inducing chromosomal instability in myelodysplastic syndrome: Pitfalls and successes. Cancer Genet. 2016 Apr 22. pii: S2210-7762(16)30043-6. doi: 10.1016/j.cancergen.2016.04.004. [PMID: 27184732]

• Brehm MA; Powers AC; Shultz LD; Greiner DL. 2012. Advancing animal models of human type 1 diabetes by engraftment of functional human tissues in immunodeficient mice. Cold Spring Harb Perspect Med May;2(5):a007757. [PMID: 22553498]
• Buerck, L.W., Schuster, M., Oduncu, F.S., Baehr, A., Mayr, T., Guethoff, S., Abicht, J., Reichart, B., Klymiuk, N., Wolf, E., Seissler, J., 2017. LEA29Y expression in transgenic neonatal porcine islet-like cluster promotes long-lasting xenograft survival in humanized mice without immunosuppressive therapy. Sci. Rep. 7, 3572. doi:10.1038/s41598-017-03913-4. [PMID: 28620237]
• Dhawan S, Dirice E, Kulkarni RN, Bhushan A. Inhibition of TGF-beta signaling promotes human pancreatic beta cell replication. Diabetes. 2016 Mar 2. pii: db151331. [PMID: 26936960]
• Friedline RH, Ko HJ, Jung DY, Lee Y, Bortell R, Dagdeviren S, Patel PR, Hu X, Inashima K, Kearns C, Tsitsilianos N, Shafiq U, Shultz LD, Lee KW, Greiner DL, Kim JK. Genetic ablation of lymphocytes and cytokine signaling in nonobese diabetic mice prevents diet-induced obesity and insulin resistance. FASEB J. 2015 Dec 7. pii: fj.15-280610. [PMID: 26644351]
• Guo T; Landsman L; Li N; Hebrok M. 2013. Factors Expressed by Murine Embryonic Pancreatic Mesenchyme Enhance Generation of Insulin-Producing Cells From hESCs. Diabetes. May;62(5):1581-92. [PMID: 23305648]
• Hickey RD; Galivo F; Schug J; Brehm MA; Haft A; Wang Y; Benedetti E; Gu G; Magnuson MA; Shultz LD; Lagasse E; Greiner DL; Kaestner KH; Grompe M. 2013. Generation of islet-like cells from mouse gall bladder by direct ex vivo reprogramming. Stem Cell Res. Feb 18;11(1):503-515. [PMID: 23562832]
• Huang, D., Wang, Y., Hawthorne, W.J., Hu, M., Hawkes, J., Burns, H., Davies, S., Gao, F., Chew, Y.V., Yi, S., O’Connell, P.J., 2017. Ex vivo-expanded baboon CD39 + regulatory T cells prevent rejection of porcine islet xenografts in NOD-SCID IL-2rγ(-/-) mice reconstituted with baboon peripheral blood mononuclear cells. Xenotransplantation. doi:10.1111/xen.12344. [PMID: 28963731]
• King M; Pearson T; Shultz LD; Leif J; Bottino R; Trucco M; Atkinson MA; Wasserfall C; Herold KC; Woodland RT; Schmidt MR; Woda BA; Thompson MJ; Rossini AA; Greiner DL. 2008. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. Clin Immunol. Mar;126(3):303-14. [PMID: 18096436]
• King M; Pearson T; Rossini AA; Shultz LD; Greiner DL. 2008. Humanized mice for the study of type 1 diabetes and beta cell function. Ann N Y Acad Sci Dec;1150:46-53. [PMID: 19120266]
• Klymiuk N; van Buerck L; Bähr A; Offers M; Kessler B; Wuensch A; Kurome M; Thormann M; Lochner K; Nagashima H; Herbach N; Wanke R; Seissler J; Wolf E. 2012. Xenografted Islet Cell Clusters From INSLEA29Y Transgenic Pigs Rescue Diabetes and Prevent Immune Rejection in Humanized Mice. Diabetes Jun;61(6):1527-32. [PMID: 22522620]
• Liu G; Dou S; Akalin A; Rusckowski M; Streeter PR; Shultz LD; Greiner DL. 2012. Pretargeting vs. direct targeting of human betalox5 islet cells subcutaneously implanted in mice using an anti-human islet cell antibody. Nucl Med Biol Jul;39(5):645-51. [PMID: 22316614]
• Min SY, Kady J, Nam M, Rojas-Rodriguez R, Berkenwald A, Kim JH, Noh HL, Kim JK, Cooper MP, Fitzgibbons T, Brehm MA, Corvera S. Human 'brite/beige' adipocytes develop from capillary networks, and their implantation improves metabolic homeostasis in mice. Nat Med. 2016 Jan 25. doi: 10.1038/nm.4031. [Epub ahead of print]. [PMID: 26808348]
• Pearson T; Shultz LD; Lief J; Burzenski L; Gott B; Chase T; Foreman O; Rossini AA; Bottino R; Trucco M; Greiner DL. 2008. A new immunodeficient hyperglycaemic mouse model based on the Ins2 ( Akita ) mutation for analyses of human islet and beta stem and progenitor cell function. Diabetologia 51(8):1449-56. [PMID: 18563383]
• Presa M, Chen YG, Grier AE, Leiter EH, Brehm MA, Greiner DL, Shultz LD, Serreze DV. The Presence and Preferential Activation of Regulatory T Cells Diminish Adoptive Transfer of Autoimmune Diabetes by Polyclonal Nonobese Diabetic (NOD) T Cell Effectors into NSG versus NOD-scid Mice.  J Immunol. 2015 Aug 17. [PMID: 26283479]
• Serr I, Fürst RW, Achenbach P, Scherm MG, Gökmen F, Haupt F, Sedlmeier EM, Knopff A, Shultz L, Willis RA, Ziegler AG, Daniel C. 2016. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice. Nat Commun. 2016 Mar 15;7:10991. [PMID: 26975663]
• Shultz LD; Pearson T; King M; Giassi L; Carney L; Gott B; Lyons B; Rossini AA; Greiner DL. 2007. Humanized NOD/LtSz-scid IL2 receptor common gamma chain knockout mice in diabetes research. Ann N Y Acad Sci Apr;1103:77-89. Review. [PMID: 17332083]
• Unger WW; Pearson T; Abreu JR; Laban S; van der Slik AR; der Kracht SM; Kester MG; Serreze DV; Shultz LD; Griffioen M; Drijfhout JW; Greiner DL; Roep BO. 2012. Islet-Specific CTL Cloned from a Type 1 Diabetes Patient Cause Beta-Cell Destruction after Engraftment into HLA-A2 Transgenic NOD/SCID/IL2RG Null Mice. PLoS One. 7(11):e49213. [PMID: 23155466]
• Whitfield-Larry F; Young EF; Talmage G; Fudge E; Azam A; Patel S; Largay J; Byrd W; Buse J; Calikoglu AS; Shultz LD; Frelinger JA. 2011. HLA-A2-Matched Peripheral Blood Mononuclear Cells From Type 1 Diabetic Patients, but not Nondiabetic Donors, Transfer Insulitis to NOD-scid/{gamma}cnull/HLA-A2 Transgenic Mice Concurrent With the Expansion of Islet-Specific CD8+ T cells. Diabetes Jun;60(6):1726-33. [PMID: 21521873]
• Wolf-van Buerck L, Schuster M, Baehr A, Mayr T, Guethoff S, Abicht J, Reichart B, Nam-Apostolopoulos YC, Klymiuk N, Wolf E, Seissler J. Engraftment and reversal of diabetes after intramuscular transplantation of neonatal porcine islet-like clusters. Xenotransplantation. 2015 Oct 21. [PMID: 26490671]
• Yi S; Ji M; Wu J; Ma X; Phillips P; Hawthorne WJ; O'Connell PJ. 2012. Adoptive Transfer With In Vitro Expanded Human Regulatory T Cells Protects Against Porcine Islet Xenograft Rejection via Interleukin-10 in Humanized Mice. Diabetes May;61(5):1180-91. [PMID: 22403295]
• Zhao Y; Guo C; Hwang D; Lin B; Dingeldein M; Mihailescu D; Sam S; Sidhwani S; Zhang Y; Jain S; Skidgel RA; Prabhakar BS; Mazzone T; Holterman MJ. 2010. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model. Biochem Biophys Res Commun Sep 3;399(4):629-36. [PMID: 20691153]

Differentiation of embryonic stem cells into hematopoetic cells

• Abraham, M., Pereg, Y., Bulvik, B., Klein, S., Mishalian, I., Wald, H., Eizenberg, O., Beider, K., Nagler, A., Golan, R., Vainstein, A., Aharon, A., Galun, E., Caraco, Y., Or, R., Peled, A., 2017. Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34+ Cells in Healthy Volunteers. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. doi:10.1158/1078-0432.CCR-16-2919 [PMID: 28835380]
• Carretta, M., de Boer, B., Jaques, J., Antonelli, A., Horton, S.J., Yuan, H., de Bruijn, J.D., Groen, R.W.J., Vellenga, E., Schuringa, J.J., 2017. Genetically engineered mesenchymal stromal cells producing IL3 and TPO to further improve human scaffold-based xenograft models. Exp. Hematol. doi:10.1016/j.exphem.2017.04.008 [PMID: 28456746]
• Futrega, K., Atkinson, K., Lott, W.B., Doran, M.R., 2017. Spheroid Coculture of Hematopoietic Stem/Progenitor Cells and Monolayer Expanded Mesenchymal Stem/Stromal Cells in Polydimethylsiloxane Microwells Modestly Improves In Vitro Hematopoietic Stem/Progenitor Cell Expansion. Tissue Eng. Part C Methods 23, 200–218. doi:10.1089/ten.tec.2016.0329 [PMID: 28406754]
• Gori JL; Tian X; Swanson D; Gunther R; Shultz LD; McIvor RS; Kaufman DS. 2010. In vivo selection of human embryonic stem cell-derived cells expressing methotrexate-resistant dihydrofolate reductase. Gene Ther Feb;17(2):238-49. [PMID: 19829316]
• Guo, B., Huang, X., Cooper, S., Broxmeyer, H.E., 2017. Glucocorticoid hormone-induced chromatin remodeling enhances human hematopoietic stem cell homing and engraftment. Nat. Med. doi:10.1038/nm.4298 [PMID: 28263313]
• Janel, A., Berger, J., Bourgne, C., Lemal, R., Boiret-Dupré, N., Dubois-Galopin, F., Déchelotte, P., Bothorel, C., Hermet, E., Chabi, S., Bay, J.-O., Lambert, C., Pereira, B., Pflumio, F., Haddad, R., Berger, M.G., 2017. Bone Marrow Hematons: An Access Point to the Human Hematopoietic Niche. Am. J. Hematol. doi:10.1002/ajh.24830 [PMID: 28639326]
• Ledran MH; Krassowska A; Armstrong L; Dimmick I; Renström J; Lang R; Yung S; Santibanez-Coref M; Dzierzak E; Stojkovic M; Oostendorp RA; Forrester L; Lako M. 2008. Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches. Cell Stem Cell Jul 3;3(1):85-98 [PMID: 18593561]
• Sumide, K., Matsuoka, Y., Kawamura, H., Nakatsuka, R., Fujioka, T., Asano, H., Takihara, Y., Sonoda, Y., 2018a. A revised road map for the commitment of human cord blood CD34-negative hematopoietic stem cells. Nat Commun 9. [PMID: 29875383]
• Svalgaard, J.D., Talkhoncheh, M.S., Haastrup, E.K., Munthe-Fog, L., Clausen, C., Hansen, M.B., Andersen, P., Gørløv, J.S., Larsson, J., Fischer-Nielsen, A., 2018. Pentaisomaltose, an Alternative to DMSO. Engraftment of Cryopreserved Human CD34+ Cells in Immunodeficient NSG Mice. Cell Transplant 963689718786226. [PMID: 30056762]
• Szabo E; Rampalli S; Risueño RM; Schnerch A; Mitchell R; Fiebig-Comyn A; Levadoux-Martin M; Bhatia M. 2010. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature Nov 25;468(7323):521-6. [PMID: 21057492]
• Tormo, A., Khodayarian, F., Cui, Y., Al-Chami, E., Kanjarawi, R., Noé, B., Wang, H., Rafei, M., 2017. Interleukin-21 promotes thymopoiesis recovery following hematopoietic stem cell transplantation. J. Hematol. Oncol.J Hematol Oncol 10, 120. doi:10.1186/s13045-017-0490-3 [PMID: 28615039]

Differentiation of embryonic stem cells into endothelial cells

• Chen VC; Couture SM; Ye J; Lin Z; Hua G; Huang HI; Wu J; Hsu D; Carpenter MK; Couture LA. 2012. Scalable GMP compliant suspension culture system for human ES cells. Stem Cell Res May;8(3):388-402. [PMID: 22459095]
• Gori JL; Tian X; Swanson D; Gunther R; Shultz LD; McIvor RS; Kaufman DS. 2010. In vivo selection of human embryonic stem cell-derived cells expressing methotrexate-resistant dihydrofolate reductase. Gene Ther Feb;17(2):238-49. [PMID: 19829316]
• Ma M; Ding S; Lundqvist A; San H; Fang F; Konoplyannikov M; Berry C; Beltran LE; Chen G; Kovacic JC; Boehm M. 2010. Major histocompatibility complex-I expression on embryonic stem cell-derived vascular progenitor cells is critical for syngeneic transplant survival. Stem Cells Sep;28(9):1465-75. [PMID: 20629173]
• Papapetrou EP; Lee G; Malani N; Setty M; Riviere I; Tirunagari LM; Kadota K; Roth SL; Giardina P; Viale A; Leslie C; Bushman FD; Studer L; Sadelain M. 2011. Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells. Nat Biotechnol Jan;29(1):73-8. [PMID: 21151124]
• Sullivan GJ; Hay DC; Park IH; Fletcher J; Hannoun Z; Payne CM; Dalgetty D; Black JR; Ross JA; Samuel K; Wang G; Daley GQ; Lee JH; Church GM; Forbes SJ; Iredale JP; Wilmut I. 2010. Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology. Jan;51(1):329-35. [PMID: 19877180]
• Tian X; Hexum MK; Penchev VR; Taylor RJ; Shultz LD; Kaufman DS. 2009. Bioluminescent imaging demonstrates that transplanted human embryonic stem cell-derived CD34(+) cells preferentially develop into endothelial cells. Stem Cells Nov;27(11):2675-85. [PMID: 19711457]

Hematopoietic stem cells

• Baldwin K; Urbinati F; Romero Z; Campo-Fernandez B; Kaufman ML; Cooper AR; Masiuk K; Hollis RP; Kohn DB. 2015. Enrichment of Human Hematopoietic Stem/Progenitor Cells Facilitates Transduction for Stem Cell Gene Therapy. Stem Cells. Epub ahead of print. [PMID: 25588820]
• Chang CH, Hale SJ, Cox CV, Blair A, Kronsteiner B, Grabowska R, Zhang Y, Cook D, Khoo CP, Schrader JB, Buglass Kabuga S, Martin-Rendon E, Watt SM. Jam-a is highly expressed on human hematopoietic repopulating cells and associates with the key hematopoietic chemokine receptor cxcr4. Stem Cells. 2016 Feb 11. doi: 10.1002/stem.2340. [PMID: 26866290]
• De Luca L, Trino S, Laurenzana I, Simeon V, Calice G, Raimondo S, Podestà M, Santodirocco M, Di Mauro L, La Rocca F, Caivano A, Morano A, Frassoni F, Cilloni D, Del Vecchio L, Musto P. MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a new insight in transplantation. Oncotarget. 2015 Dec 29. doi: 10.18632/oncotarget.6791. [Epub ahead of print] [PMID: 26760763]
• De Ravin, S.S., Li, L., Wu, X., Choi, U., Allen, C., Koontz, S., Lee, J., Theobald-Whiting, N., Chu, J., Garofalo, M., Sweeney, C., Kardava, L., Moir, S., Viley, A., Natarajan, P., Su, L., Kuhns, D., Zarember, K.A., Peshwa, M.V., Malech, H.L., 2017. CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease. Sci. Transl. Med. 9. doi:10.1126/scitranslmed.aah3480 [PMID: 28077679]
• Duinhouwer LE; Tüysüz N; Rombouts EW; Ter Borg MN; Mastrobattista E; Spanholtz J; Cornelissen JJ; Ten Berge D; Braakman E. Wnt3a protein reduces growth factor-driven expansion of human hematopoietic stem and progenitor cells in serum-free cultures. PLoS One. 2015 Mar 25;10(3):e0119086. [PMID: 25807521]
• Futrega K, Lott WB, Doran MR. 2016. Direct bone marrow HSC transplantation enhances local engraftment at the expense of systemic engraftment in NSG mice. Sci Rep. Apr 11;6:23886. [PMID: 27065210]
• Guenther, K.L., Cheruku, P.S., Cash, A., Smith, R.H., Alvarado, L.J., Burkett, S., Townsley, D.M., Winkler, T., Larochelle, A., 2019. Eltrombopag promotes DNA repair in human hematopoietic stem and progenitor cells. Exp. Hematol. [PMID: 30986494]
• Guo, B., Huang, X., Cooper, S., Broxmeyer, H.E., 2017. Glucocorticoid hormone-induced chromatin remodeling enhances human hematopoietic stem cell homing and engraftment. Nat. Med. [PMID: 28263313]
• Haemmerle R; Phaltane R; Rothe M; Schröder S; Schambach A; Moritz T; Modlich U. 2014. Clonal Dominance With Retroviral Vector Insertions Near the ANGPT1 and ANGPT2 Genes in a Human Xenotransplant Mouse Model. Mol Ther Nucleic Acids. Oct 7;3:e200. [PMID: 25291142]
• Hasgur S, Aryee KE, Shultz LD, Greiner DL, Brehm MA. Generation of Immunodeficient Mice Bearing Human Immune Systems by the Engraftment of Hematopoietic Stem Cells. Methods Mol Biol. 2016;1438:67-78. doi: 10.1007/978-1-4939-3661-8_4. [PMID: 27150084]
• Heffner, G.C., Bonner, M., Christiansen, L., Pierciey, F.J., Campbell, D., Smurnyy, Y., Zhang, W., Hamel, A., Shaw, S., Lewis, G., Goss, K.A., Garijo, O., Torbett, B.E., Horton, H., Finer, M.H., Gregory, P.D., Veres, G., 2018. Prostaglandin E2 Increases Lentiviral Vector Transduction Efficiency of Adult Human Hematopoietic Stem and Progenitor Cells. Mol. Ther. 26, 320–328. [PMID: 29102562]
• Huang, N., Lou, M., Liu, H., Avila, C., Ma, Y., 2016. Identification of a potent small molecule capable of regulating polyploidization, megakaryocyte maturation, and platelet production. J. Hematol. Oncol.J Hematol Oncol 9, 136. [PMID: 27927231]
• Jangalwe, S., Shultz, L.D., Mathew, A., Brehm, M.A., 2016. Improved B cell development in humanized NOD-scid IL2Rγ(null) mice transgenically expressing human stem cell factor, granulocyte-macrophage colony-stimulating factor and interleukin-3. Immun. Inflamm. Dis. 4, 427–440 [PMID: 27980777]
• Kang, K., Kim, Y., Lee, S.B., Kim, J.S., Park, S., Kim, W.-D., Yang, H.-M., Kim, S.-J., Jeong, J., Choi, D., 2017. Three-dimensional bio-printing of hepatic structures with direct-converted hepatocyte-like cells. Tissue Eng. Part A. doi:10.1089/ten.TEA.2017.0161 [PMID: 28726547]
• Kao, R.L., Truscott, L.C., Chiou, T.-T., Tsai, W., Wu, A.M., De Oliveira, S.N., 2019. A Cetuximab-Mediated Suicide System in Chimeric Antigen Receptor-Modified Hematopoietic Stem Cells for Cancer Therapy. Hum. Gene Ther. 30, 413—428. [PMID: 30860401]
• Kays SK; Kaufmann KB; Abel T; Brendel C; Bonig H; Grez M; Buchholz CJ; Kneissl S. 2014. CD105 is a surface marker for receptor-targeted gene transfer into human long-term repopulating hematopoietic stem cells. Stem Cells Dev. Dec 17; Epub ahead of print. [PMID: 25517513]
• Lapostolle, V., Chevaleyre, J., Duchez, P., Rodriguez, L., Vlaski-Lafarge, M., Sandvig, I., Brunet de la Grange, P., Ivanovic, Z., 2018. Repopulating hematopoietic stem cells from steady-state blood before and after ex vivo culture are enriched in CD34+CD133+CXCR4low fraction. Haematologica. [PMID: 29858385]
• Nowlan, B., Williams, E.D., Doran, M.R., Levesque, J.-P., 2019. CD27, CD201, FLT3, CD48, and CD150 cell surface staining identifies long-term mouse hematopoietic stem cells in immunodeficient non-obese diabetic severe combined immune deficient derived strains. Haematologica. [PMID: 31073070]
• Radtke S, Haworth KG, Kiem HP. 2016. The frequency of multipotent CD133+CD45RA-CD34+ hematopoietic stem cells is not increased in fetal liver compared with adult stem cell sources. Exp Hematol. 2016 Mar 22. pii: S0301-472X(16)30023-6. [PMID: 27016273]
• Sweeney, C.L., Choi, U., Liu, C., Koontz, S., Ha, S.-K., Malech, H.L., 2017. CRISPR-Mediated Knockout of Cybb in NSG Mice Establishes a Model of Chronic Granulomatous Disease for Human Stem-Cell Gene Therapy Transplants. Hum. Gene Ther. [PMID: 28264583]
• Wang, W., Fujii, H., Kim, H.J., Hermans, K., Usenko, T., Xie, S., Luo, Z.-J., Ma, J., Celso, C.L., Dick, J.E., Schroeder, T., Krueger, J., Wall, D., Egeler, R.M., Zandstra, P.W., 2017. Enhanced human hematopoietic stem and progenitor cell engraftment by blocking donor T cell-mediated TNFα signaling. Sci Transl Med 9. [PMID: 29263228]

Human mammary stem cells

• Eirew P; Stingl J; Raouf A; Turashvili G; Aparicio S; Emerman JT; Eaves CJ. 2008. A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability. Nat Med 14(12):1384-1389. [PMID: 19029987]

Induced pluripotent stem (iPS) cells

• Amabile G; Welner RS; Nombela-Arrieta C; D'Alise AM; Di Ruscio A; Ebralidze AK; Kraytsberg Y; Ye M; Kocher O; Neuberg DS; Khrapko K; Silberstein LE; Tenen DG. 2013. In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. Blood. Feb 21;121(8):1255-64. [PMID: 23212524]
• Ben-David U; Gan QF; Golan-Lev T; Arora P; Yanuka O; Oren YS; Leikin-Frenkel A; Graf M; Garippa R; Boehringer M; Gromo G; Benvenisty N. 2013. Selective Elimination of Human Pluripotent Stem Cells by an Oleate Synthesis Inhibitor Discovered in a High-Throughput Screen. Cell Stem Cell.  Feb 7;12(2):167-79. [PMID: 23318055]
• Darabi R; Arpke RW; Irion S; Dimos JT; Grskovic M; Kyba M; Perlingeiro RC. 2012. Human ES- and iPS-Derived Myogenic Progenitors Restore DYSTROPHIN and Improve Contractility upon Transplantation in Dystrophic Mice. Cell Stem Cell May 4;10(5):610-9. [PMID: 22560081]
• Fagoonee S; Bearzi C; Di Cunto F; Clohessy JG; Rizzi R; Reschke M; Tolosano E; Provero P; Pandolfi PP; Silengo L; Altruda F. 2013. The RNA Binding Protein ESRP1 Fine-Tunes the Expression of Pluripotency-Related Factors in Mouse Embryonic Stem Cells. PLoS One. Aug 27;8(8):e72300. [PMID: 24015231]
• Gori JL; Butler JM; Chan YY; Chandrasekaran D; Poulos MG; Ginsberg M; Nolan DJ; Elemento O; Wood BL; Adair JE; Rafii S; Kiem HP. Vascular niche promotes hematopoietic multipotent progenitor formation from pluripotent stem cells. J Clin Invest. 2015 Feb 9. Epub ahead of print. [PMID: 25664855]
• Kahler DJ; Ahmad FS; Ritz A; Hua H; Moroziewicz DN; Sproul AA; Dusenberry CR; Shang L; Paull D; Zimmer M; Weiss KA; Egli D; Noggle SA. 2013. Improved methods for reprogramming human dermal fibroblasts using fluorescence activated cell sorting. PLoS One. 8(3):e59867. [PMID: 23555815]
• Liu J; Koscielska KA; Cao Z; Hulsizer S; Grace N; Mitchell G; Nacey C; Githinji J; McGee J; Garcia-Arocena D; Hagerman RJ; Nolta J; Pessah IN; Hagerman PJ. 2012. Signaling defects in iPSC-derived fragile X premutation neurons. Hum Mol Genet Sep 1;21(17):3795-805 [PMID: 22641815]
• Merkl C; Saalfrank A; Riesen N; Kühn R; Pertek A; Eser S; Hardt MS; Kind A; Saur D; Wurst W; Iglesias A; Schnieke A. 2013. Efficient generation of rat induced pluripotent stem cells using a non-viral inducible vector. PLoS One. 8(1):e55170. [PMID: 23383095]
• Mitchell, A., Wanczyk, H., Jensen, T., Finck, C., 2019. Assessment of iPSC teratogenicity throughout directed differentiation toward an alveolar-like phenotype. Differentiation 105, 45—53. [PMID: 30711828]
• Noggle S; Fung HL; Gore A; Martinez H; Satriani KC; Prosser R; Oum K; Paull D; Druckenmiller S; Freeby M; Greenberg E; Zhang K; Goland R; Sauer MV; Leibel RL; Egli D. 2011. Human oocytes reprogram somatic cells to a pluripotent state. Nature Oct 5;478(7367):70-5. [PMID: 21979046]
• Parameswaran S; Balasubramanian S; Babai N; Deldebbio CB; Harms DW; Gurumurthy CB; Rao MS; Sharp JG; Ahmad I. 2012. Nucleic Acid and non-nucleic Acid-based reprogramming of adult limbal progenitors to pluripotency. PLoS One. 7(10):e46734. [PMID: 23056428]
• Pelosi E; Castelli G; Martin-Padura I; Bordoni V; Santoro S; Conigliaro A; Cerio AM; De Santis Puzzonia M; Marighetti P; Biffoni M; Alonzi T; Amicone L; Alcalay M; Bertolini F; Testa U; Tripodi M. 2012. Human Haemato-Endothelial Precursors: Cord Blood CD34+ Cells Produce Haemogenic Endothelium. PLoS One. 7(12):e51109. [PMID: 23226561]
• Ruiz S; Brennand K; Panopoulos AD; Herrerías A; Gage FH; Izpisua-Belmonte JC. 2010. High-Efficient Generation of Induced Pluripotent Stem Cells from Human Astrocytes. PLoS ONE 5(12): e15526. [PMID: 21170306]
• Su RJ; Yang Y; Neises A; Payne KJ; Wang J; Viswanathan K; Wakeland EK; Fang X; Zhang XB. 2013. Few single nucleotide variations in exomes of human cord blood induced pluripotent stem cells. PLoS One. 8(4):e59908. [PMID: 23573220]
• Su RJ; Baylink DJ; Neises A; Kiroyan JB; Meng X; Payne KJ; y-Seney B; Duan Y; Appleby N; Kearns-Jonker M; Gridley DS; Wang J; Lau KH; Zhang XB. 2013. Efficient generation of integration-free ips cells from human adult peripheral blood using BCL-XL together with Yamanaka factors. PLoS One. May 21;8(5):e64496. [PMID: 23704989]
• Tozawa, K., Ono-Uruga, Y., Yazawa, M., Mori, T., Murata, M., Okamoto, S., Ikeda, Y., Matsubara, Y., 2018. Unique megakaryocytes and platelets from novel human adipose-derived mesenchymal stem cell line. Blood. [PMID: 30487128]
• Wang W; Yang J; Liu H; Lu D; Chen X; Zenonos Z; Campos LS; Rad R; Guo G; Zhang S; Bradley A; Liu P. 2011. Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1. Proc Natl Acad Sci U S A Nov 8;108(45):18283-8. [PMID: 21990348]
• Winkler T; Hong SG; Decker JE; Morgan MJ; Wu C; Hughes WM 5th; Yang Y; Wangsa D; Padilla-Nash HM; Ried T; Young NS; Dunbar CE; Calado RT. 2013. Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs. J Clin Invest. May 1;123(5):1952-63. [PMID: 23585473]
• Wu, J., Matthias, N., Lo, J., Ortiz-Vitali, J.L., Shieh, A.W., Wang, S.H., Darabi, R., 2018. A Myogenic Double-Reporter Human Pluripotent Stem Cell Line Allows Prospective Isolation of Skeletal Muscle Progenitors. Cell Rep 25, 1966-1981.e4. [PMID: 30428361]

Intestinal stem cells

• Lahar N; Lei NY; Wang J; Jabaji Z; Tung SC; Joshi V; Lewis M; Stelzner M; Martín MG; Dunn JC. 2011. Intestinal subepithelial myofibroblasts support in vitro and in vivo growth of human small intestinal epithelium. PLoS One 6(11):e26898 [PMID: 22125602]

Other stem cell publications

• Baldwin K; Urbinati F; Romero Z; Campo-Fernandez B; Kaufman ML; Cooper AR; Masiuk K; Hollis RP; Kohn DB. 2015. Enrichment of Human Hematopoietic Stem/Progenitor Cells Facilitates Transduction for Stem Cell Gene Therapy. Stem Cells. Epub ahead of print. [PMID: 25588820]
• Barclay GR; Tura O; Samuel K; Hadoke PW; Mills NL; Newby DE; Turner ML. 2012. Systematic assessment in an animal model of the angiogenic potential of different human cell sources for therapeutic revascularisation. Stem Cell Res Ther. 2012 Jul 3;3(4):23 [PMID: 22759659]
• Beegle J; Lakatos K; Kalomoiris S; Stewart H; Isseroff RR; Nolta JA; Fierro FA. Hypoxic Preconditioning of Mesenchymal Stromal Cells Induces Metabolic Changes Enhances Survival and Promotes Cell Retention in Vivo. Stem Cells. 2015 Feb 19. Epub ahead of print. [PMID: 25702874]
• Bono, B., Ostano, P., Peritore, M., Gregnanin, I., Belgiovine, C., Liguori, M., Allavena, P., Chiorino, G., Chiodi, I., Mondello, C., 2018. Cells with stemness features are generated from in vitro transformed human fibroblasts. Sci Rep 8, 13838. [PMID: 30218041]
• Darzi, S., Deane, J.A., Nold, C.A., Edwards, S.E., Gough, D.J., Mukherjee, S., Gurung, S., Tan, K.S., Vashi, A.V., Werkmeister, J.A., Gargett, C.E., 2018. Endometrial Mesenchymal Stem/Stromal Cells Modulate the Macrophage Response to Implanted Polyamide/Gelatin Composite Mesh in Immunocompromised and Immunocompetent Mice. Sci Rep 8, 6554. [PMID: 29700360]
• Foo, K.S., Lehtinen, M.L., Leung, C.Y., Lian, X., Xu, J., Keung, W., Geng, L., Kolstad, T.R.S., Thams, S., Wong, A.O.-T., Wong, N., Bylund, K., Zhou, C., He, X., Jin, S.-B., Clarke, J., Lendahl, U., Li, R.A., Louch, W.E., Chien, K.R., 2018. Human ISL1+ Ventricular Progenitors Self-Assemble into an In Vivo Functional Heart Patch and Preserve Cardiac Function Post Infarction. Mol. Ther. 26, 1644–1659. [PMID: 29606507]
• Gedye C, Sirskyj D, Lobo NC, Meens J, Hyatt E, Robinette M, Fleshner N, Hamilton RJ, Kulkarni G, Zlotta A, Evans A, Finelli A, Jewett MA, Ailles LE. 2016. Cancer stem cells are underestimated by standard experimental methods in clear cell renal cell carcinoma. Sci Rep. 2016 Apr 28;6:25220. [PMID: 27121191]
• Ginsberg M; James D; Ding BS; Nolan D; Geng F; Butler JM; Schachterle W; Pulijaal VR; Mathew S; Chasen ST; Xiang J; Rosenwaks Z; Shido K; Elemento O; Rabbany SY; Rafii S. 2012. Efficient Direct Reprogramming of Mature Amniotic Cells into Endothelial Cells by ETS Factors and TGFβ Suppression. Cell Oct 26;151(3):559-75. [PMID: 23084400]
• Gurung, S., Deane, J.A., Darzi, S., Werkmeister, J.A., Gargett, C.E., 2017. In Vivo Survival of Human Endometrial Mesenchymal Stem Cells Transplanted Under the Kidney Capsule of Immunocompromised Mice. Stem Cells Dev. [PMID: 29105567]
• Hofmann NA; Ortner A; Jacamo RO; Reinisch A; Schallmoser K; Rohban R; Etchart N; Fruehwirth M; Beham-Schmid C; Andreeff M; Strunk D. 2012. Oxygen sensing mesenchymal progenitors promote neo-vasculogenesis in a humanized mouse model in vivo. PLoS One. 7(9):e44468. [PMID: 22970226]
• Izrael, M., Slutsky, S.G., Admoni, T., Cohen, L., Granit, A., Hasson, A., Itskovitz-Eldor, J., Krush Paker, L., Kuperstein, G., Lavon, N., Yehezkel Ionescu, S., Solmesky, L.J., Zaguri, R., Zhuravlev, A., Volman, E., Chebath, J., Revel, M., 2018. Safety and efficacy of human embryonic stem cell-derived astrocytes following intrathecal transplantation in SOD1G93A and NSG animal models. Stem Cell Res Ther 9, 152. [PMID: 29871694]
• Kang YK, Ko Y, Choi A, Choi HJ, Seo JH, Lee M, Lee JA. 2016. Humanizing NOD/SCID/IL-2Rγnull (NSG) mice using busulfan and retro-orbital injection of umbilical cord blood-derived CD34(+) cells. Blood Res. Mar;51(1):31-6. doi: 10.5045/br.2016.51.1.31. [PMID:  27104189]
• Kaur S; Soto-Pantoja DR; Stein EV; Liu C; Elkahloun AG; Pendrak ML; Nicolae A; Singh SP; Nie Z; Levens D; Isenberg JS; Roberts DD. 2013. Thrombospondin-1 Signaling through CD47 Inhibits Self-renewal by Regulating c-Myc and Other Stem Cell Transcription Factors. Sci Rep. Apr 17;3:1673. [PMID: 23591719]
• Li O; Tormin A; Sundberg B; Hyllner J; Le Blanc K; Scheding S. 2013. Human Embryonic Stem Cell-Derived Mesenchymal Stroma Cells (hES-MSCs) Engraft In Vivo and Support Hematopoiesis without Suppressing Immune Function: Implications for Off-The Shelf ES-MSC Therapies. PLoS One. 8(1):e55319. [PMID: 23383153]
• Matthias, N., Hunt, S.D., Wu, J., Lo, J., Smith Callahan, L.A., Li, Y., Huard, J., Darabi, R., 2018. Volumetric muscle loss injury repair using in situ fibrin gel cast seeded with muscle-derived stem cells (MDSCs). Stem Cell Res 27, 65–73. [PMID: 29331939]
• Perrier-Groult, E., Pérès, E., Pasdeloup, M., Gazzolo, L., Duc Dodon, M., Mallein-Gerin, F., 2019. Evaluation of the biocompatibility and stability of allogeneic tissue-engineered cartilage in humanized mice. PLoS One 14. [PMID: 31107916]
• Prewitz MC; Seib FP; von Bonin M; Friedrichs J; Stißel A; Niehage C; Müller K; Anastassiadis K; Waskow C; Hoflack B; Bornhäuser M; Werner C. 2013. Tightly anchored tissue-mimetic matrices as instructive stem cell microenvironments. Nat Methods. Aug;10(8):788-94. [PMID: 23793238]
• Shehata M; Teschendorff A; Sharp G; Novcic N; Russell A; Avril S; Prater M; Eirew P; Caldas C; Watson CJ; Stingl J. 2012. Phenotypic and functional characterization of the luminal cell hierarchy of the mammary gland. Breast Cancer Res. [Epub ahead of print] [PMID: 23088371]
• Sudres, M., Maurer, M., Robinet, M., Bismuth, J., Truffault, F., Girard, D., Dragin, N., Attia, M., Fadel, E., Santelmo, N., Sicsic, C., Brenner, T., Berrih-Aknin, S., 2017. Preconditioned mesenchymal stem cells treat myasthenia gravis in a humanized preclinical model. JCI Insight 2, e89665. doi:10.1172/jci.insight.89665 [PMID: 28405609]
• Umeda K; Oda H; Yan Q; Matthias N; Zhao J; Davis BR; Nakayama N. Stem Cell Reports. Long-Term Expandable SOX9+ Chondrogenic Ectomesenchymal Cells from Human Pluripotent Stem Cells. 2015 Mar 25. Epub ahead of print. [PMID: 25818812]
• Kuhlenschmidt, T.B., Witola, W.H., Stappenbeck, T.S., Sibley, L.D., 2019. A Stem-Cell-Derived Platform Enables Complete Cryptosporidium Development In Vitro and Genetic Tractability. Cell Host Microbe 26, 123-134.e8. [PMID: 31231046]
• Yoshihara, S., Li, Y., Xia, J., Danzl, N., Sykes, M., Yang, Y.-G., 2019. Posttransplant Hemophagocytic Lymphohistiocytosis Driven by Myeloid Cytokines and Vicious Cycles of T-Cell and Macrophage Activation in Humanized Mice. Front Immunol 10, 186. [PMID: 30814997]

• Baimukanova G, Miyazawa B, Potter DR, Muench MO, Bruhn R, Gibb SL, Spinella PC, Cap AP, Cohen MJ, Pati S. 2016. Platelets regulate vascular endothelial stability: assessing the storage lesion and donor variability of apheresis platelets. Transfusion. 2016 Mar;56 Suppl 1:S65-75. [PMID: 27001364]
• Benabdallah BF; Allard E; Yao S; Friedman G; Gregory PD; Eliopoulos N; Fradette J; Spees JL; Haddad E; Holmes MC; Beauséjour CM. 2010. Targeted gene addition to human mesenchymal stromal cells as a cell-based plasma-soluble protein delivery platform. Cytotherapy May;12(3):394-9. [PMID: 20331411]
• Bernstein JM; Lehman H; Lis M; Sands A; Wilding GE; Shultz L; Bankert R; Bobek L. 2012. Humanized mouse model used to monitor MUC gene expression in nasal polyps and to preclinically evaluate the efficacy of montelukast in reducing mucus production. Ann Otol Rhinol Laryngol. May;121(5):307-16. [PMID: 22724276]
• Bertaux-Skeirik, N., Wunderlich, M., Teal, E., Chakrabarti, J., Biesiada, J., Mahe, M., Sundaram, N., Gabre, J., Hawkins, J., Gao, J., Engevik, A.C., Yang, L., Wang, J., Goldenring, J.R., Qualls, J.E., Medvedovic, M., Helmrath, M.A., Diwan, T., Mulloy, J.C., Zavros, Y., 2017. CD44 variant isoform 9 emerges in response to injury and contributes to the regeneration of the gastric epithelium. J. Pathol. doi:10.1002/path.4918 [PMID: 28497484]
• Bleijs, M., van de Wetering, M., Clevers, H., Drost, J., 2019. Xenograft and organoid model systems in cancer research. EMBO J 38. [PMID: 31282586]
• Bouchentouf M; Williams P; Forner KA; Cuerquis J; Michaud V; Paradis P; Schiffrin EL; Galipeau J. 2011. Interleukin-2 enhances angiogenesis and preserves cardiac function following myocardial infarction. Cytokine Dec;56(3):732-8. [PMID: 22004921]
• Briquet A; Grégoire C; Comblain F; Servais L; Zeddou M; Lechanteur C; Beguin Y. 2014. Human bone marrow; umbilical cord or liver mesenchymal stromal cells fail to improve liver function in a model of CCl4-induced liver damage in NOD/SCID/IL-2Rγ(null) mice. Cytotherapy. Nov;16(11):1511-8. [PMID: 25174737]
• Bufalieri, F., Infante, P., Bernardi, F., Caimano, M., Romania, P., Moretti, M., Lospinoso Severini, L., Talbot, J., Melaiu, O., Tanori, M., Di Magno, L., Bellavia, D., Capalbo, C., Puget, S., De Smaele, E., Canettieri, G., Guardavaccaro, D., Busino, L., Peschiaroli, A., Pazzaglia, S., Giannini, G., Melino, G., Locatelli, F., Gulino, A., Ayrault, O., Fruci, D., Di Marcotullio, L., 2019. ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of βTrCP. Nat Commun 10. [PMID: 31341163]
• De Los Reyes-Berbel, E., Salto-Gonzalez, R., Ortega-Muñoz, M., Reche-Perez, F.J., Jódar-Reyes, A.B., Hernández-Mateo, F., Giron-Gonzalez, M.D., Santoyo-González, F., 2018. PEI-NIR Heptamethine Cyanine Nanotheranostics for Tumor Targeted Gene Delivery. Bioconjug. Chem. [PMID: 29953208]
• Du, Y., Xie, W., Zhang, F., Choi, U., Liu, C., Sweeney, C.L., 2019. Using CRISPR/Cas9 for Gene Knockout in Immunodeficient NSG Mice. Methods Mol. Biol. 1874, 139—168. [PMID: 30353512]
• Fusil F, Calattini S, Amirache F, Mancip J, Costa C, Robbins JB, Douam F, Lavillette D, Law M, Defrance T, Verhoeyen E , Cosset FL. A Lentiviral Vector Allowing Physiologically Regulated Membrane-anchored and Secreted Antibody Expression Depending on B-cell Maturation Status. Mol Ther. 2015 Aug 18. [PMID: 26281898]
• Habiel, D.M., Espindola, M.S., Jones, I.C., Coelho, A.L., Stripp, B., Hogaboam, C.M., 2018. CCR10+ epithelial cells from idiopathic pulmonary fibrosis lungs drive remodeling. JCI Insight 3. [PMID: 30135312]
• Ho KS; Aman AM; Al-awar RS; Shoichet MS. 2012. Amphiphilic micelles of poly(2-methyl-2-carboxytrimethylene carbonate-co-D;L-lactide)-graft-poly(ethylene glycol) for anti-cancer drug delivery to solid tumours. Biomaterials Mar;33(7):2223-9. [PMID: 22182751]
• Koohestani F, Qiang W, MacNeill AL, Druschitz SA, Serna VA, Adur M, Kurita T, Nowak RA.  2016. Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft model. Hum Reprod. 2016 Apr 29. pii: dew094. [PMID:  27130615]
• Landel CP; Dunlap J; Patton JB; Manser T. 2013. A germline-competent embryonic stem cell line from NOD.Cg-Prkdc ( scid ) Il2rg ( tm1Wjl )/SzJ (NSG) mice. Transgenic Res. Feb;22(1):179-85. [PMID: 22767020]
• Lawson, M.A., Ebetino, F.H., Mazur, A., Chantry, A.D., Paton-Hough, J., Evans, H.R., Lath, D., Tsoumpra, M.K., Lundy, M.W., Dobson, R.L.M., Quijano, M., Kwaasi, A.A., Dunford, J.E., Duan, X., Triffitt, J.T., Jeans, G., Russell, R.G.G., 2017. The Pharmacological Profile of a Novel Highly Potent Bisphosphonate, OX14 (1-fluoro-2-(imidazo-[1,2-α]pyridin-3-yl)ethyl-bisphosphonate. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. [PMID: 28337806]
• Ledet, M.M., Anderson, R., Harman, R., Muth, A., Thompson, P.R., Coonrod, S.A., Van de Walle, G.R., 2018. BB-Cl-Amidine as a novel therapeutic for canine and feline mammary cancer via activation of the endoplasmic reticulum stress pathway. BMC Cancer 18, 412. [PMID: 29649984]
• Li F; Cowley DO; Banner D; Holle E; Zhang L; Su L. 2014. Efficient genetic manipulation of the NOD-Rag1-/-IL2RgammaC-null mouse by combining in vitro fertilization and CRISPR/Cas9 technology. Sci Rep. Jun 17; 4:5290. [PMID: 24936832]
• Li, F., Ulrich, M.L., Shih, V.F.-S., Cochran, J.H., Hunter, J.H., Westendorf, L., Neale, J., Benjamin, D.R., 2019. Mouse Strains Influence Clearance and Efficacy of Antibody and Antibody-Drug Conjugate Via Fc-FcγR Interaction. Mol. Cancer Ther. 18, 780–787. [PMID: 30824607]
• Lobachevsky, P.N., Ventura, J., Giannakandropoulou, L., Forrester, H., Palazzolo, J.S., Haynes, N.M., Stevenson, A.W., Hall, C.J., Mason, J., Pollakis, G., Pateras, I.S., Gorgoulis, V., Terzoudi, G.I., Hamilton, J.A., Sprung, C.N., Georgakilas, A.G., Martin, O.A., 2018. A Functional Immune System Is Required For The Systemic Genotoxic Effects Of Localised Irradiation. Int. J. Radiat. Oncol. Biol. Phys. [PMID: 30529375 ]
• Martin Gonzalez, J., Baudet, A., Abelechian, S., Bonderup, K., d’Altri, T., Porse, B., Brakebusch, C., Juliusson, G., Cammenga, J., 2018. A new genetic tool to improve immune-compromised mouse models: Derivation and CRISPR/Cas9-mediated targeting of NRG embryonic stem cell lines. Genesis. [PMID: 30010246]
• Matthias N, Hunt SD, Wu J, Darabi R. Skeletal muscle perfusion and stem cell delivery in muscle disorders using intra-femoral artery canulation in mice. Exp Cell Res. 2015 Sep 1. [PMID: 26341268]
• Meyer-Martin H, Hahn SA, Beckert H, Belz C, Heinz A, Jonuleit H, Becker C, Taube C, Korn S, Buhl R, Reuter S, Tüttenberg A. 2016. GARP inhibits allergic airway inflammation in a humanized mouse model. Allergy. 2016 Mar 15. doi: 10.1111/all.12883. [PMID: 26990894]
• Min SY, Kady J, Nam M, Rojas-Rodriguez R, Berkenwald A, Kim JH, Noh HL, Kim JK, Cooper MP, Fitzgibbons T, Brehm MA, Corvera S.Human 'brite/beige' adipocytes develop from capillary networks, and their implantation improves metabolic homeostasis in mice. Nat Med. 2016 Jan 25. doi: 10.1038/nm.4031. [Epub ahead of print]. [PMID: 26808348]
• Moscatelli, I., Löfvall, H., Schneider Thudium, C., Rothe, M., Montano, C., Kertész, Z., Sirin, M., Schulz, A., Schambach, A., Henriksen, K., Richter, J., 2017. Targeting NSG mice-engrafting cells with a clinically applicable lentiviral vector corrects osteoclasts in Infantile Malignant Osteopetrosis. Hum. Gene Ther. doi:10.1089/hum.2017.053 [PMID: 28726516]
• Moyer, A.M., Yu, J., Sinnwell, J.P., Dockter, T.J., Suman, V.J., Weinshilboum, R.M., Boughey, J.C., Goetz, M.P., Visscher, D.W., Wang, L., 2019. Spontaneous murine tumors in the development of patient-derived xenografts: a potential pitfall. Oncotarget 10, 3924—3930. [PMID: 31231469]
• Mussawy, H., Viezens, L., Hauenherm, G., Schroeder, M., Schaefer, C., 2017. In vivo functional and morphological characterization of bone and striated muscle microcirculation in NSG mice. PloS One 12, e0183186. doi:10.1371/journal.pone.0183186M [PMID: 28800593]
• Nance, M.E., Shi, R., Hakim, C.H., Wasala, N.B., Yue, Y., Pan, X., Zhang, T., Robinson, C.A., Duan, S.X., Yao, G., Yang, N.N., Chen, S.-J., Wagner, K.R., Gersbach, C.A., Duan, D., 2019. AAV9 Edits Muscle Stem Cells in Normal and Dystrophic Adult Mice. Mol. Ther. [PMID: 31327755]
• Natarajan, A., Patel, C.B., Ramakrishnan, S., Panesar, P.S., Long, S.R., Gambhir, S.S., 2018. A Novel Engineered Small Protein for Positron Emission Tomography Imaging of Human Programmed Death Ligand-1 : Validation in Mouse Models and Human Cancer Tissues. Clin. Cancer Res. [PMID: 30373750]
• Oyanadel, C., Holmes, C., Pardo, E., Retamal, C., Shaughnessy, R., Smith, P., Cortes, P., Bravo-Zehnder, M., Metz, C., Feuerhake, T., Romero, D., Roa, J.C., Montecinos, V., Soza, A., González, A., 2018. Galectin-8 induces partial epithelial-mesenchymal transition with invasive tumorigenic capabilities involving a FAK/EGFR/proteasome pathway in MDCK cells. Mol. Biol. Cell. [PMID: 29298841]
• Park, S.H., Lee, C.M., Dever, D.P., Davis, T.H., Camarena, J., Srifa, W., Zhang, Y., Paikari, A., Chang, A.K., Porteus, M.H., Sheehan, V.A., Bao, G., 2019. Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease. Nucleic Acids Res. [PMID: 31147717]
• Patton, J.B., Bonne-Année, S., Deckman, J., Hess, J.A., Torigian, A., Nolan, T.J., Wang, Z., Kliewer, S.A., Durham, A.C., Lee, J.J., Eberhard, M.L., Mangelsdorf, D.J., Lok, J.B., Abraham, D., 2018. Methylprednisolone acetate induces, and Δ7-dafachronic acid suppresses, Strongyloides stercoralis hyperinfection in NSG mice. Proc. Natl. Acad. Sci. U.S.A. 115, 204–209. [PMID: 29203662]
• Poletti, V., Urbinati, F., Charrier, S., Corre, G., Hollis, R.P., Campo Fernandez, B., Martin, S., Rothe, M., Schambach, A., Kohn, D.B., Mavilio, F., 2018. Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease. Mol Ther Methods Clin Dev 11, 167–179. [PMID: 30533448]
• Powers J; Zhang H; Battrell L; Meadows GG; Trobridge GD. 2012. Establishment of an immunodeficient alcohol mouse model to study the effects of alcohol on human cells in vivo. J Stud Alcohol Drugs. Nov;73(6):933-7. [PMID: 23036211]
• Quadros RM, Poluektova LY, Gurumurthy CB. Simple and reliable genotyping protocol for mouse PrkdcSCID mutation. J Immunol Methods. 2016 Feb 3. pii: S0022-1759(16)30017-5. doi: 10.1016/j.jim.2016.02.002. [PMID: 26851521]
• Tsuchimoto Y, Asai A, Tsuda Y, Ito I, Nishiguchi T, Garcia MC, Suzuki S, Kobayashi M, Higuchi K, Suzuki F. M2b Monocytes Provoke Bacterial Pneumonia and Gut Bacteria-Associated Sepsis in Alcoholics. J Immunol. 2015 Dec 1;195(11):5169-77. doi: 10.4049/jimmunol.1501369.  [PMID: 26525287]
• Virostko J; Henske J; Vinet L; Lamprianou S; Dai C; Radhika A; Baldwin RM; Ansari MS; Hefti F; Skovronsky D; Kung HF; Herrera PL; Peterson TE; Meda P; Powers AC. 2011. Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligands. Proc Natl Acad Sci U S A Dec 20;108(51):20719-24. [PMID: 22143775]
• Vizzardelli, C., Gindl, M., Roos, S., Möbs, C., Nagl, B., Zimmann, F., Sexl, V., Kenner, L., Neunkirchner, A., Zlabinger, G.J., Pickl, W.F., Pfützner, W., Bohle, B., 2017. Blocking antibodies induced by allergen-specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric model. Allergy. [PMID: 29159964]
• Webber, B.R., O’Connor, K.T., McElmurry, R.T., Durgin, E.N., Eide, C.R., Lees, C.J., Riddle, M.J., Mathews, W.E., Frank, N.Y., Kluth, M.A., Ganss, C., Moriarity, B.S., Frank, M.H., Osborn, M.J., Tolar, J., 2017. Rapid generation of Col7a1(-/-) mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cells. Lab. Investig. J. Tech. Methods Pathol. 97, 1218–1224. doi:10.1038/labinvest.2017.85 [PMID: 28892093]
• Woo, X.Y., Srivastava, A., Graber, J.H., Yadav, V., Sarsani, V.K., Simons, A., Beane, G., Grubb, S., Ananda, G., Liu, R., Stafford, G., Chuang, J.H., Airhart, S.D., Karuturi, R.K.M., George, J., Bult, C.J., 2019. Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines. BMC Med Genomics 12. [PMID: 31262303]
• Yong, K.S.M., Ng, J.H.J., Her, Z., Hey, Y.Y., Tan, S.Y., Tan, W.W.S., Irac, S.E., Liu, M., Chan, X.Y., Gunawan, M., Foo, R.J.H., Low, D.H.W., Mendenhall, I.H., Chionh, Y.T., Dutertre, C.-A., Chen, Q., Wang, L.-F., 2018. Bat-mouse bone marrow chimera: a novel animal model for dissecting the uniqueness of the bat immune system. Sci Rep 8, 4726. [PMID: 29549333]
• Zadrozny, L.M., Brinster, L.R., Rosenzweig, B.A., Howard, K.E., 2018. Outbreak of Opportunistic Ascending Pyelonephritis with Numerous Yeast after Experimental Humanization Surgery in NOD. Cg-Prkdcscid Il2rgtm1Wjl/SzJ and NOD.Cg-Rag1tm1Mom Il2rgtm1Wjl/SzJ Immunodeficient Mice. Comp. Med. [PMID: 30208988]
• Zhou, W., Chow, K.-H., Fleming, E., Oh, J., 2018. Selective colonization ability of human fecal microbes in different mouse gut environments. ISME J. [PMID: 30442907]

• da Silva, P.F.L., Ogrodnik, M., Kucheryavenko, O., Glibert, J., Miwa, S., Cameron, K., Ishaq, A., Saretzki, G., Nagaraja-Grellscheid, S., Nelson, G., von Zglinicki, T., 2018. The bystander effect contributes to the accumulation of senescent cells in vivo. Aging Cell e12848. [PMID: 30462359]